
<html lang="en"     class="pb-page"  data-request-id="eae60c8f-e40b-4183-832f-29d75852604c"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2010.53.issue-4;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/jm901084f"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Subtlety of the Structure−Affinity and Structure−Efficacy Relationships around a Nonpeptide Oxytocin Receptor Agonist" /></meta><meta name="dc.Creator" content="Marie-Céline  Frantz" /></meta><meta name="dc.Creator" content="Jordi  Rodrigo" /></meta><meta name="dc.Creator" content="Laure  Boudier" /></meta><meta name="dc.Creator" content="Thierry  Durroux" /></meta><meta name="dc.Creator" content="Bernard  Mouillac" /></meta><meta name="dc.Creator" content="Marcel  Hibert" /></meta><meta name="dc.Description" content="Very few nonpeptide oxytocin agonists have currently been reported, and none of them seem suitable for the in vivo investigation of the oxytocin mediated functions. In an attempt to rationalize the..." /></meta><meta name="Description" content="Very few nonpeptide oxytocin agonists have currently been reported, and none of them seem suitable for the in vivo investigation of the oxytocin mediated functions. In an attempt to rationalize the..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="January 27, 2010" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm901084f" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2010 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm901084f" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm901084f" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm901084f" /></link>
        
    
    

<title>Subtlety of the Structure−Affinity and Structure−Efficacy Relationships around a Nonpeptide Oxytocin Receptor Agonist | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm901084f" /></meta><meta property="og:title" content="Subtlety of the Structure−Affinity and Structure−Efficacy Relationships around a Nonpeptide Oxytocin Receptor Agonist" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901084f/production/images/large/jm-2009-01084f_0011.jpeg" /></meta><meta property="og:description" content="Very few nonpeptide oxytocin agonists have currently been reported, and none of them seem suitable for the in vivo investigation of the oxytocin mediated functions. In an attempt to rationalize the design of better tools, we have systematically studied the structural determinants of the affinity and efficacy of representative ligands of the V1a, V2, and OT receptor subtypes. Despite apparently obvious similarity between the ligand structures on one hand, and between the receptor subtypes on the other hand, the binding affinity and the functional activity profiles of truncated and hybrid ligands highlight the subtlety of ligand−receptor interactions for obtaining nonpeptide OT receptor agonists." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm901084f"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm901084f">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm901084f&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm901084f&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm901084f&amp;href=/doi/10.1021/jm901084f" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2010</span><span class="cit-fg-volume">, 53</span><span class="cit-fg-issue">, 4</span><span class="cit-fg-pageRange">, 1546-1562</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/53/4" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm901758f" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm9011142" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Subtlety of the Structure−Affinity and Structure−Efficacy Relationships around a Nonpeptide Oxytocin Receptor Agonist</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marie-C%C3%A9line++Frantz">Marie-Céline Frantz</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jordi++Rodrigo">Jordi Rodrigo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol "><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Laure++Boudier">Laure Boudier</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thierry++Durroux">Thierry Durroux</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bernard++Mouillac">Bernard Mouillac</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marcel++Hibert">Marcel Hibert</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Laboratoire d’Innovation Thérapeutique, UMR 7200 CNRS/Université de Strasbourg, Faculté de Pharmacie, 74 route du Rhin, BP60024, 67401 Illkirch, France</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Institut de Génomique Fonctionnelle UMR CNRS 5203/INSERM U661/Université Montpellier I & II, Dept Pharmacologie Moléculaire, 141 rue de la Cardonille, 34094 Montpellier, France</span></div><div class="corresp-info"><strong>*</strong>To whom correspondence should be addressed. Phone: +33390244232. Fax: +33390244310. E-mail: <a href="/cdn-cgi/l/email-protection#64090c0d0601161024140c051609054a1149171016051706034a0216"><span class="__cf_email__" data-cfemail="a5c8cdccc7c0d7d1e5d5cdc4d7c8c48bd088d6d1d7c4d6c7c28bc3d7">[email protected]</span></a></div><div class="corresp-fn" id="fn1">§Current address: University of Pittsburgh, Department of Chemistry, Pittsburgh, Pennsylvania 15260</div><div class="corresp-fn" id="fn2">∥Current address: Université Paris-Sud, CNRS, BioCIS-UMR 8076, Laboratoire de Chimie Thérapeutique, Faculté de Pharmacie, 5 rue J.-B. Clément, 92296 Châtenay-Malabry, France</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm901084f&amp;href=/doi/10.1021%2Fjm901084f" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2010</span></span><span class="cit-volume">, 53</span><span class="cit-issue">, 4</span><span class="cit-pageRange">, 1546–1562</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 27, 2010</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>22 July 2009</li><li><span class="item_label"><b>Published</b> online</span>27 January 2010</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 25 February 2010</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm901084f" title="DOI URL">https://doi.org/10.1021/jm901084f</a></div><div class="article_header-article-copyright"><strong>Copyright © 2010 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1546%26pageCount%3D17%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMarie-C%25C3%25A9line%2BFrantz%252C%2BJordi%2BRodrigo%252C%2BLaure%2BBoudier%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D53%26issueNum%3D4%26contentID%3Djm901084f%26title%3DSubtlety%2Bof%2Bthe%2BStructure%25E2%2588%2592Affinity%2Band%2BStructure%25E2%2588%2592Efficacy%2BRelationships%2Baround%2Ba%2BNonpeptide%2BOxytocin%2BReceptor%2BAgonist%26numPages%3D17%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1562%26publicationDate%3DFebruary%2B2010">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm901084f"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2488</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">13</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm901084f" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Subtlety of the Structure−Affinity and Structure−Efficacy Relationships around a Nonpeptide Oxytocin Receptor Agonist&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Marie-Céline&quot;,&quot;last_name&quot;:&quot;Frantz&quot;},{&quot;first_name&quot;:&quot;Jordi&quot;,&quot;last_name&quot;:&quot;Rodrigo&quot;},{&quot;first_name&quot;:&quot;Laure&quot;,&quot;last_name&quot;:&quot;Boudier&quot;},{&quot;first_name&quot;:&quot;Thierry&quot;,&quot;last_name&quot;:&quot;Durroux&quot;},{&quot;first_name&quot;:&quot;Bernard&quot;,&quot;last_name&quot;:&quot;Mouillac&quot;},{&quot;first_name&quot;:&quot;Marcel&quot;,&quot;last_name&quot;:&quot;Hibert&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2010&quot;,&quot;month&quot;:&quot;01&quot;,&quot;day&quot;:&quot;27&quot;,&quot;issue&quot;:&quot;4&quot;,&quot;volume&quot;:&quot;53&quot;,&quot;pages&quot;:&quot;1546-1562&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm901084f&quot;},&quot;abstract&quot;:&quot;Very few nonpeptide oxytocin agonists have currently been reported, and none of them seem suitable for the in vivo investigation of the oxytocin mediated functions. In an attempt to rationalize the design of better tools, we have systematically studied the structural determinants of the affinity and efficacy of representative ligands of the V1a, V2, and OT receptor subtypes. Despite apparently obvious similarity between the ligand structures on one hand, and between the receptor subtypes on the other hand, the binding affinity and the functional activity profiles of truncated and hybrid ligands highlight the subtlety of ligand−receptor interactions for obtaining nonpeptide OT receptor agonists.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm901084f&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901084f" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm901084f&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901084f" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm901084f&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901084f" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm901084f&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901084f&amp;href=/doi/10.1021/jm901084f" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm901084f" /></input><a href="/doi/pdf/10.1021/jm901084f" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm901084f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm901084f%26sid%3Dliteratum%253Aachs%26pmid%3D20104850%26genre%3Darticle%26aulast%3DFrantz%26date%3D2010%26atitle%3DSubtlety%2Bof%2Bthe%2BStructure%25E2%2588%2592Affinity%2Band%2BStructure%25E2%2588%2592Efficacy%2BRelationships%2Baround%2Ba%2BNonpeptide%2BOxytocin%2BReceptor%2BAgonist%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D53%26issue%3D4%26spage%3D1546%26epage%3D1562%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291171" title="Antagonists">Antagonists</a>,</li><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=292366" title="Ligands">Ligands</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/53/4" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901084f/production/images/medium/jm-2009-01084f_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901084f/production/images/large/jm-2009-01084f_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901084f&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Very few nonpeptide oxytocin agonists have currently been reported, and none of them seem suitable for the in vivo investigation of the oxytocin mediated functions. In an attempt to rationalize the design of better tools, we have systematically studied the structural determinants of the affinity and efficacy of representative ligands of the V<sub>1a</sub>, V<sub>2</sub>, and OT receptor subtypes. Despite apparently obvious similarity between the ligand structures on one hand, and between the receptor subtypes on the other hand, the binding affinity and the functional activity profiles of truncated and hybrid ligands highlight the subtlety of ligand−receptor interactions for obtaining nonpeptide OT receptor agonists.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04276" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04276" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Numerous animal studies have provided evidence supporting a role for oxytocin (OT<a class="ref internalNav" href="#fn9" aria-label="a">a</a><div class="NLM_fn" id="fn9">a<p class="last">Abbreviations: AVP, arginine vasopressin; BSA, bovine serum albumin; cAMP, cyclic adenosine 5′-monophosphate; CDI, carbonyldiimidazole; CHO, Chinese hamster ovary; CNS, central nervous system; CRE, cAMP response element; DCM, dichloromethane; DIEA, diisopropylethylamine; DMAP, <i>N</i>,<i>N</i>-dimethyl-4-aminopyridine; D-MEM, Dulbecco’s modified Eagle’s medium; DMF, dimethylformamide; DMSO, dimethylsulfoxide; E, extracellular loop; EDCI, 1-(3-dimethylaminopropyl)-3-ethyl-carbodiimide; EDTA, ethylenediaminetetraacetic acid; GPCR, G protein-coupled receptor; HOBt, <i>N</i>-hydroxybenzotriazole; IP<sub>1</sub>, <i>myo</i>-inositol 1-phosphate; μw, microwaves; NFAT, nuclear factor of activated T-cells; NMP, <i>N</i>-methyl-2-pyrrolidone; OT, oxytocin; OT-R, oxytocin receptor; Ro-20-1724, 4-(3-butoxy-4-methoxyphenyl)methyl-2-imidazolidone; rt, room temperature; SAR, structure−activity relationships; SEM, standard error of the mean; TFA, trifluoroacetic acid; THF, tetrahydrofuran; TM, transmembrane domain; Tris, 2-amino-2-hydroxymethyl-1,3-propanediol; V<sub>1a</sub>-R, vasopressin V<sub>1a</sub> receptor subtype; V<sub>1b</sub>-R, vasopressin V<sub>1b</sub> receptor subtype; V<sub>2</sub>-R, vasopressin V<sub>2</sub> receptor subtype.</p></div>) and vasopressin (AVP) in many central nervous system (CNS) functions including mating, affiliation, adult pairing and faithfulness, anxiety, and prosocial behaviors.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4 ref5 ref6">(1-6)</a> In humans, OT has been reported to improve trust<a onclick="showRef(event, 'ref7 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9">(7-9)</a> and to decrease fear associated to social phobia<a onclick="showRef(event, 'ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12">(10-12)</a> and symptoms related to autism.<a onclick="showRef(event, 'ref13 ref14 ref15 ref16 ref17 ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15 ref16 ref17 ref18 ref19 ref20">(13-20)</a> However, the only molecular probe that is currently available to study these functions, both in animals (usually after intracerebroventricular administration) and humans (after intranasal administration), is oxytocin itself or closely related peptide analogues that have a poor bioavailability inherent with most neuropeptides (e.g., poor intestinal and blood−brain barrier penetration, short half-life, rapid clearance). To characterize without ambiguity the different central mechanisms of action and physiopathological functions of vasopressin and oxytocin, there was an urgent need for centrally active, potent, specific, and bioavailable agonists and antagonists of the four vasopressin and oxytocin receptor subtypes, namely the V<sub>1a</sub>, V<sub>1b</sub>, V<sub>2</sub>, and OT receptors. Such antagonists became recently available.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> However, very few nonpeptide agonists have been reported.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> For OT receptor agonists, the most interesting to date (compound <b>1</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) is the optimized analogue of a hit discovered by systematic screening.<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23, 24)</a> However, its structure does not seem optimal for CNS in vivo studies because its molecular weight (MW = 600.8 Da) and its number of H-bonds (14 H-bonds possible) remain rather high.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> In addition, some of its hydrophobicity parameters do not fit the requirements for a significant blood−brain barrier penetration (ideal clogP = 2 but high PSA = 121 Å<sup>2</sup>). Furthermore, its efficacy and selectivity profile had to be further explored. We have used this molecule and closely related analogues acting at other vasopressin receptor subtypes to systematically explore the structural determinants of affinity, efficacy, and selectivity at V<sub>1a</sub>, V<sub>2</sub>, and OT receptor subtypes. Our strategy consisted in two steps. First, we tried to dissect compound <b>1</b> to identify the minimum molecular components required for affinity and to evaluate their positive (agonism) or negative (antagonism) contribution to efficacy on the three considered receptor subtypes. To this end, truncated analogues were prepared and their affinity and efficacy were measured in parallel on the target receptors. Second, we systematically prepared hybrid molecules combining the apparently homologous molecular fragments of four representative vasopressin/oxytocin ligands (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>): compound <b>1</b>, a claimed OT receptor agonist;<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> compound <b>2</b>, a reported nonselective V<sub>1a</sub>/V<sub>2</sub>/OT receptor antagonist;<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> compound <b>3</b>, WAY-VNA-932, a V<sub>2</sub> receptor agonist;<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> and compound <b>4</b>, L-371,257, the structurally closest and selective OT receptor antagonist.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> The affinity and efficacy of these chimeric molecules for the V<sub>1a</sub>, V<sub>2</sub>, and OT receptor subtypes were studied to probe the contribution to affinity and efficacy of the different corresponding fragments. The unexpected results shed an interesting and disturbing light on the mode of action of very similar ligands on very similar receptor subtypes.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901084f/production/images/medium/jm-2009-01084f_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901084f/production/images/large/jm-2009-01084f_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Schematic representation of the main results of the truncated analogues of compound <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901084f/production/images/large/jm-2009-01084f_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901084f&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Structures and Biological Activities of the Reference Compounds<a class="ref internalNav" href="#tbl1-fn1" aria-label="g">g</a></div></div></div><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col /></col></colgroup><tbody><tr valign="top"><td><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901084f/production/images/medium/jm-2009-01084f_0007.gif" alt="" id="fx1" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">The inhibition constants (<i>K</i><sub>i</sub> in nM) for human V<sub>1a</sub>, V<sub>2</sub>, and OT receptors were determined on CHO cell membranes by competition binding assays (displacement of radioactive [<sup>3</sup>H]AVP). Results are expressed as mean ± SEM of at least three separate experiments performed in triplicate. When <i>K</i><sub>i</sub> >1000 nM, these are results of at least two separate experiments performed in triplicate.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">The activation constants (<i>K</i><sub>act</sub> in nM) were measured in CHO cell lines expressing either vasopressin V<sub>1a</sub> or V<sub>2</sub> or oxytocin receptor by IP-One <sub></sub>(V<sub>1a</sub>-R and OT-R, IP<sub>1</sub> accumulation) or cAMP dynamic 2 (V<sub>2</sub>-R, cAMP accumulation) assays. These values are the mean ± SEM of at least three separate experiments performed in triplicate. The maximal stimulations (<i>E</i><sub>max</sub>) are expressed as percentages of the endogenous agonist maximal stimulation (<i>n</i> = 3). In case of a weak stimulation, results are expressed as percentages of the endogenous agonist maximal stimulation at [ligand] = 1 μM (<i>n</i> = 2). Results are not significant (ns) when there is <10% response at [ligand] = 1 μM (<i>n</i> = 2).</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">The inactivation constants (<i>K</i><sub>inact</sub> in nM) were measured in CHO cell lines expressing either vasopressin V<sub>1a</sub> or V<sub>2</sub> or oxytocin receptor by IP-One (V<sub>1a</sub>-R and OT-R, inhibition of agonist-induced IP<sub>1</sub> accumulation) or cAMP <i>dynamic 2</i> (V<sub>2</sub>-R, inhibition of agonist-induced cAMP accumulation) assays. These values are the mean ± SEM of at least three separate experiments performed in triplicate. In case of a weak inhibition, results are expressed as percentages of endogenous agonist-response inhibition at [ligand] = 1 μM (<i>n</i> = 2). Results are not significant (ns) when there is <10% response inhibition at [ligand] = 1 μM (<i>n</i> = 2).</p></div><div class="footnote" id="t1fn4"><sup>d</sup><p class="last">Not determined.</p></div><div class="footnote" id="t1fn5"><sup>e</sup><p class="last"><i>n</i> = 1.</p></div><div class="footnote" id="t1fn6"><sup>f</sup><p class="last"><i>n</i> = 2.</p></div><div class="footnote" id="tbl1-fn1"><sup>g</sup><p class="last">Putatively homologous binding components are displayed with similar colors. <b>1</b> is a claimed OT receptor agonist;<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23, 24)</a><b>2</b> is a nonselective V<sub>1a</sub>/V<sub>2</sub>/OT receptor antagonist;<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a><b>3</b>, WAY-VNA-932, is a V<sub>2</sub> receptor agonist;<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a><b>4</b>, L-371,257, is a selective OT receptor antagonist.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></p></div></div></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82514" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82514" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Reference compounds <b>2</b>, <b>3</b>, and <b>4</b> were prepared according to literature protocols.<a onclick="showRef(event, 'ref26 ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref26 ref27 ref28">(26-28)</a> Compound <b>1</b> and analogues <b>12a</b>−<b>c</b> were prepared according to Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. The general procedure is similar to the synthesis previously described by Pitt et al.<a onclick="showRef(event, 'ref24 ref29'); return false;" href="javascript:void(0);" class="ref ref24 ref29">(24, 29)</a> with some optimization, specifically for the cyclization step leading to the lactam <b>6</b>. The original preparation consisting of reflux in isopropyl alcohol for 14 days in the presence of acetic acid was difficult to reproduce. However, a 89% yield could be achieved by heating the precursor <b>5</b> in a sealed tube at 160 °C for 48 h. As described for compound <b>1</b>, the urea truncated analogues <b>12a</b> and <b>12b</b> could be isolated in high yields after coupling with the common amine intermediate <b>10</b> via preactivation with carbonyldiimidazole (CDI). Alternatively, the acetylated truncated analogue <b>12c</b> was obtained by reacting <b>10</b> with acetic anhydride.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901084f/production/images/medium/jm-2009-01084f_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901084f/production/images/large/jm-2009-01084f_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compound <b>1</b> and Truncated Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901084f/production/images/large/jm-2009-01084f_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901084f&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) 1:9 AcOH/<i>i</i>PrOH, sealed flask, 160 °C, 48 h, 89%. (ii) LiAlH<sub>4</sub>, THF, reflux, 44 h, 86%. (iii) (a) <b>8</b>, (COCl)<sub>2</sub>, cat. DMF, DCM, 2 h; (b) <b>7</b>, Et<sub>3</sub>N, DCM, 2 d, 75%. (iv) NaBH<sub>4</sub>, CoCl<sub>2</sub>·6H<sub>2</sub>O, MeOH, 1 h, quant. (v) (a) CDI, DIEA, DMF, 1 h; (b) <b>11</b> or pyrrolidine or Me<sub>2</sub>NH·HCl, DIEA, DMF, overnight, 58−82%. (vi) Ac<sub>2</sub>O, Et<sub>3</sub>N, DCM, 3 h, 38%.</p></p></figure><div class="NLM_p">A similar synthetic route was followed for the preparation of compounds <b>23a</b>−<b>d</b>, according to the general Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. The polycyclic amines <b>13</b>, <b>14</b>, and <b>15</b> were prepared according to literature protocols.<a onclick="showRef(event, 'ref30 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref30 ref31 ref32">(30-32)</a> In addition, with regard to the synthesis of the analogue <b>23c</b>, the key acid intermediate <b>20</b> was prepared starting from the acyl chloride <b>16</b> via a Sandmeyer reaction to introduce the nitrile group.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901084f/production/images/medium/jm-2009-01084f_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901084f/production/images/large/jm-2009-01084f_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of the Molecular Hybrids Conserving the Eastern Part of Compound <b>1</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901084f/production/images/large/jm-2009-01084f_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901084f&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) MeOH, 2 h, quant. (ii) SnCl<sub>2</sub>·2H<sub>2</sub>O, EtOH, reflux, 1 h, quant. (iii) (a) NaNO<sub>2</sub>, conc HCl/H<sub>2</sub>O, −15 °C, 15 min; (b) CuCN, KCN, H<sub>2</sub>O, −10 °C−rt, 2 h, 61%. (iv) LiOH·H<sub>2</sub>O, MeOH/THF, 1 h, 83%. (v) For <b>21a</b>: (a) <b>8</b>, (COCl)<sub>2</sub>, cat. DMF, DCM, 1 h; (b) <b>13</b>, pyridine, cat. DMAP, DCM, overnight, 76%; for <b>21b</b>: (a) <b>8</b>, (COCl)<sub>2</sub>, cat. DMF, DCM, 1 h; (b) <b>14</b>, pyridine, DCM, 1 h, 65%; for <b>21c</b>: (a) <b>20</b>, (COCl)<sub>2</sub>, cat. DMF, DCM, 0 °C, 1 h; (b) <b>14</b>, pyridine, cat. DMAP, DCM, μw 80 °C, 6 min, 49%; for <b>21d</b>: <b>8</b>, <b>15</b>, HOBt·H<sub>2</sub>O, EDCI·HCl, DIEA, DMF, 14 h, 65%. (vi) NaBH<sub>4</sub>, CoCl<sub>2</sub>·6H<sub>2</sub>O, MeOH, 1−3 h, 12−89%. (vii) (a) CDI, DIEA, DMF, 1−3 h; (b) <b>11</b>, DIEA, DMF, 16−40 h, 51−95%.</p></p></figure><div class="NLM_p">As described in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>, the hybrid compound <b>27</b> was prepared in a similar manner as the reference compound <b>2</b>. Finally, both hybrids <b>31a</b> and <b>31b</b> were obtained following a general route described by Kondo et al.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a></div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901084f/production/images/medium/jm-2009-01084f_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901084f/production/images/large/jm-2009-01084f_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of the Molecular Hybrids Conserving the Western Part of Compound <b>1</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901084f/production/images/large/jm-2009-01084f_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901084f&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) (a) (COCl)<sub>2</sub>, cat. DMF, DCM, 30 min; (b) <b>7</b>, Et<sub>3</sub>N, DCM, overnight, 90%. (ii) SnCl<sub>2</sub>·2H<sub>2</sub>O, EtOH, reflux, 1 h, 82%. (iii) (a) 2-Phenylbenzoic acid, (COCl)<sub>2</sub>, cat. DMF, DCM, 5 h; (b) <b>26</b>, Et<sub>3</sub>N, DCM, 36 h, 87%. (iv) 3-Methylpyrazole, K<sub>2</sub>CO<sub>3</sub>, NMP, 120 °C, 6−25 h, 9−41%. (v) HCl/H<sub>2</sub>O/AcOH, reflux, 6 h, 96−99%. (vi) (a) SOCl<sub>2</sub>, cat. NMP, DCM, overnight; (b) <b>7</b>, pyridine, cat. DMAP, DCM, 3 d, or μw 80 °C, 8 min, 53−81%.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Biology</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82683" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82683" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The affinities of the different ligands for the human vasopressin receptors subtypes and the oxytocin receptor were determined on CHO cell membranes by competition experiments against [<sup>3</sup>H]AVP, as described previously.<a onclick="showRef(event, 'ref34 ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref34 ref35 ref36">(34-36)</a></div><div class="NLM_p last">The functional agonist and competitive antagonist properties of each ligand were determined for the human vasopressin and oxytocin receptors subtypes stably expressed in CHO cells. The accumulation of <i>myo</i>-inositol 1-phosphate (V<sub>1a</sub> and OT receptors) was determined by the IP-One assay and the accumulation of cAMP (V<sub>2</sub> receptor) was determined by the cAMP <i>dynamic 2</i> assay, both kindly provided by Cisbio International. These immunoassays are based on the competition between free IP<sub>1</sub> or cAMP and IP<sub>1</sub>−d2 or cAMP−d2 conjugate, respectively (for more information on the principle, see <a href="http://www.htrf.com/products/gpcr/ipone" class="extLink">http://www.htrf.com/products/gpcr/ipone</a> and <a href="http://www.htrf.com/products/gpcr/camp" class="extLink">http://www.htrf.com/products/gpcr/camp</a>).</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Molecular Modeling</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42041" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42041" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">A three-dimensional model [model coordinates are available upon request] of the oxytocin receptor was built and refined based on the sequence alignment and the V<sub>1a</sub> model previously published by our group.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> The quality of this new model was assessed by docking first the endogenous peptide ligand oxytocin (see Figure S1 in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). OT and compound <b>1</b> were docked to this preliminary model using the Gold 3.0 program.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> The starting conformation of OT was modeled from the X-ray structure of neurophysin-bound OT.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Compound <b>1</b> was built starting from the X-ray structure of its truncated analogue <b>12c</b>, and its geometry was fully optimized with HF/6-31* level using Gaussian 03.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> The resulting binding mode of compound <b>1</b> obtained was similar to the oxytocin binding mode (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>).</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07747" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07747" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Full Characterization of Compound <b>1</b></h3><div class="NLM_p">Molecule <b>1</b> is the most active of very few nonpeptide oxytocin agonists published to date.<a onclick="showRef(event, 'ref22 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref22 ref23 ref24">(22-24)</a> It results from the optimization of a hit discovered after high throughput screening. The activity of <b>1</b> on OT receptor (EC<sub>50</sub> = 33 nM) was characterized using a NFAT-luciferase gene reporter assay. Its agonist activity for the V<sub>2</sub> receptor subtype (EC<sub>50</sub> = 850 nM) was evaluated in a similar way (CRE-luciferase). Furthermore, <b>1</b> was shown to be active in vivo after iv bolus administration in a rat model of uterine response. We have extended the characterization in studying the binding profile of this lead compound at the OT, V<sub>1a</sub>, and V<sub>2</sub> oxytocin and vasopressin receptor subtypes. Furthermore, its agonist and antagonist functional efficacy was directly measured at the level of the second messengers.</div><div class="NLM_p last">In terms of binding affinity, <b>1</b> was less potent than expected at the OT receptor with <i>K</i><sub>i</sub> = 147 nM (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Its affinity for the V<sub>1a</sub> and V<sub>2</sub> receptor subtypes was <i>K</i><sub>i</sub> = 330 nM and <i>K</i><sub>i</sub> >1000 nM, respectively. In terms of functional efficacy, <b>1</b> showed a weak but substantial agonist activity at the OT (<i>K</i><sub>act</sub> = 667 nM) and V<sub>2</sub> (<i>K</i><sub>act</sub> = 599 nM) receptors but not at the V<sub>1a</sub> receptor. However, the activation did not reach the level induced by OT or AVP, indicating a partial agonist profile with an <i>E</i><sub>max</sub> of 58% and 84% for OT and V<sub>2</sub> receptors, respectively. The capacity of <b>1</b> to antagonize the endogenous ligand activation was also measured. In the conditions of the study, compound <b>1</b> showed some weak antagonist effect at the OT receptor, no significant effect at the V<sub>2</sub> receptor, and a marked V<sub>1a</sub> antagonist effect (<i>K</i><sub>inact</sub> = 271 nM). Overall, compound <b>1</b> is a moderately active ligand of the OT receptor with a marginal selectivity versus the V<sub>1a</sub> receptor and a larger selectivity versus the V<sub>2</sub> site (>7 fold). At the level of second messengers, it behaves as a partial agonist of the OT and V<sub>2</sub> receptors and as a slightly more potent antagonist at the V<sub>1a</sub> receptor. The apparent discrepancy between the reported EC<sub>50</sub> and full efficacy at OT receptors derived from a gene reporter assay<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> and the affinity and efficacy measured here from radioligand binding and second messenger analysis can easily be explained by the fact that the gene reporter assays reflect a downstream effect with several levels of signal amplification. The extension of profiling to the V<sub>1a</sub> receptor subtype unmasked the weak selectivity of compound <b>1</b>, hampering its usefulness as a pharmacological investigation probe. However, this molecule remains a very interesting tool to investigate the ligand−receptor interactions at the molecular level and more particularly the structural determinants of affinity and efficacy in the vasopressin−oxytocin system.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Determinants for the Agonism/Antagonism Switch</h3><div class="NLM_p">The binding and the switch from agonist to antagonist among G protein-coupled receptor (GPCR) ligands remain a key issue for drug design. The vasopressin−oxytocin receptors represent a very interesting system to investigate this question. Indeed, the different receptor subtypes are very similar (37% to 47% identity), they are activated by the same endogenous agonist, arginine vasopressin (AVP), they have been cloned in many species including humans,<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> many peptidic and nonpeptidic ligands are known, and three-dimensional models validated by many experimental data are available.<a onclick="showRef(event, 'ref34 ref35 ref36 ref37 ref42 ref43 ref44 ref45 ref46 ref47 ref48 ref49 ref50 ref51 ref52 ref53 ref54 ref55 ref56 ref57 ref58 ref59'); return false;" href="javascript:void(0);" class="ref ref34 ref35 ref36 ref37 ref42 ref43 ref44 ref45 ref46 ref47 ref48 ref49 ref50 ref51 ref52 ref53 ref54 ref55 ref56 ref57 ref58 ref59">(34-37, 42-59)</a></div><div class="NLM_p">Among the structurally diverse nonpeptide ligands of vasopressin receptors disclosed over the years, the tetrahydrobenzazepine/benzodiazepine series is one of the most important so far. Ligands of this class are active at three of the four receptor subtypes, often exhibiting potent antagonist properties at the V<sub>1a</sub> and/or V<sub>2</sub> receptors, and sometimes a non-negligible OT-R antagonist activity (e.g., compound <b>2</b>).<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> To date, very few nonpeptide agonists acting at these receptors have been reported.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Interestingly, the only ones belong to the benzazepine series (e.g., compound <b>3</b>).<a onclick="showRef(event, 'ref27 ref60 ref61 ref62'); return false;" href="javascript:void(0);" class="ref ref27 ref60 ref61 ref62">(27, 60-62)</a> Their V<sub>2</sub>-R agonist properties were discovered as a result of structural modifications of the antagonists.<a onclick="showRef(event, 'ref33 ref63'); return false;" href="javascript:void(0);" class="ref ref33 ref63">(33, 63)</a> Intriguingly, the first nonpeptide OT-R agonist (compound <b>1</b>) is also related to the said chemical class.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Therefore, a systematic study of these remarkably subtle relationships between these particular ligands should be of outstanding interest to clarify the structural determinants conferring them such agonist/antagonist properties.</div><div class="NLM_p">Thus, in our attempts to understand the structural origin of compound <b>1</b> OT receptor agonist activity, we decided to cleave the structure progressively or to combine its fragments with fragments from a reported nonselective V<sub>1a</sub>/V<sub>2</sub>/OT receptor antagonist, compound <b>2</b>, a V<sub>2</sub> receptor agonist, WAY-VNA-932, compound <b>3</b>, and a benzoxazinone-type selective OT receptor antagonist, L-371,257, compound <b>4</b>. The affinity and efficacy on second messenger activation of the resulting products have been determined.</div><div id="sec5_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i12" class="anchor-spacer"></div><h4 class="article-section__title" id="_i12"> Truncated Analogues</h4><div class="NLM_p">As seen from Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, the removal of the thioamide-homopiperazine from compound <b>1</b> (compound <b>12a</b>) led to a very significant decrease in affinity for OT-R because a very low [<sup>3</sup>H]AVP displacement could be observed at a 1 μM concentration. No agonist activity could be detected, and a 37% inhibition of the response induced by OT could be observed at 1 μM, suggesting a weak and marginally reinforced antagonist effect compared to <b>1</b>. Additional cleavage leading to the urea <b>12b</b> and to the acetamide <b>12c</b> resulted in a complete loss of affinity and efficacy for the OT receptor. Again, some weak but significant antagonistic activity could still be detected for <b>12b</b>. One may then conclude that the eastern fragment of molecule <b>1</b> contributes significantly to its affinity for the OT receptor. The lack of agonist efficacy and some residual antagonist activity in compound <b>12a</b> suggested that the homopiperazine fragment is necessary for the OT receptor activation. The same trend was observed on the V<sub>2</sub> receptor subtype. The initial affinity was very weak and remained as such in compounds <b>12a</b> and <b>12b</b>. However, in contrast to OT-R, the agonist character persisted in the series of analogues although very weakened. No antagonist activity could be detected. Finally, on the V<sub>1a</sub> receptor subtype, the affinity was slightly <i>reinforced</i> upon truncating the molecule, as indicated by both the affinity and the antagonist efficacy of <b>1</b>, <b>12a</b>, and <b>12b</b>. However, the ultimate transformation of the urea in <b>12b</b> into an acetamide in <b>12c</b> was completely detrimental to the activity.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Structures and Biological Activities of Truncated Analogues of Compound <b>1</b></div></div></div><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="rowsep1"><td class="rowsep1"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901084f/production/images/medium/jm-2009-01084f_0008.gif" alt="" id="_i14" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">The inhibition constants (<i>K</i><sub>i</sub> in nM) for human V<sub>1a</sub>, V<sub>2</sub>, and OT receptors were determined on CHO cell membranes by competition binding assays (displacement of radioactive [<sup>3</sup>H]AVP). Results are expressed as mean ± SEM of at least three separate experiments performed in triplicate. When <i>K</i><sub>i</sub> >1000 nM, these are results of at least two separate experiments performed in triplicate.</p></div><div class="footnote" id="t2fn3"><sup>b</sup><p class="last">The activation constants (<i>K</i><sub>act</sub> in nM) were measured in CHO cell lines expressing either vasopressin V<sub>1a</sub> or V<sub>2</sub> or oxytocin receptor by IP-One (V<sub>1a</sub>-R and OT-R, IP<sub>1</sub> accumulation) or cAMP dynamic 2 (V<sub>2</sub>-R, cAMP accumulation) assays. These values are the mean ± SEM of at least three separate experiments performed in triplicate. The maximal stimulations (<i>E</i><sub>max</sub>) are expressed as percentages of the endogenous agonist maximal stimulation (<i>n</i> = 3). In case of a weak stimulation, results are expressed as percentages of the endogenous agonist maximal stimulation at [ligand] = 1 μM (<i>n</i> = 2). Results are not significant (ns) when there is <10% response at [ligand] = 1 μM (<i>n</i> = 2).</p></div><div class="footnote" id="twfn4"><sup>c</sup><p class="last">The inactivation constants (<i>K</i><sub>inact</sub> in nM) were measured in CHO cell lines expressing either vasopressin V<sub>1a</sub> or V<sub>2</sub> or oxytocin receptor by IP-One (V<sub>1a</sub>-R and OT-R, inhibition of agonist-induced IP<sub>1</sub> accumulation) or cAMP <i>dynamic 2</i> (V<sub>2</sub>-R, inhibition of agonist-induced cAMP accumulation) assays. These values are the mean ± SEM of at least three separate experiments performed in triplicate. In case of a weak inhibition, results are expressed as percentages of endogenous agonist-response inhibition at [ligand] = 1 μM (<i>n</i> = 2). Results are not significant (ns) when there is <10% response inhibition at [ligand] = 1 μM (<i>n</i> = 2).</p></div><div class="footnote" id="t2fn2"><sup>d</sup><p class="last">[ligand] up to 10 μM.</p></div></div></div><div class="NLM_p last">This first part of the study highlighted the crucial role of the entire chain for the OT-R affinity of <b>1</b> and the specific contribution of the homopiperazine fragment to its agonist efficacy. Unexpectedly, it also highlighted the divergent structure−activity relationships among highly similar receptor subtypes because structural variations led to a loss of affinity and a switch from agonism to antagonism in one case (OT-R), a retention of affinity and agonist efficacy in a second case (V<sub>2</sub>-R) and an increase in affinity and antagonist efficacy in the last case (V<sub>1a</sub>-R) (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).</div></div><div id="sec5_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> Hybrid Molecules</h4><div class="NLM_p">To further explore this SAR divergence, we prepared and analyzed the hybrid molecules in Tables <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> and <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>. A simple qualitative analysis of these ligands strongly suggested a shared pharmacophore around a central benzoyl fragment branched with a polycyclic aromatic amide on the western side and an aromatic or electron-rich side chain on the opposite para position (eastern). It was tempting to assume that similar fragments bind to similar regions and trigger similar effects in the highly homologous receptor subtypes.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Structures and Biological Activities of Hybrid Molecules Exchanging the Western Part of <b>1</b></div></div></div><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col /></col></colgroup><tbody><tr valign="top"><td><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901084f/production/images/medium/jm-2009-01084f_0009.gif" alt="" id="_i17" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">The inhibition constants (<i>K</i><sub>i</sub> in nM) for human V<sub>1a</sub>, V<sub>2</sub>, and OT receptors were determined on CHO cell membranes by competition binding assays (displacement of radioactive [<sup>3</sup>H]AVP). Results are expressed as mean ± SEM of at least three separate experiments performed in triplicate. When <i>K</i><sub>i</sub> >1000 nM, these are results of at least two separate experiments performed in triplicate.</p></div><div class="footnote" id="t3fn8"><sup>b</sup><p class="last">The activation constants (<i>K</i><sub>act</sub> in nM) were measured in CHO cell lines expressing either vasopressin V<sub>1a</sub> or V<sub>2</sub> or oxytocin receptor by IP-One (V<sub>1a</sub>-R and OT-R, IP<sub>1</sub> accumulation) or cAMP dynamic 2 (V<sub>2</sub>-R, cAMP accumulation) assays. These values are the mean ± SEM of at least three separate experiments performed in triplicate. The maximal stimulations (<i>E</i><sub>max</sub>) are expressed as percentages of the endogenous agonist maximal stimulation (<i>n</i> = 3). In case of a weak stimulation, results are expressed as percentages of the endogenous agonist maximal stimulation at [ligand] = 1 μM (<i>n</i> = 2). Results are not significant (ns) when there is <10% response at [ligand] = 1 μM (<i>n</i> = 2).</p></div><div class="footnote" id="t3fn9"><sup>c</sup><p class="last">The inactivation constants (<i>K</i><sub>inact</sub> in nM) were measured in CHO cell lines expressing either vasopressin V<sub>1a</sub> or V<sub>2</sub> or oxytocin receptor by IP-One (V<sub>1a</sub>-R and OT-R, inhibition of agonist-induced IP<sub>1</sub> accumulation) or cAMP <i>dynamic 2</i> (V<sub>2</sub>-R, inhibition of agonist-induced cAMP accumulation) assays. These values are the mean ± SEM of at least three separate experiments performed in triplicate. In case of a weak inhibition, results are expressed as percentages of endogenous agonist-response inhibition at [ligand] = 1 μM (<i>n</i> = 2). Results are not significant (ns) when there is <10% response inhibition at [ligand] = 1 μM (<i>n</i> = 2).</p></div><div class="footnote" id="t3fn2"><sup>d</sup><p class="last"><i>n</i> = 2.</p></div><div class="footnote" id="t3fn3"><sup>e</sup><p class="last">V<sub>2</sub>-R: 13 ± 1% of response at 10 μM (<i>n</i> = 3); OT-R: maximal stimulation could not be reached at 100 μM.</p></div><div class="footnote" id="t3fn4"><sup>f</sup><p class="last">V<sub>2</sub>-R: 43 ± 6% of inhibition at 10 μM (<i>n</i> = 3); OT-R: 11 ± 16% (<i>n</i> = 2) and 56% (<i>n</i> = 1) at 10 and 100 μM, respectively.</p></div><div class="footnote" id="t3fn5"><sup>g</sup><p class="last">[ligand] up to 100 μM (<i>n</i> = 3).</p></div><div class="footnote" id="t3fn6"><sup>h</sup><p class="last">Inhibition at 10 and 100 μM, respectively (<i>n</i> = 2): V<sub>1a</sub>-R: 7.0 ± 0.8% and 92 ± 2%, V<sub>2</sub>-R: 25 ± 1% and 94 ± 1%, OT-R: 17 ± 12% and 52 ± 14%.</p></div><div class="footnote" id="t3fn7"><sup>i</sup><p class="last">[ligand] up to 10 μM (<i>n</i> = 3).</p></div></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Structures and Biological Activities of Hybrid Mmolecules Exchanging the Eastern part of <b>1</b></div></div></div><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col /></col></colgroup><tbody><tr valign="top"><td><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901084f/production/images/medium/jm-2009-01084f_0010.gif" alt="" id="_i19" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">The inhibition constants (<i>K</i><sub>i</sub> in nM) for human V<sub>1a</sub>, V<sub>2</sub>, and OT receptors were determined on CHO cell membranes by competition binding assays (displacement of radioactive [<sup>3</sup>H]AVP). Results are expressed as mean ± SEM of at least three separate experiments performed in triplicate. When <i>K</i><sub>i</sub> >1000 nM, these are results of at least two separate experiments performed in triplicate.</p></div><div class="footnote" id="t4fn3"><sup>b</sup><p class="last">The activation constants (<i>K</i><sub>act</sub> in nM) were measured in CHO cell lines expressing either vasopressin V<sub>1a</sub> or V<sub>2</sub> or oxytocin receptor by IP-One (V<sub>1a</sub>-R and OT-R, IP<sub>1</sub> accumulation) or cAMP dynamic 2 (V<sub>2</sub>-R, cAMP accumulation) assays. These values are the mean ± SEM of at least three separate experiments performed in triplicate. The maximal stimulations (<i>E</i><sub>max</sub>) are expressed as percentages of the endogenous agonist maximal stimulation (<i>n</i> = 3). In case of a weak stimulation, results are expressed as percentages of the endogenous agonist maximal stimulation at [ligand] = 1 μM (<i>n</i> = 2). Results are not significant (ns) when there is <10% response at [ligand] = 1 μM (<i>n</i> = 2).</p></div><div class="footnote" id="t4fn4"><sup>c</sup><p class="last">The inactivation constants (<i>K</i><sub>inact</sub> in nM) were measured in CHO cell lines expressing either vasopressin V<sub>1a</sub> or V<sub>2</sub> or oxytocin receptor by IP-One (V<sub>1a</sub>-R and OT-R, inhibition of agonist-induced IP<sub>1</sub> accumulation) or cAMP <i>dynamic 2</i> (V<sub>2</sub>-R, inhibition of agonist-induced cAMP accumulation) assays. These values are the mean ± SEM of at least three separate experiments performed in triplicate. In case of a weak inhibition, results are expressed as percentages of endogenous agonist-response inhibition at [ligand] = 1 μM (<i>n</i> = 2). Results are not significant (ns) when there is <10% response inhibition at [ligand] = 1 μM (<i>n</i> = 2).</p></div><div class="footnote" id="t4fn2"><sup>d</sup><p class="last">[ligand] up to 10 μM (<i>n</i> = 3).</p></div></div></div><div class="NLM_p">The contribution of the western tricyclic part was first studied. Unexpectedly, despite the fact that compounds <b>2</b>, <b>3</b>, and <b>4</b> had a good or very good affinity for the OT-R, better or comparable to <b>1</b>, the introduction of their aromatic fragments in the structure of <b>1</b> led to a significant (<b>23a</b>,<b>b</b>,<b>d</b>) to dramatic (<b>23c</b>) decrease in affinity for the OT receptor (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). The efficacy decreased in a parallel fashion for <b>23a</b> and <b>23b</b>. Even more surprisingly, the chimeric ligand <b>23d</b> switched from OT agonist to OT antagonist upon this ring replacement. In a general manner, the affinity and efficacy on the V<sub>1a</sub> and V<sub>2</sub> homologous receptors were also decreased without change in the efficacy profile.</div><div class="NLM_p">These results led to two conclusions. The highly similar cyclic aromatic fragments of the different ligands do not contribute in the same way to their activity, probably interacting in different manners with a given receptor as well as with the different homologous receptor subtypes. The aromatic cyclic fragments of molecules <b>1</b>, <b>2</b>, and <b>3</b> stabilize the active conformation of the OT receptor, whereas the piperidino-benzoxazinone of <b>4</b> stabilizes an inactive conformation. Interestingly, both benzazepine and piperidino-benzoxazinone moieties actually derive from structural modifications of the quinolinone ligand OPC-21268, the first nonpeptide vasopressin receptor ligand described.<a onclick="showRef(event, 'ref28 ref64 ref65'); return false;" href="javascript:void(0);" class="ref ref28 ref64 ref65">(28, 64, 65)</a> Structurally speaking, there is a reasonably good similarity between the piperidino-benzoxazinone fragment of <b>4</b> and the benzazepine moiety. They both contain a cyclic aromatic moiety likely to interact with aromatic residues in the active site. They are both connected to the rest of the molecules by an amide link. The discriminant feature could be the distance between the aromatic ring and the amide link that is slightly superior in the piperidino-benzoxazinone moiety.</div><div class="NLM_p">The contribution of the eastern part of the molecule was then investigated by introducing the side chains of compounds <b>2</b> and <b>3</b> on the central and western part of <b>1</b>. Once again, the results were quite unexpected (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). The replacement of the complex electronegative side chain in <b>1</b> by the hydrophobic biphenyl amide of <b>2</b> led to compound <b>27</b> with a conserved OT receptor affinity (<i>K</i><sub>i</sub> = 111 nM versus 147 nM). The replacement by the methyl pyrazole directly branched on the central benzoyl core provided <b>31a</b>, an even more potent OT-R ligand with a <i>K</i><sub>i</sub> = 27.8 nM. This significant increase was unexpected because compounds <b>2</b> and <b>3</b> have affinity constants similar to <b>1</b> (<i>K</i><sub>i</sub> = 109 and 199 nM, respectively). However, these replacements caused a switch in functional efficacy because compounds <b>27</b> and <b>31a</b> are potent OT receptor antagonists (<i>K</i><sub>inact</sub> = 557 and 14.8 nM, respectively) without any detectable agonist activity. These results highlight the critical contribution of the large electron-rich side chain of <b>1</b> to its OT receptor activating properties. Replacement by smaller, more hydrophobic fragments increases the affinity but locks the receptor in an inactive conformation. A similar effect was observed on the V<sub>2</sub> receptor subtype. Compound <b>27</b> is also a potent and selective V<sub>2</sub> receptor antagonist (<i>K</i><sub>i</sub> = 6.4 nM, V<sub>2</sub>/V<sub>1a</sub><i>K</i><sub>inact</sub> ratio = 374, V<sub>2</sub>/OT <i>K</i><sub>inact</sub> ratio = 506). In addition, the affinity for the V<sub>1a</sub> receptor subtype increased from 10- to 20-fold (compounds <b>27</b> and <b>31a</b>, respectively) but the initial antagonist activity was retained.</div><div class="NLM_p">Of interest is also the differential action of the core benzoyl nucleus common to all ligands. With a methyl group in position 3, the compound <b>31a</b> is a potent antagonist for the V<sub>1a</sub> and OT receptors and a weak antagonist for the V<sub>2</sub> receptor. Substitution of the methyl for a chlorine in position 2 led to an equipotent ligand (<b>31b</b>) for the three receptor subtypes. However, <b>31b</b> behaves as a full agonist at the V<sub>2</sub> and as an antagonist at the V<sub>1a</sub> and OT receptor subtypes, highlighting once more the divergent SAR among highly homologous ligands acting at highly homologous receptors. Furthermore, by applying the same modification when having the large side chain of <b>1</b>, the affinity for the three receptor subtypes is dramatically lost, as illustrated by compounds <b>23b</b> and <b>23c</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Therefore, one may hypothesize that a methyl group on the central benzoyl core seems to be required at position 3 to stabilize this flexible chain in its active conformation.</div><div class="NLM_p">The second part of this study highlighted the contribution to affinity, efficacy, and specificity of each fragment of the compound <b>1</b>. With regard to the western tricyclic part, the benzazepine polycyclic moiety contributes to the affinity and the stabilization of the active conformation of the OT and V<sub>2</sub> receptors, the pyrazolobenzodiazepine scaffold of <b>1</b> remaining unequaled (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). By contrast, the piperidino-benzoxazinone is responsible for the OT-R selectivity and stabilizes an inactive conformation of this receptor. Clearly, both scaffolds are not interchangeable. Regarding the eastern part of the molecule, the large electron-rich side chain of <b>1</b> is essential for the oxytocin receptor activation. Finally, the core benzoyl nucleus is not just a common linker but can lock/unlock a specific conformation of the ligand through its different substitution patterns.</div><figure id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901084f/production/images/medium/jm-2009-01084f_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901084f/production/images/large/jm-2009-01084f_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Schematic representation of the main results of the hybrid molecules of compound <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901084f/production/images/large/jm-2009-01084f_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901084f&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In summary, the design and synthesis of several truncated analogues of <b>1</b> and of hybrid molecules enabled us to identify the key structural features responsible for its affinity and OT-R agonist efficacy. Although it was tempting to assume that similar fragments bind to similar regions and trigger similar effects in the highly homologous receptor subtypes, the reality is definitely not so straightforward. Indeed, each part of the molecule appears to play a specific role for its activity on the oxytocin receptor, and quite surprising findings arose from this systematic study regarding its behavior toward the other vasopressin receptor subtypes. The main conclusion remains that the OT-R agonist activity of compound <b>1</b> is mainly conferred by this large, rather polar, pseudopeptidic side chain present at its eastern part. The cleavage of this polar side chain and its replacement by a smaller group did not afford an OT-R agonist as it does with the same backbone on the V<sub>2</sub>-R.<a onclick="showRef(event, 'ref33 ref63'); return false;" href="javascript:void(0);" class="ref ref33 ref63">(33, 63)</a> For bioamine receptors ligands, which have to reach a deep binding cleft between the helices, agonists are typically smaller than antagonists.<a onclick="showRef(event, 'ref66 ref67'); return false;" href="javascript:void(0);" class="ref ref66 ref67">(66, 67)</a> Indeed, the switch from an antagonist to an agonist for nonpeptide receptors is generally achieved by the suppression of a bulky lipophilic side chain. Obviously, it may be more subtle for peptide receptor ligands, whose binding site also includes the extracellular region. The large size of peptides often allows the discrimination of the binding and the activation domains, both on the peptide ligand and the target receptor. This address and message concept has been widely explored and often validated.<a onclick="showRef(event, 'ref46 ref49 ref54 ref68 ref69'); return false;" href="javascript:void(0);" class="ref ref46 ref49 ref54 ref68 ref69">(46, 49, 54, 68, 69)</a> A priori, this separation renders the design of small size, potent agonists more difficult. However, morphine represents a very good example showing that a small nonpeptide molecule is able to mimic a peptide in combining affinity and functional activity on a limited molecular entity. Furthermore, the switch from agonist to antagonist on morphine skeleton follows essentially the same rules as for biogenic amine receptor ligands and can be achieved by substitution with hydrophobic fragments.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> By contrast, other examples have shown that a nonpeptide antagonist ligand of a peptide receptor could be converted into an agonist by introduction of an additional hydrophobic interaction or steric constraint.<a onclick="showRef(event, 'ref69 ref71 ref72'); return false;" href="javascript:void(0);" class="ref ref69 ref71 ref72">(69, 71, 72)</a> This phenomenon has also been studied on several receptors via mutagenesis and photoaffinity labeling of structurally similar agonist and antagonist ligands.<a onclick="showRef(event, 'ref73 ref74 ref75 ref76 ref77 ref78 ref79 ref80 ref81 ref82 ref83 ref84 ref85 ref86 ref87'); return false;" href="javascript:void(0);" class="ref ref73 ref74 ref75 ref76 ref77 ref78 ref79 ref80 ref81 ref82 ref83 ref84 ref85 ref86 ref87">(73-87)</a> As shown here, the side-chain decrease strategy leads indeed to a conserved agonist character or a switch from antagonist to agonist for the V<sub>2</sub> receptor subtype but did not operate for the OT and V<sub>1a</sub> receptors, demonstrating that the structural determinants of the antagonist/agonist switch are probably specific to every receptor−ligand complex. We have attempted to obtain an explanation for these observed subtle affinity and efficacy switches in analyzing molecular models of the OT receptor binding to OT, the endogenous ligand, or to compound <b>1</b>, a partial agonist.</div></div><div id="sec5_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> Molecular Modeling</h4><div class="NLM_p">Models for the OT, V<sub>1a</sub>, V<sub>1b</sub>, and V<sub>2</sub> receptors interacting with diverse ligands had previously been proposed and partly validated experimentally.<a onclick="showRef(event, 'ref42 ref43 ref44 ref45 ref46 ref47 ref48 ref49 ref50 ref51 ref52 ref53 ref54 ref55 ref56 ref57 ref58 ref59'); return false;" href="javascript:void(0);" class="ref ref42 ref43 ref44 ref45 ref46 ref47 ref48 ref49 ref50 ref51 ref52 ref53 ref54 ref55 ref56 ref57 ref58 ref59">(42-59)</a> They were derived from reference GPCR experimental structures with different levels of relevance and resolution. However, they proved to be sufficiently qualitative to predict binding pocket localization, residues responsible for affinity, species, and receptor specificity. We attempted to go one step further in understanding the agonism−antagonism switch for compound <b>1</b> using the best current reference templates for GPCR modeling. A three-dimensional model of the oxytocin receptor was built and refined based on the sequence alignment and the V<sub>1a</sub> model previously published by our group.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> The quality of this new model was assessed by docking the endogenous peptide ligand oxytocin (see Figure S1 in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). In agreement with most studies, the hydrophobic part of oxytocin (Tyr2 and Ile3) is accommodated by a hydrophobic pocket (M3.36, W6.48, F6.51) lying in the deep 7-transmembrane (TM) cavity between TMs III, V, VI, and VII. An important H-bonds network is established between the conserved glutamine residues (Q3.32, Q4.60, Q6.55) located at the upper rim of the cavity and the polar part of the peptide hormone, i.e., the main chain atoms as well as Gln4, Asn5, and also the Tyr2 side chain. Similar interactions have also been described for AVP into V<sub>1a</sub>-R and V<sub>1b</sub>-R in our most recent models<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> as well as in previously published binding modes.<a onclick="showRef(event, 'ref43 ref48'); return false;" href="javascript:void(0);" class="ref ref43 ref48">(43, 48)</a> Moreover, the N-terminal Gly9 of OT is interacting with E1.35 via hydrogen bonding. Thus, a very tiny network of hydrogen bonds is used to anchor OT to its receptor. On the other hand, Leu8 of OT is pointed to the F2.68, located close to the extracellular loop E1, as proposed previously.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Noteworthy, most residues proposed to participate in OT binding have been shown to be of crucial importance for AVP agonist peptide binding using site-directed mutagenesis.<a onclick="showRef(event, 'ref43 ref48 ref49'); return false;" href="javascript:void(0);" class="ref ref43 ref48 ref49">(43, 48, 49)</a> Thus, although our OT binding has not been experimentally validated, we believe that our OT-R model is a good starting point for docking other agonists.</div><div class="NLM_p">Compound <b>1</b> was docked in this model in an attempt to gain insight into the agonism−antagonism switch. The resulting binding mode obtained was similar to the oxytocin binding mode (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). More precisely, a well-defined negatively charged subsite (E1.35, D2.65) perfectly accommodates the positively charged basic amine at the eastern part of compound <b>1</b>. Very recently, we demonstrated that this subsite represents a key anchoring point for the Arg8 residue of AVP and related peptide agonists in V<sub>1a</sub> and V<sub>1b</sub> receptors.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> The western part of compound <b>1</b> is anchored via H-bonds formed between its nitrogen-enriched tricyclic fused ring and the conserved Q4.60 as well as the carbonyl belonging to the backbone of K3.29. A possible aromatic stacking interaction is also likely between the central benzene ring of the ligand and the conserved F6.51 of the receptor.</div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901084f/production/images/medium/jm-2009-01084f_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901084f/production/images/large/jm-2009-01084f_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Proposed binding mode of compound <b>1</b> to human OT receptor. The seven TM helices of each receptor are displayed by cylinders and labeled from I to VII. Some TM helices have been omitted for clarity. Compound <b>1</b> is displayed by orange sticks. This figure and Figure S1 in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> has been prepared with Sybyl.<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901084f/production/images/large/jm-2009-01084f_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901084f&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Consequently, this novel oxytocin nonpeptide agonist series represented by compound <b>1</b> seems to bind to the receptor in a similar way that the peptide ligand does. The extended pseudopeptidic structure of <b>1</b> seems to mimic the size and the shape of oxytocin itself and to establish the interactions necessary to activate the oxytocin receptor. Indeed, our results indicate that the end of the eastern part of compound <b>1</b> is required for OT-R activation and one can imagine that the basic amine of the homopiperazine fragment would be the key anchoring point to the receptor in order to confer agonism to the ligand. According to our model, this nitrogen can be in close contact with three possible acidic residues of the OT receptor, namely E1.35, D2.65 and the conserved D of the extracellular loop E2. Interestingly, only D2.65 is not conserved in the V<sub>2</sub> receptor, where it is replaced by a K. This might explain why compound <b>1</b> has a very low affinity and efficacy for the V<sub>2</sub> receptor which binds and responds to the small hydrophobic agonist WAY-VNA-932. Nevertheless, this model is not sufficient to explain the agonism of compound <b>1</b> at the OT receptor and its antagonism at the V<sub>1a</sub> receptor because oxytocin itself has no positive charge at the region considered and the three acidic residues are conserved in V<sub>1a</sub>-R.</div><div class="NLM_p last">Thus, studying the GPCR activation mechanisms still remains challenging. A lot of work has been done on the rhodopsin and the β<sub>2</sub>-adrenergic class 1 receptors.<a onclick="showRef(event, 'ref88 ref89'); return false;" href="javascript:void(0);" class="ref ref88 ref89">(88, 89)</a> According to the proposed toggle switch model,<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> a 90° rotation of the crucial conserved W6.48 side chain would lead to the movement of TM VI and TM VII around the highly conserved proline kinks, while the intracellular segments would move away from TM III to expose specific epitopes, and the extracellular segments would get closer to TM III to close the binding site. The receptor would be maintained in its inactive conformation by an aromatic cluster in TM V and VI, stabilizing the W6.48. The antagonist binding mode is located deep in the transmembrane domain and based on sufficiently strong interactions with the hydrophobic and aromatic residues of TM IV, V, VI, and VII, in order to prevent W6.48 rotation, maintaining the receptor in its inactive conformation. The agonist would adopt a more superficial binding mode between TM III, VI, and VII and close to TM III to allow rotation of the W6.48 located at the opposite part of the cavity. Established interactions are thus rather polar, with some hydrophobic contacts able to disturb the aromatic cluster. In stabilizing the active receptor conformation, small agonists would act as a molecular <i>glue</i> in the main cavity between the helices, whereas peptides would play the role of Velcro at the upper helical bundle and the extracellular loops, to maintain these helices together for an extended time. Small V<sub>2</sub>-R agonists would bind in a position close to TM III to not disturb the W6.48 rotation. Because of subtle differences of topology of the cavity in OT-R, interaction of these ligands with the aromatic cluster of TM VI would be too strong. On the contrary, the eastern chain of the OT-R agonist <b>1</b> would bring additional interactions with the upper part of TM I and II, allowing the molecule to move upward, thus acting as Velcro in peptide mimicry.</div></div></div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30601" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30601" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">The binding mode and the switch from antagonist to agonist among GPCR ligands remain a key issue for drug design. The vasopressin-oxytocin receptors and their ligands represent a very convenient model system to address such an issue because highly homologous ligands binding to highly homologous binding sites are known. We have explored the affinity and efficacy shifts around compound <b>1</b>, which is the lead of the first series of oxytocin receptor nonpeptide agonists described to date. We have fully investigated its binding and efficacy profiles on the OT, V<sub>1a</sub>, and V<sub>2</sub> oxytocin-vasopressin receptors. The first important result is that compound <b>1</b> is not a specific, full OT-R agonist. In our hands, it displays only a 2-fold selectivity versus the V<sub>1a</sub> receptor in terms of binding and behaves as a <i>partial</i> agonist (58%) at the OT-R, being equipotent as a V<sub>2</sub>-R agonist and more potent as a V<sub>1a</sub>-R antagonist. This, added to its poor bioavailability, preempts its use as specific pharmacological probe for studying oxytocin-related functional responses. It remains, however, a very interesting and relevant tool to explore the oxytocin binding and efficacy supramolecular determinants. Its study leads to the second conclusion that structure−activity relationships around vasopressin/oxytocin ligands are extremely subtle and the determinants for the antagonism/agonism switch are very difficult to identify. Thus, although qualitatively accurate, three-dimensional models of GPCR still remain of weak predictive value to address such subtle phenomenon that might be under kinetic and/or polymolecular control. Indeed, static models can not satisfactory take into account dynamic processes, conformational changes, loops movements, solvation/desolvation, allosteric interactions, dimerization/oligomerization,<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> G protein binding, membrane environment, and the multitude of parameters intervening in a living cell. Molecular modeling of GPCR, associated with extended experimental validation, is definitely an additive value to drug design but, in our hands and in this particular case study, it reaches its limits. The recent crystallographic structure of the adenosine A<sub>2A</sub> receptor further highlights the plasticity of GPCRs and the difficulty to predict precisely a given ligand binding mode.<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> Thus, for the time being, the dual challenge of discovering a full, bioavailable OT agonist on one hand and rationally designing a nonpeptide agonist for a peptide receptor on the other hand remains open. However, waiting for an oxytocin receptor crystallographic structure and having in mind that peptide GPCRs represent targets of special interest for novel therapeutics,<a onclick="showRef(event, 'ref92 ref93'); return false;" href="javascript:void(0);" class="ref ref92 ref93">(92, 93)</a> we will continue to combine molecular modeling, SAR studies, labeling,<a onclick="showRef(event, 'ref34 ref35 ref36 ref55'); return false;" href="javascript:void(0);" class="ref ref34 ref35 ref36 ref55">(34-36, 55)</a> and mutagenesis to take up the challenge.</div></div><div id="sec7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68638" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68638" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec7_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Chemistry: General Methods</h3><div class="NLM_p last">Dry solvents were purchased from Fluka (SureSeal). Microwaves irradiations were performed on a Biotage Initiator 2.0 apparatus. Melting points (mp) were determined with a Gallenkamp apparatus and are uncorrected. Optical rotations ([α]<sub>D</sub>) were determined with a Perkin-Elmer 241 MC or a Perkin-Elmer 341 polarimeter. <sup>1</sup>H and <sup>13</sup>C NMR spectra were recorded at 298 K on Bruker spectrometers at 200 or 300 and 50 or 75 MHz, respectively, in CDCl<sub>3</sub>, DMSO-<i>d</i><sub>6</sub>, or CD<sub>3</sub>OD, using residual solvent as an internal reference. Chemical shifts (δ) are reported in parts per million (ppm), coupling constants (<i>J</i>) are reported in hertz (Hz). IR spectra (ν, cm<sup>−1</sup>) were obtained with a Perkin-Elmer FT-IR 1600 or a Perkin-Elmer FT-IR 2000 spectrometers, or with a Thermo Nicolet 380 spectrometer using attenuated total reflection (ATR) technology. Mass spectra (MS) were recorded on a Mariner 5155 from Applied Biosystems using electrospray (ES) ionization mode and a time-of-flight (TOF) analyzer. High resolution mass spectra (HRMS) were recorded on a MicroTof mass spectrometer from Bruker using electrospray (ES) ionization mode and a time-of-flight (TOF) analyzer. Thin-layer chromatography (TLC) was performed on silica gel 60 F<sub>254</sub> aluminum plates from Merck. Flash chromatography was performed on silica gel 60 (230−400 mesh ASTM) from Merck. Analytical RP-HPLC analyses were performed on a Symmetry Shield column (4.6 mm × 150 mm, 5 μm, C<sub>18</sub>) from Waters under the following conditions: buffer A, 0.1% aqueous TFA; buffer B, 0.1% TFA in 8:2 CH<sub>3</sub>CN/H<sub>2</sub>O; buffer C, 0.1% TFA in CH<sub>3</sub>CN; gradient 1: 0% buffer B in buffer A for 5 min then 0−100% buffer B in buffer A over 25 min with a flow rate of 0.8 mL/min; gradient 2, 0−100% buffer C in buffer A over 30 min with a flow rate of 1 mL/min; detection: λ = 220/254 nm. Retention times (<i>t</i><sub>R</sub>) from analytical RP-HPLC are reported in minutes. Semipreparative RP-HPLC separations were performed on a Symmetry Shield column (19 mm × 300 mm, 0.7 μm, C<sub>18</sub>) from Waters under the following conditions: flow rate: 10 mL/min; buffer A, 0.1% aqueous TFA, buffer B, 0.1% TFA in CH<sub>3</sub>CN; gradients (variable): 0−100% buffer B over 30 min; detection: λ = 220/254 nm. Purity of all target compounds was determined by analytical RP-HPLC according to the conditions described above, and was >95%.</div></div><div id="sec7_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 1-Methyl-5,10-dihydropyrazolo[3,4-<i>b</i>][1,5]benzodiazepin-4(1<i>H</i>)-one (<b>6</b>)</h3><div class="NLM_p last">A solution of <b>5</b> (1.42 g, 5.45 mmol) in a 9:1 <i>i</i>PrOH/AcOH mixture (25 mL) was heated in a sealed tube at 160 °C under argon. After 48 h, the resulting mixture was allowed to stand at rt under argon for 1 or 2 days until complete crystallization of the product. The creamy to pale-gray crystals were then collected, washed with cold Et<sub>2</sub>O, and dried under high vacuum to yield the title compound (1.04 g, 89%); mp 262−264 °C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 3.66 (s, 3H), 6.75−6.95 (m, 3H), 7.03 (d, 1H, <i>J</i> = 7.5 Hz), 7.45 (s, 1H), 8.35 (bs, 1H), 8.96 (bs, 1H). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 35.0, 100.5, 120.3, 121.8, 123.4, 123.9, 129.4, 133.8, 139.9, 146.0, 163.8. IR (KBr) ν (cm<sup>−1</sup>) 3310, 3221, 3098, 3056, 1636, 1615, 1584, 1504, 1446, 1421, 1398, 1329, 1268, 1206, 747.</div></div><div id="sec7_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 1-Methyl-1,4,5,10-tetrahydropyrazolo[3,4-<i>b</i>][1,5]benzodiazepine (<b>7</b>)</h3><div class="NLM_p last">To a stirred suspension of <b>6</b> (714 mg, 3.33 mmol) in dry THF at 0 °C under argon was added portionwise LiAlH<sub>4</sub> (1.01 g, 26.67 mmol) over 10−15 min. The resulting reaction mixture was stirred at 0 °C for 15 min and was then refluxed. After 26 h, as TLC showed incomplete reaction, an additional amount of LiAlH<sub>4</sub> (755 mg, 20.00 mmol) was added. After 44 h refluxing, the reaction mixture was cooled to 0 °C and 35% NaOH (4 mL) was added dropwise over 1 h. Stirring was continued at rt for 1 h, then the mixture was filtered over celite and concentrated in vacuo. Flash chromatography (DCM to 95:5 DCM/MeOH) afforded the title compound as a brown foam (576 mg, 86%); mp 204−206 °C (from MeOH). <sup>1</sup>H NMR (200 MHz, CD<sub>3</sub>OD) δ 3.71 (s, 3H), 3.98 (s, 2H), 6.65−6.95 (m, 3H), 6.95−7.15 (m, 2H). <sup>13</sup>C NMR (75 MHz, CD<sub>3</sub>OD) δ 34.9, 45.6, 103.0, 120.5, 122.5, 123.6, 124.1, 135.4, 136.8, 139.9, 143.1. IR (KBr) ν (cm<sup>−1</sup>) 3364, 3262, 3153, 3049, 2980, 2791, 1607, 1574, 1506, 1490, 1432, 1395, 1318, 1292, 1247, 993, 821, 757. MS (ES) <i>m</i>/<i>z</i> 201.12 ([M + H]<sup>+</sup>).</div></div><div id="sec7_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 2-Methyl-4-[(1-methyl-4,10-dihydropyrazolo[3,4-<i>b</i>][1,5]benzodiazepin-5(1<i>H</i>)-yl) carbonyl]benzonitrile (<b>9</b>)</h3><div class="NLM_p last">To a stirred suspension of <b>8</b> (1.10 g, 6.81 mmol) in dry DCM (8 mL) at 0 °C under argon were added successively dry DMF (5 drops) and (COCl)<sub>2</sub> (1.17 mL, 13.61 mmol). The resulting reaction mixture was stirred at 0 °C for 15 min and then was allowed to warm to rt and stirring was continued for 2 h. The solvent was removed in vacuo, and the resulting residue was dissolved in dry THF. The solvent was removed in vacuo, and the resulting residue was dried under high vacuum for 30 min. The resulting brown solid was dissolved in dry DCM (5 mL), and this mixture was added dropwise, under argon, to a stirred ice-cold solution of <b>7</b> (1.14 g, 5.69 mmol) and Et<sub>3</sub>N (1.60 mL, 11.38 mmol) in dry DCM (10 mL). Stirring was continued at 0 °C for 30 min and then at rt overnight. As TLC showed still presence of some starting amine <b>7</b>, an additional amount of acyl chloride was prepared from the acid <b>8</b> (458 mg, 2.28 mmol), dissolved in dry DCM (2 mL) with Et<sub>3</sub>N (0.80 mL, 5.69 mmol), and added dropwise to the ice-cold reaction mixture. Stirring was continued at rt overnight and then the solvent was removed in vacuo. The resulting residue was taken up in DCM (50 mL) and 0.3 M KHSO<sub>4</sub> (75 mL). The aqueous phase was separated and extracted with a 8:2 CHCl<sub>3</sub>/<i>i</i>PrOH mixture (100 then 50 mL). The combined organic layers were washed with satd NaHCO<sub>3</sub> (75 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated in vacuo to yield a residue that was triturated in AcOEt. The precipitate was filtered, washed with AcOEt, and dried under high vacuum to yield the title compound as a pale-yellow powder (1.46 g, 75%); mp 253−256 °C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 2.34 (s, 3H), 3.77 (s, 3H), 3.95 (d, 1H, <i>J</i> = 14.3 Hz), 5.64 (d, 1H, <i>J</i> = 14.3 Hz), 6.64 (t, 1H, <i>J</i> = 7.5 Hz), 6.79 (d, 1H, <i>J</i> = 7.9 Hz), 7.01 (d, 1H, <i>J</i> = 7.9 Hz), 7.12 (t, 1H, <i>J</i> = 7.5 Hz), 7.19 (s, 1H), 7.23−7.33 (m, 2H), 7.55 (d, 1H, <i>J</i> = 7.9 Hz), 8.67 (bs, 1H). <sup>13</sup>C NMR (50 MHz, DMSO-<i>d</i><sub>6</sub>) δ 19.7, 35.4, 43.2, 100.0, 112.2, 117.3, 119.5, 121.2, 124.8, 128.7, 129.0, 130.4, 131.3, 131.9, 135.6, 139.1, 139.6, 140.8, 141.3, 166.9. IR (KBr) ν (cm<sup>−1</sup>) 3339, 2910, 2863, 2225, 1633, 1606, 1563, 1504, 1449, 1419, 1387, 1321, 1298, 1251, 1176, 1139, 991, 840, 818, 767.</div></div><div id="sec7_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 1-{2-Methyl-4-[(1-methyl-4,10-dihydropyrazolo[3,4-<i>b</i>][1,5]benzodiazepin-5(1<i>H</i>)-yl) carbonyl]phenyl}methanamine (<b>10</b>)</h3><div class="NLM_p last">To a stirred suspension of <b>9</b> (49.6 mg, 0.144 mmol) and CoCl<sub>2</sub>·6H<sub>2</sub>O (70.1 mg, 0.289 mmol) in MeOH (1.5 mL) at 0 °C under argon was added portionwise NaBH<sub>4</sub> (55.7 mg, 1.444 mmol) over 5 min. The resulting black reaction mixture was stirred at 0 °C for 10 min and then was allowed to warm to rt, and stirring was continued for 1 h. After neutralization (pH 7−8) with 1 M KHSO<sub>4</sub> (2 mL), MeOH was removed in vacuo, and the resulting aqueous residue was diluted with 1 M KHSO<sub>4</sub> (15 mL). This aqueous phase was filtered over celite, extracted with Et<sub>2</sub>O (2 × 20 mL), basified (pH > 10) with 2 N NaOH, and extracted with CHCl<sub>3</sub> (2 × 50 mL). The combined chloroformed layers were dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated in vacuo to yield the title compound as a pale-brown powder (50 mg, quant); mp 206−210 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 2.11 (s, 3H), 3.68 (s, 2H), 3.69 (s, 3H), 3.95 (d, 1H, <i>J</i> = 14.3 Hz), 5.88 (d, 1H, <i>J</i> = 14.7 Hz), 6.65 (m, 2H), 6.76−7.08 (m, 6H), 7.08−7.43 (m, 3H). <sup>13</sup>C NMR (50 MHz, CDCl<sub>3</sub>) δ 18.6, 34.8, 43.3, 43.5, 101.1, 119.1, 122.1, 125.7, 128.3, 123.0, 130.2, 130.6, 133.0, 134.1, 134.9, 136.2, 138.1, 139.6, 142.5, 169.5. IR (KBr) ν (cm<sup>−1</sup>) 3361, 3286, 3193, 3070, 2941, 2868, 1629, 1608, 1561, 1504, 1447, 1413, 1387, 1380, 1317, 1298, 1252, 1176, 1138, 993, 838, 817, 756. MS (ES) <i>m</i>/<i>z</i> 348.25 ([M + H]<sup>+</sup>), 695.47 ([2M + H]<sup>+</sup>).</div></div><div id="sec7_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> (2<i>S</i>)-<i>N</i>-{2-Methyl-4-[(1-methyl-4,10-dihydropyrazolo[3,4-<i>b</i>][1,5]benzodiazepin-5(1<i>H</i>)-yl)carbonyl]benzyl}-2-[(4-methyl-1,4-diazepan-1-yl)carbonothioyl] pyrrolidine-1-carboxamide, Bis(trifluoroacetate) (1·2TFA)</h3><div class="NLM_p last">To a stirred solution of <b>10</b> (152 mg, 0.439 mmol) and DIEA (76 μL, 0.439 mmol) in dry DMF (3 mL) was added CDI (98 mg, 0.606 mmol). The resulting reaction mixture was stirred at rt for 1 h under argon and then treated with a solution of <b>11</b> (91 mg, 0.399 mmol) and DIEA (76 μL, 0.439 mmol) in dry DMF (1 mL). Stirring was continued at rt overnight. As TLC showed still presence of some starting amine <b>11</b>, an additional amount of activated <b>10</b> was prepared (42 mg, 0.120 mmol) and added to the reaction mixture. Stirring was continued at rt for 9 h, and then the solvent was removed in vacuo. Flash chromatography (98:1:1 to 94:5:1 CHCl<sub>3</sub>/MeOH/NH<sub>4</sub>OH) afforded an oil that was further purified by semipreparative HPLC and lyophilized to yield the title compound as a white crystalline powder (193 mg, 58%); mp 160−164 °C. [α]<sub>D</sub><sup>22</sup> +72 (<i>c</i> = 1, MeOH). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.70−2.00 (m, 2H), 2.00−2.37 (m, including s at 2.09 ppm, 6H), 2.67−2.90 (m, 2H), 3.22 (m, 1H), 3.30−3.44 (m, 4H), 3.78 (s, 3H), 3.88 (d, 1H, <i>J</i> = 14.7 Hz), 4.08 (m, 2H), 4.38−5.10 (m, 8H), 5.67 (d, 1H, <i>J</i> = 14.7 Hz), 6.60−6.80 (m, 2H), 6.80−7.07 (m, 3H), 7.11 (t, 1H, <i>J</i> = 7.0 Hz), 7.20 (s, 1H), 7.29 (d, 1H, <i>J</i> = 7.9 Hz), 8.67 (bs, 1H). <sup>13</sup>C NMR (50 MHz, CD<sub>3</sub>OD) δ 19.7, 26.2, 27.2, 33.2, 36.0, 43.5, 45.3, 46.0, 47.0, 51.7, 52.5, 53.8, 54.0, 54.5, 56.1, 56.7, 57.2, 65.2, 104.7, 122.2, 124.9, 127.4 (m), 130.9, 131.3, 132.4, 135.5, 136.1, 136.3, 137.1, 140.1, 142.3, 144.6, 144.8, 159.5, 172.5, 209.8, 210.0. IR (KBr) ν (cm<sup>−1</sup>) 3367, 3210, 3092, 2958, 2874, 2672, 1683, 1645, 1635, 1564, 1558, 1502, 1454, 1417, 1393, 1382, 1317, 1202, 1183, 1136, 834, 797, 761, 721, 705. HRMS (ES): calcd for C<sub>32</sub>H<sub>41</sub>N<sub>8</sub>O<sub>2</sub>S, 601.3068; found, 601.3071. RP-HPLC (gradient 1): <i>t</i><sub>R</sub> 20.3 min, purity >98%. Anal. (C<sub>32</sub>H<sub>40</sub>N<sub>8</sub>O<sub>2</sub>S.2C<sub>2</sub>HF<sub>3</sub>O<sub>2</sub>·2H<sub>2</sub>O) C, H, N: calcd, 50.00, 5.36, 12.96; found 49.90, 5.09, 12.99.</div></div><div id="sec7_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> <i>N</i>-{2-Methyl-4-[(1-methyl-4,10-dihydropyrazolo[3,4-<i>b</i>][1,5]benzodiazepin-5(1<i>H</i>)-yl) carbonyl]benzyl}pyrrolidine-1-carboxamide (<b>12a</b>)</h3><div class="NLM_p last">Prepared from compound <b>10</b> (193 mg, 0.555 mmol) and pyrrolidine (51 μL, 0.610 mmol) as described for compound <b>1</b> and purified by flash chromatography (96:3:1 CHCl<sub>3</sub>/MeOH/Et<sub>3</sub>N); white powder (189 mg, 77%); mp 253−255 °C (from EtOH). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.78 (app t, 4H, <i>J</i> = 6.2 Hz), 2.11 (s, 3H), 3.21 (app t, 4H, <i>J</i> = 6.2 Hz), 3.77 (s, 3H), 3.88 (d, 1H, <i>J</i> = 14.3 Hz), 4.09 (app d, 2H, <i>J</i> = 5.0 Hz), 5.68 (d, 1H, <i>J</i> = 14.3 Hz), 6.48 (bt, 1H, <i>J</i> = 5.6 Hz), 6.65 (t, 1H, <i>J</i> = 7.3 Hz), 6.72 (d, 1H, <i>J</i> = 7.2 Hz), 6.92 (AB system, 2H, <i>J</i> = 7.8, 7.8 Hz), 7.00 (s, 1H), 7.11 (t, 1H, <i>J</i> = 7.6 Hz), 7.16 (s, 1H), 7.28 (d, 1H, <i>J</i> = 7.8 Hz), 8.59 (bs, 1H). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 18.4, 25.0, 35.3, 40.7, 43.2, 45.3, 100.3, 119.5, 121.3, 124.7, 125.4, 128.2, 129.0, 130.3, 132.6, 134.1, 134.2, 135.6, 138.9, 139.8, 140.4, 156.4, 168.1. IR (KBr) ν (cm<sup>−1</sup>) 3349, 3266, 3065, 2971, 2870, 1624, 1560, 1541, 1505, 1456, 1417, 1396, 1379, 1354, 1315, 1300, 1257, 1175, 990, 840, 815, 763, 730. HRMS (ES): calcd for C<sub>25</sub>H<sub>29</sub>N<sub>6</sub>O<sub>2</sub>, 445.2347; found, 445.2344. RP-HPLC (gradient 1): <i>t</i><sub>R</sub> 18.4 min, purity >98%.</div></div><div id="sec7_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> <i>N</i>,<i>N</i>-Dimethyl-<i>N</i>′-{2-methyl-4-[(1-methyl-4,10-dihydropyrazolo[3,4-<i>b</i>][1,5]benzodiazepin-5(1<i>H</i>)-yl)carbonyl]benzyl}urea (<b>12b</b>)</h3><div class="NLM_p last">Prepared from compound <b>10</b> (192 mg, 0.554 mmol) and dimethylamine hydrochloride (50 mg, 0.609 mmol) as described for compound <b>1</b> and purified by flash chromatography (98:1:1 to 96:3:1 CHCl<sub>3</sub>/MeOH/NH<sub>4</sub>OH); white foam (189 mg, 82%); mp 127−130 °C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 2.11 (s, 3H), 2.79 (s, 6H), 3.77 (s, 3H), 3.88 (d, 1H, <i>J</i> = 14.7 Hz), 4.08 (app d, 2H, <i>J</i> = 5.0 Hz), 5.67 (d, 1H, <i>J</i> = 14.4 Hz), 6.60−6.77 (m, 3H), 6.90 (AB system, 2H, <i>J</i> = 8.4, 7.8 Hz), 6.99 (s, 1H), 7.11 (t, 1H, <i>J</i> = 7.5 Hz), 7.16 (s, 1H), 7.28 (d, 1H, <i>J</i> = 8.1 Hz), 8.59 (bs, 1H). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 18.4, 35.3, 35.9, 41.0, 43.2, 100.3, 119.5, 121.3, 124.7, 125.3, 128.2, 129.1, 130.3, 132.6, 134.1, 134.3, 135.6, 138.9, 139.8, 140.4, 158.0, 168.1. IR (KBr) ν (cm<sup>−1</sup>) 3389, 3125, 3031, 2941, 2863, 2823, 1624, 1558, 1538, 1506, 1488, 1449, 1417, 1379, 1320, 1259, 1230, 1064, 839, 759, 730, 663, 618. HRMS (ES): calcd for C<sub>23</sub>H<sub>27</sub>N<sub>6</sub>O<sub>2</sub>, 419.2190; found, 419.2186. RP-HPLC (gradient 1): <i>t</i><sub>R</sub> 17.5 min, purity >95%.</div></div><div id="sec7_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> <i>N</i>-{2-Methyl-4-[(1-methyl-4,10-dihydropyrazolo[3,4-<i>b</i>][1,5]benzodiazepin-5(1<i>H</i>)-yl) carbonyl]benzyl}acetamide (<b>12c</b>)</h3><div class="NLM_p last">To a stirred solution of <b>10</b> (177 mg, 0.509 mmol) and Et<sub>3</sub>N (106 μL, 0.763 mmol) in dry DCM (4 mL) was added Ac<sub>2</sub>O (53 μL, 0.560 mmol). Stirring was continued at rt for 3 h under argon. The reaction mixture was diluted with DCM (10 mL), and the organic layer was separated, washed with 10% citric acid (5 mL) and satd NaHCO<sub>3</sub> (5 mL). The aqueous phases were basified with 10 N NaOH and extracted with CHCl<sub>3</sub> (2 × 20 mL). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated in vacuo. Flash chromatography (95:4:1 to 90:8:2 AcOEt/MeOH/Et<sub>3</sub>N) afforded the title compound as a white powder (75 mg, 38%); mp 218−220 °C (from EtOH/AcOEt). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.84 (s, 3H), 2.11 (s, 3H), 3.77 (s, 3H), 3.89 (d, 1H, <i>J</i> = 14.7 Hz), 4.12 (app d, 2H, <i>J</i> = 2.8 Hz), 5.67 (d, 1H, <i>J</i> = 14.3 Hz), 6.65 (t, 1H, <i>J</i> = 7.3 Hz), 6.72 (d, 1H, <i>J</i> = 7.2 Hz), 6.89 (AB system, 2H, <i>J</i> = 7.8, 7.8 Hz), 7.04 (s, 1H), 7.11 (t, 1H, <i>J</i> = 7.6 Hz), 7.17 (s, 1H), 7.29 (d, 1H, <i>J</i> = 8.1 Hz), 8.16 (app t, 1H), 8.61 (bs, 1H). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 18.4, 22.4, 35.3, 43.1, 100.3, 119.5, 121.3, 124.8, 126.1, 128.2, 129.3, 130.3, 132.5, 134.7, 134.9, 135.6, 138.6, 138.9, 139.8, 167.9, 169.1. IR (KBr) ν (cm<sup>−1</sup>) 3311, 3294, 3081, 2964, 2919, 1622, 1610, 1564, 1507, 1449, 1420, 1385, 1299, 1262, 1250, 1175, 1025, 996, 836, 816, 768, 750, 730. HRMS (ES): calcd for C<sub>22</sub>H<sub>24</sub>N<sub>5</sub>O<sub>2</sub>, 390.1925; found, 390.1922. RP-HPLC (gradient 1): <i>t</i><sub>R</sub> 17.0 min, purity >98%.</div></div><div id="sec7_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Methyl 2-Chloro-4-nitrobenzoate (<b>17</b>)</h3><div class="NLM_p last">A solution of 2-chloro-4-nitrobenzoyle chloride <b>16</b> (1.020 g, 4.64 mmol) in dry MeOH (5 mL) was stirred at 0 °C for 5 min and then allowed to warm to rt and stirring was continued for 2 h. The solvent was removed in vacuo and the residue dried under high vacuum to yield the title compound as a white powder (1.086 g, quant); mp 62−64 °C. <sup>1</sup>H NMR (200 MHz, CDCl<sub>3</sub>) δ 3.99 (s, 3H), 7.97 (d, 1H, <i>J</i> = 8.3 Hz), 8.16 (dd, 1H, <i>J</i> = 8.6, 2.2 Hz), 8.31 (s, 1H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 53.1, 121.4, 126.0, 132.0, 134.8, 135.7, 149.4, 164.6. IR (KBr) ν (cm<sup>−1</sup>) 3098, 3031, 2964, 1721, 1589, 1527, 1430, 1387, 1358, 1299, 1245, 1189, 1129, 1043, 945, 890, 853, 825, 780, 758, 742.</div></div><div id="sec7_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Methyl 4-Amino-2-chlorobenzoate (<b>18</b>)</h3><div class="NLM_p last">A mixture of <b>17</b> (974 mg, 4.52 mmol) and SnCl<sub>2</sub>·2H<sub>2</sub>O (5.10 g, 22.60 mmol) in EtOH (50 mL) was refluxed under argon. After 1 h, the reaction mixture was cooled to 0 °C and 1 N NaHCO<sub>3</sub> was added slowly until pH 7−8 (65 mL). The resulting milky mixture was stirred at rt for 1 h, and then the solvent was removed in vacuo and the resulting aqueous phase was extracted with AcOEt (200 mL). The organic layer was washed with brine (50 mL), and the aqueous phase was extracted with DCM (200 mL). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated in vacuo to yield the title compound as an orange crystalline solid (928 mg, quant); mp 100−102 °C. <sup>1</sup>H NMR (200 MHz, CDCl<sub>3</sub>) δ 3.85 (s, 3H), 3.96 (bs, 2H), 6.52 (dd, 1H, <i>J</i> = 8.5, 2.2 Hz), 6.69 (d, 1H, <i>J</i> = 2.2 Hz), 7.76 (d, 1H, <i>J</i> = 8.6 Hz). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 51.8, 112.3, 116.3, 118.0, 133.8, 136.1, 150.5, 165.7. IR (KBr) ν (cm<sup>−1</sup>) 3427, 3333, 3003, 2952, 1703, 1633, 1598, 1550, 1499, 1429, 1329, 1264, 1248, 1186, 1122, 1040, 906, 862, 850, 831, 773, 685.</div></div><div id="sec7_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Methyl 2-Chloro-4-cyanobenzoate (<b>19</b>)</h3><div class="NLM_p last">A suspension of <b>18</b> (510 mg, 2.75 mmol) in conc HCl (5.5 mL) was cooled to −15 °C and ice (30 mL) was added. Then a solution of NaNO<sub>2</sub> (235 mg, 3.30 mmol) in water (5 mL) was added dropwise under argon. The resulting reaction mixture was stirred at −15 °C for 15 min. The presence of HNO<sub>2</sub> excess was checked with a starch-iodide paper. The mixture was then carefully neutralized by adding solid Na<sub>2</sub>CO<sub>3</sub> with constant stirring (pH 5). At −10 °C, a mixture of KCN (497 mg, 6.87 mmol) and CuCN (320 mg, 3.57 mmol) in cold water (8 mL) was added dropwise. Stirring was continued for 2 h from −10 °C to rt. The reaction mixture was then filtered and extracted with DCM (2 × 75 mL). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated in vacuo. Flash chromatography (95:5 <i>n</i>-heptane/AcOEt) afforded the title compound as a white woolly solid (328 mg, 61%); mp 76−80 °C. <sup>1</sup>H NMR (200 MHz, CDCl<sub>3</sub>) δ 3.97 (s, 3H), 7.61 (dd, 1H, <i>J</i> = 8.1, 1.5 Hz), 7.75 (d, 1H, <i>J</i> = 1.5 Hz), 7.90 (d, 1H, <i>J</i> = 8.1 Hz). <sup>13</sup>C NMR (50 MHz, CDCl<sub>3</sub>) δ 53.0, 116.2, 116.6, 130.0, 131.8, 132.2, 134.3, 134.6, 164.7. IR (KBr) ν (cm<sup>−1</sup>) 3070, 3048, 2969, 2235, 1722, 1435, 1387, 1306, 1295, 1259, 1194, 1136, 1054, 954, 895, 845, 805, 775, 607.</div></div><div id="sec7_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 2-Chloro-4-cyanobenzoic Acid (<b>20</b>)</h3><div class="NLM_p last">A solution of <b>19</b> (967 mg, 4.94 mmol) and LiOH·H<sub>2</sub>O (318 mg, 7.41 mmol) in a 1:1 MeOH/THF mixture (10 mL) was stirred at rt for 1 h. The solvent was removed in vacuo, and then the resulting residue was taken up with water (10 mL) and acidified with 6 N HCl (pH 1). The precipitate was filtered and dried under vacuum over P<sub>2</sub>O<sub>5</sub> and then at 45 °C for 8 h to yield the title compound as a pale-pink powder (744 mg, 83%); mp 160−162 °C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.90 (m, 2H), 8.16 (s, 1H), 14.01 (bs, 1H). <sup>13</sup>C NMR (50 MHz, DMSO-<i>d</i><sub>6</sub>) δ 114.6, 116.8, 130.9, 131.1, 131.8, 133.8, 136.3, 165.7. IR (KBr) ν (cm<sup>−1</sup>) 3300−2400, 3076, 3048, 2235, 1717, 1687, 1600, 1544, 1485, 1429, 1408, 1383, 1302, 1261, 1054, 903, 884, 848, 778, 683. MS (ES) <i>m</i>/<i>z</i> 179.97 ([M − H]<sup>−</sup>).</div></div><div id="sec7_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 2-Methyl-4-(2,3,4,5-tetrahydro-1<i>H</i>-1-benzazepin-1-ylcarbonyl)benzonitrile (<b>21a</b>)</h3><div class="NLM_p last">The acyl chloride of the acid <b>8</b> (301 mg, 1.87 mmol) was prepared according to the procedure described for compound <b>9</b>. It was then dissolved in dry DCM (2 mL), and this mixture was added dropwise, under argon, to a stirred ice-cold solution of <b>13</b> (250 mg, 1.70 mmol), anhydrous pyridine (0.41 mL, 5.10 mmol), and DMAP (6.2 mg, 0.05 mmol) in dry DCM (4 mL). Stirring was continued at 0 °C for 30 min then at rt overnight. The reaction mixture was diluted in DCM (40 mL), washed with 1 N HCl (5 mL) and satd NaHCO<sub>3</sub> (5 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated in vacuo. Flash chromatography (8:2 <i>n</i>-heptane/AcOEt) afforded the title compound as a white powder (375 mg, 76%); mp 126−128 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.40−1.70 (m, 1H), 1.90−2.20 (m, 3H), 2.41 (s, 3H), 2.70−3.10 (m, 3H), 4.96 (app bd, 1H, <i>J</i> = 13.1 Hz), 6.59 (d, 1H, <i>J</i> = 7.5 Hz), 6.87−6.97 (m, 2H), 7.10 (dt, 1H, <i>J</i> = 7.5, 0.9 Hz), 7.19−7.27 (m, 2H), 7.31 (d, 1H, <i>J</i> = 7.8 Hz). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 20.3, 26.3, 29.5, 34.9, 47.8, 113.4, 117.5, 125.4, 127.1, 127.7, 128.2, 129.8, 130.2, 131.7, 139.3, 140.5, 141.7, 143.1, 167.4. IR (KBr) ν (cm<sup>−1</sup>) 3059, 2930, 2851, 2222, 1644, 1603, 1578, 1558, 1492, 1438, 1413, 1384, 1359, 1317, 1274, 895, 851, 828, 775, 759, 741.</div></div><div id="sec7_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 2-Methyl-4-(5<i>H</i>-pyrrolo[2,1-<i>c</i>][1,4]benzodiazepin-10(11<i>H</i>)-ylcarbonyl)benzonitrile (<b>21b</b>)</h3><div class="NLM_p last">Prepared from acid <b>8</b> (304 mg, 1.79 mmol) and amine <b>14</b> (300 mg, 1.63 mmol) as described for compound <b>21a</b> (without DMAP); pale-yellow powder (345 mg, 65%); mp 186−188 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 2.46 (s, 3H), 5.19 (app bs, 4H), 6.06 (m, 1H), 6.10 (t, 1H, <i>J</i> = 3.0 Hz), 6.71 (m, 1H), 6.78 (m, 1H), 6.93−7.16 (m, 2H), 7.20 (t, 1H, <i>J</i> = 7.3 Hz), 7.32−7.50 (m, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 20.4, 46.4, 51.2, 107.8, 108.7, 114.1, 117.3, 121.9, 125.6, 125.8, 128.1, 129.0, 129.5, 130.1, 131.9, 134.1, 139.4, 141.7, 142.4, 168.5. IR (ATR) ν (cm<sup>−1</sup>) 2921, 2854, 2229, 1644, 1584, 1492, 1462, 1447, 1407, 1368, 1301, 1270, 1246, 1214, 1199, 1076, 890, 853, 841, 827, 757, 728, 701, 682, 612. MS (ES) <i>m</i>/<i>z</i> 328.1 ([M + H]<sup>+</sup>), 350.1 ([M + Na]<sup>+</sup>).</div></div><div id="sec7_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 3-Chloro-4-(5<i>H</i>-pyrrolo[2,1-<i>c</i>][1,4]benzodiazepin-10(11<i>H</i>)-ylcarbonyl)benzonitrile (<b>21c</b>)</h3><div class="NLM_p last">The acyl chloride of the acid <b>20</b> (25 mg, 0.138 mmol) was prepared according to the procedure described for compound <b>9</b>. It was then dissolved in dry DCM (0.3 mL), and this mixture was added dropwise, under argon, to a stirred ice-cold solution of <b>14</b> (21 mg, 0.115 mmol), anhydrous pyridine (28 μL, 0.345 mmol), and DMAP (0.4 mg, 0.003 mmol) in dry DCM (0.3 mL). The reaction mixture was irradiated under microwaves at 80 °C (1 bar) for 6 min and then diluted in DCM (15 mL), washed with 1 N HCl (3 mL) and satd NaHCO<sub>3</sub> (3 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated in vacuo. Flash chromatography (8:2 to 7:3 <i>n</i>-heptane/AcOEt) afforded the title compound as a white powder (20 mg, 49%); mp 104−106 °C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 4.90−5.50 (m, 4H), 5.90 (t, 1H, <i>J</i> = 3.0 Hz), 6.01 (m, 1H), 6.83 (app t, 1H, <i>J</i> = 1.9 Hz), 7.00−7.10 (m, 2H), 7.10−7.18 (m, 1H), 7.40 (d, 1H, <i>J</i> = 7.2 Hz), 7.45−7.65 (m, 1H), 7.69 (d, 1H, <i>J</i> = 7.5 Hz), 7.99 (s, 1H). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 45.1, 49.2, 106.8, 108.7, 113.0, 116.9, 122.3, 124.6, 125.0, 128.1, 128.6, 128.8, 129.6, 130.8, 132.9, 135.7, 139.1, 140.6, 165.3. IR (KBr) ν (cm<sup>−1</sup>) 3098, 3064, 2952, 2919, 2852, 2230, 1653, 1600, 1580, 1493, 1390, 1371, 1351, 1303, 1273, 1194, 834, 758, 714, 686, 612.</div></div><div id="sec7_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 2-Methyl-4-{[4-(2-oxo-2<i>H</i>-3,1-benzoxazin-1(4<i>H</i>)-yl)piperidin-1-yl]carbonyl} Benzonitrile (<b>21d</b>)</h3><div class="NLM_p last">To a solution of <b>15</b> (288 mg, 1.62 mmol) in dry DMF (6 mL) were added successively EDCI·HCl (381 mg, 1.95 mmol), HOBt·H<sub>2</sub>O (269 mg, 1.95 mmol), <b>8</b> (377 mg, 1.78 mmol), and then DIEA (0.56 mL, 3.25 mmol) dropwise. Stirring was continued at rt for 14 h, and then the solvent was removed in vacuo. The resulting residue was taken up in AcOEt (50 mL). This organic layer was washed with 10% citric acid (20 mL), satd NaHCO<sub>3</sub> (20 mL) and brine (20 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated in vacuo. Flash chromatography (5:5 to 3:7 <i>n</i>-heptane/AcOEt) afforded the title compound as a white foam (394 mg, 65%); mp 64−68 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.75−2.10 (m, 2H), 2.58 (s, 3H), 2.60−3.00 (m, 3H), 3.13 (m, 1H), 3.80 (m, 1H), 4.00−4.20 (m, 1H), 4.92 (m, 1H), 5.10 (s, 2H), 7.00−7.24 (m, 3H), 7.30−7.50 (m, 3H), 7.65 (d, 1H, <i>J</i> = 7.9 Hz). <sup>13</sup>C NMR (50 MHz, CDCl<sub>3</sub>) δ 20.5, 28.0, 28.8, 42.1, 47.3, 56.4, 67.1, 113.3, 113.9, 117.4, 122.4, 123.4, 124.5, 125.0, 128.6, 129.2, 132.7, 138.6, 140.1, 142.7, 152.5, 168.5. IR (KBr) ν (cm<sup>−1</sup>) 3048, 2975, 2934, 2870, 2226, 1716, 1633, 1607, 1498, 1468, 1454, 1447, 1389, 1293, 1273, 1258, 1242, 1204, 1042, 771, 755.</div></div><div id="sec7_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 1-[2-Methyl-4-(2,3,4,5-tetrahydro-1<i>H</i>-1-benzazepin-1-ylcarbonyl)phenyl] Methanamine (<b>22a</b>)</h3><div class="NLM_p last">Prepared from compound <b>21a</b> (367 mg, 1.26 mmol) as described for compound <b>10</b>; cream-colored powder (329 mg, 89%); mp 96−98 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.30−2.20 (m, 4H), 2.16 (s, 3H), 2.50−3.10 (m, 3H), 3.73 (s, 2H), 5.00 (app bd, 1H, <i>J</i> = 12.8 Hz), 6.62 (d, 1H, <i>J</i> = 7.8 Hz), 6.75−6.92 (m, 2H), 6.95−7.08 (m, 2H), 7.11 (s, 1H), 7.20 (d, 1H, <i>J</i> = 7.2 Hz). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 18.6, 26.3, 29.6, 34.9, 43.5, 47.6, 125.8, 126.9, 127.0, 128.2, 129.8, 130.2, 134.5, 135.0, 139.2, 142.1, 142.2, 144.1, 168.9. IR (KBr) ν (cm<sup>−1</sup>) 3379, 3316, 3064, 3045, 2942, 2924, 2879, 2840, 1633, 1578, 1564, 1492, 1456, 1435, 1411, 1377, 1356, 1312, 1276, 1259, 1209, 1166, 1052, 1033, 967, 889, 862, 819, 761, 755.</div></div><div id="sec7_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 1-[2-Methyl-4-(5<i>H</i>-pyrrolo[2,1-<i>c</i>][1,4]benzodiazepin-10(11<i>H</i>)-ylcarbonyl)phenyl] Methanamine (<b>22b</b>)</h3><div class="NLM_p last">Prepared from compound <b>21b</b> (259 mg, 0.790 mmol) as described for compound <b>10</b>; pale-brown foam (32 mg, 12%); mp 62−66 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 2.22 (s, 3H), 3.80 (s, 2H), 5.20 (app bs, 4H), 6.04 (s, 1H), 6.09 (t, 1H, <i>J</i> = 3.1 Hz), 6.69 (s, 1H), 6.87 (m, 1H), 6.99 (m, 1H), 7.04−7.21 (m, 3H), 7.24 (m, 1H), 7.36 (d, 1H, <i>J</i> = 7.2 Hz). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 18.7, 43.5, 46.5, 51.3, 107.5, 108.1, 121.5, 126.0, 126.5, 127.4, 128.7, 128.9, 129.3, 130.4, 133.5, 134.0, 135.4, 142.9, 170.2. IR (ATR) ν (cm<sup>−1</sup>) 3369, 3306, 2920, 2851, 1650, 1640, 1634, 1583, 1574, 1568, 1493, 1454, 1446, 1408, 1366, 1348, 1303, 1271, 1188, 1148, 1075, 825, 755, 745, 710, 611. MS (ES) <i>m</i>/<i>z</i> 332.2 ([M + H]<sup>+</sup>).</div></div><div id="sec7_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 1-[3-Chloro-4-(5<i>H</i>-pyrrolo[2,1-<i>c</i>][1,4]benzodiazepin-10(11<i>H</i>)-ylcarbonyl)phenyl] Methanamine (<b>22c</b>)</h3><div class="NLM_p last">Prepared from compound <b>21c</b> (207 mg, 0.594 mmol) as described for compound <b>10</b>; pale-yellow gum (64 mg, 30%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 3.70−4.05 (m, 2H), 5.00−5.40 (m, 4H), 5.95−6.15 (m, 2H), 6.60−6.70 (m, 1H), 6.85−7.18 (m, 4H), 7.18−7.60 (m, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 45.6, 51.1, 51.3, 107.6, 108.9, 121.8, 125.7, 125.8, 127.7, 127.9, 128.0, 128.2, 128.4, 128.6, 128.9, 129.0, 131.1, 134.6, 134.8, 140.4, 148.8, 167.8. IR (CsI) ν (cm<sup>−1</sup>) 3383, 3042, 2919, 2852, 1652, 1606, 1495, 1398, 1306, 1274, 758, 718.</div></div><div id="sec7_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 1-{2-Methyl-4-[(4-(2-oxo-2<i>H</i>-3,1-benzoxazin-1(4<i>H</i>)-yl)piperidin-1-yl)carbonyl]phenyl}methanamine (<b>22d</b>)</h3><div class="NLM_p last">Prepared from compound <b>21d</b> (338 mg, 0.90 mmol) as described for compound <b>10</b>; beige powder (188 mg, 55%); mp 128−130 °C. <sup>1</sup>H NMR (200 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.50−2.00 (m, 2H), 2.00−2.35 (m, 3H), 2.55−4.80 (m, 9H), 4.80−5.20 (m, 2H), 6.80−7.50 (m, 7H). <sup>13</sup>C NMR (50 MHz, DMSO-<i>d</i><sub>6</sub>) δ 18.5, 28.4, 46.6, 55.3, 66.3, 114.0, 122.6, 123.0, 124.1, 124.8, 128.2, 128.4, 129.1, 135.5, 136.7, 138.6, 151.8, 168.8. IR (KBr) ν (cm<sup>−1</sup>) 2963, 2934, 2863, 1719, 1709, 1607, 1564, 1499, 1467, 1446, 1390, 1303, 1292, 1259, 1206, 1111, 1041, 769, 755, 620. MS (ES) <i>m</i>/<i>z</i> 380.24 ([M + H]<sup>+</sup>).</div></div><div id="sec7_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> (2<i>S</i>)-<i>N</i>-[2-Methyl-4-(2,3,4,5-tetrahydro-1<i>H</i>-1-benzazepin-1-ylcarbonyl)benzyl]-2-[(4-methyl-1,4-diazepan-1-yl)carbonothioyl]pyrrolidine-1-carboxamide (<b>23a</b>)</h3><div class="NLM_p last">Prepared from compound <b>22a</b> (159 mg, 0.539 mmol) and compound <b>11</b> (88 mg, 0.385 mmol) as described for compound <b>1</b> and purified by flash chromatography (CHCl<sub>3</sub>/Et<sub>3</sub>N 0.7 to 2%). White foam (199 mg, 95%); mp 98−100 °C; [α]<sub>D</sub><sup>22</sup> −67 (<i>c</i> = 1, CHCl<sub>3</sub>). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.30−1.50 (m, 1H), 1.60−2.22 (m, 9H), 2.25 (s, 3H), 2.35−2.78 (m, 4H), 2.80−3.10 (m, 3H), 3.16−3.50 (m, 4H), 3.50−3.64 (m, 1H), 3.72−4.30 (m, 6H), 4.83 (app bd, 1H, <i>J</i> = 13.1 Hz), 4.96 (m, 1H), 6.48 (bs, 1H), 6.68 (d, 1H, <i>J</i> = 7.5 Hz), 6.80 (app bt, 1H, <i>J</i> = 9.0 Hz), 6.87−7.13 (m, 4H), 7.28 (d, 1H, <i>J</i> = 7.5 Hz). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 18.4, 23.6, 24.6, 25.9, 26.6, 29.3, 31.3, 34.2, 45.3, 45.5, 45.6, 46.1, 46.2, 47.0, 49.9, 50.8, 53.0, 53.2, 54.9, 55.4, 55.8, 57.0, 61.9, 62.0, 124.6, 124.8, 125.2, 125.4, 126.9, 127.0, 128.1, 129.0, 129.8, 134.1, 134.2, 139.1, 140.2, 143.9, 155.5, 167.9, 205.0, 205.2. IR (KBr) ν (cm<sup>−1</sup>) 3328, 2939, 2863, 2801, 1634, 1540, 1505, 1492, 1456, 1438, 1415, 1393, 1379, 1354, 1314, 1202, 1138, 1032, 755, 744. HRMS (ES): calcd for C<sub>31</sub>H<sub>42</sub>N<sub>5</sub>O<sub>2</sub>S, 548.3054; found, 548.3054. RP-HPLC (gradient 1): <i>t</i><sub>R</sub> 20.8 min, purity >98%.</div></div><div id="sec7_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> (2<i>S</i>)-<i>N</i>-[2-Methyl-4-(5<i>H</i>-pyrrolo[2,1-<i>c</i>][1,4]benzodiazepin-10(11<i>H</i>)-ylcarbonyl) benzyl]-2-[(4-methyl-1,4-diazepan-1-yl)carbonothioyl]pyrrolidine-1-carboxamide, Trifluoroacetate (<b>23b</b>·TFA)</h3><div class="NLM_p last">Prepared from compound <b>22b</b> (32 mg, 0.096 mmol) and compound <b>11</b> (24 mg, 0.106 mmol) as described for compound <b>1</b> and purified by flash chromatography (98:1:1 to 94:5:1 CHCl<sub>3</sub>/MeOH/NH<sub>4</sub>OH) followed by semipreparative HPLC; white hygroscopic powder (29 mg, 51%); mp 140−142 °C; [α]<sub>D</sub><sup>22</sup> +17 (c=0.1, MeOH). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.83−2.10 (m, 5H), 2.20 (s, 3H), 2.38 (d, 3H, <i>J</i> = 4.3 Hz), 2.47−2.92 (m, 4H), 3.34−3.48 (m, 1H), 3.58−3.72 (m, 1H), 3.75−4.22 (m, 4H), 4.22−4.55 (m, 4H), 5.03−5.30 (m, 4H), 6.03 (s, 1H), 6.09 (app t, 1H, <i>J</i> = 2.8 Hz), 6.69 (s, 1H), 6.88 (m, 1H), 7.01 (m, 1H), 7.06−7.23 (m, 4H), 7.36 (d, 1H, <i>J</i> = 7.2 Hz). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 18.9, 24.0, 24.1, 27.1, 29.7, 31.7, 31.8, 42.2, 46.3, 46.4, 46.6, 50.6, 51.0, 51.3, 53.6, 54.0, 55.7, 55.9, 56.8, 57.8, 62.6, 62.9, 107.5, 108.0, 121.5, 121.8, 125.9, 126.5, 126.7, 127.6, 128.7, 128.9, 129.4, 130.4, 133.9, 135.9, 139.5, 142.8, 156.0, 170.1, 204.9, 205.6. IR (ATR) ν (cm<sup>−1</sup>) 3367, 2953, 2874, 2725, 2678, 1644, 1633, 1614, 1548, 1538, 1495, 1416, 1372, 1351, 1304, 1274, 1197, 1172, 1137, 796, 753, 717, 704, 593. HRMS (ES): calcd for C<sub>33</sub>H<sub>41</sub>N<sub>6</sub>O<sub>2</sub>S, 585.3006; found, 585.3002. RP-HPLC (gradient 2): <i>t</i><sub>R</sub> 18.8 min, purity >98%.</div></div><div id="sec7_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> (2<i>S</i>)-<i>N</i>-[3-Chloro-4-(5<i>H</i>-pyrrolo[2,1-<i>c</i>][1,4]benzodiazepin-10(11<i>H</i>)-ylcarbonyl) benzyl]-2-[(4-methyl-1,4-diazepan-1-yl)carbonothioyl]pyrrolidine-1-carboxamide (<b>23c</b>)</h3><div class="NLM_p last">Prepared from compound <b>22c</b> (55 mg, 0.157 mmol) and compound <b>11</b> (39 mg, 0.173 mmol) as described for compound <b>1</b> and purified by flash chromatography (CHCl<sub>3</sub>/Et<sub>3</sub>N 1 to 2%); cream powder (83 mg, 87%); mp 146−150 °C; [α]<sub>D</sub><sup>22</sup> −31 (<i>c</i> = 1, CHCl<sub>3</sub>). <sup>1</sup>H NMR (200 MHz, CDCl<sub>3</sub>) δ 1.80−3.10 (m, 14H, including d at 2.44 ppm, <i>J</i> = 8.4 Hz), 3.30−3.53 (m, 1H), 3.58−4.20 (m, 4H), 4.22−4.53 (m, 2H), 4.53−4.87 (m, 2H), 4.87−5.40 (m, 4H), 6.06 (m, 2H), 6.66 (m, 1H), 6.94−7.7.58 (m, 7H). <sup>13</sup>C NMR (50 MHz, CDCl<sub>3</sub>) δ 22.6, 22.9, 24.1, 24.2, 25.0, 26.4, 27.9, 29.6, 31.8, 43.4, 44.0, 45.6, 46.0, 46.5, 50.4, 50.7, 51.1, 51.3, 52.8, 53.9, 55.4, 55.7, 56.8, 57.5, 62.7, 62.9, 107.6, 108.8, 121.7, 125.2, 125.8, 126.1, 126.5, 126.7, 127.6, 128.1, 128.3, 128.8, 129.0, 131.1, 134.0, 134.5, 134.7, 140.5, 142.6, 156.1, 167.7, 205.1, 205.9. IR (KBr) ν (cm<sup>−1</sup>) 3400, 2930, 2863, 2796, 1641, 1531, 1494, 1458, 1382, 1200, 758, 716. HRMS (ES): calcd for C<sub>32</sub>H<sub>38</sub>ClN<sub>6</sub>O<sub>2</sub>S, 605.2460; found, 605.2443. RP-HPLC (gradient 1): <i>t</i><sub>R</sub> 21.2 min, purity >98%.</div></div><div id="sec7_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> (2<i>S</i>)-<i>N</i>-{2-Methyl-4-[(4-(2-oxo-2<i>H</i>-3,1-benzoxazin-1(4<i>H</i>)-yl)piperidin-1-yl)carbonyl] benzyl}-2-[(4-methyl-1,4-diazepan-1-yl)carbonothioyl]pyrrolidine-1-carboxamide (<b>23d</b>)</h3><div class="NLM_p last">Prepared from compound <b>22d</b> (150 mg, 0.396 mmol) and compound <b>11</b> (75 mg, 0.330 mmol) as described for compound <b>1</b> and purified by flash chromatography (98:1:1 to 97:2:1 CHCl<sub>3</sub>/MeOH/NH<sub>4</sub>OH); white foam (153 mg, 74%); mp 136−140 °C; [α]<sub>D</sub><sup>22</sup> +47 (<i>c</i> = 1, CHCl<sub>3</sub>). <sup>1</sup>H NMR (200 MHz, CDCl<sub>3</sub>) δ 0.60−5.20 (m, including s at 2.32 ppm and s at 5.09 ppm, 37H), 6.80−7.70 (m, 7H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 19.1, 24.4, 28.9, 31.8, 42.2, 45.5, 45.8, 45.9, 46.3, 50.0, 51.5, 53.3, 55.0, 55.4, 56.6, 62.6, 67.1, 113.5, 121.4, 122.4, 123.3, 124.4, 124.9, 127.3, 128.7, 129.2, 134.6, 134.8, 136.4, 138.6, 138.9, 152.6, 156.2, 170.5. IR (KBr) ν (cm<sup>−1</sup>) 3337, 2947, 2937, 2870, 2801, 1717, 1625, 1608, 1541, 1498, 1467, 1457, 1388, 1348, 1291, 1258, 1204, 1133, 1041, 769, 753. HRMS (ES): calcd for C<sub>34</sub>H<sub>45</sub>N<sub>6</sub>O<sub>4</sub>S, 633.3218; found, 633.3190. RP-HPLC (gradient 1): <i>t</i><sub>R</sub> 20.1 min, purity >98%.</div></div><div id="sec7_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 1-Methyl-5-(3-methyl-4-nitrobenzoyl)-1,4,5,10-tetrahydropyrazolo[3,4-<i>b</i>][1,5] Benzodiazepine (<b>25</b>)</h3><div class="NLM_p last">The acyl chloride of 3-methyl-4-nitrobenzoic acid <b>24</b> (271 mg, 1.50 mmol) was prepared according to the procedure described for compound <b>9</b>. It was then dissolved in dry DCM (2 mL), and this mixture was added dropwise, under argon, to a stirred ice-cold solution of <b>7</b> (250 mg, 1.25 mmol) and Et<sub>3</sub>N (0.52 mL, 3.74 mmol) in dry DCM (3 mL). Stirring was continued at 0 °C for 30 min then at rt overnight. The reaction mixture was diluted in DCM (25 mL), washed with 10% citric acid (10 mL) and satd NaHCO<sub>3</sub> (15 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated in vacuo to yield a residue that was triturated in AcOEt. The precipitate was filtered, washed with AcOEt, and dried under high vacuum to yield the title compound as a yellow powder (409 mg, 90%); mp 222−224 °C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 2.36 (s, 3H), 3.78 (s, 3H), 3.97 (d, 1H, <i>J</i> = 14.3 Hz), 5.65 (d, 1H, <i>J</i> = 14.7 Hz), 6.66 (td, 1H, <i>J</i> = 7.8, 1.2 Hz), 6.83 (dd, 1H, <i>J</i> = 7.8, 1.6 Hz), 7.07−7.17 (m, 2H), 7.20 (s, 1H), 7.29 (dd, 1H, <i>J</i> = 8.4, 1.3 Hz), 7.32 (s, 1H), 7.74 (d, 1H, <i>J</i> = 8.4 Hz), 8.67 (bs, 1H). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 19.4, 35.5, 43.4, 100.2, 119.7, 121.5, 124.0, 125.8, 129.0, 130.6, 131.5, 131.6, 132.6, 135.9, 139.2, 139.8, 141.1, 148.9, 166.8. IR (KBr) ν (cm<sup>−1</sup>) 3343, 3098, 3076, 2986, 2930, 2858, 1632, 1605, 1565, 1524, 1503, 1414, 1382, 1356, 1318, 1293, 1252, 1180, 843, 769, 734.</div></div><div id="sec7_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 2-Methyl-4-[(1-methyl-4,10-dihydropyrazolo[3,4-<i>b</i>][1,5]benzodiazepin-5(1<i>H</i>)-yl) carbonyl]aniline (<b>26</b>)</h3><div class="NLM_p last">A mixture of <b>25</b> (318 mg, 0.875 mmol) and SnCl<sub>2</sub>·2H<sub>2</sub>O (987 mg, 4.374 mmol) in EtOH (11 mL) was refluxed under argon. After 1 h, the reaction mixture was cooled to 0 °C and 1 N NaHCO<sub>3</sub> was added slowly until pH 7−8 (7 mL). The resulting mixture was stirred at rt for 1.5 h and then extracted with AcOEt (2 × 100 mL). The aqueous phase was filtered over celite to eliminate the excess of salts and extracted with AcOEt (100 mL). The combined organic layers were washed with brine (30 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated in vacuo to yield a residue that was triturated in AcOEt. The precipitate was filtered, washed with AcOEt, and dried under high vacuum to yield the title compound as a white powder (240 mg, 82%); mp 250−252 °C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.88 (s, 3H), 3.76 (m, 3H), 3.75−3.90 (m, 1H), 5.17 (bs, 2H), 5.66 (app bd, 1H, <i>J</i> = 14.3 Hz), 6.25 (d, 1H, <i>J</i> = 8.1 Hz), 6.67 (m, 3H), 6.88 (s, 1H), 7.12 (m, 2H), 7.29 (d, 1H, <i>J</i> = 8.1 Hz), 8.53 (bs, 1H). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 17.2, 35.3, 43.2, 100.6, 111.9, 119.3, 119.5, 121.3, 122.4, 127.2, 127.6, 130.2, 130.8, 133.6, 135.5, 138.6, 140.0, 148.3, 168.3. IR (KBr) ν (cm<sup>−1</sup>) 3428, 3346, 3221, 3064, 2969, 2935, 1620, 1605, 1562, 1506, 1446, 1421, 1381, 1317, 1302, 1261, 1177, 1157, 824, 755, 732, 629. MS (ES) <i>m</i>/<i>z</i> 334.23 ([M + H]<sup>+</sup>).</div></div><div id="sec7_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 5-[4-[(1,1′-Biphenyl-2-ylcarbonyl)amino]-3-methylbenzoyl]-1-methyl-1,4,5,10-tetrahydropyrazolo[3,4-<i>b</i>][1,5]benzodiazepine (<b>27</b>)</h3><div class="NLM_p last">Prepared from 2-phenylbenzoic acid (445 mg, 2.25 mmol) and amine <b>26</b> (150 mg, 0.45 mmol) as described for compound <b>25</b> and purified by flash chromatography (95:5 AcOEt/MeOH) followed by recrystallization in EtOH. Yellow crystalline powder (202 mg, 87%); mp 240−242 °C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.79 (s, 3H), 3.77 (s, 3H), 3.89 (d, 1H, <i>J</i> = 14.7 Hz), 5.67 (d, 1H, <i>J</i> = 14.7 Hz), 6.60−6.80 (m, 2H), 6.87 (d, 1H, <i>J</i> = 7.5 Hz), 7.03 (s, 1H), 7.08−7.23 (m, 3H), 7.23−7.65 (m, 10H), 8.60 (s, 1H), 9.45 (s, 1H). <sup>13</sup>C NMR (50 MHz, DMSO-<i>d</i><sub>6</sub>) δ 17.2, 35.3, 43.2, 100.3, 119.6, 121.4, 123.4, 125.1, 127.2, 127.4, 127.9, 128.3, 128.5, 129.7, 129.9, 130.3, 132.5, 132.8, 135.6, 136.9, 137.1, 138.9, 139.1, 139.8, 140.1, 167.7, 167.9. IR (KBr) ν (cm<sup>−1</sup>) 3303, 3203, 3154, 3014, 2968, 2913, 2863, 1650, 1641, 1611, 1591, 1563, 1539, 1505, 1449, 1386, 1326, 1298, 1268, 1254, 1177, 1136, 1000, 893, 830, 761, 742, 699. HRMS (ES): calcd for C<sub>32</sub>H<sub>28</sub>N<sub>5</sub>O<sub>2</sub>, 514.2238; found, 514.2255. RP-HPLC (gradient 1): <i>t</i><sub>R</sub> 22.3 min, purity >98%. Anal. (C<sub>32</sub>H<sub>27</sub>N<sub>5</sub>O<sub>2</sub>) C, H, N: calcd, 74.84, 5.30, 13.64; found 74.60, 5.49, 13.55.</div></div><div id="sec7_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> Methyl 3-Methyl-4-(3-methyl-1<i>H</i>-pyrazol-1-yl)benzoate (<b>29a</b>)</h3><div class="NLM_p last">A solution of methyl 4-fluoro-3-methylbenzoate <b>28a</b> (417 mg, 2.48 mmol), 3-methylpyrazole (0.30 mL, 3.72 mmol), and K<sub>2</sub>CO<sub>3</sub> (686 mg, 4.96 mmol) in dry NMP (3 mL) was heated at 120 °C under argon. As TLC showed incomplete reaction after 5 h, an additional amount of 3-methylpyrazole (0.30 mL, 3.72 mmol) was added and heating was continued for 20 h. The reaction mixture was then poured into water (30 mL) and extracted with AcOEt (2 × 150 mL). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated in vacuo. Flash chromatography (<i>n</i>-heptane to 75:25 <i>n</i>-heptane/Et<sub>2</sub>O) afforded the title compound as a colorless oil (<i>R</i><sub>f</sub> = 0.2, 49.2 mg, 9%). <sup>1</sup>H NMR (200 MHz, CDCl<sub>3</sub>) δ 2.37 (s, 3H), 2.38 (s, 3H), 3.93 (s, 3H), 6.25 (d, 1H, <i>J</i> = 2.4 Hz), 7.42 (d, 1H, <i>J</i> = 8.3 Hz), 7.55 (d, 1H, <i>J</i> = 2.2 Hz), 7.93 (m, 1H), 7.99 (m, 1H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 13.5, 18.6, 52.2, 106.7, 125.7, 128.0, 129.2, 131.2, 132.8, 132.9, 143.4, 150.2, 166.4. IR (CsI) ν (cm<sup>−1</sup>) 2953, 2928, 2852, 1721, 1610, 1585, 1535, 1505, 1437, 1394, 1364, 1288, 1267, 1248, 1218, 1198, 1130, 1112, 1040, 1012, 980, 949, 843, 788, 770, 716. The isomer methyl 3-methyl-4-(5-methyl-1<i>H</i>-pyrazol-1-yl)benzoate was also isolated as a yellow solid (<i>R</i><sub>f</sub> = 0.1, 3.7 mg, 1%); mp 58−60 °C. <sup>1</sup>H NMR (200 MHz, CDCl<sub>3</sub>) δ 2.10 (s, 3H), 2.12 (s, 3H), 3.94 (s, 3H), 6.20 (s, 1H), 7.30 (d, 1H, <i>J</i> = 8.0 Hz), 7.60 (d, 1H, <i>J</i> = 1.6 Hz), 7.96 (m, 1H), 8.02 (m, 1H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 11.3, 17.3, 52.3, 105.7, 127.8, 130.7, 132.3, 136.6, 139.46, 139.9, 142.3, 142.4, 166.4. IR (CsI) ν (cm<sup>−1</sup>) 2954, 2924, 2852, 1726, 1613, 1586, 1544, 1509, 1438, 1411, 1391, 1297, 1257, 1201, 1132, 1106, 1018, 976, 923, 786, 773, 724.</div></div><div id="sec7_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> Methyl 2-Chloro-4-(3-methyl-1<i>H</i>-pyrazol-1-yl)benzoate (<b>29b</b>)</h3><div class="NLM_p last">Prepared from methyl 2-chloro-4-fluorobenzoate <b>28b</b> (1.00 g, 5.30 mmol) and 3-methylpyrazole (0.51 mL, 6.36 mmol) as described for compound <b>29a</b> (6 h reflux); white solid (545 mg, 41%); <i>R</i><sub>f</sub><b>=</b> 0.5 (7:3 <i>n</i>-heptane/AcOEt); mp 64−65 °C. <sup>1</sup>H NMR (200 MHz, CDCl<sub>3</sub>) δ 2.38 (s, 3H), 3.94 (s, 3H), 6.31 (d, 1H, <i>J</i> = 2.4 Hz), 7.60 (dd, 1H, <i>J</i> = 8.6, 2.2 Hz), 7.82 (d, 1H, <i>J</i> = 2.2 Hz), 7.86 (d, 1H, <i>J</i> = 2.4 Hz), 7.97 (d, 1H, <i>J</i> = 8.6 Hz). <sup>13</sup>C NMR (50 MHz, CDCl<sub>3</sub>) δ 13.7, 52.4, 109.0, 115.6, 120.4, 126.1, 127.5, 133.0, 135.6, 142.8, 152.0, 165.3. IR (KBr) ν (cm<sup>−1</sup>) 3153, 2987, 2947, 2929, 2848, 1730, 1604, 1572, 1541, 1505, 1439, 1395, 1378, 1359, 1310, 1264, 1251, 1226, 1194, 1124, 1088, 1044, 965, 951, 834, 769, 750. Isomer methyl 2-chloro-4-(5-methyl-1<i>H</i>-pyrazol-1-yl)benzoate; cream-colored solid (93 mg, 7%); <i>R</i><sub>f</sub><b>=</b> 0.4 (7:3 <i>n</i>-heptane/AcOEt); mp 80−81 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 2.44 (s, 3H), 3.97 (s, 3H), 6.24 (s, 1H), 7.48 (dd, 1H, <i>J</i> = 8.4, 1.9 Hz), 7.62 (s, 1H), 7.67 (d, 1H, <i>J</i> = 2.2 Hz), 7.98 (d, 1H, <i>J</i> = 8.4 Hz). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 12.8, 52.5, 108.4, 121.7, 126.3, 128.1, 132.2, 134.7, 139.0, 141.0, 143.0, 165.3. IR (KBr) ν (cm<sup>−1</sup>) 3111, 3053, 2989, 2950, 2846, 1733, 1604, 1403, 1261, 1119, 1054, 504.</div></div><div id="sec7_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 3-Methyl-4-(3-methyl-1<i>H</i>-pyrazol-1-yl)benzoic Acid (<b>30a</b>)</h3><div class="NLM_p last">A solution of <b>29a</b> (137 mg, 0.597 mmol) in a 1:1 6 N HCl/AcOH mixture (2 mL) was refluxed for 6 h and then poured in an ice/water mixture (30 mL) and extracted with CHCl<sub>3</sub> (2 × 50 mL). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated in vacuo to yield the title compound as a white powder (128 mg, 99%); mp 142−144 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 2.39 (s, 3H), 2.40 (s, 3H), 6.27 (d, 1H, <i>J</i> = 2.2 Hz), 7.46 (d, 1H, <i>J</i> = 8.1 Hz), 7.57 (d, 1H, <i>J</i> = 2.2 Hz), 8.00 (dd, 1H, <i>J</i> = 8.3, 1.7 Hz), 8.06 (s, 1H), 10.53 (bs, 1H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 13.5, 18.7, 106.9, 125.8, 128.5, 128.6, 131.3, 132.9, 133.5, 143.8, 150.4, 170.8. IR (KBr) ν (cm<sup>−1</sup>) 3200−2400, 2986, 2929, 1678, 1610, 1579, 1540, 1508, 1433, 1402, 1367, 1317, 1304, 1284, 1221, 1068, 1041, 952, 926, 911, 834, 771, 754, 577.</div></div><div id="sec7_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> 2-Chloro-4-(3-methyl-1<i>H</i>-pyrazol-1-yl)benzoic Acid (<b>30b</b>)</h3><div class="NLM_p last">A solution of <b>29b</b> (545 mg, 2.17 mmol) in a 1:1 6 N HCl/AcOH mixture (7 mL) was refluxed for 6 h and then poured in an ice/water mixture (50 mL). The precipitate was filtered, washed with water, and dried in vacuo under P<sub>2</sub>O<sub>5</sub> to yield the title compound as a white powder (493 mg, 99%); mp 166−168 °C (sublimation). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 2.26 (s, 3H), 6.40 (d, 1H, <i>J</i> = 2.5 Hz), 7.80−8.00 (m, 3H), 8.53 (d, 1H, <i>J</i> = 2.2 Hz), 13.32 (bs, 1H). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.4, 109.0, 115.8, 119.0, 126.9, 129.1, 132.8, 133.6, 142.1, 151.1, 165.8. IR (KBr) ν (cm<sup>−1</sup>) 3146, 3081, 2952, 2800−2300, 1731, 1602, 1538, 1433, 1369, 1298, 1252, 1123, 1047, 965, 831.</div></div><div id="sec7_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> 1-Methyl-5-[3-methyl-4-(3-methyl-1<i>H</i>-pyrazol-1-yl)benzoyl]-1,4,5,10-tetrahydropyrazolo[3,4-<i>b</i>][1,5]benzodiazepine (<b>31a</b>)</h3><div class="NLM_p last">To a stirred solution of <b>30a</b> (114 mg, 0.530 mmol) in dry DCM (3 mL) at 0 °C under argon were added successively dry NMP (3 drops) and SOCl<sub>2</sub> (0.10 mL, 1.325 mmol). The resulting reaction mixture was stirred at rt overnight. The solvent was removed in vacuo, and the resulting residue was dissolved in dry THF. The solvent was removed in vacuo, and the resulting residue was dried under high vacuum for 1 h. Amide coupling was then performed starting from the acyl chloride and amine <b>7</b> (116.7 mg, 0.583 mmol) as described for compound <b>21a</b> (stirring at rt for 3 days, 10% citric acid wash instead of 1 N HCl, flash chromatography in 98:2 DCM/MeOH); cream-colored foam (113 mg, 53%); mp 140−142 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 2.15 (s, 3H), 2.32 (s, 3H), 3.84 (s, 3H), 3.98 (d, 1H, <i>J</i> = 14.6 Hz), 5.92 (d, 1H, <i>J</i> = 14.6 Hz), 6.17 (s, 1H), 6.72 (s, 2H), 6.91 (bs, 1H), 6.95−7.15 (m, 4H), 7.30 (s, 2H), 7.39 (s, 1H). <sup>13</sup>C NMR (50 MHz, CDCl<sub>3</sub>) δ 13.5, 18.3, 35.0, 43.3, 101.7, 106.4, 119.4, 122.9, 124.9, 126.1, 128.7, 130.6, 131.2, 131.4, 132.6, 132.7, 135.1, 135.5, 137.7, 140.2, 140.8, 149.8, 168.6. IR (KBr) ν (cm<sup>−1</sup>) 3289, 3137, 3064, 2958, 2927, 2872, 1634, 1606, 1561, 1532, 1504, 1447, 1397, 1380, 1322, 1295, 1251, 1178, 1136, 1040, 992, 951, 837, 815, 758, 733. HRMS (ES): calcd for C<sub>23</sub>H<sub>23</sub>N<sub>6</sub>O, 399.1928; found, 399.1922. RP-HPLC (gradient 1, flow rate: 1 mL/min): <i>t</i><sub>R</sub> 19.6 min, purity >98%.</div></div><div id="sec7_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> 5-[2-Chloro-4-(3-methyl-1<i>H</i>-pyrazol-1-yl)benzoyl]-1-methyl-1,4,5,10-tetrahydro pyrazolo[3,4-<i>b</i>][1,5]benzodiazepine (<b>31b</b>)</h3><div class="NLM_p last">Prepared from acid <b>30b</b> (280 mg, 1.18 mmol) and amine <b>7</b> (182 mg, 0.91 mmol) as described for compound <b>31a</b>, but the reaction mixture was irradiated under microwaves at 80 °C (2 bar) for 8 min; beige powder (309 mg, 81%); two isomers present in 3:1 proportions; mp 176−178 °C (from EtOH). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 2.32 (s, 2.27H), 2.39 (s, 0.73H), 3.76 (s, 3H), 4.05 (d, 1H, <i>J</i> = 14.3 Hz), 5.87 (d, 1H, <i>J</i> = 14.4 Hz), 6.22 (d, 0.9H, <i>J</i> = 2.2 Hz), 6.32 (s, 1H), 6.68 (t, 1H, <i>J</i> = 7.5 Hz), 6.86 (d, 1H, <i>J</i> = 7.8 Hz), 6.90−7.20 (m, 3H), 7.20−7.45 (m, 2H), 7.58 (d, 0.9H, <i>J</i> = 1.9 Hz), 7.70 (d, 0.9H, <i>J</i> = 2.2 Hz), 7.83 (d, 0.2H, <i>J</i> = 2.2 Hz), 7.91 (app bs, 0.2H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 13.65, 34.80, 42.98, 100.96, 108.4, 115.7, 119.1, 119.2, 122.3, 127.4, 128.5, 129.0, 129.9, 132.2, 133.4, 136.4, 138.1, 139.1, 140.6, 151.4, 166.6. IR (ATR) ν (cm<sup>−1</sup>) 3304, 2929, 1627, 1603, 1563, 1558, 1537, 1504, 1448, 1410, 1398, 1360, 1323, 1301, 1254, 1246, 1229, 1151, 1049, 956, 947, 838, 827, 788, 767, 756, 731, 718, 702, 522, 440. HRMS (ES): calcd for C<sub>22</sub>H<sub>20</sub>ClN<sub>6</sub>O, 419.1382; found, 419.1376. RP-HPLC (gradient 2): <i>t</i><sub>R</sub> 18.7 min, purity 97.2% (254 nm).</div></div><div id="sec7_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> Biology: Material and Methods</h3><div class="NLM_p last">AVP and OT were purchased from Bachem or Novabiochem, [<sup>3</sup>H]AVP from Amersham or PerkinElmer Life and Analytical Sciences, BSA from Sigma and Ro-20-1724 (4-(3-butoxy-4-methoxyphenyl)methyl-2-imidazolidone) from Calbiochem. Synthesized compounds were initially dissolved in DMSO at 10 or 1 μM and then diluted to the desired concentration with the assay buffer.</div></div><div id="sec7_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> Cell Culture</h3><div class="NLM_p last">The CHO cell lines, which stably express the human vasopressin V<sub>1a</sub>, V<sub>2</sub>, or oxytocin receptors, were maintained in culture in Dulbecco’s modified Eagle’s medium (D-MEM) supplemented with 10% fetal calf serum, one dose of nonessential aminoacids, 100 units/mL penicillin, and 100 μg/mL streptomycin in an atmosphere of 95% air and 5% CO<sub>2</sub> at 37 °C.</div></div><div id="sec7_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> Membrane Preparations</h3><div class="NLM_p last">To increase the level of expression of some receptors (OT-R, V<sub>1a</sub>-R), the cells were treated overnight with 5 mM sodium butyrate.<a onclick="showRef(event, 'ref35 ref55'); return false;" href="javascript:void(0);" class="ref ref35 ref55">(35, 55)</a> As already published, this treatment does not modify the pharmacological properties of the receptors. The membranes were prepared as already described.<a onclick="showRef(event, 'ref34 ref35 ref36 ref50 ref55'); return false;" href="javascript:void(0);" class="ref ref34 ref35 ref36 ref50 ref55">(34-36, 50, 55)</a> Briefly, culture dishes of CHO cells expressing the human vasopressin V<sub>1a</sub>, V<sub>2</sub>, or oxytocin receptors were washed twice in phosphate-buffered saline without Ca<sup>2+</sup> and Mg<sup>2+</sup>, and cold lysis buffer (15 mM Tris-HCl, 2 mM MgCl<sub>2</sub>, 0.3 mM EDTA, pH 7.4) was added. Cells were scraped with a rubber, Polytron-homogenized, and centrifuged at 800<i>g</i> for 7 min at 4 °C. Supernatants were recovered and centrifuged at 44000<i>g</i> for 25 min at 4 °C. Pellets were resuspended in a suspension medium (50 mM Tris-HCl, 5 mM MgCl<sub>2</sub>, pH 7.4) and centrifuged at 44000<i>g</i> for 25 min at 4 °C. Pellets were resuspended in an appropriate volume of the same buffer, and the protein content was determined by the Bradford method (Bio-Rad) using BSA as the standard. Aliquots of membranes were used immediately for binding assays or stored at −80 °C.</div></div><div id="sec7_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> Radioligand Binding Assays</h3><div class="NLM_p last">Binding assays were performed at 30 °C using [<sup>3</sup>H]AVP as the radioligand and CHO cells-membrane proteins (10−15 μg for V<sub>1a</sub> and OT receptors, 5 μg for V<sub>2</sub> receptor), as previously described.<a onclick="showRef(event, 'ref34 ref35 ref36 ref50 ref55'); return false;" href="javascript:void(0);" class="ref ref34 ref35 ref36 ref50 ref55">(34-36, 50, 55)</a> Briefly, membranes of CHO cells stably expressing human vasopressin V<sub>1a</sub>, V<sub>2</sub>, or oxytocin receptors were incubated for 30 min at 30 °C in the binding buffer (50 mM Tris-HCl, 5 mM MgCl<sub>2</sub>, 1 mg/mL BSA, pH 7.4) with the radiolabeled and displacing ligands. The affinities (<i>K</i><sub>d</sub>) of [<sup>3</sup>H]AVP for the human vasopressin V<sub>1a</sub>, V<sub>2</sub>, and oxytocin receptors have already been described earlier in saturation experiments, respectively <i>K</i><sub>d</sub> = (0.70 ± 0.17) nM, (1.36 ± 0.45) nM, and (1.36 ± 1.00) nM.<a onclick="showRef(event, 'ref50 ref55'); return false;" href="javascript:void(0);" class="ref ref50 ref55">(50, 55)</a> The affinities (<i>K</i><sub>i</sub>) of the unlabeled ligands were determined by competition experiments using [<sup>3</sup>H]AVP (1−2 nM) and varying the concentrations of the displacing ligands from 0.1 pM to 100 μM (without exceeding a 4% final concentration in DMSO). Nonspecific binding was determined by adding an excess of AVP (10 μM). Bound and free radioactivity were separated by filtration on a Brandel apparatus over Whatman GF/C filters presoaked in a 10 mg/mL BSA solution for 3−4 h. Radioactivity on the filters was counted on a β-counter Tricarb 2100TR (Packard). The ligand binding data were analyzed by nonlinear least-squares regression using the computer program Kell Radlig. The inhibition constants (<i>K</i><sub>i</sub>) for unlabeled ligands were calculated according to the Cheng and Prusoff equation: <i>K</i><sub>i</sub> = IC<sub>50</sub>/(1 + [L*]/<i>K</i><sub>d</sub>), where IC<sub>50</sub> is the concentration of unlabeled ligand leading to half-maximal inhibition of specific binding, [L*] is the concentration of the radioligand present in the assay, and <i>K</i><sub>d</sub> is its affinity for the receptor studied. The given <i>K</i><sub>i</sub> values are expressed as the mean ± SEM of at least three independent experiments, each performed in triplicate, unless otherwise specified.</div></div><div id="sec7_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> Functional Assays</h3><div class="NLM_p last">The functional agonist and competitive antagonist properties of each ligand were determined for the human vasopressin and oxytocin receptors subtypes stably expressed in CHO cells. The accumulation of <i>myo</i>-inositol 1-phosphate (V<sub>1a</sub> and OT receptors) was determined by the IP-One assay, and the accumulation of cAMP (V<sub>2</sub> receptor) was determined by the cAMP <i>dynamic 2</i> assay, both kindly provided by Cisbio International. Briefly, CHO cells stably expressing the human vasopressin V<sub>1a</sub>, V<sub>2</sub>, or oxytocin receptors were seeded (at 80−90% confluence) at a density of 80000 cells/well for V<sub>1a</sub> and OT receptors, and 1000 cells/well for V<sub>2</sub> receptor, in 96-well culture plates (Greiner) in their culture medium in an atmosphere of 95% air and 5% CO<sub>2</sub> at 37 °C overnight. After removal of the culture medium, ligands in the stimulation buffer (already furnished in the IP-One kit; D-MEM supplemented with 0.1 mM of the phosphodiesterases inhibitor Ro-20-1724 and 1 mg/mL BSA for the cAMP assay) were added in increasing final concentrations ranging from 10 fM to 100 μM (without exceeding a 1% final concentration in DMSO). To test the agonist effect, cells were incubated with the ligands for 30 min (37 °C + 5% CO<sub>2</sub>), the positive control used being 1 μM AVP for V<sub>1a</sub>-R, 0.1 μM AVP for V<sub>2</sub>-R, and 1 μM OT for OT-R. To test the competitive antagonist effect, cells were preincubated with the ligands for 10 min (37 °C + 5% CO<sub>2</sub>) and then stimulated by the corresponding endogenous agonist (2 nM AVP for V<sub>1a</sub>-R, 1 nM AVP for V<sub>2</sub>-R, and 50 nM OT for OT-R) and incubated for 30 min (37 °C + 5% CO<sub>2</sub>). The cells were lysed and incubated at rt with the IP<sub>1</sub>−d2 and anti-IP<sub>1</sub>−cryptate conjugates (IP-One), or cAMP−d2 and anti-cAMP−cryptate conjugates (cAMP <i>dynamic 2</i>). After 1−2 h incubation, fluorescence emissions were measured both at 620 nm and at 665 nm on a RubyStar fluorometer (BMG Labtechnologies) equipped with a nitrogen laser as excitation source (337 nm). A 400 μs reading was measured after a 50 μs delay to eliminate the short-lived fluorescence background from the specific signal. The fluorescence intensities measured at 620 nm and at 665 nm correspond to the total europium cryptate emission and to the FRET signal, respectively. The specific signal was calculated using the following equation: Δ<i>F</i> = (<i>R</i> − <i>R</i><sub>neg</sub>)/<i>R</i><sub>neg</sub>. <i>R</i> is the ratio (fluorescence 665 nm/fluorescence 620 nm) × 100 calculated in wells incubated with both donor- and acceptor-labeled antibodies, whereas <i>R</i><sub>neg</sub> is the same ratio for the negative control. The functional data were analyzed by nonlinear regression using GraphPad Prism. For the agonist properties, concentrations of ligands leading to half-maximal IP<sub>1</sub> or cAMP accumulation (EC<sub>50</sub> or activation constant <i>K</i><sub>act</sub>) were calculated from the sigmoidal dose−response curves, and the maximal responses induced by ligands (<i>E</i><sub>max</sub>) are expressed as percentages of maximal stimulation of IP<sub>1</sub> or cAMP accumulation by the corresponding endogenous agonist. For the antagonist properties, concentrations of ligands leading to half-maximal inhibition (IC<sub>50</sub>) of IP<sub>1</sub> or cAMP accumulation were calculated from the inversed sigmoidal dose−response curve. The inactivation constants (<i>K</i><sub>inact</sub>) were calculated as: <i>K</i><sub>inact</sub> = IC<sub>50</sub>/(1 + [ago]/<i>K</i><sub>act</sub>), where [ago] is the concentration of the endogenous agonist present in the assay ([AVP] = 2 nM for V<sub>1a</sub>-R, [AVP] = 1 nM for V<sub>2</sub>-R, and [OT] = 50 nM for OT-R), and <i>K</i><sub>act</sub> is the concentration of this agonist inducing half-maximal stimulation of IP<sub>1</sub> or cAMP accumulation (<i>K</i><sub>act</sub> (AVP) = (1.20 ± 0.33) nM for V<sub>1a</sub>-R, <i>K</i><sub>act</sub> (AVP) = (0.25 ± 0.07) nM for V<sub>2</sub>-R, and <i>K</i><sub>act</sub> (OT) = (10.6 ± 0.3) nM for OT-R). Results are expressed as the mean ± SEM of at least three independent experiments, each performed in triplicate, unless otherwise specified.</div></div><div id="sec7_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> Molecular Modeling</h3><div class="NLM_p">The protocol used for molecular modeling studies was as published recently by our group.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Very briefly, the residue numbering proposed by Ballesteros and Weinstein<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> was used throughout this manuscript. It allows an unambiguous comparison of TM residues for any class A GPCR by assigning position 50 to a fully conserved amino acid at each TM and numbering other amino acids according to this reference residue. Residue x.y is thus the amino acid describing position y of TMx. For purposes of clarification, amino acids from the peptide ligands will be labeled using a three-letter code, whereas receptor residues will be labeled using a single-letter code.</div><div class="NLM_p last">The amino acid sequences of human OT receptor was retrieved from the Swiss-Prot database and aligned to the sequence of bovine rhodopsin using the in-house developed GPCRmod program<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> focusing on transmembrane (TM) domains only. The alignment of the amino and carboxy-terminal domains as well as of the intra- and extracellular loops was realized using ClustalW.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> Modeling the AVP-bound conformation of human V<sub>1a</sub> and V<sub>1b</sub> receptors 3-D ground-state models of human V<sub>1a</sub> and V<sub>1b</sub> receptors have recently been reported by our group.<a onclick="showRef(event, 'ref37 ref55 ref97 ref98'); return false;" href="javascript:void(0);" class="ref ref37 ref55 ref97 ref98">(37, 55, 97, 98)</a> To achieve an agonist-bound model from an antagonist-bound model, we followed a five-step protocol as proposed by Bissantz et al.<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> It should be observed that the starting conformation of OT was modeled from the X-ray structure of neurophysin-bound OT.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Compound <b>1</b> was built starting from the X-ray structure of its truncated analogue <b>12c</b>, and then it was fully optimized with HF/6-31* level using geometry optimization with Gaussian 03.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> OT and compound <b>1</b> were docked to this preliminary model using the Gold 3.0 program.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> For each of the 10 independent genetic algorithm (GA) runs, a maximum number of 1000 GA operations was performed on a single population of 50 individuals. Operator weights for crossover, mutation, and migration were set to 100, 100, and 0, respectively. To allow poor nonbonded contacts at the start of each GA run, the maximum distance between hydrogen donors and fitting points was set to 5 Å, and nonbonded van der Waals energies were cut off at a value equal to <i>kij</i> (well depth of the van der Waals energy for the atom pair <i>i</i>,<i>j</i>). To further speed up the calculation, the GA docking was stopped when the top three solutions were within 1.5 Å rmsd. If this criterion is met, we can assume that these top solutions represent a reproducible pose for the ligand.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i64"><a href="/doi/suppl/10.1021/jm901084f">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74214" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74214" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Proposed binding mode of oxytocin to human oxytocin receptor and HPLC tracings for target compounds. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm901084f/suppl_file/jm901084f_si_001.pdf">jm901084f_si_001.pdf (1.64 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm901084f" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67653" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67653" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marcel Hibert</span> - <span class="hlFld-Affiliation affiliation">Laboratoire d’Innovation Thérapeutique, UMR 7200 CNRS/Université de Strasbourg, Faculté de Pharmacie, 74 route du Rhin, BP60024, 67401 Illkirch, France</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#7d1015141f180f093d0d151c0f101c5308500e090f1c0e1f1a531b0f"><span class="__cf_email__" data-cfemail="bcd1d4d5ded9cec8fcccd4ddced1dd92c991cfc8ceddcfdedb92dace">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marie-Céline Frantz</span> - <span class="hlFld-Affiliation affiliation">Laboratoire d’Innovation Thérapeutique, UMR 7200 CNRS/Université de Strasbourg, Faculté de Pharmacie, 74 route du Rhin, BP60024, 67401 Illkirch, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jordi Rodrigo</span> - <span class="hlFld-Affiliation affiliation">Laboratoire d’Innovation Thérapeutique, UMR 7200 CNRS/Université de Strasbourg, Faculté de Pharmacie, 74 route du Rhin, BP60024, 67401 Illkirch, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laure Boudier</span> - <span class="hlFld-Affiliation affiliation">Institut de Génomique Fonctionnelle UMR CNRS 5203/INSERM U661/Université Montpellier I & II, Dept Pharmacologie Moléculaire, 141 rue de la Cardonille, 34094 Montpellier, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thierry Durroux</span> - <span class="hlFld-Affiliation affiliation">Institut de Génomique Fonctionnelle UMR CNRS 5203/INSERM U661/Université Montpellier I & II, Dept Pharmacologie Moléculaire, 141 rue de la Cardonille, 34094 Montpellier, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bernard Mouillac</span> - <span class="hlFld-Affiliation affiliation">Institut de Génomique Fonctionnelle UMR CNRS 5203/INSERM U661/Université Montpellier I & II, Dept Pharmacologie Moléculaire, 141 rue de la Cardonille, 34094 Montpellier, France</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i63">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12885" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12885" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Warm thanks are due to Dr. Hadjila Chabane for the preparation of compound <b>15</b> and for her constant connection to the project, and to Dr. Dominique Bonnet and Didier Rognan for their scientific support. This work was supported by the Ministère de la Recherche for fundings to MCF and by the European Commission for the Marie-Curie fellowship to J.R. (HPMF-CT-2002-02141). L.B. was supported by grants from the French Agence Nationale de la Recherche (ANR-06-PCVI-0021-03). This work was possible due to the Plateforme Pharmacologie-Criblage-Interactome of the Institut Fédératif de Recherche no. 3 in Montpellier. This work was supported by grants from CNRS, INSERM, Université de Strasbourg, and Université Montpellier 1 and 2. We thank Pascale Buisine and Patrick Werhung (IFR85) for MS analyses and Cyril Antheaume for NMR analyses.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i65">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70047" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70047" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 99 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Carter, C. S.</span><span> </span><span class="NLM_article-title">Neuroendocrine perspectives on social attachment and love</span> <span class="citation_source-journal">Psychoneuroendocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">779</span><span class="NLM_x">–</span> <span class="NLM_lpage">818</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1998&pages=779-818&author=C.+S.+Carter&title=Neuroendocrine+perspectives+on+social+attachment+and+love"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarter%26aufirst%3DC.%2BS.%26atitle%3DNeuroendocrine%2520perspectives%2520on%2520social%2520attachment%2520and%2520love%26jtitle%3DPsychoneuroendocrinology%26date%3D1998%26volume%3D23%26spage%3D779%26epage%3D818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Insel, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, L. J.</span><span> </span><span class="NLM_article-title">The neurobiology of attachment</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">129</span><span class="NLM_x">–</span> <span class="NLM_lpage">136</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm901084f&amp;key=10.1038%2F35053579" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm901084f&amp;key=11252992" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADC%252BD3MXisl2qu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2001&pages=129-136&author=T.+R.+Inselauthor=L.+J.+Young&title=The+neurobiology+of+attachment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The neurobiology of attachment</span></div><div class="casAuthors">Insel, Thomas R.; Young, Larry J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">129-136</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review, with 92 refs.  Attachment behavior is both biol. important and tech. difficult to study.  The behavior is complex and there are changes in several cognitive and affective variables to consider.  Nevertheless, recent studies with chicks, rats, sheep, voles and now humans have begun to reveal some important candidates for the neurobiol. of social attachment.  The neuropeptides oxytocin and vasopressin have yielded a model that links mol., cellular and systems approaches.  Dopamine pathways in the forebrain, esp. the nucleus accumbens and ventral pallidum, seem to be important for certain aspects of partner preference formation.  It seems likely that for attachment to occur, these neuropeptides must link social stimuli to dopamine pathways assocd. with reinforcement.  It is also possible that neural mechanisms that we assoc. with drug abuse and addiction might have evolved for social recognition, reward and euphoria - crit. elements in the process of attachment.  In the very near future, we can hope that discoveries of the mol. and cellular mechanisms of addiction might be applied to the neurobiol. of attachment, providing a new understanding of one of our most complex and intriguing emotions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrV7XeeQsaynbVg90H21EOLACvtfcHk0liQ0Ls01p-6iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXisl2qu7w%253D&md5=9aeb3652478b32aea51a08bea47dfad6</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2F35053579&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35053579%26sid%3Dliteratum%253Aachs%26aulast%3DInsel%26aufirst%3DT.%2BR.%26aulast%3DYoung%26aufirst%3DL.%2BJ.%26atitle%3DThe%2520neurobiology%2520of%2520attachment%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2001%26volume%3D2%26spage%3D129%26epage%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Komisaruk, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whipple, B.</span><span> </span><span class="NLM_article-title">Love as sensory stimulation: physiological consequences of its deprivation and expression</span> <span class="citation_source-journal">Psychoneuroendocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">927</span><span class="NLM_x">–</span> <span class="NLM_lpage">944</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1998&pages=927-944&author=B.+R.+Komisarukauthor=B.+Whipple&title=Love+as+sensory+stimulation%3A+physiological+consequences+of+its+deprivation+and+expression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKomisaruk%26aufirst%3DB.%2BR.%26aulast%3DWhipple%26aufirst%3DB.%26atitle%3DLove%2520as%2520sensory%2520stimulation%253A%2520physiological%2520consequences%2520of%2520its%2520deprivation%2520and%2520expression%26jtitle%3DPsychoneuroendocrinology%26date%3D1998%26volume%3D23%26spage%3D927%26epage%3D944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Zeki, S.</span><span> </span><span class="NLM_article-title">The neurobiology of love</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">581</span><span class="NLM_x">, </span> <span class="NLM_fpage">2575</span><span class="NLM_x">–</span> <span class="NLM_lpage">2579</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=581&publication_year=2007&pages=2575-2579&author=S.+Zeki&title=The+neurobiology+of+love"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZeki%26aufirst%3DS.%26atitle%3DThe%2520neurobiology%2520of%2520love%26jtitle%3DFEBS%2520Lett.%26date%3D2007%26volume%3D581%26spage%3D2575%26epage%3D2579" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Debiec, J.</span><span> </span><span class="NLM_article-title">From affiliative behaviours to romantic feelings: a role of nanopeptides</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">581</span><span class="NLM_x">, </span> <span class="NLM_fpage">2580</span><span class="NLM_x">–</span> <span class="NLM_lpage">2586</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=581&publication_year=2007&pages=2580-2586&author=J.+Debiec&title=From+affiliative+behaviours+to+romantic+feelings%3A+a+role+of+nanopeptides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDebiec%26aufirst%3DJ.%26atitle%3DFrom%2520affiliative%2520behaviours%2520to%2520romantic%2520feelings%253A%2520a%2520role%2520of%2520nanopeptides%26jtitle%3DFEBS%2520Lett.%26date%3D2007%26volume%3D581%26spage%3D2580%26epage%3D2586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Porges, S. W.</span><span> </span><span class="NLM_article-title">Love: an emergent property of the mammalian autonomic nervous system</span> <span class="citation_source-journal">Psychoneuroendocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">837</span><span class="NLM_x">–</span> <span class="NLM_lpage">861</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1998&pages=837-861&author=S.+W.+Porges&title=Love%3A+an+emergent+property+of+the+mammalian+autonomic+nervous+system"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPorges%26aufirst%3DS.%2BW.%26atitle%3DLove%253A%2520an%2520emergent%2520property%2520of%2520the%2520mammalian%2520autonomic%2520nervous%2520system%26jtitle%3DPsychoneuroendocrinology%26date%3D1998%26volume%3D23%26spage%3D837%26epage%3D861" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Zak, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurzban, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matzner, W. T.</span><span> </span><span class="NLM_article-title">The neurobiology of trust</span> <span class="citation_source-journal">Ann. N. Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">1032</span><span class="NLM_x">, </span> <span class="NLM_fpage">224</span><span class="NLM_x">–</span> <span class="NLM_lpage">227</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1032&publication_year=2004&pages=224-227&author=P.+J.+Zakauthor=R.+Kurzbanauthor=W.+T.+Matzner&title=The+neurobiology+of+trust"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZak%26aufirst%3DP.%2BJ.%26aulast%3DKurzban%26aufirst%3DR.%26aulast%3DMatzner%26aufirst%3DW.%2BT.%26atitle%3DThe%2520neurobiology%2520of%2520trust%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2004%26volume%3D1032%26spage%3D224%26epage%3D227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Zak, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurzban, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matzner, W. T.</span><span> </span><span class="NLM_article-title">Oxytocin is associated with human trustworthiness</span> <span class="citation_source-journal">Horm. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">522</span><span class="NLM_x">–</span> <span class="NLM_lpage">527</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm901084f&amp;key=10.1016%2Fj.yhbeh.2005.07.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm901084f&amp;key=16109416" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Ghtb7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=522-527&author=P.+J.+Zakauthor=R.+Kurzbanauthor=W.+T.+Matzner&title=Oxytocin+is+associated+with+human+trustworthiness"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Oxytocin is associated with human trustworthiness</span></div><div class="casAuthors">Zak, Paul J.; Kurzban, Robert; Matzner, William T.</div><div class="citationInfo"><span class="NLM_cas:title">Hormones and Behavior</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">522-527</span>CODEN:
                <span class="NLM_cas:coden">HOBEAO</span>;
        ISSN:<span class="NLM_cas:issn">0018-506X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Human beings exhibit substantial interpersonal trust-even with strangers.  The neuroactive hormone oxytocin facilitates social recognition in animals, and we examine if oxytocin is related to trustworthiness between humans.  This paper reports the results of an expt. to test this hypothesis, where trust and trustworthiness are measured using the sequential anonymous "trust game" with monetary payoffs.  We find that oxytocin levels are higher in subjects who receive a monetary transfer that reflects an intention of trust relative to an unintentional monetary transfer of the same amt.  In addn., higher oxytocin levels are assocd. with trustworthy behavior (the reciprocation of trust).  Absent intentionality, both the oxytocin and behavioral responses are extinguished.  We conclude that perceptions of intentions of trust affect levels of circulating oxytocin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1SoMEe6-MrbVg90H21EOLACvtfcHk0liWeSLItFuJRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Ghtb7J&md5=61247d15e77adbc9377e436b3dc2b690</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.yhbeh.2005.07.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yhbeh.2005.07.009%26sid%3Dliteratum%253Aachs%26aulast%3DZak%26aufirst%3DP.%2BJ.%26aulast%3DKurzban%26aufirst%3DR.%26aulast%3DMatzner%26aufirst%3DW.%2BT.%26atitle%3DOxytocin%2520is%2520associated%2520with%2520human%2520trustworthiness%26jtitle%3DHorm.%2520Behav.%26date%3D2005%26volume%3D48%26spage%3D522%26epage%3D527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Kosfeld, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinrichs, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zak, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischbacher, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fehr, E.</span><span> </span><span class="NLM_article-title">Oxytocin increases trust in humans</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">435</span><span class="NLM_x">, </span> <span class="NLM_fpage">673</span><span class="NLM_x">–</span> <span class="NLM_lpage">676</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=435&publication_year=2005&pages=673-676&author=M.+Kosfeldauthor=M.+Heinrichsauthor=P.+J.+Zakauthor=U.+Fischbacherauthor=E.+Fehr&title=Oxytocin+increases+trust+in+humans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKosfeld%26aufirst%3DM.%26aulast%3DHeinrichs%26aufirst%3DM.%26aulast%3DZak%26aufirst%3DP.%2BJ.%26aulast%3DFischbacher%26aufirst%3DU.%26aulast%3DFehr%26aufirst%3DE.%26atitle%3DOxytocin%2520increases%2520trust%2520in%2520humans%26jtitle%3DNature%26date%3D2005%26volume%3D435%26spage%3D673%26epage%3D676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Heinrichs, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumgartner, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirschbaum, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehlert, U.</span><span> </span><span class="NLM_article-title">Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1389</span><span class="NLM_x">–</span> <span class="NLM_lpage">1398</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm901084f&amp;key=10.1016%2FS0006-3223%2803%2900465-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm901084f&amp;key=14675803" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpvVWqt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2003&pages=1389-1398&author=M.+Heinrichsauthor=T.+Baumgartnerauthor=C.+Kirschbaumauthor=U.+Ehlert&title=Social+support+and+oxytocin+interact+to+suppress+cortisol+and+subjective+responses+to+psychosocial+stress"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress</span></div><div class="casAuthors">Heinrichs, Markus; Baumgartner, Thomas; Kirschbaum, Clemens; Ehlert, Ulrike</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1389-1398</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">The presence of social support was assocd. with decreased stress responsiveness.  Recent animal studies suggest that the neuropeptide oxytocin is implicated both in prosocial behavior and in the central nervous control of neuroendocrine responses to stress.  This study was designed to det. the effects of social support and oxytocin on cortisol, mood, and anxiety responses to psychosocial stress in humans.  In a placebo-controlled, double-blind study, 37 healthy men were exposed to the Trier Social Stress Test.  All participants were randomly assigned to receive intranasal oxytocin (24 IU) or placebo 50 min before stress, and either social support from their best friend during the prepn. period or no social support.  Salivary free cortisol levels were suppressed by social support in response to stress.  Comparisons of pre- and poststress anxiety levels revealed an anxiolytic effect of oxytocin.  More importantly, the combination of oxytocin and social support exhibited the lowest cortisol concns. as well as increased calmness and decreased anxiety during stress.  Oxytocin seems to enhance the buffering effect of social support on stress responsiveness.  These results concur with data from animal research suggesting an important role of oxytocin as an underlying biol. mechanism for stress-protective effects of pos. social interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgqpFvk8yjfLVg90H21EOLACvtfcHk0lgQDxyW22iOIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpvVWqt7o%253D&md5=d3f47cf6cf602ace7cb6d3b32fbf6f0f</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FS0006-3223%2803%2900465-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-3223%252803%252900465-7%26sid%3Dliteratum%253Aachs%26aulast%3DHeinrichs%26aufirst%3DM.%26aulast%3DBaumgartner%26aufirst%3DT.%26aulast%3DKirschbaum%26aufirst%3DC.%26aulast%3DEhlert%26aufirst%3DU.%26atitle%3DSocial%2520support%2520and%2520oxytocin%2520interact%2520to%2520suppress%2520cortisol%2520and%2520subjective%2520responses%2520to%2520psychosocial%2520stress%26jtitle%3DBiol.%2520Psychiatry%26date%3D2003%26volume%3D54%26spage%3D1389%26epage%3D1398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Uvnäs-Moberg, K.</span><span> </span><span class="NLM_article-title">Oxytocin may mediate the benefits of positive social interaction and emotions</span> <span class="citation_source-journal">Psychoneuroendocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">819</span><span class="NLM_x">–</span> <span class="NLM_lpage">835</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1998&pages=819-835&author=K.+Uvn%C3%A4s-Moberg&title=Oxytocin+may+mediate+the+benefits+of+positive+social+interaction+and+emotions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUvn%25C3%25A4s-Moberg%26aufirst%3DK.%26atitle%3DOxytocin%2520may%2520mediate%2520the%2520benefits%2520of%2520positive%2520social%2520interaction%2520and%2520emotions%26jtitle%3DPsychoneuroendocrinology%26date%3D1998%26volume%3D23%26spage%3D819%26epage%3D835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">DeVries, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glasper, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Detillion, C. E.</span><span> </span><span class="NLM_article-title">Social modulation of stress responses</span> <span class="citation_source-journal">Physiol. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">339</span><span class="NLM_x">–</span> <span class="NLM_lpage">407</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2003&pages=339-407&author=A.+C.+DeVriesauthor=E.+R.+Glasperauthor=C.+E.+Detillion&title=Social+modulation+of+stress+responses"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDeVries%26aufirst%3DA.%2BC.%26aulast%3DGlasper%26aufirst%3DE.%2BR.%26aulast%3DDetillion%26aufirst%3DC.%2BE.%26atitle%3DSocial%2520modulation%2520of%2520stress%2520responses%26jtitle%3DPhysiol.%2520Behav.%26date%3D2003%26volume%3D79%26spage%3D339%26epage%3D407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Insel, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Brien, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leckman, J. F.</span><span> </span><span class="NLM_article-title">Oxytocin, vasopressin, and autism: is there a connection?</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">145</span><span class="NLM_x">–</span> <span class="NLM_lpage">157</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm901084f&amp;key=10.1016%2FS0006-3223%2898%2900142-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm901084f&amp;key=9951561" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADyaK1MXhtVequr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1999&pages=145-157&author=T.+R.+Inselauthor=D.+J.+O%27Brienauthor=J.+F.+Leckman&title=Oxytocin%2C+vasopressin%2C+and+autism%3A+is+there+a+connection%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Oxytocin, vasopressin, and autism: is there a connection?</span></div><div class="casAuthors">Insel, Thomas R.; O'Brien, Derek J.; Leckman, James F.</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">145-157</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review, with 121 refs., discussing autism, which is a poorly understood developmental disorder characterized by social impairment, communication deficits, and compulsive behavior.  The authors review evidence from animal studies demonstrating that the nonapeptides, oxytocin and vasopressin, have unique effects on the normal expression of species-typical social behavior, communication, and rituals.  Based on this evidence, they hypothesize that an abnormality in oxytocin or vasopressin neurotransmission may account for several features of autism.  As autism appears to be a genetic disorder, mutations in the various peptide, peptide receptor, or lineage-specific developmental genes could lead to altered oxytocin or vasopressin neurotransmission.  Many of these genes have been cloned and sequenced, and several polymorphisms have been identified.  Recent gene targeting studies that alter expression of either the peptides or their receptors in the rodent brain partially support the autism hypothesis.  While previous experience suggests caution in hypothesizing a cause or suggesting a treatment for autism, the available preclin. evidence with oxytocin and vasopressin recommends the need for clin. studies using gene scanning, pharmacol. and neurobiol. approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_nme_mqBvx7Vg90H21EOLACvtfcHk0lgQDxyW22iOIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhtVequr8%253D&md5=9915c5a9d9ad2add78eca8714c5e5012</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2FS0006-3223%2898%2900142-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-3223%252898%252900142-5%26sid%3Dliteratum%253Aachs%26aulast%3DInsel%26aufirst%3DT.%2BR.%26aulast%3DO%2527Brien%26aufirst%3DD.%2BJ.%26aulast%3DLeckman%26aufirst%3DJ.%2BF.%26atitle%3DOxytocin%252C%2520vasopressin%252C%2520and%2520autism%253A%2520is%2520there%2520a%2520connection%253F%26jtitle%3DBiol.%2520Psychiatry%26date%3D1999%26volume%3D45%26spage%3D145%26epage%3D157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Kim, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veenstra-VanderWeele, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courchesne, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courchesne, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leventhal, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, E. H.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Insel, T. R.</span><span> </span><span class="NLM_article-title">Transmission disequilibrium testing of arginine vasopressin receptor 1A (AVPR1A) polymorphisms in autism</span> <span class="citation_source-journal">Mol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">503</span><span class="NLM_x">–</span> <span class="NLM_lpage">507</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm901084f&amp;key=10.1038%2Fsj.mp.4001125" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm901084f&amp;key=12082568" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADC%252BD38XkslKmt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2002&pages=503-507&author=S.+J.+Kimauthor=L.+J.+Youngauthor=D.+Gonenauthor=J.+Veenstra-VanderWeeleauthor=R.+Courchesneauthor=E.+Courchesneauthor=C.+Lordauthor=B.+L.+Leventhalauthor=E.+H.+Cookauthor=T.+R.+Insel&title=Transmission+disequilibrium+testing+of+arginine+vasopressin+receptor+1A+%28AVPR1A%29+polymorphisms+in+autism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Transmission disequilibrium testing of arginine vasopressin receptor 1A (AVPR1A) polymorphisms in autism</span></div><div class="casAuthors">Kim, S-J.; Young, L. J.; Gonen, D.; Veenstra-VanderWeele, J.; Courchesne, R.; Courchesne, E.; Lord, C.; Leventhal, B. L.; Cook, E. H., Jr.; Insel, T. R.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Psychiatry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">503-507</span>CODEN:
                <span class="NLM_cas:coden">MOPSFQ</span>;
        ISSN:<span class="NLM_cas:issn">1359-4184</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Impairment in social reciprocity is a central component of autism.  In preclin. studies, arginine vasopressin (AVP) has been shown to increase a range of social behaviors, including affiliation and attachment, via the V1a receptor (AVPR1A) in the brain.  Both the behavioral effects of AVP and the neural distribution of the V1a receptor vary greatly across mammalian species.  This difference in regional receptor expression as well as differences in social behavior may result from a highly variable repetitive sequence in the 5' flanking region of the V1a gene (AVPR1A).  Given this comparative evidence for a role in inter-species variation in social behavior, the authors explored whether within our own species, variation in the human AVPR1A may contribute to individual variations in social behavior, with autism representing an extreme form of social impairment.  The authors genotyped two microsatellite polymorphisms from the 5' flanking region of AVPR1A for 115 autism trios and found nominally significant transmission disequil. between autism and one of the microsatellite markers by Multiallelic Transmission/Disequil. test (MTDT) that was not significant after Bonferroni correction.  They also screened approx. 2 kb of the 5' flanking region and the coding region and identified 10 single nucleotide polymorphisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdRwMCFdzxlbVg90H21EOLACvtfcHk0lgUwxfo8o8MFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XkslKmt78%253D&md5=29d9a30e6be3bf383800cc7aa69e9506</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fsj.mp.4001125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.mp.4001125%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DS.%2BJ.%26aulast%3DYoung%26aufirst%3DL.%2BJ.%26aulast%3DGonen%26aufirst%3DD.%26aulast%3DVeenstra-VanderWeele%26aufirst%3DJ.%26aulast%3DCourchesne%26aufirst%3DR.%26aulast%3DCourchesne%26aufirst%3DE.%26aulast%3DLord%26aufirst%3DC.%26aulast%3DLeventhal%26aufirst%3DB.%2BL.%26aulast%3DCook%26aufirst%3DE.%2BH.%26aulast%3DInsel%26aufirst%3DT.%2BR.%26atitle%3DTransmission%2520disequilibrium%2520testing%2520of%2520arginine%2520vasopressin%2520receptor%25201A%2520%2528AVPR1A%2529%2520polymorphisms%2520in%2520autism%26jtitle%3DMol.%2520Psychiatry%26date%3D2002%26volume%3D7%26spage%3D503%26epage%3D507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Wu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, D.</span><span> </span><span class="NLM_article-title">Positive association of the oxytocin receptor gene (OXTR) with autism in the Chinese Han population</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">74</span><span class="NLM_x">–</span> <span class="NLM_lpage">77</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm901084f&amp;key=10.1016%2Fj.biopsych.2005.03.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm901084f&amp;key=15992526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlslynurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2005&pages=74-77&author=S.+Wuauthor=M.+Jiaauthor=Y.+Ruanauthor=J.+Liuauthor=Y.+Guoauthor=M.+Shuangauthor=X.+Gongauthor=Y.+Zhangauthor=X.+Yangauthor=D.+Zhang&title=Positive+association+of+the+oxytocin+receptor+gene+%28OXTR%29+with+autism+in+the+Chinese+Han+population"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Positive Association of the Oxytocin Receptor Gene (OXTR) with Autism in the Chinese Han Population</span></div><div class="casAuthors">Wu, Suping; Jia, Meixiang; Ruan, Yan; Liu, Jing; Guo, Yanqing; Mei, Shuang; Gong, Xiaohong; Zhang, Yanbo; Yang, Xiaoling; Zhang, Dai</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">74-77</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Previous research has suggested that the social impairments exhibited by individuals with autism are assocd. with changes in plasma oxytocin (OT) levels.  The physiol. effects of oxytocin are mediated through its specific receptors (OTRs), and numerous studies have implicated OTRs in the regulation of social cognition and behavior.  Animal models and linkage data from genome screens indicate that the oxytocin receptor gene (OXTR) is an excellent candidate for research concerning psychiatric disorders, particularly those involving social impairments, such as autism.  We genotyped four single nucleotide polymorphisms (SNPs) located within the OXTR gene of 195 Chinese Han autism trios, using polymerase chain reaction-restriction fragment length polymorphism anal.  The family-based assocn. test (FBAT) revealed a significant genetic assocn. between autism and two of the SNPs tested (rs2254298 A: Z = 2.287, p = .0222; rs53576 A: Z = 2.573, p = .0101).  When haplotypes were constructed with two, three, and four markers, the haplotype-specific FBAT revealed that a no. of haplotypes, particularly those involving rs53576, were significantly assocd. with autism.  Furthermore, haplotypes constructed with all markers showed a significant excess transmission for the specific and global haplotype analyses (p = .0020 and .0289, resp.).  These data suggest an involvement of OXTR in the susceptibility to autism, and replication is important.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTdJutXtrhBbVg90H21EOLACvtfcHk0lgUwxfo8o8MFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlslynurw%253D&md5=e4acfcbd4c3c1f7a6abb7fb2d0e66633</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2005.03.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2005.03.013%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DS.%26aulast%3DJia%26aufirst%3DM.%26aulast%3DRuan%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DGuo%26aufirst%3DY.%26aulast%3DShuang%26aufirst%3DM.%26aulast%3DGong%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DD.%26atitle%3DPositive%2520association%2520of%2520the%2520oxytocin%2520receptor%2520gene%2520%2528OXTR%2529%2520with%2520autism%2520in%2520the%2520Chinese%2520Han%2520population%26jtitle%3DBiol.%2520Psychiatry%26date%3D2005%26volume%3D58%26spage%3D74%26epage%3D77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Jacob, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brune, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leventhal, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, E. H.,  Jr.</span><span> </span><span class="NLM_article-title">Association of the oxytocin receptor gene (OXTR) in Caucasian children and adolescents with autism</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">417</span><span class="NLM_x">, </span> <span class="NLM_fpage">6</span><span class="NLM_x">–</span> <span class="NLM_lpage">9</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=417&publication_year=2007&pages=6-9&author=S.+Jacobauthor=C.+W.+Bruneauthor=C.+S.+Carterauthor=B.+L.+Leventhalauthor=C.+Lordauthor=E.+H.+Cook&title=Association+of+the+oxytocin+receptor+gene+%28OXTR%29+in+Caucasian+children+and+adolescents+with+autism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJacob%26aufirst%3DS.%26aulast%3DBrune%26aufirst%3DC.%2BW.%26aulast%3DCarter%26aufirst%3DC.%2BS.%26aulast%3DLeventhal%26aufirst%3DB.%2BL.%26aulast%3DLord%26aufirst%3DC.%26aulast%3DCook%26aufirst%3DE.%2BH.%26atitle%3DAssociation%2520of%2520the%2520oxytocin%2520receptor%2520gene%2520%2528OXTR%2529%2520in%2520Caucasian%2520children%2520and%2520adolescents%2520with%2520autism%26jtitle%3DNeurosci.%2520Lett.%26date%3D2007%26volume%3D417%26spage%3D6%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Modahl, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fein, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waterhouse, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feinstein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levin, H.</span><span> </span><span class="NLM_article-title">Plasma oxytocin levels in autistic children</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">270</span><span class="NLM_x">–</span> <span class="NLM_lpage">277</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm901084f&amp;key=10.1016%2FS0006-3223%2897%2900439-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm901084f&amp;key=9513736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A280%3ADyaK1c7nsV2hsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1998&pages=270-277&author=C.+Modahlauthor=L.+Greenauthor=D.+Feinauthor=M.+Morrisauthor=L.+Waterhouseauthor=C.+Feinsteinauthor=H.+Levin&title=Plasma+oxytocin+levels+in+autistic+children"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Plasma oxytocin levels in autistic children</span></div><div class="casAuthors">Modahl C; Green L; Fein D; Morris M; Waterhouse L; Feinstein C; Levin H</div><div class="citationInfo"><span class="NLM_cas:title">Biological psychiatry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">270-7</span>
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    </div><div class="casAbstract">BACKGROUND:  Social impairments are central to the syndrome of autism.  The neuropeptide oxytocin (OT) has been implicated in the regulation of social behavior in animals but has not yet been examined in autistic subjects.  METHODS:  To determine whether autistic children have abnormalities in OT, midday plasma samples from 29 autistic and 30 age-matched normal children, all prepubertal, were analyzed by radioimmunoassay for levels of OT.  RESULTS:  Despite individual variability and overlapping group distributions, the autistic group had significantly lower plasma OT levels than the normal group.  OT increased with age in the normal but not the autistic children.  Elevated OT was associated with higher scores on social and developmental measures for the normal children, but was associated with lower scores for the autistic children.  These relationships were strongest in a subset of autistic children identified as aloof.  CONCLUSIONS:  Although making inferences to central OT functioning from peripheral measurement is difficult, the data suggest that OT abnormalities may exist in autism, and that more direct investigation of central nervous system OT function is warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTkrIn8D9W2z2LFM_lbR1VmfW6udTcc2eYiZKtvIvMR_Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1c7nsV2hsQ%253D%253D&md5=36ba0a757dc1cfee81be20d30132122b</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2FS0006-3223%2897%2900439-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-3223%252897%252900439-3%26sid%3Dliteratum%253Aachs%26aulast%3DModahl%26aufirst%3DC.%26aulast%3DGreen%26aufirst%3DL.%26aulast%3DFein%26aufirst%3DD.%26aulast%3DMorris%26aufirst%3DM.%26aulast%3DWaterhouse%26aufirst%3DL.%26aulast%3DFeinstein%26aufirst%3DC.%26aulast%3DLevin%26aufirst%3DH.%26atitle%3DPlasma%2520oxytocin%2520levels%2520in%2520autistic%2520children%26jtitle%3DBiol.%2520Psychiatry%26date%3D1998%26volume%3D43%26spage%3D270%26epage%3D277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Green, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fein, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modahl, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feinstein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waterhouse, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, M.</span><span> </span><span class="NLM_article-title">Oxytocin and autistic disorder: alterations in peptide forms</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">609</span><span class="NLM_x">–</span> <span class="NLM_lpage">613</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm901084f&amp;key=10.1016%2FS0006-3223%2801%2901139-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm901084f&amp;key=11690596" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnvFGqsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2001&pages=609-613&author=L.+Greenauthor=D.+Feinauthor=C.+Modahlauthor=C.+Feinsteinauthor=L.+Waterhouseauthor=M.+Morris&title=Oxytocin+and+autistic+disorder%3A+alterations+in+peptide+forms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Oxytocin and autistic disorder: alterations in peptide forms</span></div><div class="casAuthors">Green, LeeAnne; Fein, Deborah; Modahl, Charlotte; Feinstein, Carl; Waterhouse, Lynn; Morris, Mariana</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">609-613</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Oxytocin (OT) is synthesized as a prohormone that is sequentially processed to peptides.  These peptides are the bioactive amidated form (OT) and the C-terminal extended peptides, OT-Gly, OT-Gly-Lys and OT-Gly-Lys-Arg, which are designated together as OT-X.  As an extension of our previous study finding decreased plasma OT in autism, studies were conducted to det. whether there were changes in OT peptide forms in autistic children.  28 Male subjects (97 ± 20 mo; range, 70-139 mo), diagnosed with DSM-IV autistic disorder through observation and semi-structured interview, were compared with 31 age-matched nonpsychiatric control subjects (106 ± 22 mo; range, 74-140 mo).  Using OT antisera with different specificity for the peptide forms, the authors measured plasma OT and OT-X in each group.  T tests showed that there was a decrease in plasma OT (t = 4.4, p < .0001), an increase in OT-X (t = 2.3, p < .03) and an increase in the ratio of OT-X/OT (t = 4.5, p < .0001) in the autistic sample, compared with control subjects.  The results suggest that children with autistic disorder show alterations in the endocrine OT system.  Deficits in OT peptide processing in children with autism may be important in the development of this syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoy-zzsrIaaKbVg90H21EOLACvtfcHk0lh6njW18LJ83Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnvFGqsLc%253D&md5=50b8f68beebf1d162e59b8f4e5f8132e</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2FS0006-3223%2801%2901139-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-3223%252801%252901139-8%26sid%3Dliteratum%253Aachs%26aulast%3DGreen%26aufirst%3DL.%26aulast%3DFein%26aufirst%3DD.%26aulast%3DModahl%26aufirst%3DC.%26aulast%3DFeinstein%26aufirst%3DC.%26aulast%3DWaterhouse%26aufirst%3DL.%26aulast%3DMorris%26aufirst%3DM.%26atitle%3DOxytocin%2520and%2520autistic%2520disorder%253A%2520alterations%2520in%2520peptide%2520forms%26jtitle%3DBiol.%2520Psychiatry%26date%3D2001%26volume%3D50%26spage%3D609%26epage%3D613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Hollander, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novotny, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanratty, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yaffe, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeCaria, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aronowitz, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosovich, S.</span><span> </span><span class="NLM_article-title">Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger's disorders</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">193</span><span class="NLM_x">–</span> <span class="NLM_lpage">198</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2003&pages=193-198&author=E.+Hollanderauthor=S.+Novotnyauthor=M.+Hanrattyauthor=R.+Yaffeauthor=C.+M.+DeCariaauthor=B.+R.+Aronowitzauthor=S.+Mosovich&title=Oxytocin+infusion+reduces+repetitive+behaviors+in+adults+with+autistic+and+Asperger%27s+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHollander%26aufirst%3DE.%26aulast%3DNovotny%26aufirst%3DS.%26aulast%3DHanratty%26aufirst%3DM.%26aulast%3DYaffe%26aufirst%3DR.%26aulast%3DDeCaria%26aufirst%3DC.%2BM.%26aulast%3DAronowitz%26aufirst%3DB.%2BR.%26aulast%3DMosovich%26aufirst%3DS.%26atitle%3DOxytocin%2520infusion%2520reduces%2520repetitive%2520behaviors%2520in%2520adults%2520with%2520autistic%2520and%2520Asperger%2527s%2520disorders%26jtitle%3DNeuropsychopharmacology%26date%3D2003%26volume%3D28%26spage%3D193%26epage%3D198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Hollander, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaplin, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sumner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soorya, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anagnostou, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wasserman, S.</span><span> </span><span class="NLM_article-title">Oxytocin increases retention of social cognition in autism</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">498</span><span class="NLM_x">–</span> <span class="NLM_lpage">503</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm901084f&amp;key=10.1016%2Fj.biopsych.2006.05.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm901084f&amp;key=16904652" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlWjurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2007&pages=498-503&author=E.+Hollanderauthor=J.+Bartzauthor=W.+Chaplinauthor=A.+Phillipsauthor=J.+Sumnerauthor=L.+Sooryaauthor=E.+Anagnostouauthor=S.+Wasserman&title=Oxytocin+increases+retention+of+social+cognition+in+autism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Oxytocin Increases Retention of Social Cognition in Autism</span></div><div class="casAuthors">Hollander, Eric; Bartz, Jennifer; Chaplin, William; Phillips, Ann; Sumner, Jennifer; Soorya, Latha; Anagnostou, Evdokia; Wasserman, Stacey</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">498-503</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Background: Oxytocin dysfunction might contribute to the development of social deficits in autism, a core symptom domain and potential target for intervention.  This study explored the effect of i.v. oxytocin administration on the retention of social information in autism.  Methods: Oxytocin and placebo challenges were administered to 15 adult subjects diagnosed with autism or Asperger's disorder, and comprehension of affective speech (happy, indifferent, angry, and sad) in neutral content sentences was tested.  Results: All subjects showed improvements in affective speech comprehension from pre- to post-infusion; however, whereas those who received placebo first tended to revert to baseline after a delay, those who received oxytocin first retained the ability to accurately assign emotional significance to speech intonation on the speech comprehension task.  Conclusions: These results are consistent with studies linking oxytocin to social recognition in rodents as well as studies linking oxytocin to prosocial behavior in humans and suggest that oxytocin might facilitate social information processing in those with autism.  These findings also provide preliminary support for the use of oxytocin in the treatment of autism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreES3yFX-HhbVg90H21EOLACvtfcHk0li5HTCcGKkWVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlWjurk%253D&md5=e6276eeae44187f43175e253393f141a</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2006.05.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2006.05.030%26sid%3Dliteratum%253Aachs%26aulast%3DHollander%26aufirst%3DE.%26aulast%3DBartz%26aufirst%3DJ.%26aulast%3DChaplin%26aufirst%3DW.%26aulast%3DPhillips%26aufirst%3DA.%26aulast%3DSumner%26aufirst%3DJ.%26aulast%3DSoorya%26aufirst%3DL.%26aulast%3DAnagnostou%26aufirst%3DE.%26aulast%3DWasserman%26aufirst%3DS.%26atitle%3DOxytocin%2520increases%2520retention%2520of%2520social%2520cognition%2520in%2520autism%26jtitle%3DBiol.%2520Psychiatry%26date%3D2007%26volume%3D61%26spage%3D498%26epage%3D503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Vassart, G.</span><span> </span><span class="NLM_article-title">Non-peptide arginine-vasopressin antagonists: the vaptans</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">371</span><span class="NLM_x">, </span> <span class="NLM_fpage">1624</span><span class="NLM_x">–</span> <span class="NLM_lpage">1632</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=371&publication_year=2008&pages=1624-1632&author=G.+Vassart&title=Non-peptide+arginine-vasopressin+antagonists%3A+the+vaptans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVassart%26aufirst%3DG.%26atitle%3DNon-peptide%2520arginine-vasopressin%2520antagonists%253A%2520the%2520vaptans%26jtitle%3DLancet%26date%3D2008%26volume%3D371%26spage%3D1624%26epage%3D1632" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Manning, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoev, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chini, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durroux, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouillac, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillon, G.</span><span> </span><span class="NLM_article-title">Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V<sub>1a</sub>, V<sub>1b</sub>, V<sub>2</sub> and OT receptors: research tools and potential therapeutic agents</span> <span class="citation_source-journal">Prog. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">170</span><span class="NLM_x">, </span> <span class="NLM_fpage">473</span><span class="NLM_x">–</span> <span class="NLM_lpage">512</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm901084f&amp;key=10.1016%2FS0079-6123%2808%2900437-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm901084f&amp;key=18655903" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1CjtrfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=170&publication_year=2008&pages=473-512&author=M.+Manningauthor=S.+Stoevauthor=B.+Chiniauthor=T.+Durrouxauthor=B.+Mouillacauthor=G.+Guillon&title=Peptide+and+non-peptide+agonists+and+antagonists+for+the+vasopressin+and+oxytocin+V1a%2C+V1b%2C+V2+and+OT+receptors%3A+research+tools+and+potential+therapeutic+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents</span></div><div class="casAuthors">Manning, Maurice; Stoev, Stoytcho; Chini, Bice; Durroux, Thierry; Mouillac, Bernard; Guillon, Gilles</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Brain Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">170</span>
        (<span class="NLM_cas:issue">Advances in Vasopressin and Oxytocin</span>),
    <span class="NLM_cas:pages">473-512</span>CODEN:
                <span class="NLM_cas:coden">PBRRA4</span>;
        ISSN:<span class="NLM_cas:issn">0079-6123</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Oxytocin (OT) and vasopressin (AVP) mediate their biol. actions by acting on four known receptors: The OT (uterine) and the AVP V1a (vasopressor), V1b (pituitary), V2 (renal) receptors and a fifth putative AVP V1c (vasodilating) receptor.  This presentation will summarize some highlights of the recent progress, in the design and synthesis of selective peptide agonists, antagonists, radioiodinated ligands, fluorescent ligands and bivalent ligands for these receptors.  Here we present published and unpublished pharmacol. data on the most widely used agonists, antagonists and labeled ligands.  The pharmacol. properties of promising new selective OT antagonists and V1b agonists are also presented.  This review should serve as a useful guide for the selection of the most appropriate ligand for a given study.  The current status of non-peptide OT and AVP antagonists and agonists is also summarized.  The relative merits of peptide and non-peptide AVP and OT agonists and antagonists as: (1) research tools and (2) therapeutic agents will be evaluated.  Many of the receptor selective peptide agonists and antagonists from this and other labs. are far more widely used as pharmacol. tools for studies on the peripheral and central effects of OT and AVP than their non-peptide counterparts.  In addn. to OT and to a lesser extent AVP (pitressin), a no. of OT and AVP analogs; such as carbetocin (OT agonist) dDAVP (desmopressin, V2 agonist), terlipressin (V1a agonist), felypressin (V1a agonist) and atosiban (Tractocile OT antagonist) are also in clin. use.  Despite much early promise, no non-peptide V1a or OT antagonists are currently in clin. trials.  While a no. of orally active non-peptide V2 antagonists (Vaptans); notably, Tolvaptan, Lixivaptan and Satavaptan, are currently in Phase III clin. trials; to date, only the mixed V2/V1a, antagonist Conivaptan (Vaprisol), has been approved by the US FDA for clin. use (by i.v. administration), for the treatment of euvolemic and hypervolemic hyponatremia in hospitalized patients.  Promising new non-peptide V1b and OT antagonists, as well as non-peptide V2 and OT agonists are now in pre-clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3jiQ5LZT5gLVg90H21EOLACvtfcHk0lhGzY7d2kZNlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1CjtrfJ&md5=c21ad467eaee4a2651232a16c7dc61c5</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2FS0079-6123%2808%2900437-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0079-6123%252808%252900437-8%26sid%3Dliteratum%253Aachs%26aulast%3DManning%26aufirst%3DM.%26aulast%3DStoev%26aufirst%3DS.%26aulast%3DChini%26aufirst%3DB.%26aulast%3DDurroux%26aufirst%3DT.%26aulast%3DMouillac%26aufirst%3DB.%26aulast%3DGuillon%26aufirst%3DG.%26atitle%3DPeptide%2520and%2520non-peptide%2520agonists%2520and%2520antagonists%2520for%2520the%2520vasopressin%2520and%2520oxytocin%2520V1a%252C%2520V1b%252C%2520V2%2520and%2520OT%2520receptors%253A%2520research%2520tools%2520and%2520potential%2520therapeutic%2520agents%26jtitle%3DProg.%2520Brain%2520Res.%26date%3D2008%26volume%3D170%26spage%3D473%26epage%3D512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Ashworth, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batt, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baxter, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broqua, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haigh, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heeney, C. M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laporte, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitt, G. R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robson, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rooker, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tartar, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yea, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roe, M. B.</span><span> </span><span class="NLM_article-title">Nonpeptide oxytocin agonists</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">345</span><span class="NLM_x">–</span> <span class="NLM_lpage">353</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm901084f&amp;key=10.1358%2Fdof.2006.031.04.980655" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADC%252BD28XntVyltr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2006&pages=345-353&author=D.+M.+Ashworthauthor=A.+R.+Battauthor=A.+J.+Baxterauthor=P.+Broquaauthor=R.+M.+Haighauthor=P.+Hudsonauthor=C.+M.+S.+Heeneyauthor=R.+Laporteauthor=A.+Pensonauthor=G.+R.+W.+Pittauthor=P.+A.+Robsonauthor=D.+P.+Rookerauthor=A.+L.+Tartarauthor=C.+M.+Yeaauthor=M.+B.+Roe&title=Nonpeptide+oxytocin+agonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Nonpeptide oxytocin agonists</span></div><div class="casAuthors">Ashworth, Doreen M.; Batt, Andrzej R.; Baxter, Andrew J.; Broqua, Pierre; Haigh, Robert M.; Hudson, Peter; Heeney, Celine M. S.; Laporte, Regent; Penson, Andrew; Pitt, Gary R. W.; Robson, Peter A.; Rooker, David P.; Tartar, Andre L.; Yea, Chris M.; Roe, Michael B.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of the Future</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">345-353</span>CODEN:
                <span class="NLM_cas:coden">DRFUD4</span>;
        ISSN:<span class="NLM_cas:issn">0377-8282</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  Oxytocin is a neurohypophyseal hormone that acts at the oxytocin receptor localized both peripherally and centrally and is particularly highly expressed in the pregnant human myometrium.  Synthetic oxytocin has long been used to induce labor and oxytocin antagonists have been introduced for the treatment of preterm labor.  New compds. are described that are potent, selective and efficacious oxytocin receptor agonists with potential utility in promoting labor and for the treatment of conditions such as male and female sexual dysfunction.  These new agents may also be useful as tools for further elucidating the roles of the oxytocin receptor system.  Furthermore, as they are nonpeptidic in nature, they may offer advantages over peptide oxytocin analogs in terms of oral availability and central penetration.  This article describes the various approaches that have been used to discover such compds.  Compds. such as 27, the first nonpeptide oxytocin agonists reported, are currently being investigated as pharmacol. tools in animal models of oxytocin activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxThz83ckUprVg90H21EOLACvtfcHk0lhGzY7d2kZNlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntVyltr4%253D&md5=398b1bc9e09f4682997567457d6905c8</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1358%2Fdof.2006.031.04.980655&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdof.2006.031.04.980655%26sid%3Dliteratum%253Aachs%26aulast%3DAshworth%26aufirst%3DD.%2BM.%26aulast%3DBatt%26aufirst%3DA.%2BR.%26aulast%3DBaxter%26aufirst%3DA.%2BJ.%26aulast%3DBroqua%26aufirst%3DP.%26aulast%3DHaigh%26aufirst%3DR.%2BM.%26aulast%3DHudson%26aufirst%3DP.%26aulast%3DHeeney%26aufirst%3DC.%2BM.%2BS.%26aulast%3DLaporte%26aufirst%3DR.%26aulast%3DPenson%26aufirst%3DA.%26aulast%3DPitt%26aufirst%3DG.%2BR.%2BW.%26aulast%3DRobson%26aufirst%3DP.%2BA.%26aulast%3DRooker%26aufirst%3DD.%2BP.%26aulast%3DTartar%26aufirst%3DA.%2BL.%26aulast%3DYea%26aufirst%3DC.%2BM.%26aulast%3DRoe%26aufirst%3DM.%2BB.%26atitle%3DNonpeptide%2520oxytocin%2520agonists%26jtitle%3DDrugs%2520Future%26date%3D2006%26volume%3D31%26spage%3D345%26epage%3D353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Pitt, G. R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batt, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haigh, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penson, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robson, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rooker, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tartar, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trim, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yea, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roe, M. B.</span><span> </span><span class="NLM_article-title">Non-peptide oxytocin agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">4585</span><span class="NLM_x">–</span> <span class="NLM_lpage">4589</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=4585-4589&author=G.+R.+W.+Pittauthor=A.+R.+Battauthor=R.+M.+Haighauthor=A.+M.+Pensonauthor=P.+A.+Robsonauthor=D.+P.+Rookerauthor=A.+L.+Tartarauthor=J.+E.+Trimauthor=C.+M.+Yeaauthor=M.+B.+Roe&title=Non-peptide+oxytocin+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPitt%26aufirst%3DG.%2BR.%2BW.%26aulast%3DBatt%26aufirst%3DA.%2BR.%26aulast%3DHaigh%26aufirst%3DR.%2BM.%26aulast%3DPenson%26aufirst%3DA.%2BM.%26aulast%3DRobson%26aufirst%3DP.%2BA.%26aulast%3DRooker%26aufirst%3DD.%2BP.%26aulast%3DTartar%26aufirst%3DA.%2BL.%26aulast%3DTrim%26aufirst%3DJ.%2BE.%26aulast%3DYea%26aufirst%3DC.%2BM.%26aulast%3DRoe%26aufirst%3DM.%2BB.%26atitle%3DNon-peptide%2520oxytocin%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D4585%26epage%3D4589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Pardridge, W. M.</span><span> </span><span class="NLM_article-title">Blood−brain barrier delivery</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">54</span><span class="NLM_x">–</span> <span class="NLM_lpage">61</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=54-61&author=W.+M.+Pardridge&title=Blood%E2%88%92brain+barrier+delivery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPardridge%26aufirst%3DW.%2BM.%26atitle%3DBlood%25E2%2588%2592brain%2520barrier%2520delivery%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2007%26volume%3D12%26spage%3D54%26epage%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Matsuhisa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kikuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yatsu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanagisawa, I.</span><span> </span><span class="NLM_article-title">Nonpeptide arginine vasopressin antagonists for both V<sub>1a</sub> and V<sub>2</sub> receptors: synthesis and pharmacological properties of 2-phenyl-4′-[(2,3,4,5-tetrahydro-1<i>H</i>-1-benzazepin-1-yl)carbonyl]benzanilide derivatives</span> <span class="citation_source-journal">Chem. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">1870</span><span class="NLM_x">–</span> <span class="NLM_lpage">1874</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1997&pages=1870-1874&author=A.+Matsuhisaauthor=A.+Tanakaauthor=K.+Kikuchiauthor=Y.+Shimadaauthor=T.+Yatsuauthor=I.+Yanagisawa&title=Nonpeptide+arginine+vasopressin+antagonists+for+both+V1a+and+V2+receptors%3A+synthesis+and+pharmacological+properties+of+2-phenyl-4%E2%80%B2-%5B%282%2C3%2C4%2C5-tetrahydro-1H-1-benzazepin-1-yl%29carbonyl%5Dbenzanilide+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMatsuhisa%26aufirst%3DA.%26aulast%3DTanaka%26aufirst%3DA.%26aulast%3DKikuchi%26aufirst%3DK.%26aulast%3DShimada%26aufirst%3DY.%26aulast%3DYatsu%26aufirst%3DT.%26aulast%3DYanagisawa%26aufirst%3DI.%26atitle%3DNonpeptide%2520arginine%2520vasopressin%2520antagonists%2520for%2520both%2520V1a%2520and%2520V2%2520receptors%253A%2520synthesis%2520and%2520pharmacological%2520properties%2520of%25202-phenyl-4%25E2%2580%25B2-%255B%25282%252C3%252C4%252C5-tetrahydro-1H-1-benzazepin-1-yl%2529carbonyl%255Dbenzanilide%2520derivatives%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D1997%26volume%3D45%26spage%3D1870%26epage%3D1874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Caggiano, T. J.</span><span> </span><span class="NLM_article-title">WAY-VNA-932</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">248</span><span class="NLM_x">–</span> <span class="NLM_lpage">253</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm901084f&amp;key=10.1358%2Fdof.2002.027.03.659890" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADC%252BD38XkslaitL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2002&pages=248-253&author=T.+J.+Caggiano&title=WAY-VNA-932"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">WAY-VNA-932</span></div><div class="casAuthors">Caggiano, Thomas J.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of the Future</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">248-253</span>CODEN:
                <span class="NLM_cas:coden">DRFUD4</span>;
        ISSN:<span class="NLM_cas:issn">0377-8282</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review. WAY-VNA-932 is a novel, orally active nonpeptide small mol. which exhibits vasopressin V2 receptor agonism.  In CHO cells transfected with human V1a, V2, V1b and oxytocin receptors, WAY-VNA-932 is a potent agonist at the V2 receptor, with an EC50 for 2nd messenger (cAMP) generation of 0.7 nM.  In water-loaded normotensive rats, Brattleboro rats, dogs and cynomolgus monkeys WAY-VNA-932 lowers urine output in a dose-dependent manner with a concomitant increase in osmolality.  It is expected that WAY-VNA-932 will offer several advantages over desmopressin, a peptide vasopressin V2 agonist, including greater and more consistent bioavailability and the lack of pressor activity.  WAY-VNA-932 is expected to be useful in conditions characterized by excessive prodn. and/or diln. of urine such as central diabetes insipidus and nocturnal enuresis as well as in conditions characterized by inappropriate prodn. of vasopressin.  WAY-VNA-932 is the 1st nonpeptide vasopressin V2 agonist to enter phase I trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqod3Z1TipNcrVg90H21EOLACvtfcHk0ljx45bCRRIvWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XkslaitL4%253D&md5=4d8946fd3c506cd1b9d20658d5ca0d42</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1358%2Fdof.2002.027.03.659890&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdof.2002.027.03.659890%26sid%3Dliteratum%253Aachs%26aulast%3DCaggiano%26aufirst%3DT.%2BJ.%26atitle%3DWAY-VNA-932%26jtitle%3DDrugs%2520Future%26date%3D2002%26volume%3D27%26spage%3D248%26epage%3D253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Williams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clineschmidt, B. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erb, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freidinger, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guidotti, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lis, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawluczyk, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettibone, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiss, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veber, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woyden, C. J.</span><span> </span><span class="NLM_article-title">1-{1-[4-[(<i>N</i>-Acetyl-4-piperidinyl)oxy]-2-methoxybenzoyl]piperidin-4-yl}-4<i>H</i>-3,1-benzoxazin-2(1<i>H</i>)-one (L-371,257): a new, orally bioavailable, non-peptide oxytocin antagonist</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">4634</span><span class="NLM_x">–</span> <span class="NLM_lpage">4636</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00023a002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=4634-4636&author=P.+D.+Williamsauthor=B.+V.+Clineschmidtauthor=J.+M.+Erbauthor=R.+M.+Freidingerauthor=M.+T.+Guidottiauthor=E.+V.+Lisauthor=J.+M.+Pawluczykauthor=D.+J.+Pettiboneauthor=D.+R.+Reissauthor=D.+F.+Veberauthor=C.+J.+Woyden&title=1-%7B1-%5B4-%5B%28N-Acetyl-4-piperidinyl%29oxy%5D-2-methoxybenzoyl%5Dpiperidin-4-yl%7D-4H-3%2C1-benzoxazin-2%281H%29-one+%28L-371%2C257%29%3A+a+new%2C+orally+bioavailable%2C+non-peptide+oxytocin+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm00023a002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00023a002%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DP.%2BD.%26aulast%3DClineschmidt%26aufirst%3DB.%2BV.%26aulast%3DErb%26aufirst%3DJ.%2BM.%26aulast%3DFreidinger%26aufirst%3DR.%2BM.%26aulast%3DGuidotti%26aufirst%3DM.%2BT.%26aulast%3DLis%26aufirst%3DE.%2BV.%26aulast%3DPawluczyk%26aufirst%3DJ.%2BM.%26aulast%3DPettibone%26aufirst%3DD.%2BJ.%26aulast%3DReiss%26aufirst%3DD.%2BR.%26aulast%3DVeber%26aufirst%3DD.%2BF.%26aulast%3DWoyden%26aufirst%3DC.%2BJ.%26atitle%3D1-%257B1-%255B4-%255B%2528N-Acetyl-4-piperidinyl%2529oxy%255D-2-methoxybenzoyl%255Dpiperidin-4-yl%257D-4H-3%252C1-benzoxazin-2%25281H%2529-one%2520%2528L-371%252C257%2529%253A%2520a%2520new%252C%2520orally%2520bioavailable%252C%2520non-peptide%2520oxytocin%2520antagonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1995%26volume%3D38%26spage%3D4634%26epage%3D4636" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Pitt, G. R. W.; Roe, M. B.; Rooker, D. P.</span><span> </span><span class="NLM_article-title">Oxytocin agonists</span>. Patent WO 03/000692 A3,<span class="NLM_x"> </span><span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=G.+R.+W.+Pitt&author=M.+B.+Roe&author=D.+P.+Rooker&title=Oxytocin+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DPitt%26aufirst%3DG.%2BR.%2BW.%26atitle%3DOxytocin%2520agonists%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Sasatani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyazaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruoka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, H.</span><span> </span><span class="NLM_article-title">Diisobutylaluminium hydride: a novel reagent for the reduction of oximes</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">4711</span><span class="NLM_x">–</span> <span class="NLM_lpage">4712</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1983&pages=4711-4712&author=S.+Sasataniauthor=T.+Miyazakiauthor=K.+Maruokaauthor=H.+Yamamoto&title=Diisobutylaluminium+hydride%3A+a+novel+reagent+for+the+reduction+of+oximes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSasatani%26aufirst%3DS.%26aulast%3DMiyazaki%26aufirst%3DT.%26aulast%3DMaruoka%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DH.%26atitle%3DDiisobutylaluminium%2520hydride%253A%2520a%2520novel%2520reagent%2520for%2520the%2520reduction%2520of%2520oximes%26jtitle%3DTetrahedron%2520Lett.%26date%3D1983%26volume%3D24%26spage%3D4711%26epage%3D4712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Artico, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Martino, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filacchioni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giuliano, R.</span><span> </span><span class="NLM_article-title">Ricerche su sostanze ad attivita’ antiblastica</span> <span class="citation_source-journal">Il Farmaco—Ed. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1969</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">276</span><span class="NLM_x">–</span> <span class="NLM_lpage">284</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm901084f&amp;key=5822122" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADyaF1MXps1Oktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1969&pages=276-284&author=M.+Articoauthor=G.+De+Martinoauthor=G.+Filacchioniauthor=R.+Giuliano&title=Ricerche+su+sostanze+ad+attivita%E2%80%99+antiblastica"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Antiblastic agents.  XXXVI.  Anthramycin and analogous compounds.  1.  Synthesis of 10,11-dihydro-5H-pyrrolo-[2,1-s][1,4]-benzodiazepine</span></div><div class="casAuthors">Artico, Marino; De Martino, Giovanni; Filacchioni, G.; Giuliano, Raffaele</div><div class="citationInfo"><span class="NLM_cas:title">Farmaco, Edizione Scientifica</span>
        (<span class="NLM_cas:date">1969</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">276-84</span>CODEN:
                <span class="NLM_cas:coden">FRPSAX</span>;
        ISSN:<span class="NLM_cas:issn">0430-0920</span>.
    </div><div class="casAbstract">10-(R-Substituted)-10,11-dihydro-5H-pyrrolo[2,1-c][1,4]benzodiazepines (I) are prepd.  Thus, N is passed through a soln. of 4.75 g. 2-pyrrolecarboxaldehyde in 100 ml. tetrahydrofuran (THF), 1.56 g. K is added, the mixt. is refluxed to give a soln., a soln. of 8.64 g. o-O2NC6H4COBr in 100 ml. THF is added, and the mixt. is agitated 8 hrs. at 65° to give 1-(o-nitrobenzoyl)-2-pyrrolecarboxaldehyde (II), m. 136-8°; oxime m. 130-2°.  II (2.3 g.) is dissolved in 250 ml. mixt. of EtOAc and EtOH and hydrogenated over 200 mg. 10% Pd/C 3 hrs. at 4 atm. to give 1.2 g. 10,11-dihydro-5H-pyrrolo-[2,1-c][1,4]benzodiazepine (III), m. 152-4° (decompn.).  III is converted to the following I (R and m.p. given): Ac, 154-5°; ClCH2CO, 122-3°; Cl2CHCO, 118-19°.  Ir data are given; also given is the ir spectrum of III.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3kywPi1TwNrVg90H21EOLACvtfcHk0lip2i35kGy1DA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF1MXps1Oktw%253D%253D&md5=b66a573f9e4491d69d10c3488c0d7aa3</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArtico%26aufirst%3DM.%26aulast%3DDe%2BMartino%26aufirst%3DG.%26aulast%3DFilacchioni%26aufirst%3DG.%26aulast%3DGiuliano%26aufirst%3DR.%26atitle%3DRicerche%2520su%2520sostanze%2520ad%2520attivita%25E2%2580%2599%2520antiblastica%26jtitle%3DIl%2520Farmaco%25E2%2580%2594Ed.%2520Sci.%26date%3D1969%26volume%3D24%26spage%3D276%26epage%3D284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Bell, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erb, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freidinger, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallicchio, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guare, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guidotti, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halpin, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hobbs, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Homnick, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lis, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathre, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michelson, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawluczyk, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettibone, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiss, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vickers, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woyden, C. J.</span><span> </span><span class="NLM_article-title">Development of orally active oxytocin antagonists: studies on 1-(1-{4-[1-(2-methyl-1-oxidopyridin-3-ylmethyl)piperidin-4-yloxy]-2-methoxybenzoyl}piperidin-4-yl)-1,4-dihydrobenz[<i>d</i>][1,3]oxazin-2-one (L-372,662) and related pyridines</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">2146</span><span class="NLM_x">–</span> <span class="NLM_lpage">2163</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9800797" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=2146-2163&author=I.+M.+Bellauthor=J.+M.+Erbauthor=R.+M.+Freidingerauthor=S.+N.+Gallicchioauthor=J.+P.+Guareauthor=M.+T.+Guidottiauthor=R.+A.+Halpinauthor=D.+W.+Hobbsauthor=C.+F.+Homnickauthor=M.+S.+Kuoauthor=E.+V.+Lisauthor=D.+J.+Mathreauthor=S.+R.+Michelsonauthor=J.+M.+Pawluczykauthor=D.+J.+Pettiboneauthor=D.+R.+Reissauthor=S.+Vickersauthor=P.+D.+Williamsauthor=C.+J.+Woyden&title=Development+of+orally+active+oxytocin+antagonists%3A+studies+on+1-%281-%7B4-%5B1-%282-methyl-1-oxidopyridin-3-ylmethyl%29piperidin-4-yloxy%5D-2-methoxybenzoyl%7Dpiperidin-4-yl%29-1%2C4-dihydrobenz%5Bd%5D%5B1%2C3%5Doxazin-2-one+%28L-372%2C662%29+and+related+pyridines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm9800797&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9800797%26sid%3Dliteratum%253Aachs%26aulast%3DBell%26aufirst%3DI.%2BM.%26aulast%3DErb%26aufirst%3DJ.%2BM.%26aulast%3DFreidinger%26aufirst%3DR.%2BM.%26aulast%3DGallicchio%26aufirst%3DS.%2BN.%26aulast%3DGuare%26aufirst%3DJ.%2BP.%26aulast%3DGuidotti%26aufirst%3DM.%2BT.%26aulast%3DHalpin%26aufirst%3DR.%2BA.%26aulast%3DHobbs%26aufirst%3DD.%2BW.%26aulast%3DHomnick%26aufirst%3DC.%2BF.%26aulast%3DKuo%26aufirst%3DM.%2BS.%26aulast%3DLis%26aufirst%3DE.%2BV.%26aulast%3DMathre%26aufirst%3DD.%2BJ.%26aulast%3DMichelson%26aufirst%3DS.%2BR.%26aulast%3DPawluczyk%26aufirst%3DJ.%2BM.%26aulast%3DPettibone%26aufirst%3DD.%2BJ.%26aulast%3DReiss%26aufirst%3DD.%2BR.%26aulast%3DVickers%26aufirst%3DS.%26aulast%3DWilliams%26aufirst%3DP.%2BD.%26aulast%3DWoyden%26aufirst%3DC.%2BJ.%26atitle%3DDevelopment%2520of%2520orally%2520active%2520oxytocin%2520antagonists%253A%2520studies%2520on%25201-%25281-%257B4-%255B1-%25282-methyl-1-oxidopyridin-3-ylmethyl%2529piperidin-4-yloxy%255D-2-methoxybenzoyl%257Dpiperidin-4-yl%2529-1%252C4-dihydrobenz%255Bd%255D%255B1%252C3%255Doxazin-2-one%2520%2528L-372%252C662%2529%2520and%2520related%2520pyridines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D2146%26epage%3D2163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Kondo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinohara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurimura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tominaga, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itai, A.</span><span> </span><span class="NLM_article-title">Novel design of nonpeptide AVP V<sub>2</sub> receptor agonists: structural requirements for an agonist having 1-(4-aminobenzoyl)-2,3,4,5-tetrahydro-1<i>H</i>-1-benzazepine as a template</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">4388</span><span class="NLM_x">–</span> <span class="NLM_lpage">4397</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm000108p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=4388-4397&author=K.+Kondoauthor=H.+Ogawaauthor=T.+Shinoharaauthor=M.+Kurimuraauthor=Y.+Tanadaauthor=K.+Kanauthor=H.+Yamashitaauthor=S.+Nakamuraauthor=T.+Hiranoauthor=Y.+Yamamuraauthor=T.+Moriauthor=M.+Tominagaauthor=A.+Itai&title=Novel+design+of+nonpeptide+AVP+V2+receptor+agonists%3A+structural+requirements+for+an+agonist+having+1-%284-aminobenzoyl%29-2%2C3%2C4%2C5-tetrahydro-1H-1-benzazepine+as+a+template"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm000108p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000108p%26sid%3Dliteratum%253Aachs%26aulast%3DKondo%26aufirst%3DK.%26aulast%3DOgawa%26aufirst%3DH.%26aulast%3DShinohara%26aufirst%3DT.%26aulast%3DKurimura%26aufirst%3DM.%26aulast%3DTanada%26aufirst%3DY.%26aulast%3DKan%26aufirst%3DK.%26aulast%3DYamashita%26aufirst%3DH.%26aulast%3DNakamura%26aufirst%3DS.%26aulast%3DHirano%26aufirst%3DT.%26aulast%3DYamamura%26aufirst%3DY.%26aulast%3DMori%26aufirst%3DT.%26aulast%3DTominaga%26aufirst%3DM.%26aulast%3DItai%26aufirst%3DA.%26atitle%3DNovel%2520design%2520of%2520nonpeptide%2520AVP%2520V2%2520receptor%2520agonists%253A%2520structural%2520requirements%2520for%2520an%2520agonist%2520having%25201-%25284-aminobenzoyl%2529-2%252C3%252C4%252C5-tetrahydro-1H-1-benzazepine%2520as%2520a%2520template%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D4388%26epage%3D4397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Carnazzi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aumelas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phalipou, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouillac, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barberis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seyer, R.</span><span> </span><span class="NLM_article-title">Efficient photoaffinity labeling of the rat V<sub>1a</sub> vasopressin receptor using a linear azidopeptidic antagonist</span> <span class="citation_source-journal">Eur. J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">247</span><span class="NLM_x">, </span> <span class="NLM_fpage">906</span><span class="NLM_x">–</span> <span class="NLM_lpage">913</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm901084f&amp;key=10.1111%2Fj.1432-1033.1997.00906.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm901084f&amp;key=9288914" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADyaK2sXlsVCmtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=247&publication_year=1997&pages=906-913&author=E.+Carnazziauthor=A.+Aumelasauthor=S.+Phalipouauthor=B.+Mouillacauthor=G.+Guillonauthor=C.+Barberisauthor=R.+Seyer&title=Efficient+photoaffinity+labeling+of+the+rat+V1a+vasopressin+receptor+using+a+linear+azidopeptidic+antagonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient photoaffinity labeling of the rat V1a vasopressin receptor using a linear azidopeptidic antagonist</span></div><div class="casAuthors">Carnazzi, Eric; Aumelas, Andre; Phalipou, Sylvie; Mouillac, Bernard; Guillon, Gilles; Barberis, Claude; Seyer, Rene</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">247</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">906-913</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">We have synthesized and fully characterized by fast-atom-bombardment-mass, NMR and UV spectroscopies the vasopressin antagonist 3-azidophenylpropionyl-D-Tyr(Me)-Phe-Gln-Asn-Arg-Pro-Arg-Tyr(3I)-NH2.  Easily radioiodinatable just before use, it has a high affinity for the natural rat liver V1a receptor [dissocn. const. (Kd) = 54±20 pM; Carnazzi, E., Aumelas, A., Barberis, C., Guillon, G. & Seyer, R. (1994) J. Med. Chem. 37, 1841-1849] and for both the rat vasopressin V1a receptor expressed in Spodoptera frugiperda 9 cells (Sf9 cells, Kd = 688±35 pM) and in COS-7 cells (Kd = 320±20 pM).  This probe labels specifically the V1a receptors in an UV-dependent manner, and binds covalently to about 12% of the receptors with high stability over several days, even in dissocn. or solubilization conditions.  SDS-PAGE studies and autoradiog. analyses of the photolabeled receptors reveal a single band (49.5 kDa) and two bands (63 kDa and 93.6 kDa) for receptor-probe assocns. obtained in Sf9 and COS-7 cells resp.  These mol. masses are consistent with non-glycosylated and highly glycosylated forms of the receptor, according to each expression system.  In rat liver membranes, we have identified apparent mol. masses of about 32, 45 and more than 67 kDa.  We finally demonstrated a proteolysis of the receptor that appeared to be Zn2+ and leupeptin sensitive.  The high potency of this ligand is promising for the monitoring of the purifn. of the V1a receptor and for mapping its antagonist-binding site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNhoLFb7QqhLVg90H21EOLACvtfcHk0lgqyMB_4MazAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXlsVCmtbk%253D&md5=5fe00e92128003cdf81f7a757f835cbb</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1111%2Fj.1432-1033.1997.00906.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1432-1033.1997.00906.x%26sid%3Dliteratum%253Aachs%26aulast%3DCarnazzi%26aufirst%3DE.%26aulast%3DAumelas%26aufirst%3DA.%26aulast%3DPhalipou%26aufirst%3DS.%26aulast%3DMouillac%26aufirst%3DB.%26aulast%3DGuillon%26aufirst%3DG.%26aulast%3DBarberis%26aufirst%3DC.%26aulast%3DSeyer%26aufirst%3DR.%26atitle%3DEfficient%2520photoaffinity%2520labeling%2520of%2520the%2520rat%2520V1a%2520vasopressin%2520receptor%2520using%2520a%2520linear%2520azidopeptidic%2520antagonist%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D1997%26volume%3D247%26spage%3D906%26epage%3D913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Phalipou, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cotte, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carnazzi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seyer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahé, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barberis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouillac, B.</span><span> </span><span class="NLM_article-title">Mapping peptide-binding domains of the human V<sub>1a</sub> vasopressin receptor with a photoactivatable linear peptide antagonist</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x">, </span> <span class="NLM_fpage">26536</span><span class="NLM_x">–</span> <span class="NLM_lpage">26544</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=26536-26544&author=S.+Phalipouauthor=N.+Cotteauthor=E.+Carnazziauthor=R.+Seyerauthor=E.+Mah%C3%A9author=S.+Jardauthor=C.+Barberisauthor=B.+Mouillac&title=Mapping+peptide-binding+domains+of+the+human+V1a+vasopressin+receptor+with+a+photoactivatable+linear+peptide+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPhalipou%26aufirst%3DS.%26aulast%3DCotte%26aufirst%3DN.%26aulast%3DCarnazzi%26aufirst%3DE.%26aulast%3DSeyer%26aufirst%3DR.%26aulast%3DMah%25C3%25A9%26aufirst%3DE.%26aulast%3DJard%26aufirst%3DS.%26aulast%3DBarberis%26aufirst%3DC.%26aulast%3DMouillac%26aufirst%3DB.%26atitle%3DMapping%2520peptide-binding%2520domains%2520of%2520the%2520human%2520V1a%2520vasopressin%2520receptor%2520with%2520a%2520photoactivatable%2520linear%2520peptide%2520antagonist%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26spage%3D26536%26epage%3D26544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Phalipou, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seyer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cotte, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breton, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barberis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hibert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouillac, B.</span><span> </span><span class="NLM_article-title">Docking of linear peptide antagonists into the human V<sub>1a</sub> vasopressin receptor: identification of binding domains by photoaffinity labelling</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">23316</span><span class="NLM_x">–</span> <span class="NLM_lpage">23327</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=23316-23327&author=S.+Phalipouauthor=R.+Seyerauthor=N.+Cotteauthor=C.+Bretonauthor=C.+Barberisauthor=M.+Hibertauthor=B.+Mouillac&title=Docking+of+linear+peptide+antagonists+into+the+human+V1a+vasopressin+receptor%3A+identification+of+binding+domains+by+photoaffinity+labelling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPhalipou%26aufirst%3DS.%26aulast%3DSeyer%26aufirst%3DR.%26aulast%3DCotte%26aufirst%3DN.%26aulast%3DBreton%26aufirst%3DC.%26aulast%3DBarberis%26aufirst%3DC.%26aulast%3DHibert%26aufirst%3DM.%26aulast%3DMouillac%26aufirst%3DB.%26atitle%3DDocking%2520of%2520linear%2520peptide%2520antagonists%2520into%2520the%2520human%2520V1a%2520vasopressin%2520receptor%253A%2520identification%2520of%2520binding%2520domains%2520by%2520photoaffinity%2520labelling%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D23316%26epage%3D23327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Rodrigo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pena, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murat, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trueba, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durroux, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rognan, D.</span><span> </span><span class="NLM_article-title">Mapping the binding site of arginine vasopressin to V<sub>1a</sub> and V<sub>1b</sub> vasopressin receptors</span> <span class="citation_source-journal">Mol. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">512</span><span class="NLM_x">–</span> <span class="NLM_lpage">523</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm901084f&amp;key=10.1210%2Fme.2006-0202" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm901084f&amp;key=17082326" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVWisbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2007&pages=512-523&author=J.+Rodrigoauthor=A.+Penaauthor=B.+Muratauthor=M.+Truebaauthor=T.+Durrouxauthor=G.+Guillonauthor=D.+Rognan&title=Mapping+the+binding+site+of+arginine+vasopressin+to+V1a+and+V1b+vasopressin+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Mapping the binding site of arginine vasopressin to V1a and V1b vasopressin receptors</span></div><div class="casAuthors">Rodrigo, Jordi; Pena, Ana; Murat, Brigitte; Trueba, Miguel; Durroux, Thierry; Guillon, Gilles; Rognan, Didier</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">512-523</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Starting from the 2.8-Å resoln. x-ray structure of bovine rhodopsin, three-dimensional mol. models of the complexes between arginine vasopressin and two receptor subtypes (V1a, V1b) have been built.  Amino acid sequence alignment and docking studies suggest that four key residues (1.35, 2.65, 4.61, and 5.35) fine tune the binding of vasopressin and related peptide agonists to both receptor subtypes.  To validate these predictions, a series of single or double mutants were engineered at V1a and V1b receptor subtypes and tested for their binding and functional properties.  Two neg. charged amino acids at positions 1.35 and 2.65 are key anchoring residues to the Arg8 residue of arginine vasopressin.  Moreover, two amino acids (V4.61 and P5.35) delineating a hydrophobic subsite at the human V1b receptor are responsible for the recognition of V1b selective peptide agonists.  Last, one of the latter positions (5.35) is hypothesized to explain the pharmacol. species differences between rat and human vasopressin receptors for a V1b peptide agonist.  Altogether these refined three-dimensional models of V1a and V1b human receptors should enable the identification of further new selective V1a and V1b agonists as pharmacol. but also therapeutic tools.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiSR2zAZAfYrVg90H21EOLACvtfcHk0lhFaVp6PBu2uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVWisbg%253D&md5=3da9d009a1b55b8e9420dfba0b0b77f3</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1210%2Fme.2006-0202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2006-0202%26sid%3Dliteratum%253Aachs%26aulast%3DRodrigo%26aufirst%3DJ.%26aulast%3DPena%26aufirst%3DA.%26aulast%3DMurat%26aufirst%3DB.%26aulast%3DTrueba%26aufirst%3DM.%26aulast%3DDurroux%26aufirst%3DT.%26aulast%3DGuillon%26aufirst%3DG.%26aulast%3DRognan%26aufirst%3DD.%26atitle%3DMapping%2520the%2520binding%2520site%2520of%2520arginine%2520vasopressin%2520to%2520V1a%2520and%2520V1b%2520vasopressin%2520receptors%26jtitle%3DMol.%2520Endocrinol.%26date%3D2007%26volume%3D21%26spage%3D512%26epage%3D523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Verdonk, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartshorn, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, R. D.</span><span> </span><span class="NLM_article-title">Improved protein-ligand docking using GOLD</span> <span class="citation_source-journal">Proteins</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">609</span><span class="NLM_x">–</span> <span class="NLM_lpage">623</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm901084f&amp;key=10.1002%2Fprot.10465" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm901084f&amp;key=12910460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmvFGrsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2003&pages=609-623&author=M.+L.+Verdonkauthor=J.+C.+Coleauthor=M.+J.+Hartshornauthor=C.+W.+Murrayauthor=R.+D.+Taylor&title=Improved+protein-ligand+docking+using+GOLD"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Improved protein-ligand docking using GOLD</span></div><div class="casAuthors">Verdonk, Marcel L.; Cole, Jason C.; Hartshorn, Michael J.; Murray, Christopher W.; Taylor, Richard D.</div><div class="citationInfo"><span class="NLM_cas:title">Proteins: Structure, Function, and Genetics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">609-623</span>CODEN:
                <span class="NLM_cas:coden">PSFGEY</span>;
        ISSN:<span class="NLM_cas:issn">0887-3585</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The Chemscore function was implemented as a scoring function for the protein-ligand docking program GOLD, and its performance compared to the original Goldscore function and two consensus docking protocols, "Goldscore-CS" and "Chemscore-GS," in terms of docking accuracy, prediction of binding affinities, and speed.  In the "Goldscore-CS" protocol, dockings produced with the Goldscore function are scored and ranked with the Chemscore function; in the "Chemscore-GS" protocol, dockings produced with the Chemscore function are scored and ranked with the Goldscore function.  Comparisons were made for a "clean" set of 224 protein-ligand complexes, and for two subsets of this set, one for which the ligands are "drug-like," the other for which they are "fragment-like.".  For "drug-like" and "fragment-like" ligands, the docking accuracies obtained with Chemscore and Goldscore functions are similar.  For larger ligands, Goldscore gives superior results.  Docking with the Chemscore function is up to three times faster than docking with the Goldscore function.  Both combined docking protocols give significant improvements in docking accuracy over the use of the Goldscore or Chemscore function alone.  "Goldscore-CS" gives success rates of up to 81% (top-ranked GOLD soln. within 2.0 Å of the exptl. binding mode) for the "clean list," but at the cost of long search times.  For most virtual screening applications, "Chemscore-GS" seems optimal; search settings that give docking speeds of around 0.25-1.3 min/compd. have success rates of about 78% for "drug-like" compds. and 85% for "fragment-like" compds.  In terms of producing binding energy ests., the Goldscore function appears to perform better than the Chemscore function and the two consensus protocols, particularly for faster search settings.  Even at docking speeds of around 1-2 min/compd., the Goldscore function predicts binding energies with a std. deviation of ∼10.5 kJ/mol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKKgOct_CAcbVg90H21EOLACvtfcHk0lhU8C75J-5Q1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmvFGrsLg%253D&md5=73a627d99dab6de1ae364c8e8e5f0fea</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1002%2Fprot.10465&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.10465%26sid%3Dliteratum%253Aachs%26aulast%3DVerdonk%26aufirst%3DM.%2BL.%26aulast%3DCole%26aufirst%3DJ.%2BC.%26aulast%3DHartshorn%26aufirst%3DM.%2BJ.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DTaylor%26aufirst%3DR.%2BD.%26atitle%3DImproved%2520protein-ligand%2520docking%2520using%2520GOLD%26jtitle%3DProteins%26date%3D2003%26volume%3D52%26spage%3D609%26epage%3D623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Rose, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsiao, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breslow, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B. C.</span><span> </span><span class="NLM_article-title">Crystal structure of the neurophysin−oxytocin complex</span> <span class="citation_source-journal">Nat. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">163</span><span class="NLM_x">–</span> <span class="NLM_lpage">169</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1996&pages=163-169&author=J.+P.+Roseauthor=C.+K.+Wuauthor=C.+D.+Hsiaoauthor=E.+Breslowauthor=B.+C.+Wang&title=Crystal+structure+of+the+neurophysin%E2%88%92oxytocin+complex"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRose%26aufirst%3DJ.%2BP.%26aulast%3DWu%26aufirst%3DC.%2BK.%26aulast%3DHsiao%26aufirst%3DC.%2BD.%26aulast%3DBreslow%26aufirst%3DE.%26aulast%3DWang%26aufirst%3DB.%2BC.%26atitle%3DCrystal%2520structure%2520of%2520the%2520neurophysin%25E2%2588%2592oxytocin%2520complex%26jtitle%3DNat.%2520Struct.%2520Biol.%26date%3D1996%26volume%3D3%26spage%3D163%26epage%3D169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_publisher-name">Gaussian, Inc.</span>, <span class="NLM_publisher-loc">Wallingford CT</span>,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Gaussian%2C+Inc.%2C+Wallingford+CT%2C+2004."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26pub%3DGaussian%252C%2520Inc%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Barberis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouillac, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durroux, T.</span><span> </span><span class="NLM_article-title">Structural bases of vasopressin/oxytocin function</span> <span class="citation_source-journal">J. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">156</span><span class="NLM_x">, </span> <span class="NLM_fpage">223</span><span class="NLM_x">–</span> <span class="NLM_lpage">229</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm901084f&amp;key=10.1677%2Fjoe.0.1560223" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm901084f&amp;key=9518866" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADyaK1cXhtV2lu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=1998&pages=223-229&author=C.+Barberisauthor=B.+Mouillacauthor=T.+Durroux&title=Structural+bases+of+vasopressin%2Foxytocin+function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Structural bases of vasopressin/oxytocin receptor function</span></div><div class="casAuthors">Barberis, C.; Mouillac, B.; Durroux, T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Endocrinology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">156</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">223-229</span>CODEN:
                <span class="NLM_cas:coden">JOENAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-0795</span>.
    
            (<span class="NLM_cas:orgname">Journal of Endocrinology</span>)
        </div><div class="casAbstract">A review with 50 refs. in which the focus is to summarize recent studies that have led to novel insights into the mol. bases of vasopressin and oxytocin receptor functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFMQaSS44BJ7Vg90H21EOLACvtfcHk0lhU8C75J-5Q1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhtV2lu70%253D&md5=c7c46e9cbe99e90ff99ed8cd9a0ea152</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1677%2Fjoe.0.1560223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1677%252Fjoe.0.1560223%26sid%3Dliteratum%253Aachs%26aulast%3DBarberis%26aufirst%3DC.%26aulast%3DMouillac%26aufirst%3DB.%26aulast%3DDurroux%26aufirst%3DT.%26atitle%3DStructural%2520bases%2520of%2520vasopressin%252Foxytocin%2520function%26jtitle%3DJ.%2520Endocrinol.%26date%3D1998%26volume%3D156%26spage%3D223%26epage%3D229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Hojro, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eich, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gimpl, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fahrenholz, F.</span><span> </span><span class="NLM_article-title">Direct identification of an extracellular agonist binding site in the renal V<sub>2</sub> vasopressin receptor</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">13537</span><span class="NLM_x">–</span> <span class="NLM_lpage">13544</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1993&pages=13537-13544&author=E.+Hojroauthor=P.+Eichauthor=G.+Gimplauthor=F.+Fahrenholz&title=Direct+identification+of+an+extracellular+agonist+binding+site+in+the+renal+V2+vasopressin+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHojro%26aufirst%3DE.%26aulast%3DEich%26aufirst%3DP.%26aulast%3DGimpl%26aufirst%3DG.%26aulast%3DFahrenholz%26aufirst%3DF.%26atitle%3DDirect%2520identification%2520of%2520an%2520extracellular%2520agonist%2520binding%2520site%2520in%2520the%2520renal%2520V2%2520vasopressin%2520receptor%26jtitle%3DBiochemistry%26date%3D1993%26volume%3D32%26spage%3D13537%26epage%3D13544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Mouillac, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chini, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balestre, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elands, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trumpp-Kallmeyer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoflack, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hibert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barberis, C.</span><span> </span><span class="NLM_article-title">The binding site of neuropeptide vasopressin V<sub>1a</sub> receptor: evidence for a major localization within transmembrane regions</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">270</span><span class="NLM_x">, </span> <span class="NLM_fpage">25771</span><span class="NLM_x">–</span> <span class="NLM_lpage">25777</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=270&publication_year=1995&pages=25771-25777&author=B.+Mouillacauthor=B.+Chiniauthor=M.+N.+Balestreauthor=J.+Elandsauthor=S.+Trumpp-Kallmeyerauthor=J.+Hoflackauthor=M.+Hibertauthor=S.+Jardauthor=C.+Barberis&title=The+binding+site+of+neuropeptide+vasopressin+V1a+receptor%3A+evidence+for+a+major+localization+within+transmembrane+regions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMouillac%26aufirst%3DB.%26aulast%3DChini%26aufirst%3DB.%26aulast%3DBalestre%26aufirst%3DM.%2BN.%26aulast%3DElands%26aufirst%3DJ.%26aulast%3DTrumpp-Kallmeyer%26aufirst%3DS.%26aulast%3DHoflack%26aufirst%3DJ.%26aulast%3DHibert%26aufirst%3DM.%26aulast%3DJard%26aufirst%3DS.%26aulast%3DBarberis%26aufirst%3DC.%26atitle%3DThe%2520binding%2520site%2520of%2520neuropeptide%2520vasopressin%2520V1a%2520receptor%253A%2520evidence%2520for%2520a%2520major%2520localization%2520within%2520transmembrane%2520regions%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1995%26volume%3D270%26spage%3D25771%26epage%3D25777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Chini, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouillac, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ala, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balestre, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trumpp-Kallmeyer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoflack, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elands, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hibert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manning, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barberis, C</span><span> </span><span class="NLM_article-title">Tyr 115 is the key residue for determining agonist selectivity in the V<sub>1a</sub> vasopressin receptor</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">2176</span><span class="NLM_x">–</span> <span class="NLM_lpage">2182</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1995&pages=2176-2182&author=B.+Chiniauthor=B.+Mouillacauthor=Y.+Alaauthor=M.+N.+Balestreauthor=S.+Trumpp-Kallmeyerauthor=J.+Hoflackauthor=J.+Elandsauthor=M.+Hibertauthor=M.+Manningauthor=S.+Jardauthor=C+Barberis&title=Tyr+115+is+the+key+residue+for+determining+agonist+selectivity+in+the+V1a+vasopressin+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChini%26aufirst%3DB.%26aulast%3DMouillac%26aufirst%3DB.%26aulast%3DAla%26aufirst%3DY.%26aulast%3DBalestre%26aufirst%3DM.%2BN.%26aulast%3DTrumpp-Kallmeyer%26aufirst%3DS.%26aulast%3DHoflack%26aufirst%3DJ.%26aulast%3DElands%26aufirst%3DJ.%26aulast%3DHibert%26aufirst%3DM.%26aulast%3DManning%26aufirst%3DM.%26aulast%3DJard%26aufirst%3DS.%26aulast%3DBarberis%26aufirst%3DC%26atitle%3DTyr%2520115%2520is%2520the%2520key%2520residue%2520for%2520determining%2520agonist%2520selectivity%2520in%2520the%2520V1a%2520vasopressin%2520receptor%26jtitle%3DEMBO%2520J.%26date%3D1995%26volume%3D14%26spage%3D2176%26epage%3D2182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Ufer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Postina, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorbulev, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fahrenholz, F.</span><span> </span><span class="NLM_article-title">An extracellular residue determines the agonist specificity of V<sub>2</sub> vasopressin receptors</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">362</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="NLM_x">–</span> <span class="NLM_lpage">23</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=362&publication_year=1995&pages=19-23&author=E.+Uferauthor=R.+Postinaauthor=V.+Gorbulevauthor=F.+Fahrenholz&title=An+extracellular+residue+determines+the+agonist+specificity+of+V2+vasopressin+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUfer%26aufirst%3DE.%26aulast%3DPostina%26aufirst%3DR.%26aulast%3DGorbulev%26aufirst%3DV.%26aulast%3DFahrenholz%26aufirst%3DF.%26atitle%3DAn%2520extracellular%2520residue%2520determines%2520the%2520agonist%2520specificity%2520of%2520V2%2520vasopressin%2520receptors%26jtitle%3DFEBS%2520Lett.%26date%3D1995%26volume%3D362%26spage%3D19%26epage%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Chini, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouillac, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balestre, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trumpp-Kallmeyer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoflack, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hibert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andriolo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pupier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barberis, C.</span><span> </span><span class="NLM_article-title">Two aromatic residues regulate the response of the human oxytocin receptor to the partial agonist arginine vasopressin</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">397</span><span class="NLM_x">, </span> <span class="NLM_fpage">201</span><span class="NLM_x">–</span> <span class="NLM_lpage">206</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=397&publication_year=1996&pages=201-206&author=B.+Chiniauthor=B.+Mouillacauthor=M.+N.+Balestreauthor=S.+Trumpp-Kallmeyerauthor=J.+Hoflackauthor=M.+Hibertauthor=M.+Andrioloauthor=S.+Pupierauthor=S.+Jardauthor=C.+Barberis&title=Two+aromatic+residues+regulate+the+response+of+the+human+oxytocin+receptor+to+the+partial+agonist+arginine+vasopressin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChini%26aufirst%3DB.%26aulast%3DMouillac%26aufirst%3DB.%26aulast%3DBalestre%26aufirst%3DM.%2BN.%26aulast%3DTrumpp-Kallmeyer%26aufirst%3DS.%26aulast%3DHoflack%26aufirst%3DJ.%26aulast%3DHibert%26aufirst%3DM.%26aulast%3DAndriolo%26aufirst%3DM.%26aulast%3DPupier%26aufirst%3DS.%26aulast%3DJard%26aufirst%3DS.%26aulast%3DBarberis%26aufirst%3DC.%26atitle%3DTwo%2520aromatic%2520residues%2520regulate%2520the%2520response%2520of%2520the%2520human%2520oxytocin%2520receptor%2520to%2520the%2520partial%2520agonist%2520arginine%2520vasopressin%26jtitle%3DFEBS%2520Lett.%26date%3D1996%26volume%3D397%26spage%3D201%26epage%3D206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Postina, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kojro, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fahrenholz, F.</span><span> </span><span class="NLM_article-title">Separate agonist and peptide antagonist binding sites of the oxytocin receptor defined by their transfer into the V<sub>2</sub> vasopressin receptor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">271</span><span class="NLM_x">, </span> <span class="NLM_fpage">31593</span><span class="NLM_x">–</span> <span class="NLM_lpage">31601</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=31593-31601&author=R.+Postinaauthor=E.+Kojroauthor=F.+Fahrenholz&title=Separate+agonist+and+peptide+antagonist+binding+sites+of+the+oxytocin+receptor+defined+by+their+transfer+into+the+V2+vasopressin+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPostina%26aufirst%3DR.%26aulast%3DKojro%26aufirst%3DE.%26aulast%3DFahrenholz%26aufirst%3DF.%26atitle%3DSeparate%2520agonist%2520and%2520peptide%2520antagonist%2520binding%2520sites%2520of%2520the%2520oxytocin%2520receptor%2520defined%2520by%2520their%2520transfer%2520into%2520the%2520V2%2520vasopressin%2520receptor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26spage%3D31593%26epage%3D31601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Hibert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoflack, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trumpp-Kallmeyer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouillac, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chini, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahé, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cotte, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manning, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barberis, C.</span><span> </span><span class="NLM_article-title">Functional architecture of vasopressin/oxytocin receptors</span> <span class="citation_source-journal">J. Recept. Signal Transduction Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">589</span><span class="NLM_x">–</span> <span class="NLM_lpage">596</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm901084f&amp;key=10.3109%2F10799899909036674" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm901084f&amp;key=10071787" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADyaK1MXhslWgs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1999&pages=589-596&author=M.+Hibertauthor=J.+Hoflackauthor=S.+Trumpp-Kallmeyerauthor=B.+Mouillacauthor=B.+Chiniauthor=E.+Mah%C3%A9author=N.+Cotteauthor=S.+Jardauthor=M.+Manningauthor=C.+Barberis&title=Functional+architecture+of+vasopressin%2Foxytocin+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Functional architecture of vasopressin/oxytocin receptors</span></div><div class="casAuthors">Hibert, M.; Hoflack, J.; Trumpp-Kallmeyer, S.; Mouillac, B.; Chini, B.; Mahe, E.; Cotte, N.; Jard, S.; Manning, M.; Barberis, C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Receptor and Signal Transduction Research</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1-4</span>),
    <span class="NLM_cas:pages">589-596</span>CODEN:
                <span class="NLM_cas:coden">JRETET</span>;
        ISSN:<span class="NLM_cas:issn">1079-9893</span>.
    
            (<span class="NLM_cas:orgname">Marcel Dekker, Inc.</span>)
        </div><div class="casAbstract">A review with 12 refs.  Three-dimensional models of G protein-coupled receptors (GPCR) have been defined using most exptl. data available and protein modeling techniques.  The endogenous ligand binding sites have been qual. described and putative receptor activation mechanisms have been proposed.  The model has been recently refined to take into account recent crystallog. data.  Most exptl. published are in excellent qual. agreement with the initial model.  The authors have undertaken to study more systematically by site directed mutagenesis the vasopressin/oxytocin receptor binding domain as a prototype of neuropeptide receptors.  The exptl. are in very good agreement with the models.  The residues responsible for the neuropeptide binding have been identified and confirm the predicted localization of the neuromediator in the transmembrane domain of the receptors.  The side chain of the 8th residue of vasopressin interacts with a non-conserved receptor residue located in the first extracellular loop.  As predicted from the model, this interaction is completely responsible for the selectivity of the ligand-receptor interaction.  Finally, arom. residues which allow the modulation of the efficacy of agonists have been identified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmpWY3HKKjVLVg90H21EOLACvtfcHk0lgXzJ_Mb_nFEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhslWgs70%253D&md5=036f8eabc18f3d16763b0caf4ffb98e0</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.3109%2F10799899909036674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F10799899909036674%26sid%3Dliteratum%253Aachs%26aulast%3DHibert%26aufirst%3DM.%26aulast%3DHoflack%26aufirst%3DJ.%26aulast%3DTrumpp-Kallmeyer%26aufirst%3DS.%26aulast%3DMouillac%26aufirst%3DB.%26aulast%3DChini%26aufirst%3DB.%26aulast%3DMah%25C3%25A9%26aufirst%3DE.%26aulast%3DCotte%26aufirst%3DN.%26aulast%3DJard%26aufirst%3DS.%26aulast%3DManning%26aufirst%3DM.%26aulast%3DBarberis%26aufirst%3DC.%26atitle%3DFunctional%2520architecture%2520of%2520vasopressin%252Foxytocin%2520receptors%26jtitle%3DJ.%2520Recept.%2520Signal%2520Transduction%2520Res.%26date%3D1999%26volume%3D19%26spage%3D589%26epage%3D596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Cotte, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balestre, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aumelas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahé, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phalipou, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hibert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manning, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durroux, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barberis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouillac, B.</span><span> </span><span class="NLM_article-title">Conserved aromatic residues in the transmembrane region VI of the V<sub>1a</sub> vasopressin receptor differenciate agonist vs antagonist ligand binding</span> <span class="citation_source-journal">Eur. J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">267</span><span class="NLM_x">, </span> <span class="NLM_fpage">4253</span><span class="NLM_x">–</span> <span class="NLM_lpage">4263</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Fjm901084f&amp;key=10.1046%2Fj.1432-1033.2000.01472.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Fjm901084f&amp;key=10866830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADC%252BD3cXkvFClsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=2000&pages=4253-4263&author=N.+Cotteauthor=M.+N.+Balestreauthor=A.+Aumelasauthor=E.+Mah%C3%A9author=S.+Phalipouauthor=D.+Morinauthor=M.+Hibertauthor=M.+Manningauthor=T.+Durrouxauthor=C.+Barberisauthor=B.+Mouillac&title=Conserved+aromatic+residues+in+the+transmembrane+region+VI+of+the+V1a+vasopressin+receptor+differenciate+agonist+vs+antagonist+ligand+binding"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Conserved aromatic residues in the transmembrane region VI of the V1a vasopressin receptor differentiate agonist vs. antagonist ligand binding</span></div><div class="casAuthors">Cotte, Nathalie; Balestre, Marie-Noelle; Aumelas, Andre; Mahe, Eve; Phalipou, Sylvie; Morin, Denis; Hibert, Marcel; Manning, Maurice; Durroux, Thierry; Barberis, Claude; Mouillac, Bernard</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">267</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4253-4263</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">Despite their opposite effects on signal transduction, the nonapeptide hormone arginine-vasopressin (AVP) and its V1a receptor-selective cyclic peptide antagonist d(CH2)5[Tyr(Me)2]AVP display homologous primary structures, differing only at residues 1 and 2.  These structural similarities led the authors to hypothesize that both ligands could interact with the same binding pocket in the V1a receptor.  To det. receptor residues responsible for discriminating binding of agonist and antagonist ligands, the authors performed site-directed mutagenesis of conserved arom. and hydrophilic residues as well as nonconserved residues, all located in the transmembrane binding pocket of the V1a receptor.  Mutation of arom. residues of transmembrane region VI (W304, F307, F308) reduced affinity for the d(CH2)5[Tyr(Me)2]AVP and markedly decreased affinity for the unrelated strongly hydrophobic V1a-selective nonpeptide antagonist SR 49059.  Replacement of these arom. residues had no effect on AVP binding, but increased AVP-induced coupling efficacy of the receptor for its G protein.  Mutating hydrophilic residues Q108, K128 and Q185 in transmembrane regions II, III and IV, resp., led to a decrease in affinity for both agonists and antagonists.  Finally, the nonconserved residues T333 and A334 in transmembrane region VII, controlled the V1a/V2 binding selectivity for both nonpeptide and cyclic peptide antagonists.  Thus, because conserved arom. residues of the V1a receptor binding pocket seem essential for antagonists and do not contribute at all to the binding of agonists, the authors propose that these residues differentiate agonist vs. antagonist ligand binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNtKvaC7KA_LVg90H21EOLACvtfcHk0lgXzJ_Mb_nFEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXkvFClsbY%253D&md5=5f0463deaf00f467763eea911e729b43</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1046%2Fj.1432-1033.2000.01472.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1432-1033.2000.01472.x%26sid%3Dliteratum%253Aachs%26aulast%3DCotte%26aufirst%3DN.%26aulast%3DBalestre%26aufirst%3DM.%2BN.%26aulast%3DAumelas%26aufirst%3DA.%26aulast%3DMah%25C3%25A9%26aufirst%3DE.%26aulast%3DPhalipou%26aufirst%3DS.%26aulast%3DMorin%26aufirst%3DD.%26aulast%3DHibert%26aufirst%3DM.%26aulast%3DManning%26aufirst%3DM.%26aulast%3DDurroux%26aufirst%3DT.%26aulast%3DBarberis%26aufirst%3DC.%26aulast%3DMouillac%26aufirst%3DB.%26atitle%3DConserved%2520aromatic%2520residues%2520in%2520the%2520transmembrane%2520region%2520VI%2520of%2520the%2520V1a%2520vasopressin%2520receptor%2520differenciate%2520agonist%2520vs%2520antagonist%2520ligand%2520binding%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D2000%26volume%3D267%26spage%3D4253%26epage%3D4263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Breton, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chellil, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kabbaj-Benmansour, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carnazzi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seyer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phalipou, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durroux, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zingg, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barberis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouillac, B.</span><span> </span><span class="NLM_article-title">Direct identification of human oxytocin receptor-binding domains using a photoactivatable cyclic peptide antagonist: comparison with the human V<sub>1a</sub> vasopressin receptor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">26931</span><span class="NLM_x">–</span> <span class="NLM_lpage">26941</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=26931-26941&author=C.+Bretonauthor=H.+Chellilauthor=M.+Kabbaj-Benmansourauthor=E.+Carnazziauthor=R.+Seyerauthor=S.+Phalipouauthor=D.+Morinauthor=T.+Durrouxauthor=H.+Zinggauthor=C.+Barberisauthor=B.+Mouillac&title=Direct+identification+of+human+oxytocin+receptor-binding+domains+using+a+photoactivatable+cyclic+peptide+antagonist%3A+comparison+with+the+human+V1a+vasopressin+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBreton%26aufirst%3DC.%26aulast%3DChellil%26aufirst%3DH.%26aulast%3DKabbaj-Benmansour%26aufirst%3DM.%26aulast%3DCarnazzi%26aufirst%3DE.%26aulast%3DSeyer%26aufirst%3DR.%26aulast%3DPhalipou%26aufirst%3DS.%26aulast%3DMorin%26aufirst%3DD.%26aulast%3DDurroux%26aufirst%3DT.%26aulast%3DZingg%26aufirst%3DH.%26aulast%3DBarberis%26aufirst%3DC.%26aulast%3DMouillac%26aufirst%3DB.%26atitle%3DDirect%2520identification%2520of%2520human%2520oxytocin%2520receptor-binding%2520domains%2520using%2520a%2520photoactivatable%2520cyclic%2520peptide%2520antagonist%253A%2520comparison%2520with%2520the%2520human%2520V1a%2520vasopressin%2520receptor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D26931%26epage%3D26941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Thibonnier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coles, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thibonnier, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoham, M.</span><span> </span><span class="NLM_article-title">Molecular pharmacology and modelling of vasopressin receptors</span> <span class="citation_source-journal">Prog. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">139</span><span class="NLM_x">, </span> <span class="NLM_fpage">179</span><span class="NLM_x">–</span> <span class="NLM_lpage">196</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Fjm901084f&amp;key=10.1016%2FS0079-6123%2802%2939016-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Fjm901084f&amp;key=12436935" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADC%252BD38XovFGrs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=2002&pages=179-196&author=M.+Thibonnierauthor=P.+Colesauthor=A.+Thibonnierauthor=M.+Shoham&title=Molecular+pharmacology+and+modelling+of+vasopressin+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular pharmacology and modeling of vasopressin receptors</span></div><div class="casAuthors">Thibonnier, M.; Coles, P.; Thibonnier, A.; Shoham, M.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Brain Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">139</span>
        (<span class="NLM_cas:issue">Vasopressin and Oxytocin: From Genes to Clinical Applications</span>),
    <span class="NLM_cas:pages">179-196</span>CODEN:
                <span class="NLM_cas:coden">PBRRA4</span>;
        ISSN:<span class="NLM_cas:issn">0079-6123</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  AVP receptors represent a logical target for drug development.  As a new class of therapeutic agents, orally active AVP analogs could be used to treat several human pathophysiol. conditions including neurogenic diabetes insipidus, the syndrome of inappropriate secretion of AVP (SIADH), congestive heart failure, arterial hypertension, liver cirrhosis, nephrotic syndrome, dysmenorrhea, and ocular hypertension.  By immunopptn. and immunoblotting, we elucidated the phosphorylation pattern of green fluorescent protein-tagged AVP receptors and showed interactions with the specific kinases PKC and GRK5 that are agonist, time, and receptor subtype dependent.  The tyrosine residue of the NPWIY motif present in the 7th helix of AVP receptors is rapidly and transiently phosphorylated after agonist stimulation.  This phosphorylation is instrumental in the genesis of the mitogenic cascade linked to the activation of this receptor, presumably by establishing key intramol. contacts and by participating in the creation of a scaffold of proteins that produce the activation of downstream kinases.  The random screening of chem. entities and optimization of lead compds. recently resulted in the development of orally active non-peptide AVP receptor agonists and antagonists.  Furthermore, the identification of the mol. determinants of receptor-ligand interactions should facilitate the development of more potent and very selective orally active compds. via the approach of structure-based drug design.  We developed 3-dimensional mol. docking models of peptide and non-peptide ligands to the human V1 vascular, V2 renal and V3 pituitary AVP receptors.  Docking of the peptide hormone AVP to the receptor ligand binding pockets reflects its dual polar and non-polar structure, but is receptor subtype specific.  The characteristics of non-peptide AVP analogs docking to the receptors are clearly distinct from those of peptide analogs docking.  Mol. modeling of the results of site-directed mutagenesis expts. performed in CHO cells stably transfected with the human AVP receptor subtypes revealed that non-peptide antagonists establish key contacts with a few amino acid residues of the receptor subtypes that are different from those involved in agonist binding.  Moreover, these interactions are species specific.  These findings provide further understanding of the signal transduction pathways of AVP receptors and new leads for elucidation of drug-receptor interactions and optimization of drug design.  Note to the reader: The recent cloning and mol. characterization of AVP/OT receptor subtypes call for the revision of their nomenclature.  For the sake of clarity and in ref. to their main site of expression, we call the V1a receptor the V1 vascular receptor, the V2 receptor the V2 renal receptor and the V1b or V3 receptor the V3 pituitary receptor in the present review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiwlOo6b2iM7Vg90H21EOLACvtfcHk0lh6fy577i_SPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XovFGrs78%253D&md5=46ae6f89e8e119686089c78b263a4b04</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2FS0079-6123%2802%2939016-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0079-6123%252802%252939016-2%26sid%3Dliteratum%253Aachs%26aulast%3DThibonnier%26aufirst%3DM.%26aulast%3DColes%26aufirst%3DP.%26aulast%3DThibonnier%26aufirst%3DA.%26aulast%3DShoham%26aufirst%3DM.%26atitle%3DMolecular%2520pharmacology%2520and%2520modelling%2520of%2520vasopressin%2520receptors%26jtitle%3DProg.%2520Brain%2520Res.%26date%3D2002%26volume%3D139%26spage%3D179%26epage%3D196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Hawtin, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesley, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parslow, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simms, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miles, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McEwan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheatley, M.</span><span> </span><span class="NLM_article-title">A single residue (Arg<sup>46</sup>) located within the N-terminus of the V<sub>1a</sub> vasopressin receptor is critical for binding vasopressin but not peptide or nonpeptide antagonists</span> <span class="citation_source-journal">Mol. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">600</span><span class="NLM_x">–</span> <span class="NLM_lpage">609</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Fjm901084f&amp;key=10.1210%2Fme.16.3.600" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Fjm901084f&amp;key=11875119" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADC%252BD38XitFSisLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2002&pages=600-609&author=S.+R.+Hawtinauthor=V.+J.+Wesleyauthor=R.+A.+Parslowauthor=J.+Simmsauthor=A.+Milesauthor=K.+McEwanauthor=M.+Wheatley&title=A+single+residue+%28Arg46%29+located+within+the+N-terminus+of+the+V1a+vasopressin+receptor+is+critical+for+binding+vasopressin+but+not+peptide+or+nonpeptide+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">A single residue (Arg46) located within the N-terminus of the V1a vasopressin receptor is critical for binding vasopressin but not peptide or nonpeptide antagonists</span></div><div class="casAuthors">Hawtin, Stuart R.; Wesley, Victoria J.; Parslow, Rosemary A.; Simms, John; Miles, Alice; McEwan, Kim; Wheatley, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">600-609</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A fundamental issue in mol. endocrinol. is to define how agonist:receptor interaction differs from antagonist:receptor interaction.  The vasopressin V1a receptor (V1aR) is a member of a sub-family of related G protein-coupled receptors that are activated by the hormone AVP or related peptides.  The N-terminus of the V1aR has recently been shown to be crit. for binding agonists but not antagonists.  Using a combination of N-terminally truncated constructs and alanine-scanning mutagenesis, individual residues that provide these agonist-specific binding epitopes have now been identified in this study.  Our data establish that a single residue, Arg46, is crit. for AVP binding to the V1aR.  Systematic substitution revealed that Arg was required at this locus and could not be substituted by Lys, Glu, Leu, or Ala.  In contrast, antagonist binding (cyclic or linear, peptide or nonpeptide) was unaffected.  Disruption of Arg46 also resulted in defective intracellular signaling.  Arginine is conserved at this locus in all members of the neurohypophysial peptide hormone receptor family cloned to date, indicative of a fundamental role in receptor function.  In addn. to Arg46, the residues Leu42, Gly43, Asp45 form a patch contributing to AVP binding.  This study provides mol. insight into the role of the V1aR N-terminus and key differences between agonist and antagonist binding requirements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6AT1qxbeKmrVg90H21EOLACvtfcHk0lh6fy577i_SPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XitFSisLY%253D&md5=e68330e18be36f3d28feeb0efced5344</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1210%2Fme.16.3.600&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.16.3.600%26sid%3Dliteratum%253Aachs%26aulast%3DHawtin%26aufirst%3DS.%2BR.%26aulast%3DWesley%26aufirst%3DV.%2BJ.%26aulast%3DParslow%26aufirst%3DR.%2BA.%26aulast%3DSimms%26aufirst%3DJ.%26aulast%3DMiles%26aufirst%3DA.%26aulast%3DMcEwan%26aufirst%3DK.%26aulast%3DWheatley%26aufirst%3DM.%26atitle%3DA%2520single%2520residue%2520%2528Arg46%2529%2520located%2520within%2520the%2520N-terminus%2520of%2520the%2520V1a%2520vasopressin%2520receptor%2520is%2520critical%2520for%2520binding%2520vasopressin%2520but%2520not%2520peptide%2520or%2520nonpeptide%2520antagonists%26jtitle%3DMol.%2520Endocrinol.%26date%3D2002%26volume%3D16%26spage%3D600%26epage%3D609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Wesley, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawtin, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheatley, M.</span><span> </span><span class="NLM_article-title">Agonist-specific, high-affinity binding epitopes are contributed by an arginine in the N-terminus of the human oxytocin receptor</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">5086</span><span class="NLM_x">–</span> <span class="NLM_lpage">5092</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi015990v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2002&pages=5086-5092&author=V.+J.+Wesleyauthor=S.+R.+Hawtinauthor=H.+C.+Howardauthor=M.+Wheatley&title=Agonist-specific%2C+high-affinity+binding+epitopes+are+contributed+by+an+arginine+in+the+N-terminus+of+the+human+oxytocin+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fbi015990v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi015990v%26sid%3Dliteratum%253Aachs%26aulast%3DWesley%26aufirst%3DV.%2BJ.%26aulast%3DHawtin%26aufirst%3DS.%2BR.%26aulast%3DHoward%26aufirst%3DH.%2BC.%26aulast%3DWheatley%26aufirst%3DM.%26atitle%3DAgonist-specific%252C%2520high-affinity%2520binding%2520epitopes%2520are%2520contributed%2520by%2520an%2520arginine%2520in%2520the%2520N-terminus%2520of%2520the%2520human%2520oxytocin%2520receptor%26jtitle%3DBiochemistry%26date%3D2002%26volume%3D41%26spage%3D5086%26epage%3D5092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Hawtin, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesley, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simms, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parslow, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miles, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McEwan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheatley, M.</span><span> </span><span class="NLM_article-title">An arginyl in the N-terminus of the V<sub>1a</sub> vasopressin receptor is part of the conformational switch controlling activation by agonist</span> <span class="citation_source-journal">Eur. J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">270</span><span class="NLM_x">, </span> <span class="NLM_fpage">4681</span><span class="NLM_x">–</span> <span class="NLM_lpage">4688</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Fjm901084f&amp;key=10.1046%2Fj.1432-1033.2003.03865.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Fjm901084f&amp;key=14622255" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpsFagur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=270&publication_year=2003&pages=4681-4688&author=S.+R.+Hawtinauthor=V.+J.+Wesleyauthor=J.+Simmsauthor=R.+A.+Parslowauthor=A.+Milesauthor=K.+McEwanauthor=M.+Keenauthor=M.+Wheatley&title=An+arginyl+in+the+N-terminus+of+the+V1a+vasopressin+receptor+is+part+of+the+conformational+switch+controlling+activation+by+agonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">An arginyl in the N-terminus of the V1a vasopressin receptor is part of the conformational switch controlling activation by agonist</span></div><div class="casAuthors">Hawtin, Stuart R.; Wesley, Victoria J.; Simms, John; Parslow, Rosemary A.; Miles, Alice; McEwan, Kim; Keen, Mary; Wheatley, Mark</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">270</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">4681-4688</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Defining how the agonist-receptor interaction differs from that of the antagonist-receptor and understanding the mechanisms of receptor activation are fundamental issues in cell signaling.  The V1a vasopressin receptor (V1aR) is a member of a family of related G-protein coupled receptors that are activated by neurohypophysial peptide hormones, including vasopressin (AVP).  It has recently been reported that an arginyl in the distal N-terminus of the V1aR is crit. for binding agonists but not antagonists.  To det. specific features required at this locus to support high affinity agonist binding and second messenger generation, Arg 46 was substituted by all other 19 encoded amino acids.  The authors' data establish that there is an abs. requirement for arginyl, as none of the [R46X]V1aR mutant constructs supported high affinity agonist binding and all 19 had defective signaling.  In contrast, all of the mutant receptors possessed wildtype binding for both peptide and nonpeptide antagonists.  The ratio of Ki to EC50, an indicator of efficacy, was increased for all substitutions.  Consequently, although [R46X]V1aR constructs have a lower affinity for agonist, once AVP has bound all 19 are more likely than the wildtype V1aR to become activated.  Therefore, in the wildtype V1aR, Arg 46 constrains the inactive conformation of the receptor.  On binding AVP this constraint is alleviated, promoting the transition to active V1aR.  The authors' findings explain why arginyl is conserved at this locus throughout the evolutionary lineage of the neurohypophysial peptide hormone receptor family of G-protein coupled receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGT5k3ZRTK57Vg90H21EOLACvtfcHk0lhayM527wd_yA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpsFagur0%253D&md5=a58648c2450964c20cd1a27c4e338c2a</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1046%2Fj.1432-1033.2003.03865.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1432-1033.2003.03865.x%26sid%3Dliteratum%253Aachs%26aulast%3DHawtin%26aufirst%3DS.%2BR.%26aulast%3DWesley%26aufirst%3DV.%2BJ.%26aulast%3DSimms%26aufirst%3DJ.%26aulast%3DParslow%26aufirst%3DR.%2BA.%26aulast%3DMiles%26aufirst%3DA.%26aulast%3DMcEwan%26aufirst%3DK.%26aulast%3DKeen%26aufirst%3DM.%26aulast%3DWheatley%26aufirst%3DM.%26atitle%3DAn%2520arginyl%2520in%2520the%2520N-terminus%2520of%2520the%2520V1a%2520vasopressin%2520receptor%2520is%2520part%2520of%2520the%2520conformational%2520switch%2520controlling%2520activation%2520by%2520agonist%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D2003%26volume%3D270%26spage%3D4681%26epage%3D4688" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Tahtaoui, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balestre, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klotz, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rognan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barberis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouillac, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hibert, M.</span><span> </span><span class="NLM_article-title">Identification of the binding sites of the SR49059 nonpeptide antagonist into the V<sub>1a</sub> vasopressin receptor using sulfydryl-reactive ligands and cysteine mutants as chemical sensors</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">40010</span><span class="NLM_x">–</span> <span class="NLM_lpage">40019</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=40010-40019&author=C.+Tahtaouiauthor=M.+N.+Balestreauthor=P.+Klotzauthor=D.+Rognanauthor=C.+Barberisauthor=B.+Mouillacauthor=M.+Hibert&title=Identification+of+the+binding+sites+of+the+SR49059+nonpeptide+antagonist+into+the+V1a+vasopressin+receptor+using+sulfydryl-reactive+ligands+and+cysteine+mutants+as+chemical+sensors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTahtaoui%26aufirst%3DC.%26aulast%3DBalestre%26aufirst%3DM.%2BN.%26aulast%3DKlotz%26aufirst%3DP.%26aulast%3DRognan%26aufirst%3DD.%26aulast%3DBarberis%26aufirst%3DC.%26aulast%3DMouillac%26aufirst%3DB.%26aulast%3DHibert%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520the%2520binding%2520sites%2520of%2520the%2520SR49059%2520nonpeptide%2520antagonist%2520into%2520the%2520V1a%2520vasopressin%2520receptor%2520using%2520sulfydryl-reactive%2520ligands%2520and%2520cysteine%2520mutants%2520as%2520chemical%2520sensors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D40010%26epage%3D40019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Gimpl, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Postina, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fahrenholz, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinheimer, T.</span><span> </span><span class="NLM_article-title">Binding domains of the oxytocin receptor for the selective oxytocin receptor antagonist barusiban in comparison to the agonists oxytocin and carbetocin</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">510</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Fjm901084f&amp;key=10.1016%2Fj.ejphar.2005.01.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Fjm901084f&amp;key=15740719" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhvVCksrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=510&publication_year=2005&pages=9-16&author=G.+Gimplauthor=R.+Postinaauthor=F.+Fahrenholzauthor=T.+Reinheimer&title=Binding+domains+of+the+oxytocin+receptor+for+the+selective+oxytocin+receptor+antagonist+barusiban+in+comparison+to+the+agonists+oxytocin+and+carbetocin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Binding domains of the oxytocin receptor for the selective oxytocin receptor antagonist barusiban in comparison to the agonists oxytocin and carbetocin</span></div><div class="casAuthors">Gimpl, Gerald; Postina, Rolf; Fahrenholz, Falk; Reinheimer, Torsten</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">510</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">9-16</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The authors have analyzed binding domains of the oxytocin receptor for barusiban, a highly selective oxytocin receptor antagonist, in comparison to the combined vasopressin V1A/oxytocin receptor antagonist atosiban and the agonists oxytocin and carbetocin.  For this purpose, chimeric 'gain-in function' oxytocin/vasopressin V2 receptors were expressed in COS-7 cells.  These recombinant receptors have been produced by transfer of domains from the oxytocin receptor into the related vasopressin V2 receptor and have already been successfully employed for the identification of ligand binding domains at the oxytocin receptor (Postina, R., Kojro, E., Fahrenholz, F., 1996. Sep. agonist and peptide antagonist binding sites of the oxytocin receptor defined by their transfer into the V2 vasopressin receptor. J. Biol. Chem. 271, 31593-31601).  In displacement studies with 10 chimeric receptor constructs, the binding profile of barusiban was compared with the binding profiles of the ligands oxytocin, [Arg8]vasopressin, carbetocin, and atosiban.  The binding profiles for the agonists oxytocin and carbetocin were found to be similar.  For both agonists, important binding domains were the extracellular N-terminus (=E1) and the extracellular loops E2 and E3 from the oxytocin receptor.  For the vasopressin V1A/oxytocin receptor antagonist atosiban, none of the receptor constructs were able to provide a binding with higher affinity than the starting vasopressin V2 receptor.  In contrast, the binding of barusiban was significantly improved when the transmembrane domains 1 and 2 were transferred from the oxytocin receptor to the vasopressin V2 receptor.  The binding domain of barusiban differs from the binding domain of the agonists and the nonselective oxytocin receptor antagonist d(CH2)5[Tyr-(Me)2,Thr4,Orn8,Tyr9]vasotocin that has been used in previous studies.  Overall, the data supported the concept of a central pocket site within the oxytocin receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEYqNb3Eu8HLVg90H21EOLACvtfcHk0lhz3ID7MeWe0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhvVCksrc%253D&md5=88536ac27555378a10d0849bfa89563c</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2005.01.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2005.01.010%26sid%3Dliteratum%253Aachs%26aulast%3DGimpl%26aufirst%3DG.%26aulast%3DPostina%26aufirst%3DR.%26aulast%3DFahrenholz%26aufirst%3DF.%26aulast%3DReinheimer%26aufirst%3DT.%26atitle%3DBinding%2520domains%2520of%2520the%2520oxytocin%2520receptor%2520for%2520the%2520selective%2520oxytocin%2520receptor%2520antagonist%2520barusiban%2520in%2520comparison%2520to%2520the%2520agonists%2520oxytocin%2520and%2520carbetocin%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2005%26volume%3D510%26spage%3D9%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Hawtin, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simms, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawson, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parslow, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheppard, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheatley, M.</span><span> </span><span class="NLM_article-title">Charged extracellular residues, conserved throughout a G-protein-coupled receptor family, are required for ligand binding, receptor activation, and cell-surface expression</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">281</span><span class="NLM_x">, </span> <span class="NLM_fpage">38478</span><span class="NLM_x">–</span> <span class="NLM_lpage">38488</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=38478-38488&author=S.+R.+Hawtinauthor=J.+Simmsauthor=M.+Connerauthor=Z.+Lawsonauthor=R.+A.+Parslowauthor=J.+Trimauthor=A.+Sheppardauthor=M.+Wheatley&title=Charged+extracellular+residues%2C+conserved+throughout+a+G-protein-coupled+receptor+family%2C+are+required+for+ligand+binding%2C+receptor+activation%2C+and+cell-surface+expression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHawtin%26aufirst%3DS.%2BR.%26aulast%3DSimms%26aufirst%3DJ.%26aulast%3DConner%26aufirst%3DM.%26aulast%3DLawson%26aufirst%3DZ.%26aulast%3DParslow%26aufirst%3DR.%2BA.%26aulast%3DTrim%26aufirst%3DJ.%26aulast%3DSheppard%26aufirst%3DA.%26aulast%3DWheatley%26aufirst%3DM.%26atitle%3DCharged%2520extracellular%2520residues%252C%2520conserved%2520throughout%2520a%2520G-protein-coupled%2520receptor%2520family%252C%2520are%2520required%2520for%2520ligand%2520binding%252C%2520receptor%2520activation%252C%2520and%2520cell-surface%2520expression%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D38478%26epage%3D38488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Macion-Dazard, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callahan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thibonnier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoham, M.</span><span> </span><span class="NLM_article-title">Mapping the binding site of six nonpeptide antagonists to the human V<sub>2</sub>-renal vasopressin receptor</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">316</span><span class="NLM_x">, </span> <span class="NLM_fpage">564</span><span class="NLM_x">–</span> <span class="NLM_lpage">571</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Fjm901084f&amp;key=10.1124%2Fjpet.105.095554" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Fjm901084f&amp;key=16234409" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlWqsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=316&publication_year=2006&pages=564-571&author=R.+Macion-Dazardauthor=N.+Callahanauthor=Z.+Xuauthor=N.+Wuauthor=M.+Thibonnierauthor=M.+Shoham&title=Mapping+the+binding+site+of+six+nonpeptide+antagonists+to+the+human+V2-renal+vasopressin+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Mapping the binding site of six nonpeptide antagonists to the human V2-renal vasopressin receptor</span></div><div class="casAuthors">Macion-Dazard, Rosemarie; Callahan, Nicholas; Xu, Zhen; Wu, Nan; Thibonnier, Marc; Shoham, Menachem</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">316</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">564-571</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Whereas arginine vasopressin binds to its receptor subtypes V1R and V2R with equal affinity of approx. 2 nM, nonpeptide antagonists interact differently with vasopressin receptor subtypes.  The V2R antagonist binding site was mapped by site-directed mutagenesis at six selected amino acid positions, K100D, A110W, M120V, L175Y, R202S, and F307I, predicted to be involved in antagonist binding differences between V2R and V1R.  These mutations did not alter the affinity for arginine vasopressin.  However, the affinity for six nonpeptide receptor antagonists SR121463B [1-[4-(N-tert-butylcarbamoyl)-2-methoxybenzenesulfonyl]-5-ethoxy-3-spiro- [4[(2 morpholinoethoxy)cyclohexane]indoline-2-one, phosphate monohydrate cis-isomer]], SR49059 [(2S)1-[(2R3S)-5-chloro-3-(2 chlorophenyl)-1-(3,4-dimethoxybenzene-sulfonyl)-3-hydroxy-2,3-dihydro-1H-indole-2-carbonyl]-pyrrolidine-2-carboxamide], SSR149415 [(2S,4R)-1-[5-chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-3-(2-methoxyphenyl)-2-oxo-2,3-dihydro-1H-indol-3-yl]-4-hydroxy-N, N-dimethyl-2pyrrolidine carboxamide, isomer(-)], OPC21268 [1-[1-[4-(3-acetylaminopropoxy)benzoyl]-4-piperidyl]-3,4-dihydro-2(1H)-quinolinone], OPC41061 [(±)-4'-[(7-chloro-2,3,4,5-tetrahydro-5-hydroxy-1H-1-benzazepin-1-yl)carbonyl]-o-tolu-m-toluidide], and OPC31260, [(±)-5-dimethylamino-1-[4-(2-methylbenzoylamino)benzyl]-1,2,3,4,5-tetrahydro-1H-benzazepine monohydrochloride], was altered to varying degrees, resulting in differences up to 6000-fold.  Replacement of the small alanine for the bulky tryptophan in position 110 resulted in a reduced affinity for all six antagonists.  In contrast, replacement of the large methionine for the smaller valine in position 120 caused a dramatic increase in affinity, up to a Ki of 7 fM for OPC31260.  Mol. modeling revealed that the binding sites for arginine vasopressin and the nonpeptide antagonists are partially overlapping.  Whereas arginine vasopressin binds on the extracellular surface of V2R, the nonpeptide antagonists penetrate deeper into the transmembrane region of the receptor, in particular OPC21268.  The mutagenesis data point to significant differences in the shape of the V1R and V2R antagonist binding pockets.  The most important factor detg. the specificity of nonpeptide antagonists seems to be the shape of the binding pocket on the receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpckh1l27h0q7Vg90H21EOLACvtfcHk0lhz3ID7MeWe0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlWqsLo%253D&md5=43156c3ccc4e2795e91eb378393065eb</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.095554&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.095554%26sid%3Dliteratum%253Aachs%26aulast%3DMacion-Dazard%26aufirst%3DR.%26aulast%3DCallahan%26aufirst%3DN.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DN.%26aulast%3DThibonnier%26aufirst%3DM.%26aulast%3DShoham%26aufirst%3DM.%26atitle%3DMapping%2520the%2520binding%2520site%2520of%2520six%2520nonpeptide%2520antagonists%2520to%2520the%2520human%2520V2-renal%2520vasopressin%2520receptor%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2006%26volume%3D316%26spage%3D564%26epage%3D571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Conner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawtin, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simms, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wootten, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawson, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conner, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parslow, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheatley, M.</span><span> </span><span class="NLM_article-title">Systematic analysis of the entire second extracellular loop of the V<sub>1a</sub> vasopressin receptor: key residues, conserved throughout a G-protein-coupled receptor family, identified</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">17405</span><span class="NLM_x">–</span> <span class="NLM_lpage">17412</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=17405-17412&author=M.+Connerauthor=S.+R.+Hawtinauthor=J.+Simmsauthor=D.+Woottenauthor=Z.+Lawsonauthor=A.+C.+Connerauthor=R.+A.+Parslowauthor=M.+Wheatley&title=Systematic+analysis+of+the+entire+second+extracellular+loop+of+the+V1a+vasopressin+receptor%3A+key+residues%2C+conserved+throughout+a+G-protein-coupled+receptor+family%2C+identified"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DConner%26aufirst%3DM.%26aulast%3DHawtin%26aufirst%3DS.%2BR.%26aulast%3DSimms%26aufirst%3DJ.%26aulast%3DWootten%26aufirst%3DD.%26aulast%3DLawson%26aufirst%3DZ.%26aulast%3DConner%26aufirst%3DA.%2BC.%26aulast%3DParslow%26aufirst%3DR.%2BA.%26aulast%3DWheatley%26aufirst%3DM.%26atitle%3DSystematic%2520analysis%2520of%2520the%2520entire%2520second%2520extracellular%2520loop%2520of%2520the%2520V1a%2520vasopressin%2520receptor%253A%2520key%2520residues%252C%2520conserved%2520throughout%2520a%2520G-protein-coupled%2520receptor%2520family%252C%2520identified%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D17405%26epage%3D17412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Nakamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsujimae, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoyama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinohara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teramoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sumida, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sekiguchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kambe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsujimoto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tominaga, M.</span><span> </span><span class="NLM_article-title">Characterization of a novel nonpeptide vasopressin V<sub>2</sub>-agonist, OPC-51803, in cells transfected human vasopressin receptor subtypes</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">129</span><span class="NLM_x">, </span> <span class="NLM_fpage">1700</span><span class="NLM_x">–</span> <span class="NLM_lpage">1706</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Fjm901084f&amp;key=10.1038%2Fsj.bjp.0703221" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Fjm901084f&amp;key=10780976" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjtV2ru7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2000&pages=1700-1706&author=S.+Nakamuraauthor=Y.+Yamamuraauthor=S.+Itohauthor=T.+Hiranoauthor=K.+Tsujimaeauthor=M.+Aoyamaauthor=K.+Kondoauthor=H.+Ogawaauthor=T.+Shinoharaauthor=K.+Kanauthor=Y.+Tanadaauthor=S.+Teramotoauthor=T.+Sumidaauthor=S.+Nakayamaauthor=K.+Sekiguchiauthor=T.+Kambeauthor=G.+Tsujimotoauthor=T.+Moriauthor=M.+Tominaga&title=Characterization+of+a+novel+nonpeptide+vasopressin+V2-agonist%2C+OPC-51803%2C+in+cells+transfected+human+vasopressin+receptor+subtypes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of a novel nonpeptide vasopressin V2-agonist, OPC-51803, in cells transfected human vasopressin receptor subtypes</span></div><div class="casAuthors">Nakamura, Shigeki; Yamamura, Yoshitaka; Itoh, Shuji; Hirano, Takahiro; Tsujimae, Kenji; Aoyama, Masashi; Kondo, Kazumi; Ogawa, Hidenori; Shinohara, Tomoichi; Kan, Keizo; Tanada, Yoshihisa; Teramoto, Shuji; Sumida, Takumi; Nakayama, Sunao; Sekiguchi, Kazuo; Kambe, Toshimi; Tsujimoto, Gozoh; Mori, Toyoki; Tominaga, Michiaki</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1700-1706</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We discovered the first nonpeptide arginine-vasopressin (AVP) V2-receptor agonist, OPC-51803.  Pharmacol. properties of OPC-51803 were elucidated using HeLa cells expressing human AVP receptor subtypes (V2, V1a and V1b) and compared with those of 1-desamino-8-D-arginine vasopressin (dDAVP), a peptide V2-receptor agonist.  OPC-51803 and dDAVP displaced [3H]-AVP binding to human V2- and V1a-receptors with Ki values of 91.9±10.8 nM (n=6) and 3.12±0.38 nM (n=6) for V2-receptors, and 819±39 nM (n=6) and 41.5±9.9 nM (n=6) for V1a-receptors, indicating that OPC-51803 was about nine times more selective for V2-receptors, similar to the selectivity of dDAVP.  OPC-51803 scarcely displaced [3H]-AVP binding to human V1b-receptors even at 10-4 M, while dDAVP showed potent affinity to human V1b-receptors with the Ki value of 13.7±3.2 nM (n=4).  OPC-51803 concn.-dependently increased cyclic adenosine 3', 5'-monophosphate (cAMP) prodn. in HeLa cells expressing human V2-receptors with an EC50 value of 189±14 nM (n=6).  The concn.-response curve for cAMP prodn. induced by OPC-51803 was shifted to the right in the presence of a V2-antagonist, OPC-31260.  At 10-5 M, OPC-51803 did not increase the intracellular Ca2+ concn. ([Ca2+]i) in HeLa cells expressing human V1a-receptors.  On the other hand, dDAVP increased [Ca2+]i in HeLa cells expressing human V1a- and V1b-receptors in a concn.-dependent fashion.  From these results, OPC-51803 has been confirmed to be the first nonpeptide agonist for human AVP V2-receptors without agonistic activities for V1a- and V1b-receptors.  OPC-51803 may be useful for the treatment of AVP-deficient pathophysiol. states and as a tool for AVP researches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtP6Ey2VlQ77Vg90H21EOLACvtfcHk0liFKXN0NjVqog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjtV2ru7k%253D&md5=435c824ff32701169445cb4a1c35a94c</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0703221&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0703221%26sid%3Dliteratum%253Aachs%26aulast%3DNakamura%26aufirst%3DS.%26aulast%3DYamamura%26aufirst%3DY.%26aulast%3DItoh%26aufirst%3DS.%26aulast%3DHirano%26aufirst%3DT.%26aulast%3DTsujimae%26aufirst%3DK.%26aulast%3DAoyama%26aufirst%3DM.%26aulast%3DKondo%26aufirst%3DK.%26aulast%3DOgawa%26aufirst%3DH.%26aulast%3DShinohara%26aufirst%3DT.%26aulast%3DKan%26aufirst%3DK.%26aulast%3DTanada%26aufirst%3DY.%26aulast%3DTeramoto%26aufirst%3DS.%26aulast%3DSumida%26aufirst%3DT.%26aulast%3DNakayama%26aufirst%3DS.%26aulast%3DSekiguchi%26aufirst%3DK.%26aulast%3DKambe%26aufirst%3DT.%26aulast%3DTsujimoto%26aufirst%3DG.%26aulast%3DMori%26aufirst%3DT.%26aulast%3DTominaga%26aufirst%3DM.%26atitle%3DCharacterization%2520of%2520a%2520novel%2520nonpeptide%2520vasopressin%2520V2-agonist%252C%2520OPC-51803%252C%2520in%2520cells%2520transfected%2520human%2520vasopressin%2520receptor%2520subtypes%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2000%26volume%3D129%26spage%3D1700%26epage%3D1706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span> </span><span class="NLM_article-title">WAY-141608</span>,  <span class="citation_source-journal">Drug Data Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">520</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=WAY-141608%2C+Drug+Data+Rep.+2000%2C+22%2C+520."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26atitle%3DWAY-141608%26jtitle%3DDrug%2520Data%2520Rep.%26date%3D2000%26volume%3D22%26spage%3D520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Kondo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bando, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinohara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurimura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kido, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tominaga, M.</span><span> </span><span class="NLM_article-title">Characterization of orally active nonpeptide vasopressin V<sub>2</sub> receptor agonists: synthesis and biological evaluation of both the (5<i>R</i>)- and (5<i>S</i>)-enantioisomers of 2-[1-(2-chloro-4-pyrrolidin-1-yl-benzoyl)-2,3,4,5-tetrahydro-1<i>H</i>-1-benzazepin-5-yl]-<i>N</i>-isopropylacetamide</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">3805</span><span class="NLM_x">–</span> <span class="NLM_lpage">3808</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020133q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=3805-3808&author=K.+Kondoauthor=K.+Kanauthor=Y.+Tanadaauthor=M.+Bandoauthor=T.+Shinoharaauthor=M.+Kurimuraauthor=H.+Ogawaauthor=S.+Nakamuraauthor=T.+Hiranoauthor=Y.+Yamamuraauthor=M.+Kidoauthor=T.+Moriauthor=M.+Tominaga&title=Characterization+of+orally+active+nonpeptide+vasopressin+V2+receptor+agonists%3A+synthesis+and+biological+evaluation+of+both+the+%285R%29-+and+%285S%29-enantioisomers+of+2-%5B1-%282-chloro-4-pyrrolidin-1-yl-benzoyl%29-2%2C3%2C4%2C5-tetrahydro-1H-1-benzazepin-5-yl%5D-N-isopropylacetamide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Fjm020133q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020133q%26sid%3Dliteratum%253Aachs%26aulast%3DKondo%26aufirst%3DK.%26aulast%3DKan%26aufirst%3DK.%26aulast%3DTanada%26aufirst%3DY.%26aulast%3DBando%26aufirst%3DM.%26aulast%3DShinohara%26aufirst%3DT.%26aulast%3DKurimura%26aufirst%3DM.%26aulast%3DOgawa%26aufirst%3DH.%26aulast%3DNakamura%26aufirst%3DS.%26aulast%3DHirano%26aufirst%3DT.%26aulast%3DYamamura%26aufirst%3DY.%26aulast%3DKido%26aufirst%3DM.%26aulast%3DMori%26aufirst%3DT.%26aulast%3DTominaga%26aufirst%3DM.%26atitle%3DCharacterization%2520of%2520orally%2520active%2520nonpeptide%2520vasopressin%2520V2%2520receptor%2520agonists%253A%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520both%2520the%2520%25285R%2529-%2520and%2520%25285S%2529-enantioisomers%2520of%25202-%255B1-%25282-chloro-4-pyrrolidin-1-yl-benzoyl%2529-2%252C3%252C4%252C5-tetrahydro-1H-1-benzazepin-5-yl%255D-N-isopropylacetamide%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D3805%26epage%3D3808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Failli, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shumsky, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steffan, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caggiano, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trybulski, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ning, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lock, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanikella, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, C. H.</span><span> </span><span class="NLM_article-title">Pyridobenzodiazepines: a novel class of orally active, vasopressin V<sub>2</sub> receptor selective agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">954</span><span class="NLM_x">–</span> <span class="NLM_lpage">959</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=954-959&author=A.+A.+Failliauthor=J.+S.+Shumskyauthor=R.+J.+Steffanauthor=T.+J.+Caggianoauthor=D.+K.+Williamsauthor=E.+J.+Trybulskiauthor=X.+Ningauthor=Y.+Lockauthor=T.+Tanikellaauthor=D.+Hartmannauthor=P.+S.+Chanauthor=C.+H.+Park&title=Pyridobenzodiazepines%3A+a+novel+class+of+orally+active%2C+vasopressin+V2+receptor+selective+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFailli%26aufirst%3DA.%2BA.%26aulast%3DShumsky%26aufirst%3DJ.%2BS.%26aulast%3DSteffan%26aufirst%3DR.%2BJ.%26aulast%3DCaggiano%26aufirst%3DT.%2BJ.%26aulast%3DWilliams%26aufirst%3DD.%2BK.%26aulast%3DTrybulski%26aufirst%3DE.%2BJ.%26aulast%3DNing%26aufirst%3DX.%26aulast%3DLock%26aufirst%3DY.%26aulast%3DTanikella%26aufirst%3DT.%26aulast%3DHartmann%26aufirst%3DD.%26aulast%3DChan%26aufirst%3DP.%2BS.%26aulast%3DPark%26aufirst%3DC.%2BH.%26atitle%3DPyridobenzodiazepines%253A%2520a%2520novel%2520class%2520of%2520orally%2520active%252C%2520vasopressin%2520V2%2520receptor%2520selective%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D954%26epage%3D959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Yamamura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chihara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onogawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tominaga, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yabuuchi, Y.</span><span> </span><span class="NLM_article-title">OPC-21268, an orally effective, nonpeptide vasopressin V<sub>1</sub> receptor antagonist</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">252</span><span class="NLM_x">, </span> <span class="NLM_fpage">572</span><span class="NLM_x">–</span> <span class="NLM_lpage">574</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=252&publication_year=1991&pages=572-574&author=Y.+Yamamuraauthor=H.+Ogawaauthor=T.+Chiharaauthor=K.+Kondoauthor=T.+Onogawaauthor=S.+Nakamuraauthor=T.+Moriauthor=M.+Tominagaauthor=Y.+Yabuuchi&title=OPC-21268%2C+an+orally+effective%2C+nonpeptide+vasopressin+V1+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYamamura%26aufirst%3DY.%26aulast%3DOgawa%26aufirst%3DH.%26aulast%3DChihara%26aufirst%3DT.%26aulast%3DKondo%26aufirst%3DK.%26aulast%3DOnogawa%26aufirst%3DT.%26aulast%3DNakamura%26aufirst%3DS.%26aulast%3DMori%26aufirst%3DT.%26aulast%3DTominaga%26aufirst%3DM.%26aulast%3DYabuuchi%26aufirst%3DY.%26atitle%3DOPC-21268%252C%2520an%2520orally%2520effective%252C%2520nonpeptide%2520vasopressin%2520V1%2520receptor%2520antagonist%26jtitle%3DScience%26date%3D1991%26volume%3D252%26spage%3D572%26epage%3D574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Ogawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyamoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakaya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tominaga, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yabuuchi, Y.</span><span> </span><span class="NLM_article-title">Orally active, nonpeptide vasopressin V<sub>2</sub> receptor antagonists: a novel series of 1-[4-(benzoylamino)benzoyl]-2,3,4,5-tetrahydro-1<i>H</i>-benzazepines and related compounds</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">3547</span><span class="NLM_x">–</span> <span class="NLM_lpage">3555</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm960133o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=3547-3555&author=H.+Ogawaauthor=H.+Yamashitaauthor=K.+Kondoauthor=Y.+Yamamuraauthor=H.+Miyamotoauthor=K.+Kanauthor=K.+Kitanoauthor=M.+Tanakaauthor=K.+Nakayaauthor=S.+Nakamuraauthor=T.+Moriauthor=M.+Tominagaauthor=Y.+Yabuuchi&title=Orally+active%2C+nonpeptide+vasopressin+V2+receptor+antagonists%3A+a+novel+series+of+1-%5B4-%28benzoylamino%29benzoyl%5D-2%2C3%2C4%2C5-tetrahydro-1H-benzazepines+and+related+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Fjm960133o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm960133o%26sid%3Dliteratum%253Aachs%26aulast%3DOgawa%26aufirst%3DH.%26aulast%3DYamashita%26aufirst%3DH.%26aulast%3DKondo%26aufirst%3DK.%26aulast%3DYamamura%26aufirst%3DY.%26aulast%3DMiyamoto%26aufirst%3DH.%26aulast%3DKan%26aufirst%3DK.%26aulast%3DKitano%26aufirst%3DK.%26aulast%3DTanaka%26aufirst%3DM.%26aulast%3DNakaya%26aufirst%3DK.%26aulast%3DNakamura%26aufirst%3DS.%26aulast%3DMori%26aufirst%3DT.%26aulast%3DTominaga%26aufirst%3DM.%26aulast%3DYabuuchi%26aufirst%3DY.%26atitle%3DOrally%2520active%252C%2520nonpeptide%2520vasopressin%2520V2%2520receptor%2520antagonists%253A%2520a%2520novel%2520series%2520of%25201-%255B4-%2528benzoylamino%2529benzoyl%255D-2%252C3%252C4%252C5-tetrahydro-1H-benzazepines%2520and%2520related%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D3547%26epage%3D3555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Ariëns, E. J.</span><span> </span><span class="NLM_article-title">A molecular basis for the action of drugs. I. Receptor−theory and structure−effect relations</span> <span class="citation_source-journal">Arzneim. Forsch.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1966</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1376</span><span class="NLM_x">–</span> <span class="NLM_lpage">1395</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADyaF2sXltl2kug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1966&pages=1376-1395&author=E.+J.+Ari%C3%ABns&title=A+molecular+basis+for+the+action+of+drugs.+I.+Receptor%E2%88%92theory+and+structure%E2%88%92effect+relations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular basis for the activity of drugs.  I.  Receptor theory and structure-activity relation</span></div><div class="casAuthors">Ariens, Everhardus J.</div><div class="citationInfo"><span class="NLM_cas:title">Arzneimittel-Forschung</span>
        (<span class="NLM_cas:date">1966</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1376-93</span>CODEN:
                <span class="NLM_cas:coden">ARZNAD</span>;
        ISSN:<span class="NLM_cas:issn">0004-4172</span>.
    </div><div class="casAbstract">The theory of the mode of action of drugs, based on the receptor concept is reviewed.  The relation between structure and activity, esp. between the structure of agonists and their competitive antagonists, is analyzed.  The introduction of centers of asymmetry into the various moieties of drug mols., particularly anticholinergic drugs, and the activities of various stereoisomers thus obtained, were compared.  It was concluded that agonists and competitive antagonists, although they compete for "common" receptors, often interact with different but functionally related receptor areas.  Further, the relation between the degree of freedom in the conformation of drugs and the specificity of their action and the degree of freedom in the chem. structure of particular moieties of drug mols. and the degree of involvement of these particular moieties in the drug-receptor interaction are discussed.  63 references.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRZFA4Ek2V1bVg90H21EOLACvtfcHk0liKhdsjQYKpPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2sXltl2kug%253D%253D&md5=07da98f6e61608dd7e29723cbfb6fc8b</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAri%25C3%25ABns%26aufirst%3DE.%2BJ.%26atitle%3DA%2520molecular%2520basis%2520for%2520the%2520action%2520of%2520drugs.%2520I.%2520Receptor%25E2%2588%2592theory%2520and%2520structure%25E2%2588%2592effect%2520relations%26jtitle%3DArzneim.%2520Forsch.%26date%3D1966%26volume%3D16%26spage%3D1376%26epage%3D1395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Goddard, W. A.,  III; Abrol, R.</span><span> </span><span class="NLM_article-title">3-Dimensional structures of G-protein-coupled receptors and binding sites of agonists and antagonists</span>.  <span class="citation_source-journal">J. Nutr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">137</span><span class="NLM_x">, </span> <span class="NLM_fpage">1528S</span>− <span class="NLM_lpage">1538S</span>, and references cited therein.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2007&pages=1528S-1538S&author=W.+A.+Goddard&author=R.+Abrol&title=3-Dimensional+structures+of+G-protein-coupled+receptors+and+binding+sites+of+agonists+and+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGoddard%26aufirst%3DW.%2BA.%26atitle%3D3-Dimensional%2520structures%2520of%2520G-protein-coupled%2520receptors%2520and%2520binding%2520sites%2520of%2520agonists%2520and%2520antagonists%26jtitle%3DJ.%2520Nutr.%26date%3D2007%26volume%3D137%26spage%3D1528S%26epage%3D1538S" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Portoghese, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipkowski, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takemori, A. E.</span><span> </span><span class="NLM_article-title">Bimorphans as highly selective, potent kappa opioid receptor antagonist</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">238</span><span class="NLM_x">–</span> <span class="NLM_lpage">239</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00385a002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1987&pages=238-239&author=P.+S.+Portogheseauthor=A.+W.+Lipkowskiauthor=A.+E.+Takemori&title=Bimorphans+as+highly+selective%2C+potent+kappa+opioid+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1021%2Fjm00385a002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00385a002%26sid%3Dliteratum%253Aachs%26aulast%3DPortoghese%26aufirst%3DP.%2BS.%26aulast%3DLipkowski%26aufirst%3DA.%2BW.%26aulast%3DTakemori%26aufirst%3DA.%2BE.%26atitle%3DBimorphans%2520as%2520highly%2520selective%252C%2520potent%2520kappa%2520opioid%2520receptor%2520antagonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1987%26volume%3D30%26spage%3D238%26epage%3D239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Perlman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costa-Neto, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyakawa, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schambye, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hjorth, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paiva, A. C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivero, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, T. W.</span><span> </span><span class="NLM_article-title">Dual agonistic and antagonistic property of nonpeptide angiotensin AT1 ligands: susceptibility to receptor mutations</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">301</span><span class="NLM_x">–</span> <span class="NLM_lpage">311</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1997&pages=301-311&author=S.+Perlmanauthor=C.+M.+Costa-Netoauthor=A.+A.+Miyakawaauthor=H.+T.+Schambyeauthor=S.+A.+Hjorthauthor=A.+C.+M.+Paivaauthor=R.+A.+Riveroauthor=W.+J.+Greenleeauthor=T.+W.+Schwartz&title=Dual+agonistic+and+antagonistic+property+of+nonpeptide+angiotensin+AT1+ligands%3A+susceptibility+to+receptor+mutations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPerlman%26aufirst%3DS.%26aulast%3DCosta-Neto%26aufirst%3DC.%2BM.%26aulast%3DMiyakawa%26aufirst%3DA.%2BA.%26aulast%3DSchambye%26aufirst%3DH.%2BT.%26aulast%3DHjorth%26aufirst%3DS.%2BA.%26aulast%3DPaiva%26aufirst%3DA.%2BC.%2BM.%26aulast%3DRivero%26aufirst%3DR.%2BA.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DSchwartz%26aufirst%3DT.%2BW.%26atitle%3DDual%2520agonistic%2520and%2520antagonistic%2520property%2520of%2520nonpeptide%2520angiotensin%2520AT1%2520ligands%253A%2520susceptibility%2520to%2520receptor%2520mutations%26jtitle%3DMol.%2520Pharmacol.%26date%3D1997%26volume%3D51%26spage%3D301%26epage%3D311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Fürst, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosztafi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedmann, T.</span><span> </span><span class="NLM_article-title">Structure−activity relationships of synthetic and semisynthetic opioid agonists and antagonists</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">423</span><span class="NLM_x">–</span> <span class="NLM_lpage">440</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADyaK2MXlt1ygu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1995&pages=423-440&author=S.+F%C3%BCrstauthor=S.+Hosztafiauthor=T.+Friedmann&title=Structure%E2%88%92activity+relationships+of+synthetic+and+semisynthetic+opioid+agonists+and+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationships of synthetic and semisynthetic opioid agonists and antagonists</span></div><div class="casAuthors">Fuerst, S.; Hosztafi, S.; Friedmann, T.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">423-40</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers BV</span>)
        </div><div class="casAbstract">A review with 205 refs.  This paper surveys the relations between the chem. structures and pharmacol. activities of natural or semisynthetic 4,5α-epoxymorphinans, synthetic morphinans and benzomorphans.  Substitution of the N-Me group affords strong analgesics, opioid antagonists and mixed agonist-antagonists resp.  The role of opioid agonists and antagonists in the development of opioid receptor models is also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXl_XzHf57iLVg90H21EOLACvtfcHk0lhTwruRsELbeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXlt1ygu7w%253D&md5=5475fc9501af3335680a580aa86aede5</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DF%25C3%25BCrst%26aufirst%3DS.%26aulast%3DHosztafi%26aufirst%3DS.%26aulast%3DFriedmann%26aufirst%3DT.%26atitle%3DStructure%25E2%2588%2592activity%2520relationships%2520of%2520synthetic%2520and%2520semisynthetic%2520opioid%2520agonists%2520and%2520antagonists%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D1995%26volume%3D1%26spage%3D423%26epage%3D440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Aquino, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armour, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berman, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birkemo, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, R. A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croom, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dezube, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dougherty, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ervin, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grizzle, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Head, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirst, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Queen, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rimele, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugg, E. E.</span><span> </span><span class="NLM_article-title">Discovery of 1,5-benzodiazepines with peripheral cholecystokinin (CCK-A) receptor agonist activity. 1. Optimization of the agonist “trigger”</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">562</span><span class="NLM_x">–</span> <span class="NLM_lpage">569</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm950626d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=562-569&author=C.+J.+Aquinoauthor=D.+R.+Armourauthor=J.+M.+Bermanauthor=L.+S.+Birkemoauthor=R.+A.+E.+Carrauthor=D.+K.+Croomauthor=M.+Dezubeauthor=R.+W.+Doughertyauthor=G.+N.+Ervinauthor=M.+K.+Grizzleauthor=J.+E.+Headauthor=G.+C.+Hirstauthor=M.+K.+Jamesauthor=M.+F.+Johnsonauthor=L.+J.+Millerauthor=K.+L.+Queenauthor=T.+J.+Rimeleauthor=D.+N.+Smithauthor=E.+E.+Sugg&title=Discovery+of+1%2C5-benzodiazepines+with+peripheral+cholecystokinin+%28CCK-A%29+receptor+agonist+activity.+1.+Optimization+of+the+agonist+%E2%80%9Ctrigger%E2%80%9D"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1021%2Fjm950626d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm950626d%26sid%3Dliteratum%253Aachs%26aulast%3DAquino%26aufirst%3DC.%2BJ.%26aulast%3DArmour%26aufirst%3DD.%2BR.%26aulast%3DBerman%26aufirst%3DJ.%2BM.%26aulast%3DBirkemo%26aufirst%3DL.%2BS.%26aulast%3DCarr%26aufirst%3DR.%2BA.%2BE.%26aulast%3DCroom%26aufirst%3DD.%2BK.%26aulast%3DDezube%26aufirst%3DM.%26aulast%3DDougherty%26aufirst%3DR.%2BW.%26aulast%3DErvin%26aufirst%3DG.%2BN.%26aulast%3DGrizzle%26aufirst%3DM.%2BK.%26aulast%3DHead%26aufirst%3DJ.%2BE.%26aulast%3DHirst%26aufirst%3DG.%2BC.%26aulast%3DJames%26aufirst%3DM.%2BK.%26aulast%3DJohnson%26aufirst%3DM.%2BF.%26aulast%3DMiller%26aufirst%3DL.%2BJ.%26aulast%3DQueen%26aufirst%3DK.%2BL.%26aulast%3DRimele%26aufirst%3DT.%2BJ.%26aulast%3DSmith%26aufirst%3DD.%2BN.%26aulast%3DSugg%26aufirst%3DE.%2BE.%26atitle%3DDiscovery%2520of%25201%252C5-benzodiazepines%2520with%2520peripheral%2520cholecystokinin%2520%2528CCK-A%2529%2520receptor%2520agonist%2520activity.%25201.%2520Optimization%2520of%2520the%2520agonist%2520%25E2%2580%259Ctrigger%25E2%2580%259D%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D562%26epage%3D569" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Asano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatori, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inamura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kayakiri, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satoh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abe, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizutani, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oku, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakahara, K.</span><span> </span><span class="NLM_article-title">Pharmacological characterization of a nonpeptide bradykinin B2 receptor antagonist, FR165649, and agonist, FR190997</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">124</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span><span class="NLM_x">–</span> <span class="NLM_lpage">446</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Fjm901084f&amp;key=10.1038%2Fsj.bjp.0701813" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Fjm901084f&amp;key=9647466" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADyaK1cXjslSju7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=1998&pages=441-446&author=M.+Asanoauthor=C.+Hatoriauthor=H.+Sawaiauthor=S.+Johkiauthor=N.+Inamuraauthor=H.+Kayakiriauthor=S.+Satohauthor=Y.+Abeauthor=T.+Inoueauthor=Y.+Sawadaauthor=T.+Mizutaniauthor=T.+Okuauthor=K.+Nakahara&title=Pharmacological+characterization+of+a+nonpeptide+bradykinin+B2+receptor+antagonist%2C+FR165649%2C+and+agonist%2C+FR190997"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological characterization of a nonpeptide bradykinin B2 receptor antagonist, FR165649, and agonist, FR190997</span></div><div class="casAuthors">Asano, Masayuki; Hatori, Chie; Sawai, Hiroe; Johki, Shigeru; Inamura, Noriaki; Kayakiri, Hiroshi; Satoh, Shigeki; Abe, Yoshito; Inoue, Takayuki; Sawada, Yuki; Mizutani, Tsuyoshi; Oku, Teruo; Nakahara, Kunio</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">441-446</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Stockton Press</span>)
        </div><div class="casAbstract">The nonpeptide bradykinin (BK) B2 receptor antagonist FR165649 (8-[2,6-dichloro-3-[N-[(E)-4-(N-methylcarbamoyl)cinnamidoacetyl]-N-methylamino]benzyloxy]-2-methylquinoline) and agonist FR190997 (8-[2,6-dichloro-3-[N-[(E)-4-(N-methylcarbamoyl)cinnamidoacetyl]-N-methylamino]benzyloxy]-2-methyl-4-(2-pyridylmethoxy)quinoline) were studied.  These compds. have a very similar chem. structure, the 2-pyridylmethoxy group being the only structural difference between them.  Both FR165649 and FR190997 displaced [3H]-BK binding to B2 receptors in guinea pig ileum membranes, with an IC50 of 4.7 × 10-10M and 1.5 × 10-9M, resp.  They also displaced [3H]-BK binding to B2 receptors in human lung fibroblast IMR-90 cells, with an IC50 of 1.6 × 10-9M and 9.8 × 10-10M, resp.  In guinea pig isolated ileum prepns., FR165649 had no agonistic effect on contraction and caused parallel rightward shifts of the concn.-contraction response curves to BK.  Anal. of the data produced a nominal pA2 value of 9.2±0.1 and a slope of 1.4.  On the other hand, FR190997 induced concn.-dependent contractions of guinea pig ilea, with a pD2 of 7.9±0.2, and the contraction was inhibited by a specific peptide B2 receptor antagonist, Hoe 140 (D-Arg-[Hyp3,Thi5,D-Tic7,Oic8]BK) in a noncompetitive manner.  In IMR-90 cells, FR165649 had no agonistic effect on phosphatidylinositol (PI) hydrolysis and caused parallel rightward shifts (approx. 200-fold shift at 10-7M) of the concn.-hydrolysis response curves to BK.  FR190997 induced concn.-dependent PI hydrolysis in IMR-90 cells with a pD2 of 8.4, and this effect was inhibited by Hoe 140.  These results indicate that FR165649 and FR190997 are, resp., a potent BK B2 receptor antagonist and agonist, and that the agonistic activity depends on the small difference in structure.  FR165649 and FR190997 may be useful tools for studying the relationship between ligands and receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCLi1Ka1_30LVg90H21EOLACvtfcHk0lhTwruRsELbeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjslSju7c%253D&md5=c9a8e3bcf5863d529518a82547049522</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0701813&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0701813%26sid%3Dliteratum%253Aachs%26aulast%3DAsano%26aufirst%3DM.%26aulast%3DHatori%26aufirst%3DC.%26aulast%3DSawai%26aufirst%3DH.%26aulast%3DJohki%26aufirst%3DS.%26aulast%3DInamura%26aufirst%3DN.%26aulast%3DKayakiri%26aufirst%3DH.%26aulast%3DSatoh%26aufirst%3DS.%26aulast%3DAbe%26aufirst%3DY.%26aulast%3DInoue%26aufirst%3DT.%26aulast%3DSawada%26aufirst%3DY.%26aulast%3DMizutani%26aufirst%3DT.%26aulast%3DOku%26aufirst%3DT.%26aulast%3DNakahara%26aufirst%3DK.%26atitle%3DPharmacological%2520characterization%2520of%2520a%2520nonpeptide%2520bradykinin%2520B2%2520receptor%2520antagonist%252C%2520FR165649%252C%2520and%2520agonist%252C%2520FR190997%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1998%26volume%3D124%26spage%3D441%26epage%3D446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Gouldson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Legoux, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carillon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delpech, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Fur, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrara, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shire, D.</span><span> </span><span class="NLM_article-title">The agonist SR146131 and the antagonist SR27897 occupy different sites on the human CCK<sub>1</sub> receptor</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">400</span><span class="NLM_x">, </span> <span class="NLM_fpage">185</span><span class="NLM_x">–</span> <span class="NLM_lpage">194</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Fjm901084f&amp;key=10.1016%2FS0014-2999%2800%2900414-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Fjm901084f&amp;key=10988332" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADC%252BD3cXkvFSlsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=400&publication_year=2000&pages=185-194&author=P.+Gouldsonauthor=P.+Legouxauthor=C.+Carillonauthor=B.+Delpechauthor=G.+Le+Furauthor=P.+Ferraraauthor=D.+Shire&title=The+agonist+SR146131+and+the+antagonist+SR27897+occupy+different+sites+on+the+human+CCK1+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">The agonist SR 146131 and the antagonist SR 27897 occupy different sites on the human CCK1 receptor</span></div><div class="casAuthors">Gouldson, P.; Legoux, P.; Carillon, C.; Delpech, B.; Le Fur, G.; Ferrara, P.; Shire, D.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">400</span>
        (<span class="NLM_cas:issue">2/3</span>),
    <span class="NLM_cas:pages">185-194</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">1-[2-(4-(2-Chlorophenyl)thiazol-2-yl) aminocarbonyl indoyl] acetic acid (SR 27897) is an effective CCK1 receptor antagonist, while the structurally related mol. 2-[4-(4-chloro-2,5-dimethoxyphenyl)-5-(2-cyclohexyl-ethyl)-thiazol-2-ylcarbamoyl]-5,7-dimethyl-indol-1-yl-1-acetic acid (SR 146131) is a highly potent and specific agonist for the same receptor.  To discover how the two mols. interact with the human cholecystokinin (CCK) CCK1 receptor, we have carried out binding and activity studies with 33-point mutated receptors.  Only six mutants showed altered [3H]SR 27897 binding properties, Lys115, Lys187, Phe198, Trp209, Leu214 and Asn333.  In contrast, numerous mutations throughout the receptor either reduced SR 146131 agonist potency, Phe97, Gly122, Phe198, Trp209, Ile229, Asn333, Arg336 and Leu356 or increased it, Tyr48, Cys94, Asn98, Leu217 and Ser359.  Only mutations of Phe198, Trp209 and Asn333 affected both SR 27897 and SR 146131 binding or activity.  The collated information was used to construct mol. models of SR 27897 and SR 146131 bound to the human CCK1 receptor.  The clear difference in the binding sites of SR 27897 and SR 146131 offers a mol. explanation for their contrasting pharmacol. characteristics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWybwRkZ5TMLVg90H21EOLACvtfcHk0lhDuC1BQGx5cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXkvFSlsr8%253D&md5=cb46d142bdba42944eb8a8d717b40495</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2800%2900414-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252800%252900414-3%26sid%3Dliteratum%253Aachs%26aulast%3DGouldson%26aufirst%3DP.%26aulast%3DLegoux%26aufirst%3DP.%26aulast%3DCarillon%26aufirst%3DC.%26aulast%3DDelpech%26aufirst%3DB.%26aulast%3DLe%2BFur%26aufirst%3DG.%26aulast%3DFerrara%26aufirst%3DP.%26aulast%3DShire%26aufirst%3DD.%26atitle%3DThe%2520agonist%2520SR146131%2520and%2520the%2520antagonist%2520SR27897%2520occupy%2520different%2520sites%2520on%2520the%2520human%2520CCK1%2520receptor%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2000%26volume%3D400%26spage%3D185%26epage%3D194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Escrieut, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gigoux, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Archer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verrier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maigret, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behrendt, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moroder, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bignon, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silvente-Poirot, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pradayrol, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fourmy, D.</span><span> </span><span class="NLM_article-title">The biologically crucial C terminus of cholecystokinin and the non-peptide agonist SR-146,131 share a common binding site in the human CCK1 receptor: evidence for a crucial role of Met-121 in the activation process</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">7546</span><span class="NLM_x">–</span> <span class="NLM_lpage">7555</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=7546-7555&author=C.+Escrieutauthor=V.+Gigouxauthor=E.+Archerauthor=S.+Verrierauthor=B.+Maigretauthor=R.+Behrendtauthor=L.+Moroderauthor=E.+Bignonauthor=S.+Silvente-Poirotauthor=L.+Pradayrolauthor=D.+Fourmy&title=The+biologically+crucial+C+terminus+of+cholecystokinin+and+the+non-peptide+agonist+SR-146%2C131+share+a+common+binding+site+in+the+human+CCK1+receptor%3A+evidence+for+a+crucial+role+of+Met-121+in+the+activation+process"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEscrieut%26aufirst%3DC.%26aulast%3DGigoux%26aufirst%3DV.%26aulast%3DArcher%26aufirst%3DE.%26aulast%3DVerrier%26aufirst%3DS.%26aulast%3DMaigret%26aufirst%3DB.%26aulast%3DBehrendt%26aufirst%3DR.%26aulast%3DMoroder%26aufirst%3DL.%26aulast%3DBignon%26aufirst%3DE.%26aulast%3DSilvente-Poirot%26aufirst%3DS.%26aulast%3DPradayrol%26aufirst%3DL.%26aulast%3DFourmy%26aufirst%3DD.%26atitle%3DThe%2520biologically%2520crucial%2520C%2520terminus%2520of%2520cholecystokinin%2520and%2520the%2520non-peptide%2520agonist%2520SR-146%252C131%2520share%2520a%2520common%2520binding%2520site%2520in%2520the%2520human%2520CCK1%2520receptor%253A%2520evidence%2520for%2520a%2520crucial%2520role%2520of%2520Met-121%2520in%2520the%2520activation%2520process%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D7546%26epage%3D7555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group">Holst, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mokrosinski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandt, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nygaard, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frimurer, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck-Sickinger, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, T. W.</span><span> </span><span class="NLM_article-title">Identification of an efficacy switch region in the ghrelin receptor responsible for interchange between agonism and inverse agonism</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">15799</span><span class="NLM_x">–</span> <span class="NLM_lpage">15811</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Fjm901084f&amp;key=10.1074%2Fjbc.M609796200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Fjm901084f&amp;key=17371869" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltl2ns7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=15799-15811&author=B.+Holstauthor=J.+Mokrosinskiauthor=M.+Langauthor=E.+Brandtauthor=R.+Nygaardauthor=T.+M.+Frimurerauthor=A.+G.+Beck-Sickingerauthor=T.+W.+Schwartz&title=Identification+of+an+efficacy+switch+region+in+the+ghrelin+receptor+responsible+for+interchange+between+agonism+and+inverse+agonism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of an Efficacy Switch Region in the Ghrelin Receptor Responsible for Interchange between Agonism and Inverse Agonism</span></div><div class="casAuthors">Holst, Birgitte; Mokrosinski, Jacek; Lang, Manja; Brandt, Erik; Nygaard, Rie; Frimurer, Thomas M.; Beck-Sickinger, Annette G.; Schwartz, Thue W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">15799-15811</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The carboxyamidated wFwLL peptide was used as a core ligand to probe the structural basis for agonism vs. inverse agonism in the constitutively active ghrelin receptor.  In the ligand, an efficacy switch could be built at the N terminus, as exemplified by AwFwLL, which functioned as a high potency agonist, whereas KwFwLL was an equally high potency inverse agonist.  The wFw-contg. peptides, agonists as well as inverse agonists, were affected by receptor mutations covering the whole main ligand-binding pocket with key interaction sites being an arom. cluster in transmembrane (TM)-VI and -VII and residues on the opposing face of TM-III.  Gain-of-function in respect of either increased agonist or inverse agonist potency or swap between high potency versions of these properties was obtained by substitutions at a no. of positions covering a broad area of the binding pocket on TM-III, -IV, and -V.  However, in particular, space-generating substitutions at position III:04 shifted the efficacy of the ligands from inverse agonism toward agonism, whereas similar substitutions at position III: 08, one helical turn below, shifted the efficacy from agonism toward inverse agonism.  It is suggested that the relative position of the ligand in the binding pocket between this "efficacy shift region" on TM-III and the opposing arom. cluster on TM-VI and TM-VII leads either to agonism, i.e. in a superficial binding mode, or it leads to inverse agonism, i.e. in a more profound binding mode.  This relationship between different binding modes and opposite efficacy is in accordance with the Global Toggle Switch model for 7TM receptor activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJqfgDA6O7ubVg90H21EOLACvtfcHk0ljUrNudGtMiJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltl2ns7g%253D&md5=9d994028f084be1fcd9a6b58a9547785</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M609796200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M609796200%26sid%3Dliteratum%253Aachs%26aulast%3DHolst%26aufirst%3DB.%26aulast%3DMokrosinski%26aufirst%3DJ.%26aulast%3DLang%26aufirst%3DM.%26aulast%3DBrandt%26aufirst%3DE.%26aulast%3DNygaard%26aufirst%3DR.%26aulast%3DFrimurer%26aufirst%3DT.%2BM.%26aulast%3DBeck-Sickinger%26aufirst%3DA.%2BG.%26aulast%3DSchwartz%26aufirst%3DT.%2BW.%26atitle%3DIdentification%2520of%2520an%2520efficacy%2520switch%2520region%2520in%2520the%2520ghrelin%2520receptor%2520responsible%2520for%2520interchange%2520between%2520agonism%2520and%2520inverse%2520agonism%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D15799%26epage%3D15811" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">Buck, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, J. A.</span><span> </span><span class="NLM_article-title">Disulfide trapping to localize small-molecule agonists and antagonists for a G protein-coupled receptor</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">2719</span><span class="NLM_x">–</span> <span class="NLM_lpage">2724</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=2719-2724&author=E.+Buckauthor=J.+A.+Wells&title=Disulfide+trapping+to+localize+small-molecule+agonists+and+antagonists+for+a+G+protein-coupled+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBuck%26aufirst%3DE.%26aulast%3DWells%26aufirst%3DJ.%2BA.%26atitle%3DDisulfide%2520trapping%2520to%2520localize%2520small-molecule%2520agonists%2520and%2520antagonists%2520for%2520a%2520G%2520protein-coupled%2520receptor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2005%26volume%3D102%26spage%3D2719%26epage%3D2724" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group">Wise, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duchesnes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">da Fonseca, P. C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pease, J. E.</span><span> </span><span class="NLM_article-title">Small molecule receptor agonists and antagonists of CCR3 provide insight into mechanisms of chemokine receptor activation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">27935</span><span class="NLM_x">–</span> <span class="NLM_lpage">27943</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=27935-27943&author=E.+L.+Wiseauthor=C.+Duchesnesauthor=P.+C.+A.+da+Fonsecaauthor=R.+A.+Allenauthor=T.+J.+Williamsauthor=J.+E.+Pease&title=Small+molecule+receptor+agonists+and+antagonists+of+CCR3+provide+insight+into+mechanisms+of+chemokine+receptor+activation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWise%26aufirst%3DE.%2BL.%26aulast%3DDuchesnes%26aufirst%3DC.%26aulast%3Dda%2BFonseca%26aufirst%3DP.%2BC.%2BA.%26aulast%3DAllen%26aufirst%3DR.%2BA.%26aulast%3DWilliams%26aufirst%3DT.%2BJ.%26aulast%3DPease%26aufirst%3DJ.%2BE.%26atitle%3DSmall%2520molecule%2520receptor%2520agonists%2520and%2520antagonists%2520of%2520CCR3%2520provide%2520insight%2520into%2520mechanisms%2520of%2520chemokine%2520receptor%2520activation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D27935%26epage%3D27943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group">Shen, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armstrong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagmann, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fong, T. M.</span><span> </span><span class="NLM_article-title">F200A substitution in the third transmembrane helix of human cannabinoid CB<sub>1</sub> receptor converts AM2233 from receptor agonist to inverse agonist</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">531</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">46</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Fjm901084f&amp;key=10.1016%2Fj.ejphar.2005.12.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Fjm901084f&amp;key=16438957" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhtlejurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=531&publication_year=2006&pages=41-46&author=C.+P.+Shenauthor=J.+C.+Xiaoauthor=H.+Armstrongauthor=W.+Hagmannauthor=T.+M.+Fong&title=F200A+substitution+in+the+third+transmembrane+helix+of+human+cannabinoid+CB1+receptor+converts+AM2233+from+receptor+agonist+to+inverse+agonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">F200A substitution in the third transmembrane helix of human cannabinoid CB1 receptor converts AM2233 from receptor agonist to inverse agonist</span></div><div class="casAuthors">Shen, Chun-Pyn; Xiao, Jing Chen; Armstrong, Helen; Hagmann, William; Fong, Tung M.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">531</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">41-46</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">To investigate how specific amino acid residues affect human cannabinoid CB1 receptor binding and activation, CHO cell lines stably expressing wild type and the phenylalanine 200 to alanine mutant of human cannabinoid CB1 receptor (F200A) were examd.  AM2233 functions as an agonist at the wild type receptor (EC50 = 0.93 nM), but behaves as an inverse agonist at F200A (EC50 = 4.8 nM).  The F200A mutant has significantly lower forskolin-stimulated basal cAMP accumulation than that of the wild type, indicating that the F200A mutant possesses higher constitutive activity.  F200 does not contribute substantially to the high affinity binding of AM2233 at human cannabinoid CB1 receptor.  CP55940, HU-210 and Win55212-2 still function as agonists at the F200A mutant, with similar efficacy, potency, and apparent binding affinity for both wild type human cannabinoid CB1 receptor and F200A mutant.  These data indicate that the phenylalanine 200 residue in human cannabinoid CB1 receptor is involved in the receptor activation induced by a specific class of agonists, and supports a model of agonist-structure-dependent conformational changes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1PMmJZbye7rVg90H21EOLACvtfcHk0ljUrNudGtMiJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhtlejurs%253D&md5=bd078a6a79a1fa62a839e3fdb1582a7d</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2005.12.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2005.12.026%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DC.%2BP.%26aulast%3DXiao%26aufirst%3DJ.%2BC.%26aulast%3DArmstrong%26aufirst%3DH.%26aulast%3DHagmann%26aufirst%3DW.%26aulast%3DFong%26aufirst%3DT.%2BM.%26atitle%3DF200A%2520substitution%2520in%2520the%2520third%2520transmembrane%2520helix%2520of%2520human%2520cannabinoid%2520CB1%2520receptor%2520converts%2520AM2233%2520from%2520receptor%2520agonist%2520to%2520inverse%2520agonist%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2006%26volume%3D531%26spage%3D41%26epage%3D46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group">Jensen, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nygaard, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thiele, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elder, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolbeck, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenkilde, M. M.</span><span> </span><span class="NLM_article-title">Molecular interaction of a potent nonpeptide agonist with the chemokine receptor CCR8</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">327</span><span class="NLM_x">–</span> <span class="NLM_lpage">340</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2007&pages=327-340&author=P.+C.+Jensenauthor=R.+Nygaardauthor=S.+Thieleauthor=A.+Elderauthor=G.+Zhuauthor=R.+Kolbeckauthor=S.+Ghoshauthor=T.+W.+Schwartzauthor=M.+M.+Rosenkilde&title=Molecular+interaction+of+a+potent+nonpeptide+agonist+with+the+chemokine+receptor+CCR8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJensen%26aufirst%3DP.%2BC.%26aulast%3DNygaard%26aufirst%3DR.%26aulast%3DThiele%26aufirst%3DS.%26aulast%3DElder%26aufirst%3DA.%26aulast%3DZhu%26aufirst%3DG.%26aulast%3DKolbeck%26aufirst%3DR.%26aulast%3DGhosh%26aufirst%3DS.%26aulast%3DSchwartz%26aufirst%3DT.%2BW.%26aulast%3DRosenkilde%26aufirst%3DM.%2BM.%26atitle%3DMolecular%2520interaction%2520of%2520a%2520potent%2520nonpeptide%2520agonist%2520with%2520the%2520chemokine%2520receptor%2520CCR8%26jtitle%3DMol.%2520Pharmacol.%26date%3D2007%26volume%3D72%26spage%3D327%26epage%3D340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group">Hadac, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darrow, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugg, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lybrand, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, L. J.</span><span> </span><span class="NLM_article-title">Novel benzodiazepine photoaffinity probe stereoselectively labels a site deep within the membrane-spanning domain of the cholecystokinin receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">850</span><span class="NLM_x">–</span> <span class="NLM_lpage">863</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049072h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=850-863&author=E.+M.+Hadacauthor=E.+S.+Dawsonauthor=J.+W.+Darrowauthor=E.+E.+Suggauthor=T.+P.+Lybrandauthor=L.+J.+Miller&title=Novel+benzodiazepine+photoaffinity+probe+stereoselectively+labels+a+site+deep+within+the+membrane-spanning+domain+of+the+cholecystokinin+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1021%2Fjm049072h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049072h%26sid%3Dliteratum%253Aachs%26aulast%3DHadac%26aufirst%3DE.%2BM.%26aulast%3DDawson%26aufirst%3DE.%2BS.%26aulast%3DDarrow%26aufirst%3DJ.%2BW.%26aulast%3DSugg%26aufirst%3DE.%2BE.%26aulast%3DLybrand%26aufirst%3DT.%2BP.%26aulast%3DMiller%26aufirst%3DL.%2BJ.%26atitle%3DNovel%2520benzodiazepine%2520photoaffinity%2520probe%2520stereoselectively%2520labels%2520a%2520site%2520deep%2520within%2520the%2520membrane-spanning%2520domain%2520of%2520the%2520cholecystokinin%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D850%26epage%3D863" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group">Scarselli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wess, J.</span><span> </span><span class="NLM_article-title">Multiple residues in the second extracellular loop are critical for M<sub>3</sub> muscarinic acetylcholine receptor activation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">7385</span><span class="NLM_x">–</span> <span class="NLM_lpage">7396</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=7385-7396&author=M.+Scarselliauthor=B.+Liauthor=S.+K.+Kimauthor=J.+Wess&title=Multiple+residues+in+the+second+extracellular+loop+are+critical+for+M3+muscarinic+acetylcholine+receptor+activation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DScarselli%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DKim%26aufirst%3DS.%2BK.%26aulast%3DWess%26aufirst%3DJ.%26atitle%3DMultiple%2520residues%2520in%2520the%2520second%2520extracellular%2520loop%2520are%2520critical%2520for%2520M3%2520muscarinic%2520acetylcholine%2520receptor%2520activation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D7385%26epage%3D7396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group">Banères, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesnier, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joubert, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumuis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bockaert, J.</span><span> </span><span class="NLM_article-title">Molecular characterization of a purified 5-HT<sub>4</sub> receptor: a structural basis for drug efficacy</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">20253</span><span class="NLM_x">–</span> <span class="NLM_lpage">20260</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=20253-20260&author=J.+L.+Ban%C3%A8resauthor=D.+Mesnierauthor=A.+Martinauthor=L.+Joubertauthor=A.+Dumuisauthor=J.+Bockaert&title=Molecular+characterization+of+a+purified+5-HT4+receptor%3A+a+structural+basis+for+drug+efficacy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBan%25C3%25A8res%26aufirst%3DJ.%2BL.%26aulast%3DMesnier%26aufirst%3DD.%26aulast%3DMartin%26aufirst%3DA.%26aulast%3DJoubert%26aufirst%3DL.%26aulast%3DDumuis%26aufirst%3DA.%26aulast%3DBockaert%26aufirst%3DJ.%26atitle%3DMolecular%2520characterization%2520of%2520a%2520purified%25205-HT4%2520receptor%253A%2520a%2520structural%2520basis%2520for%2520drug%2520efficacy%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D20253%26epage%3D20260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group">Fleck, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huntley, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markison, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nickolls, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoare, S. R. J.</span><span> </span><span class="NLM_article-title">Molecular interactions of nonpeptide agonists and antagonists with the melanocortin-4 receptor</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">14494</span><span class="NLM_x">–</span> <span class="NLM_lpage">14508</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi051316s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2005&pages=14494-14508&author=B.+A.+Fleckauthor=C.+Chenauthor=W.+Yangauthor=R.+Huntleyauthor=S.+Markisonauthor=S.+A.+Nickollsauthor=A.+C.+Fosterauthor=S.+R.+J.+Hoare&title=Molecular+interactions+of+nonpeptide+agonists+and+antagonists+with+the+melanocortin-4+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1021%2Fbi051316s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi051316s%26sid%3Dliteratum%253Aachs%26aulast%3DFleck%26aufirst%3DB.%2BA.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DHuntley%26aufirst%3DR.%26aulast%3DMarkison%26aufirst%3DS.%26aulast%3DNickolls%26aufirst%3DS.%2BA.%26aulast%3DFoster%26aufirst%3DA.%2BC.%26aulast%3DHoare%26aufirst%3DS.%2BR.%2BJ.%26atitle%3DMolecular%2520interactions%2520of%2520nonpeptide%2520agonists%2520and%2520antagonists%2520with%2520the%2520melanocortin-4%2520receptor%26jtitle%3DBiochemistry%26date%3D2005%26volume%3D44%26spage%3D14494%26epage%3D14508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group">Fleck, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ling, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span> </span><span class="NLM_article-title">Substituted NDP-MSH peptides paired with mutant melanocortin-4 receptors demonstrate the role of transmembrane 6 in receptor activation</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">10473</span><span class="NLM_x">–</span> <span class="NLM_lpage">10483</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi700406k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=10473-10483&author=B.+A.+Fleckauthor=N.+Lingauthor=C.+Chen&title=Substituted+NDP-MSH+peptides+paired+with+mutant+melanocortin-4+receptors+demonstrate+the+role+of+transmembrane+6+in+receptor+activation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1021%2Fbi700406k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi700406k%26sid%3Dliteratum%253Aachs%26aulast%3DFleck%26aufirst%3DB.%2BA.%26aulast%3DLing%26aufirst%3DN.%26aulast%3DChen%26aufirst%3DC.%26atitle%3DSubstituted%2520NDP-MSH%2520peptides%2520paired%2520with%2520mutant%2520melanocortin-4%2520receptors%2520demonstrate%2520the%2520role%2520of%2520transmembrane%25206%2520in%2520receptor%2520activation%26jtitle%3DBiochemistry%26date%3D2007%26volume%3D46%26spage%3D10473%26epage%3D10483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group">Foucaud, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tikhonova, I. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langer, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Escrieut, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dufresne, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seva, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maigret, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fourmy, D.</span><span> </span><span class="NLM_article-title">Partial agonism, neutral antagonism, and inverse agonism at the human wild-type and constitutively active cholecystokinin-2 receptors</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">680</span><span class="NLM_x">–</span> <span class="NLM_lpage">690</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2006&pages=680-690&author=M.+Foucaudauthor=I.+G.+Tikhonovaauthor=I.+Langerauthor=C.+Escrieutauthor=M.+Dufresneauthor=C.+Sevaauthor=B.+Maigretauthor=D.+Fourmy&title=Partial+agonism%2C+neutral+antagonism%2C+and+inverse+agonism+at+the+human+wild-type+and+constitutively+active+cholecystokinin-2+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFoucaud%26aufirst%3DM.%26aulast%3DTikhonova%26aufirst%3DI.%2BG.%26aulast%3DLanger%26aufirst%3DI.%26aulast%3DEscrieut%26aufirst%3DC.%26aulast%3DDufresne%26aufirst%3DM.%26aulast%3DSeva%26aufirst%3DC.%26aulast%3DMaigret%26aufirst%3DB.%26aulast%3DFourmy%26aufirst%3DD.%26atitle%3DPartial%2520agonism%252C%2520neutral%2520antagonism%252C%2520and%2520inverse%2520agonism%2520at%2520the%2520human%2520wild-type%2520and%2520constitutively%2520active%2520cholecystokinin-2%2520receptors%26jtitle%3DMol.%2520Pharmacol.%26date%3D2006%26volume%3D69%26spage%3D680%26epage%3D690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group">Kim, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Rompaey, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Calenbergh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Modeling the adenosine receptors: comparison of the binding domains of A<sub>2A</sub> agonists and antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">4847</span><span class="NLM_x">–</span> <span class="NLM_lpage">4859</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0300431" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=4847-4859&author=S.+K.+Kimauthor=Z.+G.+Gaoauthor=P.+Van+Rompaeyauthor=A.+S.+Grossauthor=A.+Chenauthor=S.+Van+Calenberghauthor=K.+A.+Jacobson&title=Modeling+the+adenosine+receptors%3A+comparison+of+the+binding+domains+of+A2A+agonists+and+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1021%2Fjm0300431&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0300431%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DS.%2BK.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DVan%2BRompaey%26aufirst%3DP.%26aulast%3DGross%26aufirst%3DA.%2BS.%26aulast%3DChen%26aufirst%3DA.%26aulast%3DVan%2BCalenbergh%26aufirst%3DS.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DModeling%2520the%2520adenosine%2520receptors%253A%2520comparison%2520of%2520the%2520binding%2520domains%2520of%2520A2A%2520agonists%2520and%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D4847%26epage%3D4859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group">Ghanouni, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gryczynski, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steenhuis, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrens, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lakowicz, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobilka, B. K.</span><span> </span><span class="NLM_article-title">Functionally different agonists induce distinct conformations in the G protein coupling domain of the β<sub>2</sub> adrenergic receptor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">24433</span><span class="NLM_x">–</span> <span class="NLM_lpage">24436</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=24433-24436&author=P.+Ghanouniauthor=Z.+Gryczynskiauthor=J.+J.+Steenhuisauthor=T.+W.+Leeauthor=D.+L.+Farrensauthor=J.+R.+Lakowiczauthor=B.+K.+Kobilka&title=Functionally+different+agonists+induce+distinct+conformations+in+the+G+protein+coupling+domain+of+the+%CE%B22+adrenergic+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGhanouni%26aufirst%3DP.%26aulast%3DGryczynski%26aufirst%3DZ.%26aulast%3DSteenhuis%26aufirst%3DJ.%2BJ.%26aulast%3DLee%26aufirst%3DT.%2BW.%26aulast%3DFarrens%26aufirst%3DD.%2BL.%26aulast%3DLakowicz%26aufirst%3DJ.%2BR.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26atitle%3DFunctionally%2520different%2520agonists%2520induce%2520distinct%2520conformations%2520in%2520the%2520G%2520protein%2520coupling%2520domain%2520of%2520the%2520%25CE%25B22%2520adrenergic%2520receptor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D24433%26epage%3D24436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group">Palczewski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumasaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hori, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behnke, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Motoshima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Trong, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teller, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stenkamp, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyano, M.</span><span> </span><span class="NLM_article-title">Crystal structure of rhodopsin: a G protein-coupled receptor</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">739</span><span class="NLM_x">–</span> <span class="NLM_lpage">745</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Fjm901084f&amp;key=10.1126%2Fscience.289.5480.739" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Fjm901084f&amp;key=10926528" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlslOqs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2000&pages=739-745&author=K.+Palczewskiauthor=T.+Kumasakaauthor=T.+Horiauthor=C.+A.+Behnkeauthor=H.+Motoshimaauthor=B.+A.+Foxauthor=I.+Le+Trongauthor=D.+C.+Tellerauthor=T.+Okadaauthor=R.+E.+Stenkampauthor=M.+Yamamotoauthor=M.+Miyano&title=Crystal+structure+of+rhodopsin%3A+a+G+protein-coupled+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of rhodopsin: A G protein-coupled receptor</span></div><div class="casAuthors">Palczewski, Krzysztof; Kumasaka, Takashi; Hori, Tetsuya; Behnke, Craig A.; Motoshima, Hiroyuki; Fox, Brian A.; Le Trong, Isolde; Teller, David C.; Okada, Tetsuji; Stenkamp, Ronald E.; Yamamoto, Masaki; Miyano, Masashi</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">5480</span>),
    <span class="NLM_cas:pages">739-745</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Heterotrimeric guanine nucleotide-binding protein (G protein)-coupled receptors (GPCRs) respond to a variety of different external stimuli and activate G proteins.  GPCRs share many structural features, including a bundle of seven transmembrane α-helixes connected by six loops of varying lengths.  We detd. the structure of rhodopsin from diffraction data extending to 2.8 angstroms resoln.  The highly organized structure in the extracellular region, including a conserved disulfide bridge, forms a basis for the arrangement of the seven-helix transmembrane motif.  The ground-state chromophore, 11-cis-retinal, holds the transmembrane region of the protein in the inactive conformation.  Interactions of the chromophore with a cluster of key residues det. the wavelength of the max. absorption.  Changes in these interactions among rhodopsins facilitate color discrimination.  Identification of a set of residues that mediate interactions between the transmembrane helixes and the cytoplasmic surface, where G-protein activation occurs, also suggests a possible structural change upon photoactivation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFTWGKYX8vqLVg90H21EOLACvtfcHk0lg1FSgcswyRhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlslOqs78%253D&md5=b3d229fc696247ec0f4a6efa10490922</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1126%2Fscience.289.5480.739&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.289.5480.739%26sid%3Dliteratum%253Aachs%26aulast%3DPalczewski%26aufirst%3DK.%26aulast%3DKumasaka%26aufirst%3DT.%26aulast%3DHori%26aufirst%3DT.%26aulast%3DBehnke%26aufirst%3DC.%2BA.%26aulast%3DMotoshima%26aufirst%3DH.%26aulast%3DFox%26aufirst%3DB.%2BA.%26aulast%3DLe%2BTrong%26aufirst%3DI.%26aulast%3DTeller%26aufirst%3DD.%2BC.%26aulast%3DOkada%26aufirst%3DT.%26aulast%3DStenkamp%26aufirst%3DR.%2BE.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DMiyano%26aufirst%3DM.%26atitle%3DCrystal%2520structure%2520of%2520rhodopsin%253A%2520a%2520G%2520protein-coupled%2520receptor%26jtitle%3DScience%26date%3D2000%26volume%3D289%26spage%3D739%26epage%3D745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group">Schwartz, T. W.; Frimurer, T. M.; Holst, B.; Rosenkilde, M. M.; Elling, C. E.</span><span> </span><span class="NLM_article-title">Molecular mechanism of 7TM receptor activation—a global toggle switch model</span>.  <span class="citation_source-journal">Annu. Rev. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">481</span>− <span class="NLM_lpage">519</span>, and references cited therein.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2006&pages=481-519&author=T.+W.+Schwartz&author=T.+M.+Frimurer&author=B.+Holst&author=M.+M.+Rosenkilde&author=C.+E.+Elling&title=Molecular+mechanism+of+7TM+receptor+activation%E2%80%94a+global+toggle+switch+model"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchwartz%26aufirst%3DT.%2BW.%26atitle%3DMolecular%2520mechanism%2520of%25207TM%2520receptor%2520activation%25E2%2580%2594a%2520global%2520toggle%2520switch%2520model%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2006%26volume%3D46%26spage%3D481%26epage%3D519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group">Durroux, T.</span><span> </span><span class="NLM_article-title">Principles: a model for the allosteric interactions between ligand binding sites within a dimeric GPCR</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">376</span><span class="NLM_x">–</span> <span class="NLM_lpage">384</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2005&pages=376-384&author=T.+Durroux&title=Principles%3A+a+model+for+the+allosteric+interactions+between+ligand+binding+sites+within+a+dimeric+GPCR"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDurroux%26aufirst%3DT.%26atitle%3DPrinciples%253A%2520a%2520model%2520for%2520the%2520allosteric%2520interactions%2520between%2520ligand%2520binding%2520sites%2520within%2520a%2520dimeric%2520GPCR%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2005%26volume%3D26%26spage%3D376%26epage%3D384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group">Jaakola, V.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffith, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherezov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chien, E. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, J</span><span class="NLM_x">; </span><span class="NLM_contrib-group">IJzerman, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, A. P.</span><span> </span><span class="NLM_article-title">R.C. The 2.6 Angstrom Crystal Structure of a Human A<sub>2A</sub> Adenosine Receptor Bound to an Antagonist</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">322</span><span class="NLM_x">, </span> <span class="NLM_fpage">1211</span><span class="NLM_x">–</span> <span class="NLM_lpage">1217</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=322&publication_year=2008&pages=1211-1217&author=V.-P.+Jaakolaauthor=M.+Griffithauthor=M.+A.+Hansonauthor=V.+Cherezovauthor=E.+Y.+Chienauthor=J+Laneauthor=J.+R.+IJzermanauthor=A.+P.+Stevens&title=R.C.+The+2.6+Angstrom+Crystal+Structure+of+a+Human+A2A+Adenosine+Receptor+Bound+to+an+Antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJaakola%26aufirst%3DV.-P.%26aulast%3DGriffith%26aufirst%3DM.%26aulast%3DHanson%26aufirst%3DM.%2BA.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DChien%26aufirst%3DE.%2BY.%26aulast%3DLane%26aufirst%3DJ%26aulast%3DIJzerman%26aufirst%3DJ.%2BR.%26aulast%3DStevens%26aufirst%3DA.%2BP.%26atitle%3DR.C.%2520The%25202.6%2520Angstrom%2520Crystal%2520Structure%2520of%2520a%2520Human%2520A2A%2520Adenosine%2520Receptor%2520Bound%2520to%2520an%2520Antagonist%26jtitle%3DScience%26date%3D2008%26volume%3D322%26spage%3D1211%26epage%3D1217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group">Gurrath, M.</span><span> </span><span class="NLM_article-title">Peptide-binding, G protein-coupled receptors: new opportunities for drug design</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1605</span><span class="NLM_x">–</span> <span class="NLM_lpage">1648</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Fjm901084f&amp;key=11562281" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADC%252BD3MXosV2gtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2001&pages=1605-1648&author=M.+Gurrath&title=Peptide-binding%2C+G+protein-coupled+receptors%3A+new+opportunities+for+drug+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Peptide-binding G protein-coupled receptors: new opportunities for drug design</span></div><div class="casAuthors">Gurrath, Marion</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1605-1648</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers</span>)
        </div><div class="casAbstract">A review.  Over the last decades distinct members of the G Protein-Coupled Receptor (GPCR) family emerged as prominent drug targets within pharmaceutical research, since approx. 60% of marketed prescription drugs act by selectively addressing representatives of that class of transmembrane signal transduction systems.  It is noteworthy that the majority of GPCR-targeted drugs elicit their biol. activity by selective agonism or antagonism of biogenic monoamine receptors, while the development status of peptide-binding GPCR-addressing compds. is still in its infancy.  Exemplified on selected medicinal chem. projects, this review will focus on the opportunities of therapeutic intervention into a broad spectrum of disease processes through agonizing or antagonizing the functions of peptide-binding GPCRs.  In this context, a brief overview of GPCR-mediated signal transduction pathways will be given to emphasize the biomedical relevance of a controlled modulation of receptor function.  Modern trends on lead finding and optimization strategies for peptide-binding GPCR-targeted low-mol. wt. compds. will be highlighted on the basis of current research programs conducted in the areas of angiotensin II, endothelin, bradykinin, neurokinin, neuropeptide Y, LHRH, C5a antagonists, and somatostatin agonists, resp.  Special emphasis will be laid on the elaboration and utilization of structural rationales on the potential drug candidates, thus facilitating more detailed insights into the underlying mol. recognition event.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxzBTOPJ8sjbVg90H21EOLACvtfcHk0lhY9kYTEZX1Sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXosV2gtbY%253D&md5=def2f9409abef498add257704da76582</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGurrath%26aufirst%3DM.%26atitle%3DPeptide-binding%252C%2520G%2520protein-coupled%2520receptors%253A%2520new%2520opportunities%2520for%2520drug%2520design%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2001%26volume%3D8%26spage%3D1605%26epage%3D1648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group">Blakeney, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairlie, D. P.</span><span> </span><span class="NLM_article-title">Nonpeptidic ligands for peptide-activated G protein-coupled receptors</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">2960</span><span class="NLM_x">–</span> <span class="NLM_lpage">3041</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr050984g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADC%252BD2sXns1Cru7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2007&pages=2960-3041&author=J.+S.+Blakeneyauthor=R.+C.+Reidauthor=G.+T.+Leauthor=D.+P.+Fairlie&title=Nonpeptidic+ligands+for+peptide-activated+G+protein-coupled+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Nonpeptidic ligands for peptide-activated G protein-coupled receptors</span></div><div class="casAuthors">Blakeney, Jade S.; Reid, Robert C.; Le, Giang T.; Fairlie, David P.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2960-3041</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  There are some 850 human G protein-coupled receptors (GPCRs) currently known (http://bioinfonnatics2.biol.uoa.gr), making this the most abundant family of well-characterized protein receptors on the cell surface.  This perspective review describes a necessarily limited selection of key small mol. nonpeptidic agonists and antagonists that have been identified to date as regulators of peptide-activated GPCRs, and outlines some of their pharmacol. properties.  It provides a cross section of scientific literature up to the end of 2005, in some cases through early 2006. without attempting to describe compd. syntheses or the extensive patent literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqHHwt9f_KarVg90H21EOLACvtfcHk0lhY9kYTEZX1Sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXns1Cru7o%253D&md5=755daac1f42b387d2fadd0d64ae9c065</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1021%2Fcr050984g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr050984g%26sid%3Dliteratum%253Aachs%26aulast%3DBlakeney%26aufirst%3DJ.%2BS.%26aulast%3DReid%26aufirst%3DR.%2BC.%26aulast%3DLe%26aufirst%3DG.%2BT.%26aulast%3DFairlie%26aufirst%3DD.%2BP.%26atitle%3DNonpeptidic%2520ligands%2520for%2520peptide-activated%2520G%2520protein-coupled%2520receptors%26jtitle%3DChem.%2520Rev.%26date%3D2007%26volume%3D107%26spage%3D2960%26epage%3D3041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group">Ballesteros, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstein, H.</span><span> </span><span class="NLM_article-title">Integrated methods for the construction of three dimensional models and computational probing of structure−function relations in G-protein coupled receptors</span> <span class="citation_source-journal">Methods Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">366</span><span class="NLM_x">–</span> <span class="NLM_lpage">428</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Fjm901084f&amp;key=10.1016%2FS1043-9471%2805%2980049-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADyaK2MXmt1Kmtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1995&pages=366-428&author=J.+A.+Ballesterosauthor=H.+Weinstein&title=Integrated+methods+for+the+construction+of+three+dimensional+models+and+computational+probing+of+structure%E2%88%92function+relations+in+G-protein+coupled+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors</span></div><div class="casAuthors">Ballesteros, Juan A.; Weinstein, Harel</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Neurosciences</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">366-428</span>CODEN:
                <span class="NLM_cas:coden">MENEE5</span>;
        ISSN:<span class="NLM_cas:issn">1043-9471</span>.
    </div><div class="casAbstract">A review, with 135 refs., on approaches that can be used to resolve the apparent ambiguities that burden the pharmacol. testing of G protein-coupled receptor (GPCR) models, based on the integration of structural information about the receptor, about mutants, and about the changes induced by ligand binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfENoRspqa7LVg90H21EOLACvtfcHk0lhY9kYTEZX1Sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmt1Kmtrk%253D&md5=d3f99e9d07cea245a770f3f099bc8cc7</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1016%2FS1043-9471%2805%2980049-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1043-9471%252805%252980049-7%26sid%3Dliteratum%253Aachs%26aulast%3DBallesteros%26aufirst%3DJ.%2BA.%26aulast%3DWeinstein%26aufirst%3DH.%26atitle%3DIntegrated%2520methods%2520for%2520the%2520construction%2520of%2520three%2520dimensional%2520models%2520and%2520computational%2520probing%2520of%2520structure%25E2%2588%2592function%2520relations%2520in%2520G-protein%2520coupled%2520receptors%26jtitle%3DMethods%2520Neurosci.%26date%3D1995%26volume%3D25%26spage%3D366%26epage%3D428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group">Bissantz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logean, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rognan, D.</span><span> </span><span class="NLM_article-title">High-throughput modeling of human G-protein coupled receptors: amino acid sequence alignment, three-dimensional model building, and receptor library screening</span> <span class="citation_source-journal">J. Chem. Inf. Comput. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">1162</span><span class="NLM_x">–</span> <span class="NLM_lpage">1176</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci034181a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADC%252BD2cXitVOqt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2004&pages=1162-1176&author=C.+Bissantzauthor=A.+Logeanauthor=D.+Rognan&title=High-throughput+modeling+of+human+G-protein+coupled+receptors%3A+amino+acid+sequence+alignment%2C+three-dimensional+model+building%2C+and+receptor+library+screening"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">High-throughput modeling of human g-protein coupled receptors: Amino acid sequence alignment, three-dimensional model building, and receptor library screening</span></div><div class="casAuthors">Bissantz, Caterina; Logean, Antoine; Rognan, Didier</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Computer Sciences</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1162-1176</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">0095-2338</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The current study describes the development of a computer package (GPCRmod) aimed at the high-throughput modeling of the therapeutically important family of human G-protein coupled receptors (GPCRs).  GPCRmod first proposes a reliable alignment of the seven transmembrane domains (7 TMs) of most druggable human GPCRs based on pattern/motif recognition for each of the 7 TMs that are considered independently.  It then converts the alignment into knowledge-based three-dimensional (3-D) models starting from a set of 3-D backbone templates and two sep. rotamer libraries for side chain positioning.  The 7 TMs of 277 human GPCRs have been accurately aligned, unambiguously clustered in three different classes (rhodopsin-like, secretin-like, metabotropic glutamate-like), and converted into high-quality 3-D models at a remarkable throughput (∼3s/model).  A 3-D GPCR target library of 277 receptors has consequently been setup.  Its utility for "in silico" inverse screening purpose has been demonstrated by recovering among top scorers the receptor of a selective GPCR antagonist as well as the receptors of a promiscuous antagonist.  The current GPCR target library thus constitutes a 3-D database of choice to address as soon as possible the "virtual selectivity" profile of any GPCR antagonist or inverse agonist in an early hit optimization process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpC6Zv_92nPmrVg90H21EOLACvtfcHk0lh4t4HFOOERUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXitVOqt74%253D&md5=6037a68d2d7ba136a5ab51c822d681f1</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1021%2Fci034181a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci034181a%26sid%3Dliteratum%253Aachs%26aulast%3DBissantz%26aufirst%3DC.%26aulast%3DLogean%26aufirst%3DA.%26aulast%3DRognan%26aufirst%3DD.%26atitle%3DHigh-throughput%2520modeling%2520of%2520human%2520G-protein%2520coupled%2520receptors%253A%2520amino%2520acid%2520sequence%2520alignment%252C%2520three-dimensional%2520model%2520building%252C%2520and%2520receptor%2520library%2520screening%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Comput.%2520Sci.%26date%3D2004%26volume%3D44%26spage%3D1162%26epage%3D1176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group">Thompson, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, T. J.</span><span> </span><span class="NLM_article-title">CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">4673</span><span class="NLM_x">–</span> <span class="NLM_lpage">4680</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Fjm901084f&amp;key=10.1093%2Fnar%2F22.22.4673" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Fjm901084f&amp;key=7984417" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADyaK2MXitlSgu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1994&pages=4673-4680&author=J.+D.+Thompsonauthor=D.+G.+Higginsauthor=T.+J.+Gibson&title=CLUSTAL+W%3A+improving+the+sensitivity+of+progressive+multiple+sequence+alignment+through+sequence+weighting%2C+position-specific+gap+penalties+and+weight+matrix+choice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice</span></div><div class="casAuthors">Thompson, Julie D.; Higgins, Desmond G.; Gibson, Toby J.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">4673-80</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The sensitivity of the commonly used progressive multiple sequence alignment method has been greatly improved for the alignment of divergent protein sequences.  Firstly, individual wts. are assigned to each sequence in a partial alignment in order to down-wt. near-duplicate sequences and up-wt. the most divergent ones.  Secondly, amino acid substitution matrixes are varied at different alignment stages according to the divergence of the sequences to be aligned.  Thirdly, residue-specific gap penalties and locally reduced gap penalties in hydrophilic regions encourage new gaps in potential loop regions rather than regular secondary structure.  Fourthly, positions in early alignments where gaps have been opened receive locally reduced gap penalties to encourage the opening of new gaps at these positions.  These modifications are incorporated into a new program, CLUSTAL W which is freely available.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGox0BWqmybJqbVg90H21EOLACvtfcHk0lh4t4HFOOERUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXitlSgu74%253D&md5=b219f8f0a8ea118b20a3e23461b99ccf</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1093%2Fnar%2F22.22.4673&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252F22.22.4673%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DJ.%2BD.%26aulast%3DHiggins%26aufirst%3DD.%2BG.%26aulast%3DGibson%26aufirst%3DT.%2BJ.%26atitle%3DCLUSTAL%2520W%253A%2520improving%2520the%2520sensitivity%2520of%2520progressive%2520multiple%2520sequence%2520alignment%2520through%2520sequence%2520weighting%252C%2520position-specific%2520gap%2520penalties%2520and%2520weight%2520matrix%2520choice%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D1994%26volume%3D22%26spage%3D4673%26epage%3D4680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group">Bissantz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernard, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hibert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rognan, D.</span><span> </span><span class="NLM_article-title">Protein-based virtual screening of chemical databases. II. Are homology models of G-protein coupled receptors suitable targets?</span> <span class="citation_source-journal">Proteins</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2003&pages=5-25&author=C.+Bissantzauthor=P.+Bernardauthor=M.+Hibertauthor=D.+Rognan&title=Protein-based+virtual+screening+of+chemical+databases.+II.+Are+homology+models+of+G-protein+coupled+receptors+suitable+targets%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBissantz%26aufirst%3DC.%26aulast%3DBernard%26aufirst%3DP.%26aulast%3DHibert%26aufirst%3DM.%26aulast%3DRognan%26aufirst%3DD.%26atitle%3DProtein-based%2520virtual%2520screening%2520of%2520chemical%2520databases.%2520II.%2520Are%2520homology%2520models%2520of%2520G-protein%2520coupled%2520receptors%2520suitable%2520targets%253F%26jtitle%3DProteins%26date%3D2003%26volume%3D50%26spage%3D5%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group">Derick, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pena, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durroux, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagnon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serradeil-, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hibert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rognan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillon, G.</span><span> </span><span class="NLM_article-title">Key amino acids located within the transmembrane domains 5 and 7 account for the pharmacological specificity of the human V<sub>1b</sub> vasopressin receptor</span> <span class="citation_source-journal">Mol. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">2777</span><span class="NLM_x">–</span> <span class="NLM_lpage">2789</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Fjm901084f&amp;key=10.1210%2Fme.2004-0124" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Fjm901084f&amp;key=15284336" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpslKksLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2004&pages=2777-2789&author=S.+Derickauthor=A.+Penaauthor=T.+Durrouxauthor=J.+Wagnonauthor=C.+Serradeil-author=M.+Hibertauthor=D.+Rognanauthor=G.+Guillon&title=Key+amino+acids+located+within+the+transmembrane+domains+5+and+7+account+for+the+pharmacological+specificity+of+the+human+V1b+vasopressin+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Key amino acids located within the transmembrane domains 5 and 7 account for the pharmacological specificity of the human V1b vasopressin receptor</span></div><div class="casAuthors">Derick, S.; Pena, A.; Durroux, T.; Wagnon, J.; Serradeil-Le Gal, C.; Hibert, M.; Rognan, D.; Guillon, G.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2777-2789</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">In mammals, the vasopressin V1b receptor (V1b-R) is known to regulate ACTH secretion and, more recently, stress and anxiety.  The characterization of the mol. determinant responsible for its pharmacol. selectivity was made possible by the recent discovery of the first V1b antagonist, SSR149415.  Based upon the structure of the crystd. bovine rhodopsin, we established a three-dimensional mol. model of interaction between the human V1b-R (hV1b-R) and SSR149415.  Four amino acids located in distinct transmembrane helixes (fourth, fifth, and seventh) were found potentially responsible for the hV1b-R selectivity.  To validate these assumptions, we selectively replaced the leucine 181, methionine 220, alanine 334, and serine 338 residues of hV1a-R by their corresponding amino acids present in the hV1b-R (phenylalanine 164, threonine 203, methionine 324, and asparagine 328, resp.).  Four mutants, which all exhibited nanomolar affinities for vasopressin and good coupling to phospholipase C pathway, were generated.  HV1a receptors mutated at position 220 and 334 exhibited striking increase in affinity for SSR149415 both in binding and phospholipase C assays at variance with the hV1a-R modified at position 181 or 338.  In conclusion, this study provides the first structural features concerning the hV1b-R and highlights the role of few specific residues in its pharmacol. selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4qbDQIm4cFbVg90H21EOLACvtfcHk0lgP4BzZEdyx7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpslKksLg%253D&md5=53f8487765ba5adb5a80de4d7d8924b0</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1210%2Fme.2004-0124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2004-0124%26sid%3Dliteratum%253Aachs%26aulast%3DDerick%26aufirst%3DS.%26aulast%3DPena%26aufirst%3DA.%26aulast%3DDurroux%26aufirst%3DT.%26aulast%3DWagnon%26aufirst%3DJ.%26aulast%3DSerradeil-%26aufirst%3DC.%26aulast%3DHibert%26aufirst%3DM.%26aulast%3DRognan%26aufirst%3DD.%26aulast%3DGuillon%26aufirst%3DG.%26atitle%3DKey%2520amino%2520acids%2520located%2520within%2520the%2520transmembrane%2520domains%25205%2520and%25207%2520account%2520for%2520the%2520pharmacological%2520specificity%2520of%2520the%2520human%2520V1b%2520vasopressin%2520receptor%26jtitle%3DMol.%2520Endocrinol.%26date%3D2004%26volume%3D18%26spage%3D2777%26epage%3D2789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span>SYBYL 7.3; <span class="NLM_publisher-name">Tripos International</span>, <span class="NLM_publisher-loc">1699 South Hanley Road, St. Louis, MO, 63144</span>,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=SYBYL+7.3%3B+Tripos+International%2C+1699+South+Hanley+Road%2C+St.+Louis%2C+MO%2C+63144%2C+2006."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DSYBYL%25207.3%26pub%3DTripos%2520International%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 13 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Marie-Céline Frantz, Lucie P. Pellissier, Elsa Pflimlin, Stéphanie Loison, Jorge Gandía, Claire Marsol, Thierry Durroux, Bernard Mouillac, Jérôme A. J. Becker, Julie Le Merrer, Christel Valencia, Pascal Villa, Dominique Bonnet, <span class="NLM_string-name hlFld-ContribAuthor">Marcel Hibert</span>. </span><span class="cited-content_cbyCitation_article-title">LIT-001, the First Nonpeptide Oxytocin Receptor Agonist that Improves Social Interaction in a Mouse Model of Autism. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (19)
                                     , 8670-8692. <a href="https://doi.org/10.1021/acs.jmedchem.8b00697" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00697</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00697&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00697%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DLIT-001%25252C%252Bthe%252BFirst%252BNonpeptide%252BOxytocin%252BReceptor%252BAgonist%252Bthat%252BImproves%252BSocial%252BInteraction%252Bin%252Ba%252BMouse%252BModel%252Bof%252BAutism%26aulast%3DFrantz%26aufirst%3DMarie-C%25C3%25A9line%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D02052018%26date%3D24092018%26date%3D10092018%26volume%3D61%26issue%3D19%26spage%3D8670%26epage%3D8692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Enza  Lacivita</span>, <span class="hlFld-ContribAuthor ">Roberto  Perrone</span>, <span class="hlFld-ContribAuthor ">Lucia  Margari</span>, and <span class="hlFld-ContribAuthor ">Marcello  Leopoldo</span>  . </span><span class="cited-content_cbyCitation_article-title">Targets for Drug Therapy for Autism Spectrum Disorder: Challenges and Future Directions. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (22)
                                     , 9114-9141. <a href="https://doi.org/10.1021/acs.jmedchem.7b00965" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00965</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00965&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00965%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTargets%252Bfor%252BDrug%252BTherapy%252Bfor%252BAutism%252BSpectrum%252BDisorder%25253A%252BChallenges%252Band%252BFuture%252BDirections%26aulast%3DLacivita%26aufirst%3DEnza%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D30062017%26date%3D30102017%26date%3D22112017%26date%3D17102017%26volume%3D60%26issue%3D22%26spage%3D9114%26epage%3D9141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Timothy A.  Katte</span>, <span class="hlFld-ContribAuthor ">Tristan A.  Reekie</span>, <span class="hlFld-ContribAuthor ">William T.  Jorgensen</span>, and <span class="hlFld-ContribAuthor ">Michael  Kassiou</span>  . </span><span class="cited-content_cbyCitation_article-title">The Formation of Seven-Membered Heterocycles under Mild Pictet–Spengler Conditions: A Route to Pyrazolo[3,4]benzodiazepines. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2016,</strong> <em>81 </em>
                                    (11)
                                     , 4883-4889. <a href="https://doi.org/10.1021/acs.joc.6b00710" title="DOI URL">https://doi.org/10.1021/acs.joc.6b00710</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.6b00710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.6b00710%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DThe%252BFormation%252Bof%252BSeven-Membered%252BHeterocycles%252Bunder%252BMild%252BPictet%2525E2%252580%252593Spengler%252BConditions%25253A%252BA%252BRoute%252Bto%252BPyrazolo%25255B3%25252C4%25255Dbenzodiazepines%26aulast%3DKatte%26aufirst%3DTimothy%2BA.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D02042016%26date%3D13052016%26date%3D03062016%26date%3D09052016%26volume%3D81%26issue%3D11%26spage%3D4883%26epage%3D4889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Iuliia A.  Karpenko</span>, <span class="hlFld-ContribAuthor ">Jean-François  Margathe</span>, <span class="hlFld-ContribAuthor ">Thiéric  Rodriguez</span>, <span class="hlFld-ContribAuthor ">Elsa  Pflimlin</span>, <span class="hlFld-ContribAuthor ">Elodie  Dupuis</span>, <span class="hlFld-ContribAuthor ">Marcel  Hibert</span>, <span class="hlFld-ContribAuthor ">Thierry  Durroux</span>, and <span class="hlFld-ContribAuthor ">Dominique  Bonnet</span>  . </span><span class="cited-content_cbyCitation_article-title">Selective Nonpeptidic Fluorescent Ligands for Oxytocin Receptor: Design, Synthesis, and Application to Time-Resolved FRET Binding Assay. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (5)
                                     , 2547-2552. <a href="https://doi.org/10.1021/jm501395b" title="DOI URL">https://doi.org/10.1021/jm501395b</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm501395b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm501395b%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSelective%252BNonpeptidic%252BFluorescent%252BLigands%252Bfor%252BOxytocin%252BReceptor%25253A%252BDesign%25252C%252BSynthesis%25252C%252Band%252BApplication%252Bto%252BTime-Resolved%252BFRET%252BBinding%252BAssay%26aulast%3DKarpenko%26aufirst%3DIuliia%2BA.%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D10092014%26date%3D12022015%26date%3D12032015%26date%3D02022015%26volume%3D58%26issue%3D5%26spage%3D2547%26epage%3D2552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria Antonietta  Panaro</span>, <span class="hlFld-ContribAuthor ">Tarek  Benameur</span>, <span class="hlFld-ContribAuthor ">Chiara  Porro</span>. </span><span class="cited-content_cbyCitation_article-title">Hypothalamic Neuropeptide Brain Protection: Focus on Oxytocin. </span><span class="cited-content_cbyCitation_journal-name">Journal of Clinical Medicine</span><span> <strong>2020,</strong> <em>9 </em>
                                    (5)
                                     , 1534. <a href="https://doi.org/10.3390/jcm9051534" title="DOI URL">https://doi.org/10.3390/jcm9051534</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/jcm9051534&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fjcm9051534%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Clinical%2520Medicine%26atitle%3DHypothalamic%252BNeuropeptide%252BBrain%252BProtection%25253A%252BFocus%252Bon%252BOxytocin%26aulast%3DPanaro%26aufirst%3DMaria%2BAntonietta%26date%3D2020%26date%3D2020%26volume%3D9%26issue%3D5%26spage%3D1534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hao  Xiong</span>, <span class="hlFld-ContribAuthor ">Xiaopeng  Wu</span>, <span class="hlFld-ContribAuthor ">Hepan  Wang</span>, <span class="hlFld-ContribAuthor ">Song  Sun</span>, <span class="hlFld-ContribAuthor ">Jin‐Tao  Yu</span>, <span class="hlFld-ContribAuthor ">Jiang  Cheng</span>. </span><span class="cited-content_cbyCitation_article-title">The Reaction of
              o
              ‐Aminoacetophenone
              N
              ‐Tosylhydrazone and CO
              2
              toward 1,4‐Dihydro‐2
              H
              ‐3,1‐benzoxazin‐2‐ones. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2019,</strong> <em>361 </em>
                                    (15)
                                     , 3538-3542. <a href="https://doi.org/10.1002/adsc.201900341" title="DOI URL">https://doi.org/10.1002/adsc.201900341</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201900341&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201900341%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DThe%252BReaction%252Bof%252Bo%252B%2525E2%252580%252590Aminoacetophenone%252BN%252B%2525E2%252580%252590Tosylhydrazone%252Band%252BCO%252B2%252Btoward%252B1%25252C4%2525E2%252580%252590Dihydro%2525E2%252580%2525902%252BH%252B%2525E2%252580%2525903%25252C1%2525E2%252580%252590benzoxazin%2525E2%252580%2525902%2525E2%252580%252590ones%26aulast%3DXiong%26aufirst%3DHao%26date%3D2019%26date%3D2019%26volume%3D361%26issue%3D15%26spage%3D3538%26epage%3D3542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sheryl S.  Moy</span>, <span class="hlFld-ContribAuthor ">Brian L.  Teng</span>, <span class="hlFld-ContribAuthor ">Viktoriya D.  Nikolova</span>, <span class="hlFld-ContribAuthor ">Natallia V.  Riddick</span>, <span class="hlFld-ContribAuthor ">Catherine D.  Simpson</span>, <span class="hlFld-ContribAuthor ">Amy  Van Deusen</span>, <span class="hlFld-ContribAuthor ">William P.  Janzen</span>, <span class="hlFld-ContribAuthor ">Maria F.  Sassano</span>, <span class="hlFld-ContribAuthor ">Cort A.  Pedersen</span>, <span class="hlFld-ContribAuthor ">Michael B.  Jarstfer</span>. </span><span class="cited-content_cbyCitation_article-title">Prosocial effects of an oxytocin metabolite, but not synthetic oxytocin receptor agonists, in a mouse model of autism. </span><span class="cited-content_cbyCitation_journal-name">Neuropharmacology</span><span> <strong>2019,</strong> <em>144 </em>, 301-311. <a href="https://doi.org/10.1016/j.neuropharm.2018.10.036" title="DOI URL">https://doi.org/10.1016/j.neuropharm.2018.10.036</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuropharm.2018.10.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuropharm.2018.10.036%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropharmacology%26atitle%3DProsocial%252Beffects%252Bof%252Ban%252Boxytocin%252Bmetabolite%25252C%252Bbut%252Bnot%252Bsynthetic%252Boxytocin%252Breceptor%252Bagonists%25252C%252Bin%252Ba%252Bmouse%252Bmodel%252Bof%252Bautism%26aulast%3DMoy%26aufirst%3DSheryl%2BS.%26date%3D2019%26volume%3D144%26spage%3D301%26epage%3D311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Neil T.  Burford</span>, <span class="hlFld-ContribAuthor ">John  Watson</span>, <span class="hlFld-ContribAuthor ">Andrew  Alt</span>. </span><span class="cited-content_cbyCitation_article-title">Standard Curves Are Necessary to Determine Pharmacological Properties for Ligands in Functional Assays Using Competition Binding Technologies. </span><span class="cited-content_cbyCitation_journal-name">ASSAY and Drug Development Technologies</span><span> <strong>2017,</strong> <em>15 </em>
                                    (7)
                                     , 320-329. <a href="https://doi.org/10.1089/adt.2017.811" title="DOI URL">https://doi.org/10.1089/adt.2017.811</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1089/adt.2017.811&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1089%2Fadt.2017.811%26sid%3Dliteratum%253Aachs%26jtitle%3DASSAY%2520and%2520Drug%2520Development%2520Technologies%26atitle%3DStandard%252BCurves%252BAre%252BNecessary%252Bto%252BDetermine%252BPharmacological%252BProperties%252Bfor%252BLigands%252Bin%252BFunctional%252BAssays%252BUsing%252BCompetition%252BBinding%252BTechnologies%26aulast%3DBurford%26aufirst%3DNeil%2BT.%26date%3D2017%26volume%3D15%26issue%3D7%26spage%3D320%26epage%3D329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marta  Busnelli</span>, <span class="hlFld-ContribAuthor ">Bice  Chini</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Basis of Oxytocin Receptor Signalling in the Brain: What We Know and What We Need to Know. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 3-29. <a href="https://doi.org/10.1007/7854_2017_6" title="DOI URL">https://doi.org/10.1007/7854_2017_6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7854_2017_6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7854_2017_6%26sid%3Dliteratum%253Aachs%26atitle%3DMolecular%252BBasis%252Bof%252BOxytocin%252BReceptor%252BSignalling%252Bin%252Bthe%252BBrain%25253A%252BWhat%252BWe%252BKnow%252Band%252BWhat%252BWe%252BNeed%252Bto%252BKnow%26aulast%3DBusnelli%26aufirst%3DMarta%26date%3D2017%26date%3D2017%26spage%3D3%26epage%3D29%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DBehavioral%252BPharmacology%252Bof%252BNeuropeptides%25253A%252BOxytocin%26aulast%3DHurlemann%26aufirst%3DRene%26date%3D2018%26volume%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">William T.  Jorgensen</span>, <span class="hlFld-ContribAuthor ">Damien W.  Gulliver</span>, <span class="hlFld-ContribAuthor ">Eryn L.  Werry</span>, <span class="hlFld-ContribAuthor ">Tristan  Reekie</span>, <span class="hlFld-ContribAuthor ">Mark  Connor</span>, <span class="hlFld-ContribAuthor ">Michael  Kassiou</span>. </span><span class="cited-content_cbyCitation_article-title">Flexible analogues of WAY-267,464: Synthesis and pharmacology at the human oxytocin and vasopressin 1 a receptors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>108 </em>, 730-740. <a href="https://doi.org/10.1016/j.ejmech.2015.11.050" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.11.050</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.11.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.11.050%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFlexible%252Banalogues%252Bof%252BWAY-267%25252C464%25253A%252BSynthesis%252Band%252Bpharmacology%252Bat%252Bthe%252Bhuman%252Boxytocin%252Band%252Bvasopressin%252B1%252Ba%252Breceptors%26aulast%3DJorgensen%26aufirst%3DWilliam%2BT.%26date%3D2016%26volume%3D108%26spage%3D730%26epage%3D740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tristan A.  Reekie</span>, <span class="hlFld-ContribAuthor ">Iain S.  McGregor</span>, <span class="hlFld-ContribAuthor ">Michael  Kassiou</span>. </span><span class="cited-content_cbyCitation_article-title">Pyrazolo[1,4]diazepines as non-peptidic probes of the oxytocin and vasopressin receptors. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2014,</strong> <em>55 </em>
                                    (33)
                                     , 4568-4571. <a href="https://doi.org/10.1016/j.tetlet.2014.06.022" title="DOI URL">https://doi.org/10.1016/j.tetlet.2014.06.022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2014.06.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2014.06.022%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DPyrazolo%25255B1%25252C4%25255Ddiazepines%252Bas%252Bnon-peptidic%252Bprobes%252Bof%252Bthe%252Boxytocin%252Band%252Bvasopressin%252Breceptors%26aulast%3DReekie%26aufirst%3DTristan%2BA.%26date%3D2014%26volume%3D55%26issue%3D33%26spage%3D4568%26epage%3D4571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M.  Manning</span>, <span class="hlFld-ContribAuthor ">A.  Misicka</span>, <span class="hlFld-ContribAuthor ">A.  Olma</span>, <span class="hlFld-ContribAuthor ">K.  Bankowski</span>, <span class="hlFld-ContribAuthor ">S.  Stoev</span>, <span class="hlFld-ContribAuthor ">B.  Chini</span>, <span class="hlFld-ContribAuthor ">T.  Durroux</span>, <span class="hlFld-ContribAuthor ">B.  Mouillac</span>, <span class="hlFld-ContribAuthor ">M.  Corbani</span>, <span class="hlFld-ContribAuthor ">G.  Guillon</span>. </span><span class="cited-content_cbyCitation_article-title">Oxytocin and Vasopressin Agonists and Antagonists as Research Tools and Potential Therapeutics. </span><span class="cited-content_cbyCitation_journal-name">Journal of Neuroendocrinology</span><span> <strong>2012,</strong> <em>24 </em>
                                    (4)
                                     , 609-628. <a href="https://doi.org/10.1111/j.1365-2826.2012.02303.x" title="DOI URL">https://doi.org/10.1111/j.1365-2826.2012.02303.x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/j.1365-2826.2012.02303.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fj.1365-2826.2012.02303.x%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Neuroendocrinology%26atitle%3DOxytocin%252Band%252BVasopressin%252BAgonists%252Band%252BAntagonists%252Bas%252BResearch%252BTools%252Band%252BPotential%252BTherapeutics%26aulast%3DManning%26aufirst%3DM.%26date%3D2012%26date%3D2012%26volume%3D24%26issue%3D4%26spage%3D609%26epage%3D628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nathanael  Weill</span>, <span class="hlFld-ContribAuthor ">Christel  Valencia</span>, <span class="hlFld-ContribAuthor ">Sophie  Gioria</span>, <span class="hlFld-ContribAuthor ">Pascal  Villa</span>, <span class="hlFld-ContribAuthor ">Marcel  Hibert</span>, <span class="hlFld-ContribAuthor ">Didier  Rognan</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of Nonpeptide Oxytocin Receptor Ligands by Receptor-Ligand Fingerprint Similarity Search. </span><span class="cited-content_cbyCitation_journal-name">Molecular Informatics</span><span> <strong>2011,</strong> <em>30 </em>
                                    (6-7)
                                     , 521-526. <a href="https://doi.org/10.1002/minf.201100026" title="DOI URL">https://doi.org/10.1002/minf.201100026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/minf.201100026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fminf.201100026%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Informatics%26atitle%3DIdentification%252Bof%252BNonpeptide%252BOxytocin%252BReceptor%252BLigands%252Bby%252BReceptor-Ligand%252BFingerprint%252BSimilarity%252BSearch%26aulast%3DWeill%26aufirst%3DNathanael%26date%3D2011%26date%3D2011%26volume%3D30%26issue%3D6-7%26spage%3D521%26epage%3D526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901084f/production/images/medium/jm-2009-01084f_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901084f/production/images/large/jm-2009-01084f_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901084f&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901084f/production/images/medium/jm-2009-01084f_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901084f/production/images/large/jm-2009-01084f_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Schematic representation of the main results of the truncated analogues of compound <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901084f/production/images/large/jm-2009-01084f_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901084f&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901084f/production/images/medium/jm-2009-01084f_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901084f/production/images/large/jm-2009-01084f_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compound <b>1</b> and Truncated Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901084f/production/images/large/jm-2009-01084f_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901084f&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) 1:9 AcOH/<i>i</i>PrOH, sealed flask, 160 °C, 48 h, 89%. (ii) LiAlH<sub>4</sub>, THF, reflux, 44 h, 86%. (iii) (a) <b>8</b>, (COCl)<sub>2</sub>, cat. DMF, DCM, 2 h; (b) <b>7</b>, Et<sub>3</sub>N, DCM, 2 d, 75%. (iv) NaBH<sub>4</sub>, CoCl<sub>2</sub>·6H<sub>2</sub>O, MeOH, 1 h, quant. (v) (a) CDI, DIEA, DMF, 1 h; (b) <b>11</b> or pyrrolidine or Me<sub>2</sub>NH·HCl, DIEA, DMF, overnight, 58−82%. (vi) Ac<sub>2</sub>O, Et<sub>3</sub>N, DCM, 3 h, 38%.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901084f/production/images/medium/jm-2009-01084f_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901084f/production/images/large/jm-2009-01084f_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of the Molecular Hybrids Conserving the Eastern Part of Compound <b>1</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901084f/production/images/large/jm-2009-01084f_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901084f&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) MeOH, 2 h, quant. (ii) SnCl<sub>2</sub>·2H<sub>2</sub>O, EtOH, reflux, 1 h, quant. (iii) (a) NaNO<sub>2</sub>, conc HCl/H<sub>2</sub>O, −15 °C, 15 min; (b) CuCN, KCN, H<sub>2</sub>O, −10 °C−rt, 2 h, 61%. (iv) LiOH·H<sub>2</sub>O, MeOH/THF, 1 h, 83%. (v) For <b>21a</b>: (a) <b>8</b>, (COCl)<sub>2</sub>, cat. DMF, DCM, 1 h; (b) <b>13</b>, pyridine, cat. DMAP, DCM, overnight, 76%; for <b>21b</b>: (a) <b>8</b>, (COCl)<sub>2</sub>, cat. DMF, DCM, 1 h; (b) <b>14</b>, pyridine, DCM, 1 h, 65%; for <b>21c</b>: (a) <b>20</b>, (COCl)<sub>2</sub>, cat. DMF, DCM, 0 °C, 1 h; (b) <b>14</b>, pyridine, cat. DMAP, DCM, μw 80 °C, 6 min, 49%; for <b>21d</b>: <b>8</b>, <b>15</b>, HOBt·H<sub>2</sub>O, EDCI·HCl, DIEA, DMF, 14 h, 65%. (vi) NaBH<sub>4</sub>, CoCl<sub>2</sub>·6H<sub>2</sub>O, MeOH, 1−3 h, 12−89%. (vii) (a) CDI, DIEA, DMF, 1−3 h; (b) <b>11</b>, DIEA, DMF, 16−40 h, 51−95%.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901084f/production/images/medium/jm-2009-01084f_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901084f/production/images/large/jm-2009-01084f_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of the Molecular Hybrids Conserving the Western Part of Compound <b>1</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901084f/production/images/large/jm-2009-01084f_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901084f&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) (a) (COCl)<sub>2</sub>, cat. DMF, DCM, 30 min; (b) <b>7</b>, Et<sub>3</sub>N, DCM, overnight, 90%. (ii) SnCl<sub>2</sub>·2H<sub>2</sub>O, EtOH, reflux, 1 h, 82%. (iii) (a) 2-Phenylbenzoic acid, (COCl)<sub>2</sub>, cat. DMF, DCM, 5 h; (b) <b>26</b>, Et<sub>3</sub>N, DCM, 36 h, 87%. (iv) 3-Methylpyrazole, K<sub>2</sub>CO<sub>3</sub>, NMP, 120 °C, 6−25 h, 9−41%. (v) HCl/H<sub>2</sub>O/AcOH, reflux, 6 h, 96−99%. (vi) (a) SOCl<sub>2</sub>, cat. NMP, DCM, overnight; (b) <b>7</b>, pyridine, cat. DMAP, DCM, 3 d, or μw 80 °C, 8 min, 53−81%.</p></p></figure><figure data-id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901084f/production/images/medium/jm-2009-01084f_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901084f/production/images/large/jm-2009-01084f_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Schematic representation of the main results of the hybrid molecules of compound <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901084f/production/images/large/jm-2009-01084f_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901084f&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901084f/production/images/medium/jm-2009-01084f_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901084f/production/images/large/jm-2009-01084f_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Proposed binding mode of compound <b>1</b> to human OT receptor. The seven TM helices of each receptor are displayed by cylinders and labeled from I to VII. Some TM helices have been omitted for clarity. Compound <b>1</b> is displayed by orange sticks. This figure and Figure S1 in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> has been prepared with Sybyl.<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-4/jm901084f/production/images/large/jm-2009-01084f_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901084f&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i65">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56744" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56744" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 99 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Carter, C. S.</span><span> </span><span class="NLM_article-title">Neuroendocrine perspectives on social attachment and love</span> <span class="citation_source-journal">Psychoneuroendocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">779</span><span class="NLM_x">–</span> <span class="NLM_lpage">818</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1998&pages=779-818&author=C.+S.+Carter&title=Neuroendocrine+perspectives+on+social+attachment+and+love"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarter%26aufirst%3DC.%2BS.%26atitle%3DNeuroendocrine%2520perspectives%2520on%2520social%2520attachment%2520and%2520love%26jtitle%3DPsychoneuroendocrinology%26date%3D1998%26volume%3D23%26spage%3D779%26epage%3D818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Insel, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, L. J.</span><span> </span><span class="NLM_article-title">The neurobiology of attachment</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">129</span><span class="NLM_x">–</span> <span class="NLM_lpage">136</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm901084f&amp;key=10.1038%2F35053579" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm901084f&amp;key=11252992" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADC%252BD3MXisl2qu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2001&pages=129-136&author=T.+R.+Inselauthor=L.+J.+Young&title=The+neurobiology+of+attachment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The neurobiology of attachment</span></div><div class="casAuthors">Insel, Thomas R.; Young, Larry J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">129-136</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review, with 92 refs.  Attachment behavior is both biol. important and tech. difficult to study.  The behavior is complex and there are changes in several cognitive and affective variables to consider.  Nevertheless, recent studies with chicks, rats, sheep, voles and now humans have begun to reveal some important candidates for the neurobiol. of social attachment.  The neuropeptides oxytocin and vasopressin have yielded a model that links mol., cellular and systems approaches.  Dopamine pathways in the forebrain, esp. the nucleus accumbens and ventral pallidum, seem to be important for certain aspects of partner preference formation.  It seems likely that for attachment to occur, these neuropeptides must link social stimuli to dopamine pathways assocd. with reinforcement.  It is also possible that neural mechanisms that we assoc. with drug abuse and addiction might have evolved for social recognition, reward and euphoria - crit. elements in the process of attachment.  In the very near future, we can hope that discoveries of the mol. and cellular mechanisms of addiction might be applied to the neurobiol. of attachment, providing a new understanding of one of our most complex and intriguing emotions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrV7XeeQsaynbVg90H21EOLACvtfcHk0li5xbBHyrD3Uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXisl2qu7w%253D&md5=9aeb3652478b32aea51a08bea47dfad6</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2F35053579&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35053579%26sid%3Dliteratum%253Aachs%26aulast%3DInsel%26aufirst%3DT.%2BR.%26aulast%3DYoung%26aufirst%3DL.%2BJ.%26atitle%3DThe%2520neurobiology%2520of%2520attachment%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2001%26volume%3D2%26spage%3D129%26epage%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Komisaruk, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whipple, B.</span><span> </span><span class="NLM_article-title">Love as sensory stimulation: physiological consequences of its deprivation and expression</span> <span class="citation_source-journal">Psychoneuroendocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">927</span><span class="NLM_x">–</span> <span class="NLM_lpage">944</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1998&pages=927-944&author=B.+R.+Komisarukauthor=B.+Whipple&title=Love+as+sensory+stimulation%3A+physiological+consequences+of+its+deprivation+and+expression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKomisaruk%26aufirst%3DB.%2BR.%26aulast%3DWhipple%26aufirst%3DB.%26atitle%3DLove%2520as%2520sensory%2520stimulation%253A%2520physiological%2520consequences%2520of%2520its%2520deprivation%2520and%2520expression%26jtitle%3DPsychoneuroendocrinology%26date%3D1998%26volume%3D23%26spage%3D927%26epage%3D944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Zeki, S.</span><span> </span><span class="NLM_article-title">The neurobiology of love</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">581</span><span class="NLM_x">, </span> <span class="NLM_fpage">2575</span><span class="NLM_x">–</span> <span class="NLM_lpage">2579</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=581&publication_year=2007&pages=2575-2579&author=S.+Zeki&title=The+neurobiology+of+love"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZeki%26aufirst%3DS.%26atitle%3DThe%2520neurobiology%2520of%2520love%26jtitle%3DFEBS%2520Lett.%26date%3D2007%26volume%3D581%26spage%3D2575%26epage%3D2579" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Debiec, J.</span><span> </span><span class="NLM_article-title">From affiliative behaviours to romantic feelings: a role of nanopeptides</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">581</span><span class="NLM_x">, </span> <span class="NLM_fpage">2580</span><span class="NLM_x">–</span> <span class="NLM_lpage">2586</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=581&publication_year=2007&pages=2580-2586&author=J.+Debiec&title=From+affiliative+behaviours+to+romantic+feelings%3A+a+role+of+nanopeptides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDebiec%26aufirst%3DJ.%26atitle%3DFrom%2520affiliative%2520behaviours%2520to%2520romantic%2520feelings%253A%2520a%2520role%2520of%2520nanopeptides%26jtitle%3DFEBS%2520Lett.%26date%3D2007%26volume%3D581%26spage%3D2580%26epage%3D2586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Porges, S. W.</span><span> </span><span class="NLM_article-title">Love: an emergent property of the mammalian autonomic nervous system</span> <span class="citation_source-journal">Psychoneuroendocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">837</span><span class="NLM_x">–</span> <span class="NLM_lpage">861</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1998&pages=837-861&author=S.+W.+Porges&title=Love%3A+an+emergent+property+of+the+mammalian+autonomic+nervous+system"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPorges%26aufirst%3DS.%2BW.%26atitle%3DLove%253A%2520an%2520emergent%2520property%2520of%2520the%2520mammalian%2520autonomic%2520nervous%2520system%26jtitle%3DPsychoneuroendocrinology%26date%3D1998%26volume%3D23%26spage%3D837%26epage%3D861" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Zak, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurzban, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matzner, W. T.</span><span> </span><span class="NLM_article-title">The neurobiology of trust</span> <span class="citation_source-journal">Ann. N. Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">1032</span><span class="NLM_x">, </span> <span class="NLM_fpage">224</span><span class="NLM_x">–</span> <span class="NLM_lpage">227</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1032&publication_year=2004&pages=224-227&author=P.+J.+Zakauthor=R.+Kurzbanauthor=W.+T.+Matzner&title=The+neurobiology+of+trust"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZak%26aufirst%3DP.%2BJ.%26aulast%3DKurzban%26aufirst%3DR.%26aulast%3DMatzner%26aufirst%3DW.%2BT.%26atitle%3DThe%2520neurobiology%2520of%2520trust%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2004%26volume%3D1032%26spage%3D224%26epage%3D227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Zak, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurzban, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matzner, W. T.</span><span> </span><span class="NLM_article-title">Oxytocin is associated with human trustworthiness</span> <span class="citation_source-journal">Horm. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">522</span><span class="NLM_x">–</span> <span class="NLM_lpage">527</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm901084f&amp;key=10.1016%2Fj.yhbeh.2005.07.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm901084f&amp;key=16109416" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Ghtb7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=522-527&author=P.+J.+Zakauthor=R.+Kurzbanauthor=W.+T.+Matzner&title=Oxytocin+is+associated+with+human+trustworthiness"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Oxytocin is associated with human trustworthiness</span></div><div class="casAuthors">Zak, Paul J.; Kurzban, Robert; Matzner, William T.</div><div class="citationInfo"><span class="NLM_cas:title">Hormones and Behavior</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">522-527</span>CODEN:
                <span class="NLM_cas:coden">HOBEAO</span>;
        ISSN:<span class="NLM_cas:issn">0018-506X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Human beings exhibit substantial interpersonal trust-even with strangers.  The neuroactive hormone oxytocin facilitates social recognition in animals, and we examine if oxytocin is related to trustworthiness between humans.  This paper reports the results of an expt. to test this hypothesis, where trust and trustworthiness are measured using the sequential anonymous "trust game" with monetary payoffs.  We find that oxytocin levels are higher in subjects who receive a monetary transfer that reflects an intention of trust relative to an unintentional monetary transfer of the same amt.  In addn., higher oxytocin levels are assocd. with trustworthy behavior (the reciprocation of trust).  Absent intentionality, both the oxytocin and behavioral responses are extinguished.  We conclude that perceptions of intentions of trust affect levels of circulating oxytocin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1SoMEe6-MrbVg90H21EOLACvtfcHk0ljIyUyrnJhpHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Ghtb7J&md5=61247d15e77adbc9377e436b3dc2b690</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.yhbeh.2005.07.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yhbeh.2005.07.009%26sid%3Dliteratum%253Aachs%26aulast%3DZak%26aufirst%3DP.%2BJ.%26aulast%3DKurzban%26aufirst%3DR.%26aulast%3DMatzner%26aufirst%3DW.%2BT.%26atitle%3DOxytocin%2520is%2520associated%2520with%2520human%2520trustworthiness%26jtitle%3DHorm.%2520Behav.%26date%3D2005%26volume%3D48%26spage%3D522%26epage%3D527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Kosfeld, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinrichs, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zak, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischbacher, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fehr, E.</span><span> </span><span class="NLM_article-title">Oxytocin increases trust in humans</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">435</span><span class="NLM_x">, </span> <span class="NLM_fpage">673</span><span class="NLM_x">–</span> <span class="NLM_lpage">676</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=435&publication_year=2005&pages=673-676&author=M.+Kosfeldauthor=M.+Heinrichsauthor=P.+J.+Zakauthor=U.+Fischbacherauthor=E.+Fehr&title=Oxytocin+increases+trust+in+humans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKosfeld%26aufirst%3DM.%26aulast%3DHeinrichs%26aufirst%3DM.%26aulast%3DZak%26aufirst%3DP.%2BJ.%26aulast%3DFischbacher%26aufirst%3DU.%26aulast%3DFehr%26aufirst%3DE.%26atitle%3DOxytocin%2520increases%2520trust%2520in%2520humans%26jtitle%3DNature%26date%3D2005%26volume%3D435%26spage%3D673%26epage%3D676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Heinrichs, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumgartner, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirschbaum, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehlert, U.</span><span> </span><span class="NLM_article-title">Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1389</span><span class="NLM_x">–</span> <span class="NLM_lpage">1398</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm901084f&amp;key=10.1016%2FS0006-3223%2803%2900465-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm901084f&amp;key=14675803" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpvVWqt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2003&pages=1389-1398&author=M.+Heinrichsauthor=T.+Baumgartnerauthor=C.+Kirschbaumauthor=U.+Ehlert&title=Social+support+and+oxytocin+interact+to+suppress+cortisol+and+subjective+responses+to+psychosocial+stress"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress</span></div><div class="casAuthors">Heinrichs, Markus; Baumgartner, Thomas; Kirschbaum, Clemens; Ehlert, Ulrike</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1389-1398</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">The presence of social support was assocd. with decreased stress responsiveness.  Recent animal studies suggest that the neuropeptide oxytocin is implicated both in prosocial behavior and in the central nervous control of neuroendocrine responses to stress.  This study was designed to det. the effects of social support and oxytocin on cortisol, mood, and anxiety responses to psychosocial stress in humans.  In a placebo-controlled, double-blind study, 37 healthy men were exposed to the Trier Social Stress Test.  All participants were randomly assigned to receive intranasal oxytocin (24 IU) or placebo 50 min before stress, and either social support from their best friend during the prepn. period or no social support.  Salivary free cortisol levels were suppressed by social support in response to stress.  Comparisons of pre- and poststress anxiety levels revealed an anxiolytic effect of oxytocin.  More importantly, the combination of oxytocin and social support exhibited the lowest cortisol concns. as well as increased calmness and decreased anxiety during stress.  Oxytocin seems to enhance the buffering effect of social support on stress responsiveness.  These results concur with data from animal research suggesting an important role of oxytocin as an underlying biol. mechanism for stress-protective effects of pos. social interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgqpFvk8yjfLVg90H21EOLACvtfcHk0ljIyUyrnJhpHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpvVWqt7o%253D&md5=d3f47cf6cf602ace7cb6d3b32fbf6f0f</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FS0006-3223%2803%2900465-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-3223%252803%252900465-7%26sid%3Dliteratum%253Aachs%26aulast%3DHeinrichs%26aufirst%3DM.%26aulast%3DBaumgartner%26aufirst%3DT.%26aulast%3DKirschbaum%26aufirst%3DC.%26aulast%3DEhlert%26aufirst%3DU.%26atitle%3DSocial%2520support%2520and%2520oxytocin%2520interact%2520to%2520suppress%2520cortisol%2520and%2520subjective%2520responses%2520to%2520psychosocial%2520stress%26jtitle%3DBiol.%2520Psychiatry%26date%3D2003%26volume%3D54%26spage%3D1389%26epage%3D1398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Uvnäs-Moberg, K.</span><span> </span><span class="NLM_article-title">Oxytocin may mediate the benefits of positive social interaction and emotions</span> <span class="citation_source-journal">Psychoneuroendocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">819</span><span class="NLM_x">–</span> <span class="NLM_lpage">835</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1998&pages=819-835&author=K.+Uvn%C3%A4s-Moberg&title=Oxytocin+may+mediate+the+benefits+of+positive+social+interaction+and+emotions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUvn%25C3%25A4s-Moberg%26aufirst%3DK.%26atitle%3DOxytocin%2520may%2520mediate%2520the%2520benefits%2520of%2520positive%2520social%2520interaction%2520and%2520emotions%26jtitle%3DPsychoneuroendocrinology%26date%3D1998%26volume%3D23%26spage%3D819%26epage%3D835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">DeVries, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glasper, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Detillion, C. E.</span><span> </span><span class="NLM_article-title">Social modulation of stress responses</span> <span class="citation_source-journal">Physiol. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">339</span><span class="NLM_x">–</span> <span class="NLM_lpage">407</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2003&pages=339-407&author=A.+C.+DeVriesauthor=E.+R.+Glasperauthor=C.+E.+Detillion&title=Social+modulation+of+stress+responses"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDeVries%26aufirst%3DA.%2BC.%26aulast%3DGlasper%26aufirst%3DE.%2BR.%26aulast%3DDetillion%26aufirst%3DC.%2BE.%26atitle%3DSocial%2520modulation%2520of%2520stress%2520responses%26jtitle%3DPhysiol.%2520Behav.%26date%3D2003%26volume%3D79%26spage%3D339%26epage%3D407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Insel, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Brien, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leckman, J. F.</span><span> </span><span class="NLM_article-title">Oxytocin, vasopressin, and autism: is there a connection?</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">145</span><span class="NLM_x">–</span> <span class="NLM_lpage">157</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm901084f&amp;key=10.1016%2FS0006-3223%2898%2900142-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm901084f&amp;key=9951561" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADyaK1MXhtVequr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1999&pages=145-157&author=T.+R.+Inselauthor=D.+J.+O%27Brienauthor=J.+F.+Leckman&title=Oxytocin%2C+vasopressin%2C+and+autism%3A+is+there+a+connection%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Oxytocin, vasopressin, and autism: is there a connection?</span></div><div class="casAuthors">Insel, Thomas R.; O'Brien, Derek J.; Leckman, James F.</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">145-157</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review, with 121 refs., discussing autism, which is a poorly understood developmental disorder characterized by social impairment, communication deficits, and compulsive behavior.  The authors review evidence from animal studies demonstrating that the nonapeptides, oxytocin and vasopressin, have unique effects on the normal expression of species-typical social behavior, communication, and rituals.  Based on this evidence, they hypothesize that an abnormality in oxytocin or vasopressin neurotransmission may account for several features of autism.  As autism appears to be a genetic disorder, mutations in the various peptide, peptide receptor, or lineage-specific developmental genes could lead to altered oxytocin or vasopressin neurotransmission.  Many of these genes have been cloned and sequenced, and several polymorphisms have been identified.  Recent gene targeting studies that alter expression of either the peptides or their receptors in the rodent brain partially support the autism hypothesis.  While previous experience suggests caution in hypothesizing a cause or suggesting a treatment for autism, the available preclin. evidence with oxytocin and vasopressin recommends the need for clin. studies using gene scanning, pharmacol. and neurobiol. approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_nme_mqBvx7Vg90H21EOLACvtfcHk0lhcGj2V-CSGYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhtVequr8%253D&md5=9915c5a9d9ad2add78eca8714c5e5012</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2FS0006-3223%2898%2900142-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-3223%252898%252900142-5%26sid%3Dliteratum%253Aachs%26aulast%3DInsel%26aufirst%3DT.%2BR.%26aulast%3DO%2527Brien%26aufirst%3DD.%2BJ.%26aulast%3DLeckman%26aufirst%3DJ.%2BF.%26atitle%3DOxytocin%252C%2520vasopressin%252C%2520and%2520autism%253A%2520is%2520there%2520a%2520connection%253F%26jtitle%3DBiol.%2520Psychiatry%26date%3D1999%26volume%3D45%26spage%3D145%26epage%3D157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Kim, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veenstra-VanderWeele, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courchesne, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courchesne, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leventhal, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, E. H.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Insel, T. R.</span><span> </span><span class="NLM_article-title">Transmission disequilibrium testing of arginine vasopressin receptor 1A (AVPR1A) polymorphisms in autism</span> <span class="citation_source-journal">Mol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">503</span><span class="NLM_x">–</span> <span class="NLM_lpage">507</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm901084f&amp;key=10.1038%2Fsj.mp.4001125" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm901084f&amp;key=12082568" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADC%252BD38XkslKmt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2002&pages=503-507&author=S.+J.+Kimauthor=L.+J.+Youngauthor=D.+Gonenauthor=J.+Veenstra-VanderWeeleauthor=R.+Courchesneauthor=E.+Courchesneauthor=C.+Lordauthor=B.+L.+Leventhalauthor=E.+H.+Cookauthor=T.+R.+Insel&title=Transmission+disequilibrium+testing+of+arginine+vasopressin+receptor+1A+%28AVPR1A%29+polymorphisms+in+autism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Transmission disequilibrium testing of arginine vasopressin receptor 1A (AVPR1A) polymorphisms in autism</span></div><div class="casAuthors">Kim, S-J.; Young, L. J.; Gonen, D.; Veenstra-VanderWeele, J.; Courchesne, R.; Courchesne, E.; Lord, C.; Leventhal, B. L.; Cook, E. H., Jr.; Insel, T. R.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Psychiatry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">503-507</span>CODEN:
                <span class="NLM_cas:coden">MOPSFQ</span>;
        ISSN:<span class="NLM_cas:issn">1359-4184</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Impairment in social reciprocity is a central component of autism.  In preclin. studies, arginine vasopressin (AVP) has been shown to increase a range of social behaviors, including affiliation and attachment, via the V1a receptor (AVPR1A) in the brain.  Both the behavioral effects of AVP and the neural distribution of the V1a receptor vary greatly across mammalian species.  This difference in regional receptor expression as well as differences in social behavior may result from a highly variable repetitive sequence in the 5' flanking region of the V1a gene (AVPR1A).  Given this comparative evidence for a role in inter-species variation in social behavior, the authors explored whether within our own species, variation in the human AVPR1A may contribute to individual variations in social behavior, with autism representing an extreme form of social impairment.  The authors genotyped two microsatellite polymorphisms from the 5' flanking region of AVPR1A for 115 autism trios and found nominally significant transmission disequil. between autism and one of the microsatellite markers by Multiallelic Transmission/Disequil. test (MTDT) that was not significant after Bonferroni correction.  They also screened approx. 2 kb of the 5' flanking region and the coding region and identified 10 single nucleotide polymorphisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdRwMCFdzxlbVg90H21EOLACvtfcHk0lhcGj2V-CSGYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XkslKmt78%253D&md5=29d9a30e6be3bf383800cc7aa69e9506</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fsj.mp.4001125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.mp.4001125%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DS.%2BJ.%26aulast%3DYoung%26aufirst%3DL.%2BJ.%26aulast%3DGonen%26aufirst%3DD.%26aulast%3DVeenstra-VanderWeele%26aufirst%3DJ.%26aulast%3DCourchesne%26aufirst%3DR.%26aulast%3DCourchesne%26aufirst%3DE.%26aulast%3DLord%26aufirst%3DC.%26aulast%3DLeventhal%26aufirst%3DB.%2BL.%26aulast%3DCook%26aufirst%3DE.%2BH.%26aulast%3DInsel%26aufirst%3DT.%2BR.%26atitle%3DTransmission%2520disequilibrium%2520testing%2520of%2520arginine%2520vasopressin%2520receptor%25201A%2520%2528AVPR1A%2529%2520polymorphisms%2520in%2520autism%26jtitle%3DMol.%2520Psychiatry%26date%3D2002%26volume%3D7%26spage%3D503%26epage%3D507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Wu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, D.</span><span> </span><span class="NLM_article-title">Positive association of the oxytocin receptor gene (OXTR) with autism in the Chinese Han population</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">74</span><span class="NLM_x">–</span> <span class="NLM_lpage">77</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm901084f&amp;key=10.1016%2Fj.biopsych.2005.03.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm901084f&amp;key=15992526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlslynurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2005&pages=74-77&author=S.+Wuauthor=M.+Jiaauthor=Y.+Ruanauthor=J.+Liuauthor=Y.+Guoauthor=M.+Shuangauthor=X.+Gongauthor=Y.+Zhangauthor=X.+Yangauthor=D.+Zhang&title=Positive+association+of+the+oxytocin+receptor+gene+%28OXTR%29+with+autism+in+the+Chinese+Han+population"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Positive Association of the Oxytocin Receptor Gene (OXTR) with Autism in the Chinese Han Population</span></div><div class="casAuthors">Wu, Suping; Jia, Meixiang; Ruan, Yan; Liu, Jing; Guo, Yanqing; Mei, Shuang; Gong, Xiaohong; Zhang, Yanbo; Yang, Xiaoling; Zhang, Dai</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">74-77</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Previous research has suggested that the social impairments exhibited by individuals with autism are assocd. with changes in plasma oxytocin (OT) levels.  The physiol. effects of oxytocin are mediated through its specific receptors (OTRs), and numerous studies have implicated OTRs in the regulation of social cognition and behavior.  Animal models and linkage data from genome screens indicate that the oxytocin receptor gene (OXTR) is an excellent candidate for research concerning psychiatric disorders, particularly those involving social impairments, such as autism.  We genotyped four single nucleotide polymorphisms (SNPs) located within the OXTR gene of 195 Chinese Han autism trios, using polymerase chain reaction-restriction fragment length polymorphism anal.  The family-based assocn. test (FBAT) revealed a significant genetic assocn. between autism and two of the SNPs tested (rs2254298 A: Z = 2.287, p = .0222; rs53576 A: Z = 2.573, p = .0101).  When haplotypes were constructed with two, three, and four markers, the haplotype-specific FBAT revealed that a no. of haplotypes, particularly those involving rs53576, were significantly assocd. with autism.  Furthermore, haplotypes constructed with all markers showed a significant excess transmission for the specific and global haplotype analyses (p = .0020 and .0289, resp.).  These data suggest an involvement of OXTR in the susceptibility to autism, and replication is important.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTdJutXtrhBbVg90H21EOLACvtfcHk0lhcGj2V-CSGYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlslynurw%253D&md5=e4acfcbd4c3c1f7a6abb7fb2d0e66633</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2005.03.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2005.03.013%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DS.%26aulast%3DJia%26aufirst%3DM.%26aulast%3DRuan%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DGuo%26aufirst%3DY.%26aulast%3DShuang%26aufirst%3DM.%26aulast%3DGong%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DD.%26atitle%3DPositive%2520association%2520of%2520the%2520oxytocin%2520receptor%2520gene%2520%2528OXTR%2529%2520with%2520autism%2520in%2520the%2520Chinese%2520Han%2520population%26jtitle%3DBiol.%2520Psychiatry%26date%3D2005%26volume%3D58%26spage%3D74%26epage%3D77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Jacob, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brune, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leventhal, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, E. H.,  Jr.</span><span> </span><span class="NLM_article-title">Association of the oxytocin receptor gene (OXTR) in Caucasian children and adolescents with autism</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">417</span><span class="NLM_x">, </span> <span class="NLM_fpage">6</span><span class="NLM_x">–</span> <span class="NLM_lpage">9</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=417&publication_year=2007&pages=6-9&author=S.+Jacobauthor=C.+W.+Bruneauthor=C.+S.+Carterauthor=B.+L.+Leventhalauthor=C.+Lordauthor=E.+H.+Cook&title=Association+of+the+oxytocin+receptor+gene+%28OXTR%29+in+Caucasian+children+and+adolescents+with+autism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJacob%26aufirst%3DS.%26aulast%3DBrune%26aufirst%3DC.%2BW.%26aulast%3DCarter%26aufirst%3DC.%2BS.%26aulast%3DLeventhal%26aufirst%3DB.%2BL.%26aulast%3DLord%26aufirst%3DC.%26aulast%3DCook%26aufirst%3DE.%2BH.%26atitle%3DAssociation%2520of%2520the%2520oxytocin%2520receptor%2520gene%2520%2528OXTR%2529%2520in%2520Caucasian%2520children%2520and%2520adolescents%2520with%2520autism%26jtitle%3DNeurosci.%2520Lett.%26date%3D2007%26volume%3D417%26spage%3D6%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Modahl, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fein, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waterhouse, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feinstein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levin, H.</span><span> </span><span class="NLM_article-title">Plasma oxytocin levels in autistic children</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">270</span><span class="NLM_x">–</span> <span class="NLM_lpage">277</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm901084f&amp;key=10.1016%2FS0006-3223%2897%2900439-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm901084f&amp;key=9513736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A280%3ADyaK1c7nsV2hsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1998&pages=270-277&author=C.+Modahlauthor=L.+Greenauthor=D.+Feinauthor=M.+Morrisauthor=L.+Waterhouseauthor=C.+Feinsteinauthor=H.+Levin&title=Plasma+oxytocin+levels+in+autistic+children"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Plasma oxytocin levels in autistic children</span></div><div class="casAuthors">Modahl C; Green L; Fein D; Morris M; Waterhouse L; Feinstein C; Levin H</div><div class="citationInfo"><span class="NLM_cas:title">Biological psychiatry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">270-7</span>
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    </div><div class="casAbstract">BACKGROUND:  Social impairments are central to the syndrome of autism.  The neuropeptide oxytocin (OT) has been implicated in the regulation of social behavior in animals but has not yet been examined in autistic subjects.  METHODS:  To determine whether autistic children have abnormalities in OT, midday plasma samples from 29 autistic and 30 age-matched normal children, all prepubertal, were analyzed by radioimmunoassay for levels of OT.  RESULTS:  Despite individual variability and overlapping group distributions, the autistic group had significantly lower plasma OT levels than the normal group.  OT increased with age in the normal but not the autistic children.  Elevated OT was associated with higher scores on social and developmental measures for the normal children, but was associated with lower scores for the autistic children.  These relationships were strongest in a subset of autistic children identified as aloof.  CONCLUSIONS:  Although making inferences to central OT functioning from peripheral measurement is difficult, the data suggest that OT abnormalities may exist in autism, and that more direct investigation of central nervous system OT function is warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTkrIn8D9W2z2LFM_lbR1VmfW6udTcc2ebs4lb8KDiV6bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1c7nsV2hsQ%253D%253D&md5=36ba0a757dc1cfee81be20d30132122b</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2FS0006-3223%2897%2900439-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-3223%252897%252900439-3%26sid%3Dliteratum%253Aachs%26aulast%3DModahl%26aufirst%3DC.%26aulast%3DGreen%26aufirst%3DL.%26aulast%3DFein%26aufirst%3DD.%26aulast%3DMorris%26aufirst%3DM.%26aulast%3DWaterhouse%26aufirst%3DL.%26aulast%3DFeinstein%26aufirst%3DC.%26aulast%3DLevin%26aufirst%3DH.%26atitle%3DPlasma%2520oxytocin%2520levels%2520in%2520autistic%2520children%26jtitle%3DBiol.%2520Psychiatry%26date%3D1998%26volume%3D43%26spage%3D270%26epage%3D277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Green, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fein, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modahl, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feinstein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waterhouse, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, M.</span><span> </span><span class="NLM_article-title">Oxytocin and autistic disorder: alterations in peptide forms</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">609</span><span class="NLM_x">–</span> <span class="NLM_lpage">613</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm901084f&amp;key=10.1016%2FS0006-3223%2801%2901139-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm901084f&amp;key=11690596" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnvFGqsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2001&pages=609-613&author=L.+Greenauthor=D.+Feinauthor=C.+Modahlauthor=C.+Feinsteinauthor=L.+Waterhouseauthor=M.+Morris&title=Oxytocin+and+autistic+disorder%3A+alterations+in+peptide+forms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Oxytocin and autistic disorder: alterations in peptide forms</span></div><div class="casAuthors">Green, LeeAnne; Fein, Deborah; Modahl, Charlotte; Feinstein, Carl; Waterhouse, Lynn; Morris, Mariana</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">609-613</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Oxytocin (OT) is synthesized as a prohormone that is sequentially processed to peptides.  These peptides are the bioactive amidated form (OT) and the C-terminal extended peptides, OT-Gly, OT-Gly-Lys and OT-Gly-Lys-Arg, which are designated together as OT-X.  As an extension of our previous study finding decreased plasma OT in autism, studies were conducted to det. whether there were changes in OT peptide forms in autistic children.  28 Male subjects (97 ± 20 mo; range, 70-139 mo), diagnosed with DSM-IV autistic disorder through observation and semi-structured interview, were compared with 31 age-matched nonpsychiatric control subjects (106 ± 22 mo; range, 74-140 mo).  Using OT antisera with different specificity for the peptide forms, the authors measured plasma OT and OT-X in each group.  T tests showed that there was a decrease in plasma OT (t = 4.4, p < .0001), an increase in OT-X (t = 2.3, p < .03) and an increase in the ratio of OT-X/OT (t = 4.5, p < .0001) in the autistic sample, compared with control subjects.  The results suggest that children with autistic disorder show alterations in the endocrine OT system.  Deficits in OT peptide processing in children with autism may be important in the development of this syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoy-zzsrIaaKbVg90H21EOLACvtfcHk0lgyVvtZVQ5VDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnvFGqsLc%253D&md5=50b8f68beebf1d162e59b8f4e5f8132e</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2FS0006-3223%2801%2901139-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-3223%252801%252901139-8%26sid%3Dliteratum%253Aachs%26aulast%3DGreen%26aufirst%3DL.%26aulast%3DFein%26aufirst%3DD.%26aulast%3DModahl%26aufirst%3DC.%26aulast%3DFeinstein%26aufirst%3DC.%26aulast%3DWaterhouse%26aufirst%3DL.%26aulast%3DMorris%26aufirst%3DM.%26atitle%3DOxytocin%2520and%2520autistic%2520disorder%253A%2520alterations%2520in%2520peptide%2520forms%26jtitle%3DBiol.%2520Psychiatry%26date%3D2001%26volume%3D50%26spage%3D609%26epage%3D613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Hollander, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novotny, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanratty, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yaffe, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeCaria, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aronowitz, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosovich, S.</span><span> </span><span class="NLM_article-title">Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger's disorders</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">193</span><span class="NLM_x">–</span> <span class="NLM_lpage">198</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2003&pages=193-198&author=E.+Hollanderauthor=S.+Novotnyauthor=M.+Hanrattyauthor=R.+Yaffeauthor=C.+M.+DeCariaauthor=B.+R.+Aronowitzauthor=S.+Mosovich&title=Oxytocin+infusion+reduces+repetitive+behaviors+in+adults+with+autistic+and+Asperger%27s+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHollander%26aufirst%3DE.%26aulast%3DNovotny%26aufirst%3DS.%26aulast%3DHanratty%26aufirst%3DM.%26aulast%3DYaffe%26aufirst%3DR.%26aulast%3DDeCaria%26aufirst%3DC.%2BM.%26aulast%3DAronowitz%26aufirst%3DB.%2BR.%26aulast%3DMosovich%26aufirst%3DS.%26atitle%3DOxytocin%2520infusion%2520reduces%2520repetitive%2520behaviors%2520in%2520adults%2520with%2520autistic%2520and%2520Asperger%2527s%2520disorders%26jtitle%3DNeuropsychopharmacology%26date%3D2003%26volume%3D28%26spage%3D193%26epage%3D198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Hollander, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaplin, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sumner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soorya, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anagnostou, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wasserman, S.</span><span> </span><span class="NLM_article-title">Oxytocin increases retention of social cognition in autism</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">498</span><span class="NLM_x">–</span> <span class="NLM_lpage">503</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm901084f&amp;key=10.1016%2Fj.biopsych.2006.05.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm901084f&amp;key=16904652" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlWjurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2007&pages=498-503&author=E.+Hollanderauthor=J.+Bartzauthor=W.+Chaplinauthor=A.+Phillipsauthor=J.+Sumnerauthor=L.+Sooryaauthor=E.+Anagnostouauthor=S.+Wasserman&title=Oxytocin+increases+retention+of+social+cognition+in+autism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Oxytocin Increases Retention of Social Cognition in Autism</span></div><div class="casAuthors">Hollander, Eric; Bartz, Jennifer; Chaplin, William; Phillips, Ann; Sumner, Jennifer; Soorya, Latha; Anagnostou, Evdokia; Wasserman, Stacey</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">498-503</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Background: Oxytocin dysfunction might contribute to the development of social deficits in autism, a core symptom domain and potential target for intervention.  This study explored the effect of i.v. oxytocin administration on the retention of social information in autism.  Methods: Oxytocin and placebo challenges were administered to 15 adult subjects diagnosed with autism or Asperger's disorder, and comprehension of affective speech (happy, indifferent, angry, and sad) in neutral content sentences was tested.  Results: All subjects showed improvements in affective speech comprehension from pre- to post-infusion; however, whereas those who received placebo first tended to revert to baseline after a delay, those who received oxytocin first retained the ability to accurately assign emotional significance to speech intonation on the speech comprehension task.  Conclusions: These results are consistent with studies linking oxytocin to social recognition in rodents as well as studies linking oxytocin to prosocial behavior in humans and suggest that oxytocin might facilitate social information processing in those with autism.  These findings also provide preliminary support for the use of oxytocin in the treatment of autism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreES3yFX-HhbVg90H21EOLACvtfcHk0lgyVvtZVQ5VDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlWjurk%253D&md5=e6276eeae44187f43175e253393f141a</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2006.05.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2006.05.030%26sid%3Dliteratum%253Aachs%26aulast%3DHollander%26aufirst%3DE.%26aulast%3DBartz%26aufirst%3DJ.%26aulast%3DChaplin%26aufirst%3DW.%26aulast%3DPhillips%26aufirst%3DA.%26aulast%3DSumner%26aufirst%3DJ.%26aulast%3DSoorya%26aufirst%3DL.%26aulast%3DAnagnostou%26aufirst%3DE.%26aulast%3DWasserman%26aufirst%3DS.%26atitle%3DOxytocin%2520increases%2520retention%2520of%2520social%2520cognition%2520in%2520autism%26jtitle%3DBiol.%2520Psychiatry%26date%3D2007%26volume%3D61%26spage%3D498%26epage%3D503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Vassart, G.</span><span> </span><span class="NLM_article-title">Non-peptide arginine-vasopressin antagonists: the vaptans</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">371</span><span class="NLM_x">, </span> <span class="NLM_fpage">1624</span><span class="NLM_x">–</span> <span class="NLM_lpage">1632</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=371&publication_year=2008&pages=1624-1632&author=G.+Vassart&title=Non-peptide+arginine-vasopressin+antagonists%3A+the+vaptans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVassart%26aufirst%3DG.%26atitle%3DNon-peptide%2520arginine-vasopressin%2520antagonists%253A%2520the%2520vaptans%26jtitle%3DLancet%26date%3D2008%26volume%3D371%26spage%3D1624%26epage%3D1632" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Manning, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoev, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chini, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durroux, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouillac, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillon, G.</span><span> </span><span class="NLM_article-title">Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V<sub>1a</sub>, V<sub>1b</sub>, V<sub>2</sub> and OT receptors: research tools and potential therapeutic agents</span> <span class="citation_source-journal">Prog. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">170</span><span class="NLM_x">, </span> <span class="NLM_fpage">473</span><span class="NLM_x">–</span> <span class="NLM_lpage">512</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm901084f&amp;key=10.1016%2FS0079-6123%2808%2900437-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm901084f&amp;key=18655903" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1CjtrfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=170&publication_year=2008&pages=473-512&author=M.+Manningauthor=S.+Stoevauthor=B.+Chiniauthor=T.+Durrouxauthor=B.+Mouillacauthor=G.+Guillon&title=Peptide+and+non-peptide+agonists+and+antagonists+for+the+vasopressin+and+oxytocin+V1a%2C+V1b%2C+V2+and+OT+receptors%3A+research+tools+and+potential+therapeutic+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents</span></div><div class="casAuthors">Manning, Maurice; Stoev, Stoytcho; Chini, Bice; Durroux, Thierry; Mouillac, Bernard; Guillon, Gilles</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Brain Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">170</span>
        (<span class="NLM_cas:issue">Advances in Vasopressin and Oxytocin</span>),
    <span class="NLM_cas:pages">473-512</span>CODEN:
                <span class="NLM_cas:coden">PBRRA4</span>;
        ISSN:<span class="NLM_cas:issn">0079-6123</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Oxytocin (OT) and vasopressin (AVP) mediate their biol. actions by acting on four known receptors: The OT (uterine) and the AVP V1a (vasopressor), V1b (pituitary), V2 (renal) receptors and a fifth putative AVP V1c (vasodilating) receptor.  This presentation will summarize some highlights of the recent progress, in the design and synthesis of selective peptide agonists, antagonists, radioiodinated ligands, fluorescent ligands and bivalent ligands for these receptors.  Here we present published and unpublished pharmacol. data on the most widely used agonists, antagonists and labeled ligands.  The pharmacol. properties of promising new selective OT antagonists and V1b agonists are also presented.  This review should serve as a useful guide for the selection of the most appropriate ligand for a given study.  The current status of non-peptide OT and AVP antagonists and agonists is also summarized.  The relative merits of peptide and non-peptide AVP and OT agonists and antagonists as: (1) research tools and (2) therapeutic agents will be evaluated.  Many of the receptor selective peptide agonists and antagonists from this and other labs. are far more widely used as pharmacol. tools for studies on the peripheral and central effects of OT and AVP than their non-peptide counterparts.  In addn. to OT and to a lesser extent AVP (pitressin), a no. of OT and AVP analogs; such as carbetocin (OT agonist) dDAVP (desmopressin, V2 agonist), terlipressin (V1a agonist), felypressin (V1a agonist) and atosiban (Tractocile OT antagonist) are also in clin. use.  Despite much early promise, no non-peptide V1a or OT antagonists are currently in clin. trials.  While a no. of orally active non-peptide V2 antagonists (Vaptans); notably, Tolvaptan, Lixivaptan and Satavaptan, are currently in Phase III clin. trials; to date, only the mixed V2/V1a, antagonist Conivaptan (Vaprisol), has been approved by the US FDA for clin. use (by i.v. administration), for the treatment of euvolemic and hypervolemic hyponatremia in hospitalized patients.  Promising new non-peptide V1b and OT antagonists, as well as non-peptide V2 and OT agonists are now in pre-clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3jiQ5LZT5gLVg90H21EOLACvtfcHk0lgixMXUkmQ92g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1CjtrfJ&md5=c21ad467eaee4a2651232a16c7dc61c5</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2FS0079-6123%2808%2900437-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0079-6123%252808%252900437-8%26sid%3Dliteratum%253Aachs%26aulast%3DManning%26aufirst%3DM.%26aulast%3DStoev%26aufirst%3DS.%26aulast%3DChini%26aufirst%3DB.%26aulast%3DDurroux%26aufirst%3DT.%26aulast%3DMouillac%26aufirst%3DB.%26aulast%3DGuillon%26aufirst%3DG.%26atitle%3DPeptide%2520and%2520non-peptide%2520agonists%2520and%2520antagonists%2520for%2520the%2520vasopressin%2520and%2520oxytocin%2520V1a%252C%2520V1b%252C%2520V2%2520and%2520OT%2520receptors%253A%2520research%2520tools%2520and%2520potential%2520therapeutic%2520agents%26jtitle%3DProg.%2520Brain%2520Res.%26date%3D2008%26volume%3D170%26spage%3D473%26epage%3D512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Ashworth, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batt, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baxter, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broqua, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haigh, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heeney, C. M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laporte, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitt, G. R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robson, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rooker, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tartar, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yea, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roe, M. B.</span><span> </span><span class="NLM_article-title">Nonpeptide oxytocin agonists</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">345</span><span class="NLM_x">–</span> <span class="NLM_lpage">353</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm901084f&amp;key=10.1358%2Fdof.2006.031.04.980655" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADC%252BD28XntVyltr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2006&pages=345-353&author=D.+M.+Ashworthauthor=A.+R.+Battauthor=A.+J.+Baxterauthor=P.+Broquaauthor=R.+M.+Haighauthor=P.+Hudsonauthor=C.+M.+S.+Heeneyauthor=R.+Laporteauthor=A.+Pensonauthor=G.+R.+W.+Pittauthor=P.+A.+Robsonauthor=D.+P.+Rookerauthor=A.+L.+Tartarauthor=C.+M.+Yeaauthor=M.+B.+Roe&title=Nonpeptide+oxytocin+agonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Nonpeptide oxytocin agonists</span></div><div class="casAuthors">Ashworth, Doreen M.; Batt, Andrzej R.; Baxter, Andrew J.; Broqua, Pierre; Haigh, Robert M.; Hudson, Peter; Heeney, Celine M. S.; Laporte, Regent; Penson, Andrew; Pitt, Gary R. W.; Robson, Peter A.; Rooker, David P.; Tartar, Andre L.; Yea, Chris M.; Roe, Michael B.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of the Future</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">345-353</span>CODEN:
                <span class="NLM_cas:coden">DRFUD4</span>;
        ISSN:<span class="NLM_cas:issn">0377-8282</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  Oxytocin is a neurohypophyseal hormone that acts at the oxytocin receptor localized both peripherally and centrally and is particularly highly expressed in the pregnant human myometrium.  Synthetic oxytocin has long been used to induce labor and oxytocin antagonists have been introduced for the treatment of preterm labor.  New compds. are described that are potent, selective and efficacious oxytocin receptor agonists with potential utility in promoting labor and for the treatment of conditions such as male and female sexual dysfunction.  These new agents may also be useful as tools for further elucidating the roles of the oxytocin receptor system.  Furthermore, as they are nonpeptidic in nature, they may offer advantages over peptide oxytocin analogs in terms of oral availability and central penetration.  This article describes the various approaches that have been used to discover such compds.  Compds. such as 27, the first nonpeptide oxytocin agonists reported, are currently being investigated as pharmacol. tools in animal models of oxytocin activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxThz83ckUprVg90H21EOLACvtfcHk0lgixMXUkmQ92g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntVyltr4%253D&md5=398b1bc9e09f4682997567457d6905c8</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1358%2Fdof.2006.031.04.980655&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdof.2006.031.04.980655%26sid%3Dliteratum%253Aachs%26aulast%3DAshworth%26aufirst%3DD.%2BM.%26aulast%3DBatt%26aufirst%3DA.%2BR.%26aulast%3DBaxter%26aufirst%3DA.%2BJ.%26aulast%3DBroqua%26aufirst%3DP.%26aulast%3DHaigh%26aufirst%3DR.%2BM.%26aulast%3DHudson%26aufirst%3DP.%26aulast%3DHeeney%26aufirst%3DC.%2BM.%2BS.%26aulast%3DLaporte%26aufirst%3DR.%26aulast%3DPenson%26aufirst%3DA.%26aulast%3DPitt%26aufirst%3DG.%2BR.%2BW.%26aulast%3DRobson%26aufirst%3DP.%2BA.%26aulast%3DRooker%26aufirst%3DD.%2BP.%26aulast%3DTartar%26aufirst%3DA.%2BL.%26aulast%3DYea%26aufirst%3DC.%2BM.%26aulast%3DRoe%26aufirst%3DM.%2BB.%26atitle%3DNonpeptide%2520oxytocin%2520agonists%26jtitle%3DDrugs%2520Future%26date%3D2006%26volume%3D31%26spage%3D345%26epage%3D353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Pitt, G. R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batt, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haigh, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penson, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robson, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rooker, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tartar, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trim, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yea, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roe, M. B.</span><span> </span><span class="NLM_article-title">Non-peptide oxytocin agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">4585</span><span class="NLM_x">–</span> <span class="NLM_lpage">4589</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=4585-4589&author=G.+R.+W.+Pittauthor=A.+R.+Battauthor=R.+M.+Haighauthor=A.+M.+Pensonauthor=P.+A.+Robsonauthor=D.+P.+Rookerauthor=A.+L.+Tartarauthor=J.+E.+Trimauthor=C.+M.+Yeaauthor=M.+B.+Roe&title=Non-peptide+oxytocin+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPitt%26aufirst%3DG.%2BR.%2BW.%26aulast%3DBatt%26aufirst%3DA.%2BR.%26aulast%3DHaigh%26aufirst%3DR.%2BM.%26aulast%3DPenson%26aufirst%3DA.%2BM.%26aulast%3DRobson%26aufirst%3DP.%2BA.%26aulast%3DRooker%26aufirst%3DD.%2BP.%26aulast%3DTartar%26aufirst%3DA.%2BL.%26aulast%3DTrim%26aufirst%3DJ.%2BE.%26aulast%3DYea%26aufirst%3DC.%2BM.%26aulast%3DRoe%26aufirst%3DM.%2BB.%26atitle%3DNon-peptide%2520oxytocin%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D4585%26epage%3D4589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Pardridge, W. M.</span><span> </span><span class="NLM_article-title">Blood−brain barrier delivery</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">54</span><span class="NLM_x">–</span> <span class="NLM_lpage">61</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=54-61&author=W.+M.+Pardridge&title=Blood%E2%88%92brain+barrier+delivery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPardridge%26aufirst%3DW.%2BM.%26atitle%3DBlood%25E2%2588%2592brain%2520barrier%2520delivery%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2007%26volume%3D12%26spage%3D54%26epage%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Matsuhisa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kikuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yatsu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanagisawa, I.</span><span> </span><span class="NLM_article-title">Nonpeptide arginine vasopressin antagonists for both V<sub>1a</sub> and V<sub>2</sub> receptors: synthesis and pharmacological properties of 2-phenyl-4′-[(2,3,4,5-tetrahydro-1<i>H</i>-1-benzazepin-1-yl)carbonyl]benzanilide derivatives</span> <span class="citation_source-journal">Chem. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">1870</span><span class="NLM_x">–</span> <span class="NLM_lpage">1874</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1997&pages=1870-1874&author=A.+Matsuhisaauthor=A.+Tanakaauthor=K.+Kikuchiauthor=Y.+Shimadaauthor=T.+Yatsuauthor=I.+Yanagisawa&title=Nonpeptide+arginine+vasopressin+antagonists+for+both+V1a+and+V2+receptors%3A+synthesis+and+pharmacological+properties+of+2-phenyl-4%E2%80%B2-%5B%282%2C3%2C4%2C5-tetrahydro-1H-1-benzazepin-1-yl%29carbonyl%5Dbenzanilide+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMatsuhisa%26aufirst%3DA.%26aulast%3DTanaka%26aufirst%3DA.%26aulast%3DKikuchi%26aufirst%3DK.%26aulast%3DShimada%26aufirst%3DY.%26aulast%3DYatsu%26aufirst%3DT.%26aulast%3DYanagisawa%26aufirst%3DI.%26atitle%3DNonpeptide%2520arginine%2520vasopressin%2520antagonists%2520for%2520both%2520V1a%2520and%2520V2%2520receptors%253A%2520synthesis%2520and%2520pharmacological%2520properties%2520of%25202-phenyl-4%25E2%2580%25B2-%255B%25282%252C3%252C4%252C5-tetrahydro-1H-1-benzazepin-1-yl%2529carbonyl%255Dbenzanilide%2520derivatives%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D1997%26volume%3D45%26spage%3D1870%26epage%3D1874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Caggiano, T. J.</span><span> </span><span class="NLM_article-title">WAY-VNA-932</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">248</span><span class="NLM_x">–</span> <span class="NLM_lpage">253</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm901084f&amp;key=10.1358%2Fdof.2002.027.03.659890" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADC%252BD38XkslaitL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2002&pages=248-253&author=T.+J.+Caggiano&title=WAY-VNA-932"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">WAY-VNA-932</span></div><div class="casAuthors">Caggiano, Thomas J.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of the Future</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">248-253</span>CODEN:
                <span class="NLM_cas:coden">DRFUD4</span>;
        ISSN:<span class="NLM_cas:issn">0377-8282</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review. WAY-VNA-932 is a novel, orally active nonpeptide small mol. which exhibits vasopressin V2 receptor agonism.  In CHO cells transfected with human V1a, V2, V1b and oxytocin receptors, WAY-VNA-932 is a potent agonist at the V2 receptor, with an EC50 for 2nd messenger (cAMP) generation of 0.7 nM.  In water-loaded normotensive rats, Brattleboro rats, dogs and cynomolgus monkeys WAY-VNA-932 lowers urine output in a dose-dependent manner with a concomitant increase in osmolality.  It is expected that WAY-VNA-932 will offer several advantages over desmopressin, a peptide vasopressin V2 agonist, including greater and more consistent bioavailability and the lack of pressor activity.  WAY-VNA-932 is expected to be useful in conditions characterized by excessive prodn. and/or diln. of urine such as central diabetes insipidus and nocturnal enuresis as well as in conditions characterized by inappropriate prodn. of vasopressin.  WAY-VNA-932 is the 1st nonpeptide vasopressin V2 agonist to enter phase I trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqod3Z1TipNcrVg90H21EOLACvtfcHk0lgJ3nisUlph1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XkslaitL4%253D&md5=4d8946fd3c506cd1b9d20658d5ca0d42</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1358%2Fdof.2002.027.03.659890&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdof.2002.027.03.659890%26sid%3Dliteratum%253Aachs%26aulast%3DCaggiano%26aufirst%3DT.%2BJ.%26atitle%3DWAY-VNA-932%26jtitle%3DDrugs%2520Future%26date%3D2002%26volume%3D27%26spage%3D248%26epage%3D253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Williams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clineschmidt, B. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erb, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freidinger, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guidotti, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lis, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawluczyk, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettibone, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiss, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veber, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woyden, C. J.</span><span> </span><span class="NLM_article-title">1-{1-[4-[(<i>N</i>-Acetyl-4-piperidinyl)oxy]-2-methoxybenzoyl]piperidin-4-yl}-4<i>H</i>-3,1-benzoxazin-2(1<i>H</i>)-one (L-371,257): a new, orally bioavailable, non-peptide oxytocin antagonist</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">4634</span><span class="NLM_x">–</span> <span class="NLM_lpage">4636</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00023a002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=4634-4636&author=P.+D.+Williamsauthor=B.+V.+Clineschmidtauthor=J.+M.+Erbauthor=R.+M.+Freidingerauthor=M.+T.+Guidottiauthor=E.+V.+Lisauthor=J.+M.+Pawluczykauthor=D.+J.+Pettiboneauthor=D.+R.+Reissauthor=D.+F.+Veberauthor=C.+J.+Woyden&title=1-%7B1-%5B4-%5B%28N-Acetyl-4-piperidinyl%29oxy%5D-2-methoxybenzoyl%5Dpiperidin-4-yl%7D-4H-3%2C1-benzoxazin-2%281H%29-one+%28L-371%2C257%29%3A+a+new%2C+orally+bioavailable%2C+non-peptide+oxytocin+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm00023a002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00023a002%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DP.%2BD.%26aulast%3DClineschmidt%26aufirst%3DB.%2BV.%26aulast%3DErb%26aufirst%3DJ.%2BM.%26aulast%3DFreidinger%26aufirst%3DR.%2BM.%26aulast%3DGuidotti%26aufirst%3DM.%2BT.%26aulast%3DLis%26aufirst%3DE.%2BV.%26aulast%3DPawluczyk%26aufirst%3DJ.%2BM.%26aulast%3DPettibone%26aufirst%3DD.%2BJ.%26aulast%3DReiss%26aufirst%3DD.%2BR.%26aulast%3DVeber%26aufirst%3DD.%2BF.%26aulast%3DWoyden%26aufirst%3DC.%2BJ.%26atitle%3D1-%257B1-%255B4-%255B%2528N-Acetyl-4-piperidinyl%2529oxy%255D-2-methoxybenzoyl%255Dpiperidin-4-yl%257D-4H-3%252C1-benzoxazin-2%25281H%2529-one%2520%2528L-371%252C257%2529%253A%2520a%2520new%252C%2520orally%2520bioavailable%252C%2520non-peptide%2520oxytocin%2520antagonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1995%26volume%3D38%26spage%3D4634%26epage%3D4636" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Pitt, G. R. W.; Roe, M. B.; Rooker, D. P.</span><span> </span><span class="NLM_article-title">Oxytocin agonists</span>. Patent WO 03/000692 A3,<span class="NLM_x"> </span><span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=G.+R.+W.+Pitt&author=M.+B.+Roe&author=D.+P.+Rooker&title=Oxytocin+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DPitt%26aufirst%3DG.%2BR.%2BW.%26atitle%3DOxytocin%2520agonists%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Sasatani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyazaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruoka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, H.</span><span> </span><span class="NLM_article-title">Diisobutylaluminium hydride: a novel reagent for the reduction of oximes</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">4711</span><span class="NLM_x">–</span> <span class="NLM_lpage">4712</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1983&pages=4711-4712&author=S.+Sasataniauthor=T.+Miyazakiauthor=K.+Maruokaauthor=H.+Yamamoto&title=Diisobutylaluminium+hydride%3A+a+novel+reagent+for+the+reduction+of+oximes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSasatani%26aufirst%3DS.%26aulast%3DMiyazaki%26aufirst%3DT.%26aulast%3DMaruoka%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DH.%26atitle%3DDiisobutylaluminium%2520hydride%253A%2520a%2520novel%2520reagent%2520for%2520the%2520reduction%2520of%2520oximes%26jtitle%3DTetrahedron%2520Lett.%26date%3D1983%26volume%3D24%26spage%3D4711%26epage%3D4712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Artico, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Martino, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filacchioni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giuliano, R.</span><span> </span><span class="NLM_article-title">Ricerche su sostanze ad attivita’ antiblastica</span> <span class="citation_source-journal">Il Farmaco—Ed. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1969</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">276</span><span class="NLM_x">–</span> <span class="NLM_lpage">284</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm901084f&amp;key=5822122" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADyaF1MXps1Oktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1969&pages=276-284&author=M.+Articoauthor=G.+De+Martinoauthor=G.+Filacchioniauthor=R.+Giuliano&title=Ricerche+su+sostanze+ad+attivita%E2%80%99+antiblastica"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Antiblastic agents.  XXXVI.  Anthramycin and analogous compounds.  1.  Synthesis of 10,11-dihydro-5H-pyrrolo-[2,1-s][1,4]-benzodiazepine</span></div><div class="casAuthors">Artico, Marino; De Martino, Giovanni; Filacchioni, G.; Giuliano, Raffaele</div><div class="citationInfo"><span class="NLM_cas:title">Farmaco, Edizione Scientifica</span>
        (<span class="NLM_cas:date">1969</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">276-84</span>CODEN:
                <span class="NLM_cas:coden">FRPSAX</span>;
        ISSN:<span class="NLM_cas:issn">0430-0920</span>.
    </div><div class="casAbstract">10-(R-Substituted)-10,11-dihydro-5H-pyrrolo[2,1-c][1,4]benzodiazepines (I) are prepd.  Thus, N is passed through a soln. of 4.75 g. 2-pyrrolecarboxaldehyde in 100 ml. tetrahydrofuran (THF), 1.56 g. K is added, the mixt. is refluxed to give a soln., a soln. of 8.64 g. o-O2NC6H4COBr in 100 ml. THF is added, and the mixt. is agitated 8 hrs. at 65° to give 1-(o-nitrobenzoyl)-2-pyrrolecarboxaldehyde (II), m. 136-8°; oxime m. 130-2°.  II (2.3 g.) is dissolved in 250 ml. mixt. of EtOAc and EtOH and hydrogenated over 200 mg. 10% Pd/C 3 hrs. at 4 atm. to give 1.2 g. 10,11-dihydro-5H-pyrrolo-[2,1-c][1,4]benzodiazepine (III), m. 152-4° (decompn.).  III is converted to the following I (R and m.p. given): Ac, 154-5°; ClCH2CO, 122-3°; Cl2CHCO, 118-19°.  Ir data are given; also given is the ir spectrum of III.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3kywPi1TwNrVg90H21EOLACvtfcHk0lgJ3nisUlph1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF1MXps1Oktw%253D%253D&md5=b66a573f9e4491d69d10c3488c0d7aa3</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArtico%26aufirst%3DM.%26aulast%3DDe%2BMartino%26aufirst%3DG.%26aulast%3DFilacchioni%26aufirst%3DG.%26aulast%3DGiuliano%26aufirst%3DR.%26atitle%3DRicerche%2520su%2520sostanze%2520ad%2520attivita%25E2%2580%2599%2520antiblastica%26jtitle%3DIl%2520Farmaco%25E2%2580%2594Ed.%2520Sci.%26date%3D1969%26volume%3D24%26spage%3D276%26epage%3D284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Bell, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erb, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freidinger, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallicchio, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guare, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guidotti, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halpin, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hobbs, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Homnick, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lis, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathre, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michelson, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawluczyk, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettibone, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiss, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vickers, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woyden, C. J.</span><span> </span><span class="NLM_article-title">Development of orally active oxytocin antagonists: studies on 1-(1-{4-[1-(2-methyl-1-oxidopyridin-3-ylmethyl)piperidin-4-yloxy]-2-methoxybenzoyl}piperidin-4-yl)-1,4-dihydrobenz[<i>d</i>][1,3]oxazin-2-one (L-372,662) and related pyridines</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">2146</span><span class="NLM_x">–</span> <span class="NLM_lpage">2163</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9800797" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=2146-2163&author=I.+M.+Bellauthor=J.+M.+Erbauthor=R.+M.+Freidingerauthor=S.+N.+Gallicchioauthor=J.+P.+Guareauthor=M.+T.+Guidottiauthor=R.+A.+Halpinauthor=D.+W.+Hobbsauthor=C.+F.+Homnickauthor=M.+S.+Kuoauthor=E.+V.+Lisauthor=D.+J.+Mathreauthor=S.+R.+Michelsonauthor=J.+M.+Pawluczykauthor=D.+J.+Pettiboneauthor=D.+R.+Reissauthor=S.+Vickersauthor=P.+D.+Williamsauthor=C.+J.+Woyden&title=Development+of+orally+active+oxytocin+antagonists%3A+studies+on+1-%281-%7B4-%5B1-%282-methyl-1-oxidopyridin-3-ylmethyl%29piperidin-4-yloxy%5D-2-methoxybenzoyl%7Dpiperidin-4-yl%29-1%2C4-dihydrobenz%5Bd%5D%5B1%2C3%5Doxazin-2-one+%28L-372%2C662%29+and+related+pyridines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm9800797&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9800797%26sid%3Dliteratum%253Aachs%26aulast%3DBell%26aufirst%3DI.%2BM.%26aulast%3DErb%26aufirst%3DJ.%2BM.%26aulast%3DFreidinger%26aufirst%3DR.%2BM.%26aulast%3DGallicchio%26aufirst%3DS.%2BN.%26aulast%3DGuare%26aufirst%3DJ.%2BP.%26aulast%3DGuidotti%26aufirst%3DM.%2BT.%26aulast%3DHalpin%26aufirst%3DR.%2BA.%26aulast%3DHobbs%26aufirst%3DD.%2BW.%26aulast%3DHomnick%26aufirst%3DC.%2BF.%26aulast%3DKuo%26aufirst%3DM.%2BS.%26aulast%3DLis%26aufirst%3DE.%2BV.%26aulast%3DMathre%26aufirst%3DD.%2BJ.%26aulast%3DMichelson%26aufirst%3DS.%2BR.%26aulast%3DPawluczyk%26aufirst%3DJ.%2BM.%26aulast%3DPettibone%26aufirst%3DD.%2BJ.%26aulast%3DReiss%26aufirst%3DD.%2BR.%26aulast%3DVickers%26aufirst%3DS.%26aulast%3DWilliams%26aufirst%3DP.%2BD.%26aulast%3DWoyden%26aufirst%3DC.%2BJ.%26atitle%3DDevelopment%2520of%2520orally%2520active%2520oxytocin%2520antagonists%253A%2520studies%2520on%25201-%25281-%257B4-%255B1-%25282-methyl-1-oxidopyridin-3-ylmethyl%2529piperidin-4-yloxy%255D-2-methoxybenzoyl%257Dpiperidin-4-yl%2529-1%252C4-dihydrobenz%255Bd%255D%255B1%252C3%255Doxazin-2-one%2520%2528L-372%252C662%2529%2520and%2520related%2520pyridines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D2146%26epage%3D2163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Kondo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinohara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurimura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tominaga, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itai, A.</span><span> </span><span class="NLM_article-title">Novel design of nonpeptide AVP V<sub>2</sub> receptor agonists: structural requirements for an agonist having 1-(4-aminobenzoyl)-2,3,4,5-tetrahydro-1<i>H</i>-1-benzazepine as a template</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">4388</span><span class="NLM_x">–</span> <span class="NLM_lpage">4397</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm000108p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=4388-4397&author=K.+Kondoauthor=H.+Ogawaauthor=T.+Shinoharaauthor=M.+Kurimuraauthor=Y.+Tanadaauthor=K.+Kanauthor=H.+Yamashitaauthor=S.+Nakamuraauthor=T.+Hiranoauthor=Y.+Yamamuraauthor=T.+Moriauthor=M.+Tominagaauthor=A.+Itai&title=Novel+design+of+nonpeptide+AVP+V2+receptor+agonists%3A+structural+requirements+for+an+agonist+having+1-%284-aminobenzoyl%29-2%2C3%2C4%2C5-tetrahydro-1H-1-benzazepine+as+a+template"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm000108p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000108p%26sid%3Dliteratum%253Aachs%26aulast%3DKondo%26aufirst%3DK.%26aulast%3DOgawa%26aufirst%3DH.%26aulast%3DShinohara%26aufirst%3DT.%26aulast%3DKurimura%26aufirst%3DM.%26aulast%3DTanada%26aufirst%3DY.%26aulast%3DKan%26aufirst%3DK.%26aulast%3DYamashita%26aufirst%3DH.%26aulast%3DNakamura%26aufirst%3DS.%26aulast%3DHirano%26aufirst%3DT.%26aulast%3DYamamura%26aufirst%3DY.%26aulast%3DMori%26aufirst%3DT.%26aulast%3DTominaga%26aufirst%3DM.%26aulast%3DItai%26aufirst%3DA.%26atitle%3DNovel%2520design%2520of%2520nonpeptide%2520AVP%2520V2%2520receptor%2520agonists%253A%2520structural%2520requirements%2520for%2520an%2520agonist%2520having%25201-%25284-aminobenzoyl%2529-2%252C3%252C4%252C5-tetrahydro-1H-1-benzazepine%2520as%2520a%2520template%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D4388%26epage%3D4397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Carnazzi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aumelas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phalipou, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouillac, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barberis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seyer, R.</span><span> </span><span class="NLM_article-title">Efficient photoaffinity labeling of the rat V<sub>1a</sub> vasopressin receptor using a linear azidopeptidic antagonist</span> <span class="citation_source-journal">Eur. J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">247</span><span class="NLM_x">, </span> <span class="NLM_fpage">906</span><span class="NLM_x">–</span> <span class="NLM_lpage">913</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm901084f&amp;key=10.1111%2Fj.1432-1033.1997.00906.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm901084f&amp;key=9288914" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADyaK2sXlsVCmtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=247&publication_year=1997&pages=906-913&author=E.+Carnazziauthor=A.+Aumelasauthor=S.+Phalipouauthor=B.+Mouillacauthor=G.+Guillonauthor=C.+Barberisauthor=R.+Seyer&title=Efficient+photoaffinity+labeling+of+the+rat+V1a+vasopressin+receptor+using+a+linear+azidopeptidic+antagonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient photoaffinity labeling of the rat V1a vasopressin receptor using a linear azidopeptidic antagonist</span></div><div class="casAuthors">Carnazzi, Eric; Aumelas, Andre; Phalipou, Sylvie; Mouillac, Bernard; Guillon, Gilles; Barberis, Claude; Seyer, Rene</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">247</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">906-913</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">We have synthesized and fully characterized by fast-atom-bombardment-mass, NMR and UV spectroscopies the vasopressin antagonist 3-azidophenylpropionyl-D-Tyr(Me)-Phe-Gln-Asn-Arg-Pro-Arg-Tyr(3I)-NH2.  Easily radioiodinatable just before use, it has a high affinity for the natural rat liver V1a receptor [dissocn. const. (Kd) = 54±20 pM; Carnazzi, E., Aumelas, A., Barberis, C., Guillon, G. & Seyer, R. (1994) J. Med. Chem. 37, 1841-1849] and for both the rat vasopressin V1a receptor expressed in Spodoptera frugiperda 9 cells (Sf9 cells, Kd = 688±35 pM) and in COS-7 cells (Kd = 320±20 pM).  This probe labels specifically the V1a receptors in an UV-dependent manner, and binds covalently to about 12% of the receptors with high stability over several days, even in dissocn. or solubilization conditions.  SDS-PAGE studies and autoradiog. analyses of the photolabeled receptors reveal a single band (49.5 kDa) and two bands (63 kDa and 93.6 kDa) for receptor-probe assocns. obtained in Sf9 and COS-7 cells resp.  These mol. masses are consistent with non-glycosylated and highly glycosylated forms of the receptor, according to each expression system.  In rat liver membranes, we have identified apparent mol. masses of about 32, 45 and more than 67 kDa.  We finally demonstrated a proteolysis of the receptor that appeared to be Zn2+ and leupeptin sensitive.  The high potency of this ligand is promising for the monitoring of the purifn. of the V1a receptor and for mapping its antagonist-binding site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNhoLFb7QqhLVg90H21EOLACvtfcHk0lji_D_utnz5Kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXlsVCmtbk%253D&md5=5fe00e92128003cdf81f7a757f835cbb</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1111%2Fj.1432-1033.1997.00906.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1432-1033.1997.00906.x%26sid%3Dliteratum%253Aachs%26aulast%3DCarnazzi%26aufirst%3DE.%26aulast%3DAumelas%26aufirst%3DA.%26aulast%3DPhalipou%26aufirst%3DS.%26aulast%3DMouillac%26aufirst%3DB.%26aulast%3DGuillon%26aufirst%3DG.%26aulast%3DBarberis%26aufirst%3DC.%26aulast%3DSeyer%26aufirst%3DR.%26atitle%3DEfficient%2520photoaffinity%2520labeling%2520of%2520the%2520rat%2520V1a%2520vasopressin%2520receptor%2520using%2520a%2520linear%2520azidopeptidic%2520antagonist%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D1997%26volume%3D247%26spage%3D906%26epage%3D913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Phalipou, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cotte, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carnazzi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seyer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahé, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barberis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouillac, B.</span><span> </span><span class="NLM_article-title">Mapping peptide-binding domains of the human V<sub>1a</sub> vasopressin receptor with a photoactivatable linear peptide antagonist</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x">, </span> <span class="NLM_fpage">26536</span><span class="NLM_x">–</span> <span class="NLM_lpage">26544</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=26536-26544&author=S.+Phalipouauthor=N.+Cotteauthor=E.+Carnazziauthor=R.+Seyerauthor=E.+Mah%C3%A9author=S.+Jardauthor=C.+Barberisauthor=B.+Mouillac&title=Mapping+peptide-binding+domains+of+the+human+V1a+vasopressin+receptor+with+a+photoactivatable+linear+peptide+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPhalipou%26aufirst%3DS.%26aulast%3DCotte%26aufirst%3DN.%26aulast%3DCarnazzi%26aufirst%3DE.%26aulast%3DSeyer%26aufirst%3DR.%26aulast%3DMah%25C3%25A9%26aufirst%3DE.%26aulast%3DJard%26aufirst%3DS.%26aulast%3DBarberis%26aufirst%3DC.%26aulast%3DMouillac%26aufirst%3DB.%26atitle%3DMapping%2520peptide-binding%2520domains%2520of%2520the%2520human%2520V1a%2520vasopressin%2520receptor%2520with%2520a%2520photoactivatable%2520linear%2520peptide%2520antagonist%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26spage%3D26536%26epage%3D26544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Phalipou, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seyer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cotte, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breton, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barberis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hibert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouillac, B.</span><span> </span><span class="NLM_article-title">Docking of linear peptide antagonists into the human V<sub>1a</sub> vasopressin receptor: identification of binding domains by photoaffinity labelling</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">23316</span><span class="NLM_x">–</span> <span class="NLM_lpage">23327</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=23316-23327&author=S.+Phalipouauthor=R.+Seyerauthor=N.+Cotteauthor=C.+Bretonauthor=C.+Barberisauthor=M.+Hibertauthor=B.+Mouillac&title=Docking+of+linear+peptide+antagonists+into+the+human+V1a+vasopressin+receptor%3A+identification+of+binding+domains+by+photoaffinity+labelling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPhalipou%26aufirst%3DS.%26aulast%3DSeyer%26aufirst%3DR.%26aulast%3DCotte%26aufirst%3DN.%26aulast%3DBreton%26aufirst%3DC.%26aulast%3DBarberis%26aufirst%3DC.%26aulast%3DHibert%26aufirst%3DM.%26aulast%3DMouillac%26aufirst%3DB.%26atitle%3DDocking%2520of%2520linear%2520peptide%2520antagonists%2520into%2520the%2520human%2520V1a%2520vasopressin%2520receptor%253A%2520identification%2520of%2520binding%2520domains%2520by%2520photoaffinity%2520labelling%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D23316%26epage%3D23327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Rodrigo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pena, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murat, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trueba, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durroux, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rognan, D.</span><span> </span><span class="NLM_article-title">Mapping the binding site of arginine vasopressin to V<sub>1a</sub> and V<sub>1b</sub> vasopressin receptors</span> <span class="citation_source-journal">Mol. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">512</span><span class="NLM_x">–</span> <span class="NLM_lpage">523</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm901084f&amp;key=10.1210%2Fme.2006-0202" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm901084f&amp;key=17082326" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVWisbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2007&pages=512-523&author=J.+Rodrigoauthor=A.+Penaauthor=B.+Muratauthor=M.+Truebaauthor=T.+Durrouxauthor=G.+Guillonauthor=D.+Rognan&title=Mapping+the+binding+site+of+arginine+vasopressin+to+V1a+and+V1b+vasopressin+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Mapping the binding site of arginine vasopressin to V1a and V1b vasopressin receptors</span></div><div class="casAuthors">Rodrigo, Jordi; Pena, Ana; Murat, Brigitte; Trueba, Miguel; Durroux, Thierry; Guillon, Gilles; Rognan, Didier</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">512-523</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Starting from the 2.8-Å resoln. x-ray structure of bovine rhodopsin, three-dimensional mol. models of the complexes between arginine vasopressin and two receptor subtypes (V1a, V1b) have been built.  Amino acid sequence alignment and docking studies suggest that four key residues (1.35, 2.65, 4.61, and 5.35) fine tune the binding of vasopressin and related peptide agonists to both receptor subtypes.  To validate these predictions, a series of single or double mutants were engineered at V1a and V1b receptor subtypes and tested for their binding and functional properties.  Two neg. charged amino acids at positions 1.35 and 2.65 are key anchoring residues to the Arg8 residue of arginine vasopressin.  Moreover, two amino acids (V4.61 and P5.35) delineating a hydrophobic subsite at the human V1b receptor are responsible for the recognition of V1b selective peptide agonists.  Last, one of the latter positions (5.35) is hypothesized to explain the pharmacol. species differences between rat and human vasopressin receptors for a V1b peptide agonist.  Altogether these refined three-dimensional models of V1a and V1b human receptors should enable the identification of further new selective V1a and V1b agonists as pharmacol. but also therapeutic tools.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiSR2zAZAfYrVg90H21EOLACvtfcHk0ljK5SrXGCC85Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVWisbg%253D&md5=3da9d009a1b55b8e9420dfba0b0b77f3</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1210%2Fme.2006-0202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2006-0202%26sid%3Dliteratum%253Aachs%26aulast%3DRodrigo%26aufirst%3DJ.%26aulast%3DPena%26aufirst%3DA.%26aulast%3DMurat%26aufirst%3DB.%26aulast%3DTrueba%26aufirst%3DM.%26aulast%3DDurroux%26aufirst%3DT.%26aulast%3DGuillon%26aufirst%3DG.%26aulast%3DRognan%26aufirst%3DD.%26atitle%3DMapping%2520the%2520binding%2520site%2520of%2520arginine%2520vasopressin%2520to%2520V1a%2520and%2520V1b%2520vasopressin%2520receptors%26jtitle%3DMol.%2520Endocrinol.%26date%3D2007%26volume%3D21%26spage%3D512%26epage%3D523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Verdonk, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartshorn, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, R. D.</span><span> </span><span class="NLM_article-title">Improved protein-ligand docking using GOLD</span> <span class="citation_source-journal">Proteins</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">609</span><span class="NLM_x">–</span> <span class="NLM_lpage">623</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm901084f&amp;key=10.1002%2Fprot.10465" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm901084f&amp;key=12910460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmvFGrsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2003&pages=609-623&author=M.+L.+Verdonkauthor=J.+C.+Coleauthor=M.+J.+Hartshornauthor=C.+W.+Murrayauthor=R.+D.+Taylor&title=Improved+protein-ligand+docking+using+GOLD"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Improved protein-ligand docking using GOLD</span></div><div class="casAuthors">Verdonk, Marcel L.; Cole, Jason C.; Hartshorn, Michael J.; Murray, Christopher W.; Taylor, Richard D.</div><div class="citationInfo"><span class="NLM_cas:title">Proteins: Structure, Function, and Genetics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">609-623</span>CODEN:
                <span class="NLM_cas:coden">PSFGEY</span>;
        ISSN:<span class="NLM_cas:issn">0887-3585</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The Chemscore function was implemented as a scoring function for the protein-ligand docking program GOLD, and its performance compared to the original Goldscore function and two consensus docking protocols, "Goldscore-CS" and "Chemscore-GS," in terms of docking accuracy, prediction of binding affinities, and speed.  In the "Goldscore-CS" protocol, dockings produced with the Goldscore function are scored and ranked with the Chemscore function; in the "Chemscore-GS" protocol, dockings produced with the Chemscore function are scored and ranked with the Goldscore function.  Comparisons were made for a "clean" set of 224 protein-ligand complexes, and for two subsets of this set, one for which the ligands are "drug-like," the other for which they are "fragment-like.".  For "drug-like" and "fragment-like" ligands, the docking accuracies obtained with Chemscore and Goldscore functions are similar.  For larger ligands, Goldscore gives superior results.  Docking with the Chemscore function is up to three times faster than docking with the Goldscore function.  Both combined docking protocols give significant improvements in docking accuracy over the use of the Goldscore or Chemscore function alone.  "Goldscore-CS" gives success rates of up to 81% (top-ranked GOLD soln. within 2.0 Å of the exptl. binding mode) for the "clean list," but at the cost of long search times.  For most virtual screening applications, "Chemscore-GS" seems optimal; search settings that give docking speeds of around 0.25-1.3 min/compd. have success rates of about 78% for "drug-like" compds. and 85% for "fragment-like" compds.  In terms of producing binding energy ests., the Goldscore function appears to perform better than the Chemscore function and the two consensus protocols, particularly for faster search settings.  Even at docking speeds of around 1-2 min/compd., the Goldscore function predicts binding energies with a std. deviation of ∼10.5 kJ/mol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKKgOct_CAcbVg90H21EOLACvtfcHk0ljK5SrXGCC85Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmvFGrsLg%253D&md5=73a627d99dab6de1ae364c8e8e5f0fea</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1002%2Fprot.10465&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.10465%26sid%3Dliteratum%253Aachs%26aulast%3DVerdonk%26aufirst%3DM.%2BL.%26aulast%3DCole%26aufirst%3DJ.%2BC.%26aulast%3DHartshorn%26aufirst%3DM.%2BJ.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DTaylor%26aufirst%3DR.%2BD.%26atitle%3DImproved%2520protein-ligand%2520docking%2520using%2520GOLD%26jtitle%3DProteins%26date%3D2003%26volume%3D52%26spage%3D609%26epage%3D623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Rose, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsiao, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breslow, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B. C.</span><span> </span><span class="NLM_article-title">Crystal structure of the neurophysin−oxytocin complex</span> <span class="citation_source-journal">Nat. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">163</span><span class="NLM_x">–</span> <span class="NLM_lpage">169</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1996&pages=163-169&author=J.+P.+Roseauthor=C.+K.+Wuauthor=C.+D.+Hsiaoauthor=E.+Breslowauthor=B.+C.+Wang&title=Crystal+structure+of+the+neurophysin%E2%88%92oxytocin+complex"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRose%26aufirst%3DJ.%2BP.%26aulast%3DWu%26aufirst%3DC.%2BK.%26aulast%3DHsiao%26aufirst%3DC.%2BD.%26aulast%3DBreslow%26aufirst%3DE.%26aulast%3DWang%26aufirst%3DB.%2BC.%26atitle%3DCrystal%2520structure%2520of%2520the%2520neurophysin%25E2%2588%2592oxytocin%2520complex%26jtitle%3DNat.%2520Struct.%2520Biol.%26date%3D1996%26volume%3D3%26spage%3D163%26epage%3D169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_publisher-name">Gaussian, Inc.</span>, <span class="NLM_publisher-loc">Wallingford CT</span>,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Gaussian%2C+Inc.%2C+Wallingford+CT%2C+2004."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26pub%3DGaussian%252C%2520Inc%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Barberis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouillac, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durroux, T.</span><span> </span><span class="NLM_article-title">Structural bases of vasopressin/oxytocin function</span> <span class="citation_source-journal">J. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">156</span><span class="NLM_x">, </span> <span class="NLM_fpage">223</span><span class="NLM_x">–</span> <span class="NLM_lpage">229</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm901084f&amp;key=10.1677%2Fjoe.0.1560223" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm901084f&amp;key=9518866" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADyaK1cXhtV2lu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=1998&pages=223-229&author=C.+Barberisauthor=B.+Mouillacauthor=T.+Durroux&title=Structural+bases+of+vasopressin%2Foxytocin+function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Structural bases of vasopressin/oxytocin receptor function</span></div><div class="casAuthors">Barberis, C.; Mouillac, B.; Durroux, T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Endocrinology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">156</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">223-229</span>CODEN:
                <span class="NLM_cas:coden">JOENAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-0795</span>.
    
            (<span class="NLM_cas:orgname">Journal of Endocrinology</span>)
        </div><div class="casAbstract">A review with 50 refs. in which the focus is to summarize recent studies that have led to novel insights into the mol. bases of vasopressin and oxytocin receptor functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFMQaSS44BJ7Vg90H21EOLACvtfcHk0ljK5SrXGCC85Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhtV2lu70%253D&md5=c7c46e9cbe99e90ff99ed8cd9a0ea152</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1677%2Fjoe.0.1560223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1677%252Fjoe.0.1560223%26sid%3Dliteratum%253Aachs%26aulast%3DBarberis%26aufirst%3DC.%26aulast%3DMouillac%26aufirst%3DB.%26aulast%3DDurroux%26aufirst%3DT.%26atitle%3DStructural%2520bases%2520of%2520vasopressin%252Foxytocin%2520function%26jtitle%3DJ.%2520Endocrinol.%26date%3D1998%26volume%3D156%26spage%3D223%26epage%3D229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Hojro, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eich, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gimpl, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fahrenholz, F.</span><span> </span><span class="NLM_article-title">Direct identification of an extracellular agonist binding site in the renal V<sub>2</sub> vasopressin receptor</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">13537</span><span class="NLM_x">–</span> <span class="NLM_lpage">13544</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1993&pages=13537-13544&author=E.+Hojroauthor=P.+Eichauthor=G.+Gimplauthor=F.+Fahrenholz&title=Direct+identification+of+an+extracellular+agonist+binding+site+in+the+renal+V2+vasopressin+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHojro%26aufirst%3DE.%26aulast%3DEich%26aufirst%3DP.%26aulast%3DGimpl%26aufirst%3DG.%26aulast%3DFahrenholz%26aufirst%3DF.%26atitle%3DDirect%2520identification%2520of%2520an%2520extracellular%2520agonist%2520binding%2520site%2520in%2520the%2520renal%2520V2%2520vasopressin%2520receptor%26jtitle%3DBiochemistry%26date%3D1993%26volume%3D32%26spage%3D13537%26epage%3D13544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Mouillac, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chini, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balestre, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elands, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trumpp-Kallmeyer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoflack, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hibert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barberis, C.</span><span> </span><span class="NLM_article-title">The binding site of neuropeptide vasopressin V<sub>1a</sub> receptor: evidence for a major localization within transmembrane regions</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">270</span><span class="NLM_x">, </span> <span class="NLM_fpage">25771</span><span class="NLM_x">–</span> <span class="NLM_lpage">25777</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=270&publication_year=1995&pages=25771-25777&author=B.+Mouillacauthor=B.+Chiniauthor=M.+N.+Balestreauthor=J.+Elandsauthor=S.+Trumpp-Kallmeyerauthor=J.+Hoflackauthor=M.+Hibertauthor=S.+Jardauthor=C.+Barberis&title=The+binding+site+of+neuropeptide+vasopressin+V1a+receptor%3A+evidence+for+a+major+localization+within+transmembrane+regions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMouillac%26aufirst%3DB.%26aulast%3DChini%26aufirst%3DB.%26aulast%3DBalestre%26aufirst%3DM.%2BN.%26aulast%3DElands%26aufirst%3DJ.%26aulast%3DTrumpp-Kallmeyer%26aufirst%3DS.%26aulast%3DHoflack%26aufirst%3DJ.%26aulast%3DHibert%26aufirst%3DM.%26aulast%3DJard%26aufirst%3DS.%26aulast%3DBarberis%26aufirst%3DC.%26atitle%3DThe%2520binding%2520site%2520of%2520neuropeptide%2520vasopressin%2520V1a%2520receptor%253A%2520evidence%2520for%2520a%2520major%2520localization%2520within%2520transmembrane%2520regions%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1995%26volume%3D270%26spage%3D25771%26epage%3D25777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Chini, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouillac, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ala, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balestre, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trumpp-Kallmeyer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoflack, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elands, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hibert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manning, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barberis, C</span><span> </span><span class="NLM_article-title">Tyr 115 is the key residue for determining agonist selectivity in the V<sub>1a</sub> vasopressin receptor</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">2176</span><span class="NLM_x">–</span> <span class="NLM_lpage">2182</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1995&pages=2176-2182&author=B.+Chiniauthor=B.+Mouillacauthor=Y.+Alaauthor=M.+N.+Balestreauthor=S.+Trumpp-Kallmeyerauthor=J.+Hoflackauthor=J.+Elandsauthor=M.+Hibertauthor=M.+Manningauthor=S.+Jardauthor=C+Barberis&title=Tyr+115+is+the+key+residue+for+determining+agonist+selectivity+in+the+V1a+vasopressin+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChini%26aufirst%3DB.%26aulast%3DMouillac%26aufirst%3DB.%26aulast%3DAla%26aufirst%3DY.%26aulast%3DBalestre%26aufirst%3DM.%2BN.%26aulast%3DTrumpp-Kallmeyer%26aufirst%3DS.%26aulast%3DHoflack%26aufirst%3DJ.%26aulast%3DElands%26aufirst%3DJ.%26aulast%3DHibert%26aufirst%3DM.%26aulast%3DManning%26aufirst%3DM.%26aulast%3DJard%26aufirst%3DS.%26aulast%3DBarberis%26aufirst%3DC%26atitle%3DTyr%2520115%2520is%2520the%2520key%2520residue%2520for%2520determining%2520agonist%2520selectivity%2520in%2520the%2520V1a%2520vasopressin%2520receptor%26jtitle%3DEMBO%2520J.%26date%3D1995%26volume%3D14%26spage%3D2176%26epage%3D2182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Ufer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Postina, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorbulev, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fahrenholz, F.</span><span> </span><span class="NLM_article-title">An extracellular residue determines the agonist specificity of V<sub>2</sub> vasopressin receptors</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">362</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="NLM_x">–</span> <span class="NLM_lpage">23</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=362&publication_year=1995&pages=19-23&author=E.+Uferauthor=R.+Postinaauthor=V.+Gorbulevauthor=F.+Fahrenholz&title=An+extracellular+residue+determines+the+agonist+specificity+of+V2+vasopressin+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUfer%26aufirst%3DE.%26aulast%3DPostina%26aufirst%3DR.%26aulast%3DGorbulev%26aufirst%3DV.%26aulast%3DFahrenholz%26aufirst%3DF.%26atitle%3DAn%2520extracellular%2520residue%2520determines%2520the%2520agonist%2520specificity%2520of%2520V2%2520vasopressin%2520receptors%26jtitle%3DFEBS%2520Lett.%26date%3D1995%26volume%3D362%26spage%3D19%26epage%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Chini, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouillac, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balestre, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trumpp-Kallmeyer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoflack, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hibert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andriolo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pupier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barberis, C.</span><span> </span><span class="NLM_article-title">Two aromatic residues regulate the response of the human oxytocin receptor to the partial agonist arginine vasopressin</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">397</span><span class="NLM_x">, </span> <span class="NLM_fpage">201</span><span class="NLM_x">–</span> <span class="NLM_lpage">206</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=397&publication_year=1996&pages=201-206&author=B.+Chiniauthor=B.+Mouillacauthor=M.+N.+Balestreauthor=S.+Trumpp-Kallmeyerauthor=J.+Hoflackauthor=M.+Hibertauthor=M.+Andrioloauthor=S.+Pupierauthor=S.+Jardauthor=C.+Barberis&title=Two+aromatic+residues+regulate+the+response+of+the+human+oxytocin+receptor+to+the+partial+agonist+arginine+vasopressin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChini%26aufirst%3DB.%26aulast%3DMouillac%26aufirst%3DB.%26aulast%3DBalestre%26aufirst%3DM.%2BN.%26aulast%3DTrumpp-Kallmeyer%26aufirst%3DS.%26aulast%3DHoflack%26aufirst%3DJ.%26aulast%3DHibert%26aufirst%3DM.%26aulast%3DAndriolo%26aufirst%3DM.%26aulast%3DPupier%26aufirst%3DS.%26aulast%3DJard%26aufirst%3DS.%26aulast%3DBarberis%26aufirst%3DC.%26atitle%3DTwo%2520aromatic%2520residues%2520regulate%2520the%2520response%2520of%2520the%2520human%2520oxytocin%2520receptor%2520to%2520the%2520partial%2520agonist%2520arginine%2520vasopressin%26jtitle%3DFEBS%2520Lett.%26date%3D1996%26volume%3D397%26spage%3D201%26epage%3D206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Postina, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kojro, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fahrenholz, F.</span><span> </span><span class="NLM_article-title">Separate agonist and peptide antagonist binding sites of the oxytocin receptor defined by their transfer into the V<sub>2</sub> vasopressin receptor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">271</span><span class="NLM_x">, </span> <span class="NLM_fpage">31593</span><span class="NLM_x">–</span> <span class="NLM_lpage">31601</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=31593-31601&author=R.+Postinaauthor=E.+Kojroauthor=F.+Fahrenholz&title=Separate+agonist+and+peptide+antagonist+binding+sites+of+the+oxytocin+receptor+defined+by+their+transfer+into+the+V2+vasopressin+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPostina%26aufirst%3DR.%26aulast%3DKojro%26aufirst%3DE.%26aulast%3DFahrenholz%26aufirst%3DF.%26atitle%3DSeparate%2520agonist%2520and%2520peptide%2520antagonist%2520binding%2520sites%2520of%2520the%2520oxytocin%2520receptor%2520defined%2520by%2520their%2520transfer%2520into%2520the%2520V2%2520vasopressin%2520receptor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26spage%3D31593%26epage%3D31601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Hibert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoflack, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trumpp-Kallmeyer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouillac, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chini, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahé, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cotte, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manning, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barberis, C.</span><span> </span><span class="NLM_article-title">Functional architecture of vasopressin/oxytocin receptors</span> <span class="citation_source-journal">J. Recept. Signal Transduction Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">589</span><span class="NLM_x">–</span> <span class="NLM_lpage">596</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm901084f&amp;key=10.3109%2F10799899909036674" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm901084f&amp;key=10071787" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADyaK1MXhslWgs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1999&pages=589-596&author=M.+Hibertauthor=J.+Hoflackauthor=S.+Trumpp-Kallmeyerauthor=B.+Mouillacauthor=B.+Chiniauthor=E.+Mah%C3%A9author=N.+Cotteauthor=S.+Jardauthor=M.+Manningauthor=C.+Barberis&title=Functional+architecture+of+vasopressin%2Foxytocin+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Functional architecture of vasopressin/oxytocin receptors</span></div><div class="casAuthors">Hibert, M.; Hoflack, J.; Trumpp-Kallmeyer, S.; Mouillac, B.; Chini, B.; Mahe, E.; Cotte, N.; Jard, S.; Manning, M.; Barberis, C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Receptor and Signal Transduction Research</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1-4</span>),
    <span class="NLM_cas:pages">589-596</span>CODEN:
                <span class="NLM_cas:coden">JRETET</span>;
        ISSN:<span class="NLM_cas:issn">1079-9893</span>.
    
            (<span class="NLM_cas:orgname">Marcel Dekker, Inc.</span>)
        </div><div class="casAbstract">A review with 12 refs.  Three-dimensional models of G protein-coupled receptors (GPCR) have been defined using most exptl. data available and protein modeling techniques.  The endogenous ligand binding sites have been qual. described and putative receptor activation mechanisms have been proposed.  The model has been recently refined to take into account recent crystallog. data.  Most exptl. published are in excellent qual. agreement with the initial model.  The authors have undertaken to study more systematically by site directed mutagenesis the vasopressin/oxytocin receptor binding domain as a prototype of neuropeptide receptors.  The exptl. are in very good agreement with the models.  The residues responsible for the neuropeptide binding have been identified and confirm the predicted localization of the neuromediator in the transmembrane domain of the receptors.  The side chain of the 8th residue of vasopressin interacts with a non-conserved receptor residue located in the first extracellular loop.  As predicted from the model, this interaction is completely responsible for the selectivity of the ligand-receptor interaction.  Finally, arom. residues which allow the modulation of the efficacy of agonists have been identified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmpWY3HKKjVLVg90H21EOLACvtfcHk0liv_hVBRfu3eQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhslWgs70%253D&md5=036f8eabc18f3d16763b0caf4ffb98e0</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.3109%2F10799899909036674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F10799899909036674%26sid%3Dliteratum%253Aachs%26aulast%3DHibert%26aufirst%3DM.%26aulast%3DHoflack%26aufirst%3DJ.%26aulast%3DTrumpp-Kallmeyer%26aufirst%3DS.%26aulast%3DMouillac%26aufirst%3DB.%26aulast%3DChini%26aufirst%3DB.%26aulast%3DMah%25C3%25A9%26aufirst%3DE.%26aulast%3DCotte%26aufirst%3DN.%26aulast%3DJard%26aufirst%3DS.%26aulast%3DManning%26aufirst%3DM.%26aulast%3DBarberis%26aufirst%3DC.%26atitle%3DFunctional%2520architecture%2520of%2520vasopressin%252Foxytocin%2520receptors%26jtitle%3DJ.%2520Recept.%2520Signal%2520Transduction%2520Res.%26date%3D1999%26volume%3D19%26spage%3D589%26epage%3D596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Cotte, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balestre, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aumelas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahé, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phalipou, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hibert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manning, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durroux, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barberis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouillac, B.</span><span> </span><span class="NLM_article-title">Conserved aromatic residues in the transmembrane region VI of the V<sub>1a</sub> vasopressin receptor differenciate agonist vs antagonist ligand binding</span> <span class="citation_source-journal">Eur. J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">267</span><span class="NLM_x">, </span> <span class="NLM_fpage">4253</span><span class="NLM_x">–</span> <span class="NLM_lpage">4263</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Fjm901084f&amp;key=10.1046%2Fj.1432-1033.2000.01472.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Fjm901084f&amp;key=10866830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADC%252BD3cXkvFClsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=2000&pages=4253-4263&author=N.+Cotteauthor=M.+N.+Balestreauthor=A.+Aumelasauthor=E.+Mah%C3%A9author=S.+Phalipouauthor=D.+Morinauthor=M.+Hibertauthor=M.+Manningauthor=T.+Durrouxauthor=C.+Barberisauthor=B.+Mouillac&title=Conserved+aromatic+residues+in+the+transmembrane+region+VI+of+the+V1a+vasopressin+receptor+differenciate+agonist+vs+antagonist+ligand+binding"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Conserved aromatic residues in the transmembrane region VI of the V1a vasopressin receptor differentiate agonist vs. antagonist ligand binding</span></div><div class="casAuthors">Cotte, Nathalie; Balestre, Marie-Noelle; Aumelas, Andre; Mahe, Eve; Phalipou, Sylvie; Morin, Denis; Hibert, Marcel; Manning, Maurice; Durroux, Thierry; Barberis, Claude; Mouillac, Bernard</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">267</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4253-4263</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">Despite their opposite effects on signal transduction, the nonapeptide hormone arginine-vasopressin (AVP) and its V1a receptor-selective cyclic peptide antagonist d(CH2)5[Tyr(Me)2]AVP display homologous primary structures, differing only at residues 1 and 2.  These structural similarities led the authors to hypothesize that both ligands could interact with the same binding pocket in the V1a receptor.  To det. receptor residues responsible for discriminating binding of agonist and antagonist ligands, the authors performed site-directed mutagenesis of conserved arom. and hydrophilic residues as well as nonconserved residues, all located in the transmembrane binding pocket of the V1a receptor.  Mutation of arom. residues of transmembrane region VI (W304, F307, F308) reduced affinity for the d(CH2)5[Tyr(Me)2]AVP and markedly decreased affinity for the unrelated strongly hydrophobic V1a-selective nonpeptide antagonist SR 49059.  Replacement of these arom. residues had no effect on AVP binding, but increased AVP-induced coupling efficacy of the receptor for its G protein.  Mutating hydrophilic residues Q108, K128 and Q185 in transmembrane regions II, III and IV, resp., led to a decrease in affinity for both agonists and antagonists.  Finally, the nonconserved residues T333 and A334 in transmembrane region VII, controlled the V1a/V2 binding selectivity for both nonpeptide and cyclic peptide antagonists.  Thus, because conserved arom. residues of the V1a receptor binding pocket seem essential for antagonists and do not contribute at all to the binding of agonists, the authors propose that these residues differentiate agonist vs. antagonist ligand binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNtKvaC7KA_LVg90H21EOLACvtfcHk0liv_hVBRfu3eQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXkvFClsbY%253D&md5=5f0463deaf00f467763eea911e729b43</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1046%2Fj.1432-1033.2000.01472.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1432-1033.2000.01472.x%26sid%3Dliteratum%253Aachs%26aulast%3DCotte%26aufirst%3DN.%26aulast%3DBalestre%26aufirst%3DM.%2BN.%26aulast%3DAumelas%26aufirst%3DA.%26aulast%3DMah%25C3%25A9%26aufirst%3DE.%26aulast%3DPhalipou%26aufirst%3DS.%26aulast%3DMorin%26aufirst%3DD.%26aulast%3DHibert%26aufirst%3DM.%26aulast%3DManning%26aufirst%3DM.%26aulast%3DDurroux%26aufirst%3DT.%26aulast%3DBarberis%26aufirst%3DC.%26aulast%3DMouillac%26aufirst%3DB.%26atitle%3DConserved%2520aromatic%2520residues%2520in%2520the%2520transmembrane%2520region%2520VI%2520of%2520the%2520V1a%2520vasopressin%2520receptor%2520differenciate%2520agonist%2520vs%2520antagonist%2520ligand%2520binding%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D2000%26volume%3D267%26spage%3D4253%26epage%3D4263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Breton, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chellil, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kabbaj-Benmansour, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carnazzi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seyer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phalipou, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durroux, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zingg, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barberis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouillac, B.</span><span> </span><span class="NLM_article-title">Direct identification of human oxytocin receptor-binding domains using a photoactivatable cyclic peptide antagonist: comparison with the human V<sub>1a</sub> vasopressin receptor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">26931</span><span class="NLM_x">–</span> <span class="NLM_lpage">26941</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=26931-26941&author=C.+Bretonauthor=H.+Chellilauthor=M.+Kabbaj-Benmansourauthor=E.+Carnazziauthor=R.+Seyerauthor=S.+Phalipouauthor=D.+Morinauthor=T.+Durrouxauthor=H.+Zinggauthor=C.+Barberisauthor=B.+Mouillac&title=Direct+identification+of+human+oxytocin+receptor-binding+domains+using+a+photoactivatable+cyclic+peptide+antagonist%3A+comparison+with+the+human+V1a+vasopressin+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBreton%26aufirst%3DC.%26aulast%3DChellil%26aufirst%3DH.%26aulast%3DKabbaj-Benmansour%26aufirst%3DM.%26aulast%3DCarnazzi%26aufirst%3DE.%26aulast%3DSeyer%26aufirst%3DR.%26aulast%3DPhalipou%26aufirst%3DS.%26aulast%3DMorin%26aufirst%3DD.%26aulast%3DDurroux%26aufirst%3DT.%26aulast%3DZingg%26aufirst%3DH.%26aulast%3DBarberis%26aufirst%3DC.%26aulast%3DMouillac%26aufirst%3DB.%26atitle%3DDirect%2520identification%2520of%2520human%2520oxytocin%2520receptor-binding%2520domains%2520using%2520a%2520photoactivatable%2520cyclic%2520peptide%2520antagonist%253A%2520comparison%2520with%2520the%2520human%2520V1a%2520vasopressin%2520receptor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D26931%26epage%3D26941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Thibonnier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coles, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thibonnier, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoham, M.</span><span> </span><span class="NLM_article-title">Molecular pharmacology and modelling of vasopressin receptors</span> <span class="citation_source-journal">Prog. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">139</span><span class="NLM_x">, </span> <span class="NLM_fpage">179</span><span class="NLM_x">–</span> <span class="NLM_lpage">196</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Fjm901084f&amp;key=10.1016%2FS0079-6123%2802%2939016-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Fjm901084f&amp;key=12436935" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADC%252BD38XovFGrs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=2002&pages=179-196&author=M.+Thibonnierauthor=P.+Colesauthor=A.+Thibonnierauthor=M.+Shoham&title=Molecular+pharmacology+and+modelling+of+vasopressin+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular pharmacology and modeling of vasopressin receptors</span></div><div class="casAuthors">Thibonnier, M.; Coles, P.; Thibonnier, A.; Shoham, M.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Brain Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">139</span>
        (<span class="NLM_cas:issue">Vasopressin and Oxytocin: From Genes to Clinical Applications</span>),
    <span class="NLM_cas:pages">179-196</span>CODEN:
                <span class="NLM_cas:coden">PBRRA4</span>;
        ISSN:<span class="NLM_cas:issn">0079-6123</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  AVP receptors represent a logical target for drug development.  As a new class of therapeutic agents, orally active AVP analogs could be used to treat several human pathophysiol. conditions including neurogenic diabetes insipidus, the syndrome of inappropriate secretion of AVP (SIADH), congestive heart failure, arterial hypertension, liver cirrhosis, nephrotic syndrome, dysmenorrhea, and ocular hypertension.  By immunopptn. and immunoblotting, we elucidated the phosphorylation pattern of green fluorescent protein-tagged AVP receptors and showed interactions with the specific kinases PKC and GRK5 that are agonist, time, and receptor subtype dependent.  The tyrosine residue of the NPWIY motif present in the 7th helix of AVP receptors is rapidly and transiently phosphorylated after agonist stimulation.  This phosphorylation is instrumental in the genesis of the mitogenic cascade linked to the activation of this receptor, presumably by establishing key intramol. contacts and by participating in the creation of a scaffold of proteins that produce the activation of downstream kinases.  The random screening of chem. entities and optimization of lead compds. recently resulted in the development of orally active non-peptide AVP receptor agonists and antagonists.  Furthermore, the identification of the mol. determinants of receptor-ligand interactions should facilitate the development of more potent and very selective orally active compds. via the approach of structure-based drug design.  We developed 3-dimensional mol. docking models of peptide and non-peptide ligands to the human V1 vascular, V2 renal and V3 pituitary AVP receptors.  Docking of the peptide hormone AVP to the receptor ligand binding pockets reflects its dual polar and non-polar structure, but is receptor subtype specific.  The characteristics of non-peptide AVP analogs docking to the receptors are clearly distinct from those of peptide analogs docking.  Mol. modeling of the results of site-directed mutagenesis expts. performed in CHO cells stably transfected with the human AVP receptor subtypes revealed that non-peptide antagonists establish key contacts with a few amino acid residues of the receptor subtypes that are different from those involved in agonist binding.  Moreover, these interactions are species specific.  These findings provide further understanding of the signal transduction pathways of AVP receptors and new leads for elucidation of drug-receptor interactions and optimization of drug design.  Note to the reader: The recent cloning and mol. characterization of AVP/OT receptor subtypes call for the revision of their nomenclature.  For the sake of clarity and in ref. to their main site of expression, we call the V1a receptor the V1 vascular receptor, the V2 receptor the V2 renal receptor and the V1b or V3 receptor the V3 pituitary receptor in the present review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiwlOo6b2iM7Vg90H21EOLACvtfcHk0liv_hVBRfu3eQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XovFGrs78%253D&md5=46ae6f89e8e119686089c78b263a4b04</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2FS0079-6123%2802%2939016-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0079-6123%252802%252939016-2%26sid%3Dliteratum%253Aachs%26aulast%3DThibonnier%26aufirst%3DM.%26aulast%3DColes%26aufirst%3DP.%26aulast%3DThibonnier%26aufirst%3DA.%26aulast%3DShoham%26aufirst%3DM.%26atitle%3DMolecular%2520pharmacology%2520and%2520modelling%2520of%2520vasopressin%2520receptors%26jtitle%3DProg.%2520Brain%2520Res.%26date%3D2002%26volume%3D139%26spage%3D179%26epage%3D196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Hawtin, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesley, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parslow, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simms, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miles, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McEwan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheatley, M.</span><span> </span><span class="NLM_article-title">A single residue (Arg<sup>46</sup>) located within the N-terminus of the V<sub>1a</sub> vasopressin receptor is critical for binding vasopressin but not peptide or nonpeptide antagonists</span> <span class="citation_source-journal">Mol. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">600</span><span class="NLM_x">–</span> <span class="NLM_lpage">609</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Fjm901084f&amp;key=10.1210%2Fme.16.3.600" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Fjm901084f&amp;key=11875119" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADC%252BD38XitFSisLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2002&pages=600-609&author=S.+R.+Hawtinauthor=V.+J.+Wesleyauthor=R.+A.+Parslowauthor=J.+Simmsauthor=A.+Milesauthor=K.+McEwanauthor=M.+Wheatley&title=A+single+residue+%28Arg46%29+located+within+the+N-terminus+of+the+V1a+vasopressin+receptor+is+critical+for+binding+vasopressin+but+not+peptide+or+nonpeptide+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">A single residue (Arg46) located within the N-terminus of the V1a vasopressin receptor is critical for binding vasopressin but not peptide or nonpeptide antagonists</span></div><div class="casAuthors">Hawtin, Stuart R.; Wesley, Victoria J.; Parslow, Rosemary A.; Simms, John; Miles, Alice; McEwan, Kim; Wheatley, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">600-609</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A fundamental issue in mol. endocrinol. is to define how agonist:receptor interaction differs from antagonist:receptor interaction.  The vasopressin V1a receptor (V1aR) is a member of a sub-family of related G protein-coupled receptors that are activated by the hormone AVP or related peptides.  The N-terminus of the V1aR has recently been shown to be crit. for binding agonists but not antagonists.  Using a combination of N-terminally truncated constructs and alanine-scanning mutagenesis, individual residues that provide these agonist-specific binding epitopes have now been identified in this study.  Our data establish that a single residue, Arg46, is crit. for AVP binding to the V1aR.  Systematic substitution revealed that Arg was required at this locus and could not be substituted by Lys, Glu, Leu, or Ala.  In contrast, antagonist binding (cyclic or linear, peptide or nonpeptide) was unaffected.  Disruption of Arg46 also resulted in defective intracellular signaling.  Arginine is conserved at this locus in all members of the neurohypophysial peptide hormone receptor family cloned to date, indicative of a fundamental role in receptor function.  In addn. to Arg46, the residues Leu42, Gly43, Asp45 form a patch contributing to AVP binding.  This study provides mol. insight into the role of the V1aR N-terminus and key differences between agonist and antagonist binding requirements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6AT1qxbeKmrVg90H21EOLACvtfcHk0lg3lywYSVX2Rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XitFSisLY%253D&md5=e68330e18be36f3d28feeb0efced5344</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1210%2Fme.16.3.600&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.16.3.600%26sid%3Dliteratum%253Aachs%26aulast%3DHawtin%26aufirst%3DS.%2BR.%26aulast%3DWesley%26aufirst%3DV.%2BJ.%26aulast%3DParslow%26aufirst%3DR.%2BA.%26aulast%3DSimms%26aufirst%3DJ.%26aulast%3DMiles%26aufirst%3DA.%26aulast%3DMcEwan%26aufirst%3DK.%26aulast%3DWheatley%26aufirst%3DM.%26atitle%3DA%2520single%2520residue%2520%2528Arg46%2529%2520located%2520within%2520the%2520N-terminus%2520of%2520the%2520V1a%2520vasopressin%2520receptor%2520is%2520critical%2520for%2520binding%2520vasopressin%2520but%2520not%2520peptide%2520or%2520nonpeptide%2520antagonists%26jtitle%3DMol.%2520Endocrinol.%26date%3D2002%26volume%3D16%26spage%3D600%26epage%3D609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Wesley, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawtin, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheatley, M.</span><span> </span><span class="NLM_article-title">Agonist-specific, high-affinity binding epitopes are contributed by an arginine in the N-terminus of the human oxytocin receptor</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">5086</span><span class="NLM_x">–</span> <span class="NLM_lpage">5092</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi015990v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2002&pages=5086-5092&author=V.+J.+Wesleyauthor=S.+R.+Hawtinauthor=H.+C.+Howardauthor=M.+Wheatley&title=Agonist-specific%2C+high-affinity+binding+epitopes+are+contributed+by+an+arginine+in+the+N-terminus+of+the+human+oxytocin+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fbi015990v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi015990v%26sid%3Dliteratum%253Aachs%26aulast%3DWesley%26aufirst%3DV.%2BJ.%26aulast%3DHawtin%26aufirst%3DS.%2BR.%26aulast%3DHoward%26aufirst%3DH.%2BC.%26aulast%3DWheatley%26aufirst%3DM.%26atitle%3DAgonist-specific%252C%2520high-affinity%2520binding%2520epitopes%2520are%2520contributed%2520by%2520an%2520arginine%2520in%2520the%2520N-terminus%2520of%2520the%2520human%2520oxytocin%2520receptor%26jtitle%3DBiochemistry%26date%3D2002%26volume%3D41%26spage%3D5086%26epage%3D5092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Hawtin, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesley, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simms, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parslow, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miles, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McEwan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheatley, M.</span><span> </span><span class="NLM_article-title">An arginyl in the N-terminus of the V<sub>1a</sub> vasopressin receptor is part of the conformational switch controlling activation by agonist</span> <span class="citation_source-journal">Eur. J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">270</span><span class="NLM_x">, </span> <span class="NLM_fpage">4681</span><span class="NLM_x">–</span> <span class="NLM_lpage">4688</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Fjm901084f&amp;key=10.1046%2Fj.1432-1033.2003.03865.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Fjm901084f&amp;key=14622255" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpsFagur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=270&publication_year=2003&pages=4681-4688&author=S.+R.+Hawtinauthor=V.+J.+Wesleyauthor=J.+Simmsauthor=R.+A.+Parslowauthor=A.+Milesauthor=K.+McEwanauthor=M.+Keenauthor=M.+Wheatley&title=An+arginyl+in+the+N-terminus+of+the+V1a+vasopressin+receptor+is+part+of+the+conformational+switch+controlling+activation+by+agonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">An arginyl in the N-terminus of the V1a vasopressin receptor is part of the conformational switch controlling activation by agonist</span></div><div class="casAuthors">Hawtin, Stuart R.; Wesley, Victoria J.; Simms, John; Parslow, Rosemary A.; Miles, Alice; McEwan, Kim; Keen, Mary; Wheatley, Mark</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">270</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">4681-4688</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Defining how the agonist-receptor interaction differs from that of the antagonist-receptor and understanding the mechanisms of receptor activation are fundamental issues in cell signaling.  The V1a vasopressin receptor (V1aR) is a member of a family of related G-protein coupled receptors that are activated by neurohypophysial peptide hormones, including vasopressin (AVP).  It has recently been reported that an arginyl in the distal N-terminus of the V1aR is crit. for binding agonists but not antagonists.  To det. specific features required at this locus to support high affinity agonist binding and second messenger generation, Arg 46 was substituted by all other 19 encoded amino acids.  The authors' data establish that there is an abs. requirement for arginyl, as none of the [R46X]V1aR mutant constructs supported high affinity agonist binding and all 19 had defective signaling.  In contrast, all of the mutant receptors possessed wildtype binding for both peptide and nonpeptide antagonists.  The ratio of Ki to EC50, an indicator of efficacy, was increased for all substitutions.  Consequently, although [R46X]V1aR constructs have a lower affinity for agonist, once AVP has bound all 19 are more likely than the wildtype V1aR to become activated.  Therefore, in the wildtype V1aR, Arg 46 constrains the inactive conformation of the receptor.  On binding AVP this constraint is alleviated, promoting the transition to active V1aR.  The authors' findings explain why arginyl is conserved at this locus throughout the evolutionary lineage of the neurohypophysial peptide hormone receptor family of G-protein coupled receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGT5k3ZRTK57Vg90H21EOLACvtfcHk0lg3lywYSVX2Rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpsFagur0%253D&md5=a58648c2450964c20cd1a27c4e338c2a</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1046%2Fj.1432-1033.2003.03865.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1432-1033.2003.03865.x%26sid%3Dliteratum%253Aachs%26aulast%3DHawtin%26aufirst%3DS.%2BR.%26aulast%3DWesley%26aufirst%3DV.%2BJ.%26aulast%3DSimms%26aufirst%3DJ.%26aulast%3DParslow%26aufirst%3DR.%2BA.%26aulast%3DMiles%26aufirst%3DA.%26aulast%3DMcEwan%26aufirst%3DK.%26aulast%3DKeen%26aufirst%3DM.%26aulast%3DWheatley%26aufirst%3DM.%26atitle%3DAn%2520arginyl%2520in%2520the%2520N-terminus%2520of%2520the%2520V1a%2520vasopressin%2520receptor%2520is%2520part%2520of%2520the%2520conformational%2520switch%2520controlling%2520activation%2520by%2520agonist%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D2003%26volume%3D270%26spage%3D4681%26epage%3D4688" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Tahtaoui, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balestre, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klotz, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rognan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barberis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouillac, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hibert, M.</span><span> </span><span class="NLM_article-title">Identification of the binding sites of the SR49059 nonpeptide antagonist into the V<sub>1a</sub> vasopressin receptor using sulfydryl-reactive ligands and cysteine mutants as chemical sensors</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">40010</span><span class="NLM_x">–</span> <span class="NLM_lpage">40019</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=40010-40019&author=C.+Tahtaouiauthor=M.+N.+Balestreauthor=P.+Klotzauthor=D.+Rognanauthor=C.+Barberisauthor=B.+Mouillacauthor=M.+Hibert&title=Identification+of+the+binding+sites+of+the+SR49059+nonpeptide+antagonist+into+the+V1a+vasopressin+receptor+using+sulfydryl-reactive+ligands+and+cysteine+mutants+as+chemical+sensors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTahtaoui%26aufirst%3DC.%26aulast%3DBalestre%26aufirst%3DM.%2BN.%26aulast%3DKlotz%26aufirst%3DP.%26aulast%3DRognan%26aufirst%3DD.%26aulast%3DBarberis%26aufirst%3DC.%26aulast%3DMouillac%26aufirst%3DB.%26aulast%3DHibert%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520the%2520binding%2520sites%2520of%2520the%2520SR49059%2520nonpeptide%2520antagonist%2520into%2520the%2520V1a%2520vasopressin%2520receptor%2520using%2520sulfydryl-reactive%2520ligands%2520and%2520cysteine%2520mutants%2520as%2520chemical%2520sensors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D40010%26epage%3D40019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Gimpl, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Postina, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fahrenholz, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinheimer, T.</span><span> </span><span class="NLM_article-title">Binding domains of the oxytocin receptor for the selective oxytocin receptor antagonist barusiban in comparison to the agonists oxytocin and carbetocin</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">510</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Fjm901084f&amp;key=10.1016%2Fj.ejphar.2005.01.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Fjm901084f&amp;key=15740719" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhvVCksrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=510&publication_year=2005&pages=9-16&author=G.+Gimplauthor=R.+Postinaauthor=F.+Fahrenholzauthor=T.+Reinheimer&title=Binding+domains+of+the+oxytocin+receptor+for+the+selective+oxytocin+receptor+antagonist+barusiban+in+comparison+to+the+agonists+oxytocin+and+carbetocin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Binding domains of the oxytocin receptor for the selective oxytocin receptor antagonist barusiban in comparison to the agonists oxytocin and carbetocin</span></div><div class="casAuthors">Gimpl, Gerald; Postina, Rolf; Fahrenholz, Falk; Reinheimer, Torsten</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">510</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">9-16</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The authors have analyzed binding domains of the oxytocin receptor for barusiban, a highly selective oxytocin receptor antagonist, in comparison to the combined vasopressin V1A/oxytocin receptor antagonist atosiban and the agonists oxytocin and carbetocin.  For this purpose, chimeric 'gain-in function' oxytocin/vasopressin V2 receptors were expressed in COS-7 cells.  These recombinant receptors have been produced by transfer of domains from the oxytocin receptor into the related vasopressin V2 receptor and have already been successfully employed for the identification of ligand binding domains at the oxytocin receptor (Postina, R., Kojro, E., Fahrenholz, F., 1996. Sep. agonist and peptide antagonist binding sites of the oxytocin receptor defined by their transfer into the V2 vasopressin receptor. J. Biol. Chem. 271, 31593-31601).  In displacement studies with 10 chimeric receptor constructs, the binding profile of barusiban was compared with the binding profiles of the ligands oxytocin, [Arg8]vasopressin, carbetocin, and atosiban.  The binding profiles for the agonists oxytocin and carbetocin were found to be similar.  For both agonists, important binding domains were the extracellular N-terminus (=E1) and the extracellular loops E2 and E3 from the oxytocin receptor.  For the vasopressin V1A/oxytocin receptor antagonist atosiban, none of the receptor constructs were able to provide a binding with higher affinity than the starting vasopressin V2 receptor.  In contrast, the binding of barusiban was significantly improved when the transmembrane domains 1 and 2 were transferred from the oxytocin receptor to the vasopressin V2 receptor.  The binding domain of barusiban differs from the binding domain of the agonists and the nonselective oxytocin receptor antagonist d(CH2)5[Tyr-(Me)2,Thr4,Orn8,Tyr9]vasotocin that has been used in previous studies.  Overall, the data supported the concept of a central pocket site within the oxytocin receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEYqNb3Eu8HLVg90H21EOLACvtfcHk0lhvDGOAeh9R3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhvVCksrc%253D&md5=88536ac27555378a10d0849bfa89563c</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2005.01.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2005.01.010%26sid%3Dliteratum%253Aachs%26aulast%3DGimpl%26aufirst%3DG.%26aulast%3DPostina%26aufirst%3DR.%26aulast%3DFahrenholz%26aufirst%3DF.%26aulast%3DReinheimer%26aufirst%3DT.%26atitle%3DBinding%2520domains%2520of%2520the%2520oxytocin%2520receptor%2520for%2520the%2520selective%2520oxytocin%2520receptor%2520antagonist%2520barusiban%2520in%2520comparison%2520to%2520the%2520agonists%2520oxytocin%2520and%2520carbetocin%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2005%26volume%3D510%26spage%3D9%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Hawtin, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simms, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawson, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parslow, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheppard, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheatley, M.</span><span> </span><span class="NLM_article-title">Charged extracellular residues, conserved throughout a G-protein-coupled receptor family, are required for ligand binding, receptor activation, and cell-surface expression</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">281</span><span class="NLM_x">, </span> <span class="NLM_fpage">38478</span><span class="NLM_x">–</span> <span class="NLM_lpage">38488</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=38478-38488&author=S.+R.+Hawtinauthor=J.+Simmsauthor=M.+Connerauthor=Z.+Lawsonauthor=R.+A.+Parslowauthor=J.+Trimauthor=A.+Sheppardauthor=M.+Wheatley&title=Charged+extracellular+residues%2C+conserved+throughout+a+G-protein-coupled+receptor+family%2C+are+required+for+ligand+binding%2C+receptor+activation%2C+and+cell-surface+expression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHawtin%26aufirst%3DS.%2BR.%26aulast%3DSimms%26aufirst%3DJ.%26aulast%3DConner%26aufirst%3DM.%26aulast%3DLawson%26aufirst%3DZ.%26aulast%3DParslow%26aufirst%3DR.%2BA.%26aulast%3DTrim%26aufirst%3DJ.%26aulast%3DSheppard%26aufirst%3DA.%26aulast%3DWheatley%26aufirst%3DM.%26atitle%3DCharged%2520extracellular%2520residues%252C%2520conserved%2520throughout%2520a%2520G-protein-coupled%2520receptor%2520family%252C%2520are%2520required%2520for%2520ligand%2520binding%252C%2520receptor%2520activation%252C%2520and%2520cell-surface%2520expression%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D38478%26epage%3D38488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Macion-Dazard, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callahan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thibonnier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoham, M.</span><span> </span><span class="NLM_article-title">Mapping the binding site of six nonpeptide antagonists to the human V<sub>2</sub>-renal vasopressin receptor</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">316</span><span class="NLM_x">, </span> <span class="NLM_fpage">564</span><span class="NLM_x">–</span> <span class="NLM_lpage">571</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Fjm901084f&amp;key=10.1124%2Fjpet.105.095554" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Fjm901084f&amp;key=16234409" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlWqsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=316&publication_year=2006&pages=564-571&author=R.+Macion-Dazardauthor=N.+Callahanauthor=Z.+Xuauthor=N.+Wuauthor=M.+Thibonnierauthor=M.+Shoham&title=Mapping+the+binding+site+of+six+nonpeptide+antagonists+to+the+human+V2-renal+vasopressin+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Mapping the binding site of six nonpeptide antagonists to the human V2-renal vasopressin receptor</span></div><div class="casAuthors">Macion-Dazard, Rosemarie; Callahan, Nicholas; Xu, Zhen; Wu, Nan; Thibonnier, Marc; Shoham, Menachem</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">316</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">564-571</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Whereas arginine vasopressin binds to its receptor subtypes V1R and V2R with equal affinity of approx. 2 nM, nonpeptide antagonists interact differently with vasopressin receptor subtypes.  The V2R antagonist binding site was mapped by site-directed mutagenesis at six selected amino acid positions, K100D, A110W, M120V, L175Y, R202S, and F307I, predicted to be involved in antagonist binding differences between V2R and V1R.  These mutations did not alter the affinity for arginine vasopressin.  However, the affinity for six nonpeptide receptor antagonists SR121463B [1-[4-(N-tert-butylcarbamoyl)-2-methoxybenzenesulfonyl]-5-ethoxy-3-spiro- [4[(2 morpholinoethoxy)cyclohexane]indoline-2-one, phosphate monohydrate cis-isomer]], SR49059 [(2S)1-[(2R3S)-5-chloro-3-(2 chlorophenyl)-1-(3,4-dimethoxybenzene-sulfonyl)-3-hydroxy-2,3-dihydro-1H-indole-2-carbonyl]-pyrrolidine-2-carboxamide], SSR149415 [(2S,4R)-1-[5-chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-3-(2-methoxyphenyl)-2-oxo-2,3-dihydro-1H-indol-3-yl]-4-hydroxy-N, N-dimethyl-2pyrrolidine carboxamide, isomer(-)], OPC21268 [1-[1-[4-(3-acetylaminopropoxy)benzoyl]-4-piperidyl]-3,4-dihydro-2(1H)-quinolinone], OPC41061 [(±)-4'-[(7-chloro-2,3,4,5-tetrahydro-5-hydroxy-1H-1-benzazepin-1-yl)carbonyl]-o-tolu-m-toluidide], and OPC31260, [(±)-5-dimethylamino-1-[4-(2-methylbenzoylamino)benzyl]-1,2,3,4,5-tetrahydro-1H-benzazepine monohydrochloride], was altered to varying degrees, resulting in differences up to 6000-fold.  Replacement of the small alanine for the bulky tryptophan in position 110 resulted in a reduced affinity for all six antagonists.  In contrast, replacement of the large methionine for the smaller valine in position 120 caused a dramatic increase in affinity, up to a Ki of 7 fM for OPC31260.  Mol. modeling revealed that the binding sites for arginine vasopressin and the nonpeptide antagonists are partially overlapping.  Whereas arginine vasopressin binds on the extracellular surface of V2R, the nonpeptide antagonists penetrate deeper into the transmembrane region of the receptor, in particular OPC21268.  The mutagenesis data point to significant differences in the shape of the V1R and V2R antagonist binding pockets.  The most important factor detg. the specificity of nonpeptide antagonists seems to be the shape of the binding pocket on the receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpckh1l27h0q7Vg90H21EOLACvtfcHk0lhvDGOAeh9R3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlWqsLo%253D&md5=43156c3ccc4e2795e91eb378393065eb</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.095554&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.095554%26sid%3Dliteratum%253Aachs%26aulast%3DMacion-Dazard%26aufirst%3DR.%26aulast%3DCallahan%26aufirst%3DN.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DN.%26aulast%3DThibonnier%26aufirst%3DM.%26aulast%3DShoham%26aufirst%3DM.%26atitle%3DMapping%2520the%2520binding%2520site%2520of%2520six%2520nonpeptide%2520antagonists%2520to%2520the%2520human%2520V2-renal%2520vasopressin%2520receptor%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2006%26volume%3D316%26spage%3D564%26epage%3D571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Conner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawtin, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simms, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wootten, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawson, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conner, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parslow, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheatley, M.</span><span> </span><span class="NLM_article-title">Systematic analysis of the entire second extracellular loop of the V<sub>1a</sub> vasopressin receptor: key residues, conserved throughout a G-protein-coupled receptor family, identified</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">17405</span><span class="NLM_x">–</span> <span class="NLM_lpage">17412</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=17405-17412&author=M.+Connerauthor=S.+R.+Hawtinauthor=J.+Simmsauthor=D.+Woottenauthor=Z.+Lawsonauthor=A.+C.+Connerauthor=R.+A.+Parslowauthor=M.+Wheatley&title=Systematic+analysis+of+the+entire+second+extracellular+loop+of+the+V1a+vasopressin+receptor%3A+key+residues%2C+conserved+throughout+a+G-protein-coupled+receptor+family%2C+identified"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DConner%26aufirst%3DM.%26aulast%3DHawtin%26aufirst%3DS.%2BR.%26aulast%3DSimms%26aufirst%3DJ.%26aulast%3DWootten%26aufirst%3DD.%26aulast%3DLawson%26aufirst%3DZ.%26aulast%3DConner%26aufirst%3DA.%2BC.%26aulast%3DParslow%26aufirst%3DR.%2BA.%26aulast%3DWheatley%26aufirst%3DM.%26atitle%3DSystematic%2520analysis%2520of%2520the%2520entire%2520second%2520extracellular%2520loop%2520of%2520the%2520V1a%2520vasopressin%2520receptor%253A%2520key%2520residues%252C%2520conserved%2520throughout%2520a%2520G-protein-coupled%2520receptor%2520family%252C%2520identified%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D17405%26epage%3D17412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Nakamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsujimae, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoyama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinohara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teramoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sumida, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sekiguchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kambe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsujimoto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tominaga, M.</span><span> </span><span class="NLM_article-title">Characterization of a novel nonpeptide vasopressin V<sub>2</sub>-agonist, OPC-51803, in cells transfected human vasopressin receptor subtypes</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">129</span><span class="NLM_x">, </span> <span class="NLM_fpage">1700</span><span class="NLM_x">–</span> <span class="NLM_lpage">1706</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Fjm901084f&amp;key=10.1038%2Fsj.bjp.0703221" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Fjm901084f&amp;key=10780976" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjtV2ru7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2000&pages=1700-1706&author=S.+Nakamuraauthor=Y.+Yamamuraauthor=S.+Itohauthor=T.+Hiranoauthor=K.+Tsujimaeauthor=M.+Aoyamaauthor=K.+Kondoauthor=H.+Ogawaauthor=T.+Shinoharaauthor=K.+Kanauthor=Y.+Tanadaauthor=S.+Teramotoauthor=T.+Sumidaauthor=S.+Nakayamaauthor=K.+Sekiguchiauthor=T.+Kambeauthor=G.+Tsujimotoauthor=T.+Moriauthor=M.+Tominaga&title=Characterization+of+a+novel+nonpeptide+vasopressin+V2-agonist%2C+OPC-51803%2C+in+cells+transfected+human+vasopressin+receptor+subtypes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of a novel nonpeptide vasopressin V2-agonist, OPC-51803, in cells transfected human vasopressin receptor subtypes</span></div><div class="casAuthors">Nakamura, Shigeki; Yamamura, Yoshitaka; Itoh, Shuji; Hirano, Takahiro; Tsujimae, Kenji; Aoyama, Masashi; Kondo, Kazumi; Ogawa, Hidenori; Shinohara, Tomoichi; Kan, Keizo; Tanada, Yoshihisa; Teramoto, Shuji; Sumida, Takumi; Nakayama, Sunao; Sekiguchi, Kazuo; Kambe, Toshimi; Tsujimoto, Gozoh; Mori, Toyoki; Tominaga, Michiaki</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1700-1706</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We discovered the first nonpeptide arginine-vasopressin (AVP) V2-receptor agonist, OPC-51803.  Pharmacol. properties of OPC-51803 were elucidated using HeLa cells expressing human AVP receptor subtypes (V2, V1a and V1b) and compared with those of 1-desamino-8-D-arginine vasopressin (dDAVP), a peptide V2-receptor agonist.  OPC-51803 and dDAVP displaced [3H]-AVP binding to human V2- and V1a-receptors with Ki values of 91.9±10.8 nM (n=6) and 3.12±0.38 nM (n=6) for V2-receptors, and 819±39 nM (n=6) and 41.5±9.9 nM (n=6) for V1a-receptors, indicating that OPC-51803 was about nine times more selective for V2-receptors, similar to the selectivity of dDAVP.  OPC-51803 scarcely displaced [3H]-AVP binding to human V1b-receptors even at 10-4 M, while dDAVP showed potent affinity to human V1b-receptors with the Ki value of 13.7±3.2 nM (n=4).  OPC-51803 concn.-dependently increased cyclic adenosine 3', 5'-monophosphate (cAMP) prodn. in HeLa cells expressing human V2-receptors with an EC50 value of 189±14 nM (n=6).  The concn.-response curve for cAMP prodn. induced by OPC-51803 was shifted to the right in the presence of a V2-antagonist, OPC-31260.  At 10-5 M, OPC-51803 did not increase the intracellular Ca2+ concn. ([Ca2+]i) in HeLa cells expressing human V1a-receptors.  On the other hand, dDAVP increased [Ca2+]i in HeLa cells expressing human V1a- and V1b-receptors in a concn.-dependent fashion.  From these results, OPC-51803 has been confirmed to be the first nonpeptide agonist for human AVP V2-receptors without agonistic activities for V1a- and V1b-receptors.  OPC-51803 may be useful for the treatment of AVP-deficient pathophysiol. states and as a tool for AVP researches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtP6Ey2VlQ77Vg90H21EOLACvtfcHk0ljfNGPjtFD1VQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjtV2ru7k%253D&md5=435c824ff32701169445cb4a1c35a94c</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0703221&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0703221%26sid%3Dliteratum%253Aachs%26aulast%3DNakamura%26aufirst%3DS.%26aulast%3DYamamura%26aufirst%3DY.%26aulast%3DItoh%26aufirst%3DS.%26aulast%3DHirano%26aufirst%3DT.%26aulast%3DTsujimae%26aufirst%3DK.%26aulast%3DAoyama%26aufirst%3DM.%26aulast%3DKondo%26aufirst%3DK.%26aulast%3DOgawa%26aufirst%3DH.%26aulast%3DShinohara%26aufirst%3DT.%26aulast%3DKan%26aufirst%3DK.%26aulast%3DTanada%26aufirst%3DY.%26aulast%3DTeramoto%26aufirst%3DS.%26aulast%3DSumida%26aufirst%3DT.%26aulast%3DNakayama%26aufirst%3DS.%26aulast%3DSekiguchi%26aufirst%3DK.%26aulast%3DKambe%26aufirst%3DT.%26aulast%3DTsujimoto%26aufirst%3DG.%26aulast%3DMori%26aufirst%3DT.%26aulast%3DTominaga%26aufirst%3DM.%26atitle%3DCharacterization%2520of%2520a%2520novel%2520nonpeptide%2520vasopressin%2520V2-agonist%252C%2520OPC-51803%252C%2520in%2520cells%2520transfected%2520human%2520vasopressin%2520receptor%2520subtypes%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2000%26volume%3D129%26spage%3D1700%26epage%3D1706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span> </span><span class="NLM_article-title">WAY-141608</span>,  <span class="citation_source-journal">Drug Data Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">520</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=WAY-141608%2C+Drug+Data+Rep.+2000%2C+22%2C+520."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26atitle%3DWAY-141608%26jtitle%3DDrug%2520Data%2520Rep.%26date%3D2000%26volume%3D22%26spage%3D520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Kondo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bando, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinohara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurimura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kido, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tominaga, M.</span><span> </span><span class="NLM_article-title">Characterization of orally active nonpeptide vasopressin V<sub>2</sub> receptor agonists: synthesis and biological evaluation of both the (5<i>R</i>)- and (5<i>S</i>)-enantioisomers of 2-[1-(2-chloro-4-pyrrolidin-1-yl-benzoyl)-2,3,4,5-tetrahydro-1<i>H</i>-1-benzazepin-5-yl]-<i>N</i>-isopropylacetamide</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">3805</span><span class="NLM_x">–</span> <span class="NLM_lpage">3808</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020133q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=3805-3808&author=K.+Kondoauthor=K.+Kanauthor=Y.+Tanadaauthor=M.+Bandoauthor=T.+Shinoharaauthor=M.+Kurimuraauthor=H.+Ogawaauthor=S.+Nakamuraauthor=T.+Hiranoauthor=Y.+Yamamuraauthor=M.+Kidoauthor=T.+Moriauthor=M.+Tominaga&title=Characterization+of+orally+active+nonpeptide+vasopressin+V2+receptor+agonists%3A+synthesis+and+biological+evaluation+of+both+the+%285R%29-+and+%285S%29-enantioisomers+of+2-%5B1-%282-chloro-4-pyrrolidin-1-yl-benzoyl%29-2%2C3%2C4%2C5-tetrahydro-1H-1-benzazepin-5-yl%5D-N-isopropylacetamide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Fjm020133q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020133q%26sid%3Dliteratum%253Aachs%26aulast%3DKondo%26aufirst%3DK.%26aulast%3DKan%26aufirst%3DK.%26aulast%3DTanada%26aufirst%3DY.%26aulast%3DBando%26aufirst%3DM.%26aulast%3DShinohara%26aufirst%3DT.%26aulast%3DKurimura%26aufirst%3DM.%26aulast%3DOgawa%26aufirst%3DH.%26aulast%3DNakamura%26aufirst%3DS.%26aulast%3DHirano%26aufirst%3DT.%26aulast%3DYamamura%26aufirst%3DY.%26aulast%3DKido%26aufirst%3DM.%26aulast%3DMori%26aufirst%3DT.%26aulast%3DTominaga%26aufirst%3DM.%26atitle%3DCharacterization%2520of%2520orally%2520active%2520nonpeptide%2520vasopressin%2520V2%2520receptor%2520agonists%253A%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520both%2520the%2520%25285R%2529-%2520and%2520%25285S%2529-enantioisomers%2520of%25202-%255B1-%25282-chloro-4-pyrrolidin-1-yl-benzoyl%2529-2%252C3%252C4%252C5-tetrahydro-1H-1-benzazepin-5-yl%255D-N-isopropylacetamide%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D3805%26epage%3D3808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Failli, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shumsky, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steffan, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caggiano, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trybulski, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ning, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lock, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanikella, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, C. H.</span><span> </span><span class="NLM_article-title">Pyridobenzodiazepines: a novel class of orally active, vasopressin V<sub>2</sub> receptor selective agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">954</span><span class="NLM_x">–</span> <span class="NLM_lpage">959</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=954-959&author=A.+A.+Failliauthor=J.+S.+Shumskyauthor=R.+J.+Steffanauthor=T.+J.+Caggianoauthor=D.+K.+Williamsauthor=E.+J.+Trybulskiauthor=X.+Ningauthor=Y.+Lockauthor=T.+Tanikellaauthor=D.+Hartmannauthor=P.+S.+Chanauthor=C.+H.+Park&title=Pyridobenzodiazepines%3A+a+novel+class+of+orally+active%2C+vasopressin+V2+receptor+selective+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFailli%26aufirst%3DA.%2BA.%26aulast%3DShumsky%26aufirst%3DJ.%2BS.%26aulast%3DSteffan%26aufirst%3DR.%2BJ.%26aulast%3DCaggiano%26aufirst%3DT.%2BJ.%26aulast%3DWilliams%26aufirst%3DD.%2BK.%26aulast%3DTrybulski%26aufirst%3DE.%2BJ.%26aulast%3DNing%26aufirst%3DX.%26aulast%3DLock%26aufirst%3DY.%26aulast%3DTanikella%26aufirst%3DT.%26aulast%3DHartmann%26aufirst%3DD.%26aulast%3DChan%26aufirst%3DP.%2BS.%26aulast%3DPark%26aufirst%3DC.%2BH.%26atitle%3DPyridobenzodiazepines%253A%2520a%2520novel%2520class%2520of%2520orally%2520active%252C%2520vasopressin%2520V2%2520receptor%2520selective%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D954%26epage%3D959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Yamamura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chihara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onogawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tominaga, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yabuuchi, Y.</span><span> </span><span class="NLM_article-title">OPC-21268, an orally effective, nonpeptide vasopressin V<sub>1</sub> receptor antagonist</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">252</span><span class="NLM_x">, </span> <span class="NLM_fpage">572</span><span class="NLM_x">–</span> <span class="NLM_lpage">574</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=252&publication_year=1991&pages=572-574&author=Y.+Yamamuraauthor=H.+Ogawaauthor=T.+Chiharaauthor=K.+Kondoauthor=T.+Onogawaauthor=S.+Nakamuraauthor=T.+Moriauthor=M.+Tominagaauthor=Y.+Yabuuchi&title=OPC-21268%2C+an+orally+effective%2C+nonpeptide+vasopressin+V1+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYamamura%26aufirst%3DY.%26aulast%3DOgawa%26aufirst%3DH.%26aulast%3DChihara%26aufirst%3DT.%26aulast%3DKondo%26aufirst%3DK.%26aulast%3DOnogawa%26aufirst%3DT.%26aulast%3DNakamura%26aufirst%3DS.%26aulast%3DMori%26aufirst%3DT.%26aulast%3DTominaga%26aufirst%3DM.%26aulast%3DYabuuchi%26aufirst%3DY.%26atitle%3DOPC-21268%252C%2520an%2520orally%2520effective%252C%2520nonpeptide%2520vasopressin%2520V1%2520receptor%2520antagonist%26jtitle%3DScience%26date%3D1991%26volume%3D252%26spage%3D572%26epage%3D574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Ogawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyamoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakaya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tominaga, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yabuuchi, Y.</span><span> </span><span class="NLM_article-title">Orally active, nonpeptide vasopressin V<sub>2</sub> receptor antagonists: a novel series of 1-[4-(benzoylamino)benzoyl]-2,3,4,5-tetrahydro-1<i>H</i>-benzazepines and related compounds</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">3547</span><span class="NLM_x">–</span> <span class="NLM_lpage">3555</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm960133o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=3547-3555&author=H.+Ogawaauthor=H.+Yamashitaauthor=K.+Kondoauthor=Y.+Yamamuraauthor=H.+Miyamotoauthor=K.+Kanauthor=K.+Kitanoauthor=M.+Tanakaauthor=K.+Nakayaauthor=S.+Nakamuraauthor=T.+Moriauthor=M.+Tominagaauthor=Y.+Yabuuchi&title=Orally+active%2C+nonpeptide+vasopressin+V2+receptor+antagonists%3A+a+novel+series+of+1-%5B4-%28benzoylamino%29benzoyl%5D-2%2C3%2C4%2C5-tetrahydro-1H-benzazepines+and+related+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Fjm960133o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm960133o%26sid%3Dliteratum%253Aachs%26aulast%3DOgawa%26aufirst%3DH.%26aulast%3DYamashita%26aufirst%3DH.%26aulast%3DKondo%26aufirst%3DK.%26aulast%3DYamamura%26aufirst%3DY.%26aulast%3DMiyamoto%26aufirst%3DH.%26aulast%3DKan%26aufirst%3DK.%26aulast%3DKitano%26aufirst%3DK.%26aulast%3DTanaka%26aufirst%3DM.%26aulast%3DNakaya%26aufirst%3DK.%26aulast%3DNakamura%26aufirst%3DS.%26aulast%3DMori%26aufirst%3DT.%26aulast%3DTominaga%26aufirst%3DM.%26aulast%3DYabuuchi%26aufirst%3DY.%26atitle%3DOrally%2520active%252C%2520nonpeptide%2520vasopressin%2520V2%2520receptor%2520antagonists%253A%2520a%2520novel%2520series%2520of%25201-%255B4-%2528benzoylamino%2529benzoyl%255D-2%252C3%252C4%252C5-tetrahydro-1H-benzazepines%2520and%2520related%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D3547%26epage%3D3555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Ariëns, E. J.</span><span> </span><span class="NLM_article-title">A molecular basis for the action of drugs. I. Receptor−theory and structure−effect relations</span> <span class="citation_source-journal">Arzneim. Forsch.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1966</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1376</span><span class="NLM_x">–</span> <span class="NLM_lpage">1395</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADyaF2sXltl2kug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1966&pages=1376-1395&author=E.+J.+Ari%C3%ABns&title=A+molecular+basis+for+the+action+of+drugs.+I.+Receptor%E2%88%92theory+and+structure%E2%88%92effect+relations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular basis for the activity of drugs.  I.  Receptor theory and structure-activity relation</span></div><div class="casAuthors">Ariens, Everhardus J.</div><div class="citationInfo"><span class="NLM_cas:title">Arzneimittel-Forschung</span>
        (<span class="NLM_cas:date">1966</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1376-93</span>CODEN:
                <span class="NLM_cas:coden">ARZNAD</span>;
        ISSN:<span class="NLM_cas:issn">0004-4172</span>.
    </div><div class="casAbstract">The theory of the mode of action of drugs, based on the receptor concept is reviewed.  The relation between structure and activity, esp. between the structure of agonists and their competitive antagonists, is analyzed.  The introduction of centers of asymmetry into the various moieties of drug mols., particularly anticholinergic drugs, and the activities of various stereoisomers thus obtained, were compared.  It was concluded that agonists and competitive antagonists, although they compete for "common" receptors, often interact with different but functionally related receptor areas.  Further, the relation between the degree of freedom in the conformation of drugs and the specificity of their action and the degree of freedom in the chem. structure of particular moieties of drug mols. and the degree of involvement of these particular moieties in the drug-receptor interaction are discussed.  63 references.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRZFA4Ek2V1bVg90H21EOLACvtfcHk0lh1UNL9JqNmKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2sXltl2kug%253D%253D&md5=07da98f6e61608dd7e29723cbfb6fc8b</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAri%25C3%25ABns%26aufirst%3DE.%2BJ.%26atitle%3DA%2520molecular%2520basis%2520for%2520the%2520action%2520of%2520drugs.%2520I.%2520Receptor%25E2%2588%2592theory%2520and%2520structure%25E2%2588%2592effect%2520relations%26jtitle%3DArzneim.%2520Forsch.%26date%3D1966%26volume%3D16%26spage%3D1376%26epage%3D1395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Goddard, W. A.,  III; Abrol, R.</span><span> </span><span class="NLM_article-title">3-Dimensional structures of G-protein-coupled receptors and binding sites of agonists and antagonists</span>.  <span class="citation_source-journal">J. Nutr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">137</span><span class="NLM_x">, </span> <span class="NLM_fpage">1528S</span>− <span class="NLM_lpage">1538S</span>, and references cited therein.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2007&pages=1528S-1538S&author=W.+A.+Goddard&author=R.+Abrol&title=3-Dimensional+structures+of+G-protein-coupled+receptors+and+binding+sites+of+agonists+and+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGoddard%26aufirst%3DW.%2BA.%26atitle%3D3-Dimensional%2520structures%2520of%2520G-protein-coupled%2520receptors%2520and%2520binding%2520sites%2520of%2520agonists%2520and%2520antagonists%26jtitle%3DJ.%2520Nutr.%26date%3D2007%26volume%3D137%26spage%3D1528S%26epage%3D1538S" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Portoghese, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipkowski, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takemori, A. E.</span><span> </span><span class="NLM_article-title">Bimorphans as highly selective, potent kappa opioid receptor antagonist</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">238</span><span class="NLM_x">–</span> <span class="NLM_lpage">239</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00385a002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1987&pages=238-239&author=P.+S.+Portogheseauthor=A.+W.+Lipkowskiauthor=A.+E.+Takemori&title=Bimorphans+as+highly+selective%2C+potent+kappa+opioid+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1021%2Fjm00385a002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00385a002%26sid%3Dliteratum%253Aachs%26aulast%3DPortoghese%26aufirst%3DP.%2BS.%26aulast%3DLipkowski%26aufirst%3DA.%2BW.%26aulast%3DTakemori%26aufirst%3DA.%2BE.%26atitle%3DBimorphans%2520as%2520highly%2520selective%252C%2520potent%2520kappa%2520opioid%2520receptor%2520antagonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1987%26volume%3D30%26spage%3D238%26epage%3D239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Perlman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costa-Neto, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyakawa, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schambye, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hjorth, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paiva, A. C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivero, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, T. W.</span><span> </span><span class="NLM_article-title">Dual agonistic and antagonistic property of nonpeptide angiotensin AT1 ligands: susceptibility to receptor mutations</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">301</span><span class="NLM_x">–</span> <span class="NLM_lpage">311</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1997&pages=301-311&author=S.+Perlmanauthor=C.+M.+Costa-Netoauthor=A.+A.+Miyakawaauthor=H.+T.+Schambyeauthor=S.+A.+Hjorthauthor=A.+C.+M.+Paivaauthor=R.+A.+Riveroauthor=W.+J.+Greenleeauthor=T.+W.+Schwartz&title=Dual+agonistic+and+antagonistic+property+of+nonpeptide+angiotensin+AT1+ligands%3A+susceptibility+to+receptor+mutations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPerlman%26aufirst%3DS.%26aulast%3DCosta-Neto%26aufirst%3DC.%2BM.%26aulast%3DMiyakawa%26aufirst%3DA.%2BA.%26aulast%3DSchambye%26aufirst%3DH.%2BT.%26aulast%3DHjorth%26aufirst%3DS.%2BA.%26aulast%3DPaiva%26aufirst%3DA.%2BC.%2BM.%26aulast%3DRivero%26aufirst%3DR.%2BA.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DSchwartz%26aufirst%3DT.%2BW.%26atitle%3DDual%2520agonistic%2520and%2520antagonistic%2520property%2520of%2520nonpeptide%2520angiotensin%2520AT1%2520ligands%253A%2520susceptibility%2520to%2520receptor%2520mutations%26jtitle%3DMol.%2520Pharmacol.%26date%3D1997%26volume%3D51%26spage%3D301%26epage%3D311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Fürst, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosztafi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedmann, T.</span><span> </span><span class="NLM_article-title">Structure−activity relationships of synthetic and semisynthetic opioid agonists and antagonists</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">423</span><span class="NLM_x">–</span> <span class="NLM_lpage">440</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADyaK2MXlt1ygu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1995&pages=423-440&author=S.+F%C3%BCrstauthor=S.+Hosztafiauthor=T.+Friedmann&title=Structure%E2%88%92activity+relationships+of+synthetic+and+semisynthetic+opioid+agonists+and+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationships of synthetic and semisynthetic opioid agonists and antagonists</span></div><div class="casAuthors">Fuerst, S.; Hosztafi, S.; Friedmann, T.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">423-40</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers BV</span>)
        </div><div class="casAbstract">A review with 205 refs.  This paper surveys the relations between the chem. structures and pharmacol. activities of natural or semisynthetic 4,5α-epoxymorphinans, synthetic morphinans and benzomorphans.  Substitution of the N-Me group affords strong analgesics, opioid antagonists and mixed agonist-antagonists resp.  The role of opioid agonists and antagonists in the development of opioid receptor models is also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXl_XzHf57iLVg90H21EOLACvtfcHk0lhZDtydcaYEug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXlt1ygu7w%253D&md5=5475fc9501af3335680a580aa86aede5</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DF%25C3%25BCrst%26aufirst%3DS.%26aulast%3DHosztafi%26aufirst%3DS.%26aulast%3DFriedmann%26aufirst%3DT.%26atitle%3DStructure%25E2%2588%2592activity%2520relationships%2520of%2520synthetic%2520and%2520semisynthetic%2520opioid%2520agonists%2520and%2520antagonists%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D1995%26volume%3D1%26spage%3D423%26epage%3D440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Aquino, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armour, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berman, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birkemo, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, R. A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croom, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dezube, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dougherty, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ervin, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grizzle, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Head, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirst, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Queen, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rimele, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugg, E. E.</span><span> </span><span class="NLM_article-title">Discovery of 1,5-benzodiazepines with peripheral cholecystokinin (CCK-A) receptor agonist activity. 1. Optimization of the agonist “trigger”</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">562</span><span class="NLM_x">–</span> <span class="NLM_lpage">569</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm950626d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=562-569&author=C.+J.+Aquinoauthor=D.+R.+Armourauthor=J.+M.+Bermanauthor=L.+S.+Birkemoauthor=R.+A.+E.+Carrauthor=D.+K.+Croomauthor=M.+Dezubeauthor=R.+W.+Doughertyauthor=G.+N.+Ervinauthor=M.+K.+Grizzleauthor=J.+E.+Headauthor=G.+C.+Hirstauthor=M.+K.+Jamesauthor=M.+F.+Johnsonauthor=L.+J.+Millerauthor=K.+L.+Queenauthor=T.+J.+Rimeleauthor=D.+N.+Smithauthor=E.+E.+Sugg&title=Discovery+of+1%2C5-benzodiazepines+with+peripheral+cholecystokinin+%28CCK-A%29+receptor+agonist+activity.+1.+Optimization+of+the+agonist+%E2%80%9Ctrigger%E2%80%9D"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1021%2Fjm950626d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm950626d%26sid%3Dliteratum%253Aachs%26aulast%3DAquino%26aufirst%3DC.%2BJ.%26aulast%3DArmour%26aufirst%3DD.%2BR.%26aulast%3DBerman%26aufirst%3DJ.%2BM.%26aulast%3DBirkemo%26aufirst%3DL.%2BS.%26aulast%3DCarr%26aufirst%3DR.%2BA.%2BE.%26aulast%3DCroom%26aufirst%3DD.%2BK.%26aulast%3DDezube%26aufirst%3DM.%26aulast%3DDougherty%26aufirst%3DR.%2BW.%26aulast%3DErvin%26aufirst%3DG.%2BN.%26aulast%3DGrizzle%26aufirst%3DM.%2BK.%26aulast%3DHead%26aufirst%3DJ.%2BE.%26aulast%3DHirst%26aufirst%3DG.%2BC.%26aulast%3DJames%26aufirst%3DM.%2BK.%26aulast%3DJohnson%26aufirst%3DM.%2BF.%26aulast%3DMiller%26aufirst%3DL.%2BJ.%26aulast%3DQueen%26aufirst%3DK.%2BL.%26aulast%3DRimele%26aufirst%3DT.%2BJ.%26aulast%3DSmith%26aufirst%3DD.%2BN.%26aulast%3DSugg%26aufirst%3DE.%2BE.%26atitle%3DDiscovery%2520of%25201%252C5-benzodiazepines%2520with%2520peripheral%2520cholecystokinin%2520%2528CCK-A%2529%2520receptor%2520agonist%2520activity.%25201.%2520Optimization%2520of%2520the%2520agonist%2520%25E2%2580%259Ctrigger%25E2%2580%259D%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D562%26epage%3D569" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Asano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatori, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inamura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kayakiri, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satoh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abe, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizutani, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oku, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakahara, K.</span><span> </span><span class="NLM_article-title">Pharmacological characterization of a nonpeptide bradykinin B2 receptor antagonist, FR165649, and agonist, FR190997</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">124</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span><span class="NLM_x">–</span> <span class="NLM_lpage">446</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Fjm901084f&amp;key=10.1038%2Fsj.bjp.0701813" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Fjm901084f&amp;key=9647466" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADyaK1cXjslSju7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=1998&pages=441-446&author=M.+Asanoauthor=C.+Hatoriauthor=H.+Sawaiauthor=S.+Johkiauthor=N.+Inamuraauthor=H.+Kayakiriauthor=S.+Satohauthor=Y.+Abeauthor=T.+Inoueauthor=Y.+Sawadaauthor=T.+Mizutaniauthor=T.+Okuauthor=K.+Nakahara&title=Pharmacological+characterization+of+a+nonpeptide+bradykinin+B2+receptor+antagonist%2C+FR165649%2C+and+agonist%2C+FR190997"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological characterization of a nonpeptide bradykinin B2 receptor antagonist, FR165649, and agonist, FR190997</span></div><div class="casAuthors">Asano, Masayuki; Hatori, Chie; Sawai, Hiroe; Johki, Shigeru; Inamura, Noriaki; Kayakiri, Hiroshi; Satoh, Shigeki; Abe, Yoshito; Inoue, Takayuki; Sawada, Yuki; Mizutani, Tsuyoshi; Oku, Teruo; Nakahara, Kunio</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">441-446</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Stockton Press</span>)
        </div><div class="casAbstract">The nonpeptide bradykinin (BK) B2 receptor antagonist FR165649 (8-[2,6-dichloro-3-[N-[(E)-4-(N-methylcarbamoyl)cinnamidoacetyl]-N-methylamino]benzyloxy]-2-methylquinoline) and agonist FR190997 (8-[2,6-dichloro-3-[N-[(E)-4-(N-methylcarbamoyl)cinnamidoacetyl]-N-methylamino]benzyloxy]-2-methyl-4-(2-pyridylmethoxy)quinoline) were studied.  These compds. have a very similar chem. structure, the 2-pyridylmethoxy group being the only structural difference between them.  Both FR165649 and FR190997 displaced [3H]-BK binding to B2 receptors in guinea pig ileum membranes, with an IC50 of 4.7 × 10-10M and 1.5 × 10-9M, resp.  They also displaced [3H]-BK binding to B2 receptors in human lung fibroblast IMR-90 cells, with an IC50 of 1.6 × 10-9M and 9.8 × 10-10M, resp.  In guinea pig isolated ileum prepns., FR165649 had no agonistic effect on contraction and caused parallel rightward shifts of the concn.-contraction response curves to BK.  Anal. of the data produced a nominal pA2 value of 9.2±0.1 and a slope of 1.4.  On the other hand, FR190997 induced concn.-dependent contractions of guinea pig ilea, with a pD2 of 7.9±0.2, and the contraction was inhibited by a specific peptide B2 receptor antagonist, Hoe 140 (D-Arg-[Hyp3,Thi5,D-Tic7,Oic8]BK) in a noncompetitive manner.  In IMR-90 cells, FR165649 had no agonistic effect on phosphatidylinositol (PI) hydrolysis and caused parallel rightward shifts (approx. 200-fold shift at 10-7M) of the concn.-hydrolysis response curves to BK.  FR190997 induced concn.-dependent PI hydrolysis in IMR-90 cells with a pD2 of 8.4, and this effect was inhibited by Hoe 140.  These results indicate that FR165649 and FR190997 are, resp., a potent BK B2 receptor antagonist and agonist, and that the agonistic activity depends on the small difference in structure.  FR165649 and FR190997 may be useful tools for studying the relationship between ligands and receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCLi1Ka1_30LVg90H21EOLACvtfcHk0lhZDtydcaYEug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjslSju7c%253D&md5=c9a8e3bcf5863d529518a82547049522</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0701813&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0701813%26sid%3Dliteratum%253Aachs%26aulast%3DAsano%26aufirst%3DM.%26aulast%3DHatori%26aufirst%3DC.%26aulast%3DSawai%26aufirst%3DH.%26aulast%3DJohki%26aufirst%3DS.%26aulast%3DInamura%26aufirst%3DN.%26aulast%3DKayakiri%26aufirst%3DH.%26aulast%3DSatoh%26aufirst%3DS.%26aulast%3DAbe%26aufirst%3DY.%26aulast%3DInoue%26aufirst%3DT.%26aulast%3DSawada%26aufirst%3DY.%26aulast%3DMizutani%26aufirst%3DT.%26aulast%3DOku%26aufirst%3DT.%26aulast%3DNakahara%26aufirst%3DK.%26atitle%3DPharmacological%2520characterization%2520of%2520a%2520nonpeptide%2520bradykinin%2520B2%2520receptor%2520antagonist%252C%2520FR165649%252C%2520and%2520agonist%252C%2520FR190997%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1998%26volume%3D124%26spage%3D441%26epage%3D446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Gouldson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Legoux, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carillon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delpech, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Fur, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrara, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shire, D.</span><span> </span><span class="NLM_article-title">The agonist SR146131 and the antagonist SR27897 occupy different sites on the human CCK<sub>1</sub> receptor</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">400</span><span class="NLM_x">, </span> <span class="NLM_fpage">185</span><span class="NLM_x">–</span> <span class="NLM_lpage">194</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Fjm901084f&amp;key=10.1016%2FS0014-2999%2800%2900414-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Fjm901084f&amp;key=10988332" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADC%252BD3cXkvFSlsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=400&publication_year=2000&pages=185-194&author=P.+Gouldsonauthor=P.+Legouxauthor=C.+Carillonauthor=B.+Delpechauthor=G.+Le+Furauthor=P.+Ferraraauthor=D.+Shire&title=The+agonist+SR146131+and+the+antagonist+SR27897+occupy+different+sites+on+the+human+CCK1+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">The agonist SR 146131 and the antagonist SR 27897 occupy different sites on the human CCK1 receptor</span></div><div class="casAuthors">Gouldson, P.; Legoux, P.; Carillon, C.; Delpech, B.; Le Fur, G.; Ferrara, P.; Shire, D.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">400</span>
        (<span class="NLM_cas:issue">2/3</span>),
    <span class="NLM_cas:pages">185-194</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">1-[2-(4-(2-Chlorophenyl)thiazol-2-yl) aminocarbonyl indoyl] acetic acid (SR 27897) is an effective CCK1 receptor antagonist, while the structurally related mol. 2-[4-(4-chloro-2,5-dimethoxyphenyl)-5-(2-cyclohexyl-ethyl)-thiazol-2-ylcarbamoyl]-5,7-dimethyl-indol-1-yl-1-acetic acid (SR 146131) is a highly potent and specific agonist for the same receptor.  To discover how the two mols. interact with the human cholecystokinin (CCK) CCK1 receptor, we have carried out binding and activity studies with 33-point mutated receptors.  Only six mutants showed altered [3H]SR 27897 binding properties, Lys115, Lys187, Phe198, Trp209, Leu214 and Asn333.  In contrast, numerous mutations throughout the receptor either reduced SR 146131 agonist potency, Phe97, Gly122, Phe198, Trp209, Ile229, Asn333, Arg336 and Leu356 or increased it, Tyr48, Cys94, Asn98, Leu217 and Ser359.  Only mutations of Phe198, Trp209 and Asn333 affected both SR 27897 and SR 146131 binding or activity.  The collated information was used to construct mol. models of SR 27897 and SR 146131 bound to the human CCK1 receptor.  The clear difference in the binding sites of SR 27897 and SR 146131 offers a mol. explanation for their contrasting pharmacol. characteristics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWybwRkZ5TMLVg90H21EOLACvtfcHk0lhhb2WS8iWyYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXkvFSlsr8%253D&md5=cb46d142bdba42944eb8a8d717b40495</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2800%2900414-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252800%252900414-3%26sid%3Dliteratum%253Aachs%26aulast%3DGouldson%26aufirst%3DP.%26aulast%3DLegoux%26aufirst%3DP.%26aulast%3DCarillon%26aufirst%3DC.%26aulast%3DDelpech%26aufirst%3DB.%26aulast%3DLe%2BFur%26aufirst%3DG.%26aulast%3DFerrara%26aufirst%3DP.%26aulast%3DShire%26aufirst%3DD.%26atitle%3DThe%2520agonist%2520SR146131%2520and%2520the%2520antagonist%2520SR27897%2520occupy%2520different%2520sites%2520on%2520the%2520human%2520CCK1%2520receptor%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2000%26volume%3D400%26spage%3D185%26epage%3D194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Escrieut, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gigoux, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Archer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verrier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maigret, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behrendt, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moroder, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bignon, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silvente-Poirot, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pradayrol, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fourmy, D.</span><span> </span><span class="NLM_article-title">The biologically crucial C terminus of cholecystokinin and the non-peptide agonist SR-146,131 share a common binding site in the human CCK1 receptor: evidence for a crucial role of Met-121 in the activation process</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">7546</span><span class="NLM_x">–</span> <span class="NLM_lpage">7555</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=7546-7555&author=C.+Escrieutauthor=V.+Gigouxauthor=E.+Archerauthor=S.+Verrierauthor=B.+Maigretauthor=R.+Behrendtauthor=L.+Moroderauthor=E.+Bignonauthor=S.+Silvente-Poirotauthor=L.+Pradayrolauthor=D.+Fourmy&title=The+biologically+crucial+C+terminus+of+cholecystokinin+and+the+non-peptide+agonist+SR-146%2C131+share+a+common+binding+site+in+the+human+CCK1+receptor%3A+evidence+for+a+crucial+role+of+Met-121+in+the+activation+process"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEscrieut%26aufirst%3DC.%26aulast%3DGigoux%26aufirst%3DV.%26aulast%3DArcher%26aufirst%3DE.%26aulast%3DVerrier%26aufirst%3DS.%26aulast%3DMaigret%26aufirst%3DB.%26aulast%3DBehrendt%26aufirst%3DR.%26aulast%3DMoroder%26aufirst%3DL.%26aulast%3DBignon%26aufirst%3DE.%26aulast%3DSilvente-Poirot%26aufirst%3DS.%26aulast%3DPradayrol%26aufirst%3DL.%26aulast%3DFourmy%26aufirst%3DD.%26atitle%3DThe%2520biologically%2520crucial%2520C%2520terminus%2520of%2520cholecystokinin%2520and%2520the%2520non-peptide%2520agonist%2520SR-146%252C131%2520share%2520a%2520common%2520binding%2520site%2520in%2520the%2520human%2520CCK1%2520receptor%253A%2520evidence%2520for%2520a%2520crucial%2520role%2520of%2520Met-121%2520in%2520the%2520activation%2520process%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D7546%26epage%3D7555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group">Holst, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mokrosinski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandt, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nygaard, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frimurer, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck-Sickinger, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, T. W.</span><span> </span><span class="NLM_article-title">Identification of an efficacy switch region in the ghrelin receptor responsible for interchange between agonism and inverse agonism</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">15799</span><span class="NLM_x">–</span> <span class="NLM_lpage">15811</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Fjm901084f&amp;key=10.1074%2Fjbc.M609796200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Fjm901084f&amp;key=17371869" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltl2ns7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=15799-15811&author=B.+Holstauthor=J.+Mokrosinskiauthor=M.+Langauthor=E.+Brandtauthor=R.+Nygaardauthor=T.+M.+Frimurerauthor=A.+G.+Beck-Sickingerauthor=T.+W.+Schwartz&title=Identification+of+an+efficacy+switch+region+in+the+ghrelin+receptor+responsible+for+interchange+between+agonism+and+inverse+agonism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of an Efficacy Switch Region in the Ghrelin Receptor Responsible for Interchange between Agonism and Inverse Agonism</span></div><div class="casAuthors">Holst, Birgitte; Mokrosinski, Jacek; Lang, Manja; Brandt, Erik; Nygaard, Rie; Frimurer, Thomas M.; Beck-Sickinger, Annette G.; Schwartz, Thue W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">15799-15811</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The carboxyamidated wFwLL peptide was used as a core ligand to probe the structural basis for agonism vs. inverse agonism in the constitutively active ghrelin receptor.  In the ligand, an efficacy switch could be built at the N terminus, as exemplified by AwFwLL, which functioned as a high potency agonist, whereas KwFwLL was an equally high potency inverse agonist.  The wFw-contg. peptides, agonists as well as inverse agonists, were affected by receptor mutations covering the whole main ligand-binding pocket with key interaction sites being an arom. cluster in transmembrane (TM)-VI and -VII and residues on the opposing face of TM-III.  Gain-of-function in respect of either increased agonist or inverse agonist potency or swap between high potency versions of these properties was obtained by substitutions at a no. of positions covering a broad area of the binding pocket on TM-III, -IV, and -V.  However, in particular, space-generating substitutions at position III:04 shifted the efficacy of the ligands from inverse agonism toward agonism, whereas similar substitutions at position III: 08, one helical turn below, shifted the efficacy from agonism toward inverse agonism.  It is suggested that the relative position of the ligand in the binding pocket between this "efficacy shift region" on TM-III and the opposing arom. cluster on TM-VI and TM-VII leads either to agonism, i.e. in a superficial binding mode, or it leads to inverse agonism, i.e. in a more profound binding mode.  This relationship between different binding modes and opposite efficacy is in accordance with the Global Toggle Switch model for 7TM receptor activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJqfgDA6O7ubVg90H21EOLACvtfcHk0lhhb2WS8iWyYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltl2ns7g%253D&md5=9d994028f084be1fcd9a6b58a9547785</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M609796200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M609796200%26sid%3Dliteratum%253Aachs%26aulast%3DHolst%26aufirst%3DB.%26aulast%3DMokrosinski%26aufirst%3DJ.%26aulast%3DLang%26aufirst%3DM.%26aulast%3DBrandt%26aufirst%3DE.%26aulast%3DNygaard%26aufirst%3DR.%26aulast%3DFrimurer%26aufirst%3DT.%2BM.%26aulast%3DBeck-Sickinger%26aufirst%3DA.%2BG.%26aulast%3DSchwartz%26aufirst%3DT.%2BW.%26atitle%3DIdentification%2520of%2520an%2520efficacy%2520switch%2520region%2520in%2520the%2520ghrelin%2520receptor%2520responsible%2520for%2520interchange%2520between%2520agonism%2520and%2520inverse%2520agonism%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D15799%26epage%3D15811" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">Buck, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, J. A.</span><span> </span><span class="NLM_article-title">Disulfide trapping to localize small-molecule agonists and antagonists for a G protein-coupled receptor</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">2719</span><span class="NLM_x">–</span> <span class="NLM_lpage">2724</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=2719-2724&author=E.+Buckauthor=J.+A.+Wells&title=Disulfide+trapping+to+localize+small-molecule+agonists+and+antagonists+for+a+G+protein-coupled+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBuck%26aufirst%3DE.%26aulast%3DWells%26aufirst%3DJ.%2BA.%26atitle%3DDisulfide%2520trapping%2520to%2520localize%2520small-molecule%2520agonists%2520and%2520antagonists%2520for%2520a%2520G%2520protein-coupled%2520receptor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2005%26volume%3D102%26spage%3D2719%26epage%3D2724" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group">Wise, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duchesnes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">da Fonseca, P. C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pease, J. E.</span><span> </span><span class="NLM_article-title">Small molecule receptor agonists and antagonists of CCR3 provide insight into mechanisms of chemokine receptor activation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">27935</span><span class="NLM_x">–</span> <span class="NLM_lpage">27943</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=27935-27943&author=E.+L.+Wiseauthor=C.+Duchesnesauthor=P.+C.+A.+da+Fonsecaauthor=R.+A.+Allenauthor=T.+J.+Williamsauthor=J.+E.+Pease&title=Small+molecule+receptor+agonists+and+antagonists+of+CCR3+provide+insight+into+mechanisms+of+chemokine+receptor+activation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWise%26aufirst%3DE.%2BL.%26aulast%3DDuchesnes%26aufirst%3DC.%26aulast%3Dda%2BFonseca%26aufirst%3DP.%2BC.%2BA.%26aulast%3DAllen%26aufirst%3DR.%2BA.%26aulast%3DWilliams%26aufirst%3DT.%2BJ.%26aulast%3DPease%26aufirst%3DJ.%2BE.%26atitle%3DSmall%2520molecule%2520receptor%2520agonists%2520and%2520antagonists%2520of%2520CCR3%2520provide%2520insight%2520into%2520mechanisms%2520of%2520chemokine%2520receptor%2520activation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D27935%26epage%3D27943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group">Shen, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armstrong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagmann, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fong, T. M.</span><span> </span><span class="NLM_article-title">F200A substitution in the third transmembrane helix of human cannabinoid CB<sub>1</sub> receptor converts AM2233 from receptor agonist to inverse agonist</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">531</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">46</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Fjm901084f&amp;key=10.1016%2Fj.ejphar.2005.12.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Fjm901084f&amp;key=16438957" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhtlejurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=531&publication_year=2006&pages=41-46&author=C.+P.+Shenauthor=J.+C.+Xiaoauthor=H.+Armstrongauthor=W.+Hagmannauthor=T.+M.+Fong&title=F200A+substitution+in+the+third+transmembrane+helix+of+human+cannabinoid+CB1+receptor+converts+AM2233+from+receptor+agonist+to+inverse+agonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">F200A substitution in the third transmembrane helix of human cannabinoid CB1 receptor converts AM2233 from receptor agonist to inverse agonist</span></div><div class="casAuthors">Shen, Chun-Pyn; Xiao, Jing Chen; Armstrong, Helen; Hagmann, William; Fong, Tung M.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">531</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">41-46</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">To investigate how specific amino acid residues affect human cannabinoid CB1 receptor binding and activation, CHO cell lines stably expressing wild type and the phenylalanine 200 to alanine mutant of human cannabinoid CB1 receptor (F200A) were examd.  AM2233 functions as an agonist at the wild type receptor (EC50 = 0.93 nM), but behaves as an inverse agonist at F200A (EC50 = 4.8 nM).  The F200A mutant has significantly lower forskolin-stimulated basal cAMP accumulation than that of the wild type, indicating that the F200A mutant possesses higher constitutive activity.  F200 does not contribute substantially to the high affinity binding of AM2233 at human cannabinoid CB1 receptor.  CP55940, HU-210 and Win55212-2 still function as agonists at the F200A mutant, with similar efficacy, potency, and apparent binding affinity for both wild type human cannabinoid CB1 receptor and F200A mutant.  These data indicate that the phenylalanine 200 residue in human cannabinoid CB1 receptor is involved in the receptor activation induced by a specific class of agonists, and supports a model of agonist-structure-dependent conformational changes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1PMmJZbye7rVg90H21EOLACvtfcHk0lhooXkG1UEk6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhtlejurs%253D&md5=bd078a6a79a1fa62a839e3fdb1582a7d</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2005.12.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2005.12.026%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DC.%2BP.%26aulast%3DXiao%26aufirst%3DJ.%2BC.%26aulast%3DArmstrong%26aufirst%3DH.%26aulast%3DHagmann%26aufirst%3DW.%26aulast%3DFong%26aufirst%3DT.%2BM.%26atitle%3DF200A%2520substitution%2520in%2520the%2520third%2520transmembrane%2520helix%2520of%2520human%2520cannabinoid%2520CB1%2520receptor%2520converts%2520AM2233%2520from%2520receptor%2520agonist%2520to%2520inverse%2520agonist%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2006%26volume%3D531%26spage%3D41%26epage%3D46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group">Jensen, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nygaard, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thiele, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elder, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolbeck, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenkilde, M. M.</span><span> </span><span class="NLM_article-title">Molecular interaction of a potent nonpeptide agonist with the chemokine receptor CCR8</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">327</span><span class="NLM_x">–</span> <span class="NLM_lpage">340</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2007&pages=327-340&author=P.+C.+Jensenauthor=R.+Nygaardauthor=S.+Thieleauthor=A.+Elderauthor=G.+Zhuauthor=R.+Kolbeckauthor=S.+Ghoshauthor=T.+W.+Schwartzauthor=M.+M.+Rosenkilde&title=Molecular+interaction+of+a+potent+nonpeptide+agonist+with+the+chemokine+receptor+CCR8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJensen%26aufirst%3DP.%2BC.%26aulast%3DNygaard%26aufirst%3DR.%26aulast%3DThiele%26aufirst%3DS.%26aulast%3DElder%26aufirst%3DA.%26aulast%3DZhu%26aufirst%3DG.%26aulast%3DKolbeck%26aufirst%3DR.%26aulast%3DGhosh%26aufirst%3DS.%26aulast%3DSchwartz%26aufirst%3DT.%2BW.%26aulast%3DRosenkilde%26aufirst%3DM.%2BM.%26atitle%3DMolecular%2520interaction%2520of%2520a%2520potent%2520nonpeptide%2520agonist%2520with%2520the%2520chemokine%2520receptor%2520CCR8%26jtitle%3DMol.%2520Pharmacol.%26date%3D2007%26volume%3D72%26spage%3D327%26epage%3D340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group">Hadac, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darrow, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugg, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lybrand, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, L. J.</span><span> </span><span class="NLM_article-title">Novel benzodiazepine photoaffinity probe stereoselectively labels a site deep within the membrane-spanning domain of the cholecystokinin receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">850</span><span class="NLM_x">–</span> <span class="NLM_lpage">863</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049072h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=850-863&author=E.+M.+Hadacauthor=E.+S.+Dawsonauthor=J.+W.+Darrowauthor=E.+E.+Suggauthor=T.+P.+Lybrandauthor=L.+J.+Miller&title=Novel+benzodiazepine+photoaffinity+probe+stereoselectively+labels+a+site+deep+within+the+membrane-spanning+domain+of+the+cholecystokinin+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1021%2Fjm049072h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049072h%26sid%3Dliteratum%253Aachs%26aulast%3DHadac%26aufirst%3DE.%2BM.%26aulast%3DDawson%26aufirst%3DE.%2BS.%26aulast%3DDarrow%26aufirst%3DJ.%2BW.%26aulast%3DSugg%26aufirst%3DE.%2BE.%26aulast%3DLybrand%26aufirst%3DT.%2BP.%26aulast%3DMiller%26aufirst%3DL.%2BJ.%26atitle%3DNovel%2520benzodiazepine%2520photoaffinity%2520probe%2520stereoselectively%2520labels%2520a%2520site%2520deep%2520within%2520the%2520membrane-spanning%2520domain%2520of%2520the%2520cholecystokinin%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D850%26epage%3D863" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group">Scarselli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wess, J.</span><span> </span><span class="NLM_article-title">Multiple residues in the second extracellular loop are critical for M<sub>3</sub> muscarinic acetylcholine receptor activation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">7385</span><span class="NLM_x">–</span> <span class="NLM_lpage">7396</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=7385-7396&author=M.+Scarselliauthor=B.+Liauthor=S.+K.+Kimauthor=J.+Wess&title=Multiple+residues+in+the+second+extracellular+loop+are+critical+for+M3+muscarinic+acetylcholine+receptor+activation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DScarselli%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DKim%26aufirst%3DS.%2BK.%26aulast%3DWess%26aufirst%3DJ.%26atitle%3DMultiple%2520residues%2520in%2520the%2520second%2520extracellular%2520loop%2520are%2520critical%2520for%2520M3%2520muscarinic%2520acetylcholine%2520receptor%2520activation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D7385%26epage%3D7396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group">Banères, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesnier, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joubert, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumuis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bockaert, J.</span><span> </span><span class="NLM_article-title">Molecular characterization of a purified 5-HT<sub>4</sub> receptor: a structural basis for drug efficacy</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">20253</span><span class="NLM_x">–</span> <span class="NLM_lpage">20260</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=20253-20260&author=J.+L.+Ban%C3%A8resauthor=D.+Mesnierauthor=A.+Martinauthor=L.+Joubertauthor=A.+Dumuisauthor=J.+Bockaert&title=Molecular+characterization+of+a+purified+5-HT4+receptor%3A+a+structural+basis+for+drug+efficacy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBan%25C3%25A8res%26aufirst%3DJ.%2BL.%26aulast%3DMesnier%26aufirst%3DD.%26aulast%3DMartin%26aufirst%3DA.%26aulast%3DJoubert%26aufirst%3DL.%26aulast%3DDumuis%26aufirst%3DA.%26aulast%3DBockaert%26aufirst%3DJ.%26atitle%3DMolecular%2520characterization%2520of%2520a%2520purified%25205-HT4%2520receptor%253A%2520a%2520structural%2520basis%2520for%2520drug%2520efficacy%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D20253%26epage%3D20260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group">Fleck, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huntley, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markison, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nickolls, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoare, S. R. J.</span><span> </span><span class="NLM_article-title">Molecular interactions of nonpeptide agonists and antagonists with the melanocortin-4 receptor</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">14494</span><span class="NLM_x">–</span> <span class="NLM_lpage">14508</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi051316s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2005&pages=14494-14508&author=B.+A.+Fleckauthor=C.+Chenauthor=W.+Yangauthor=R.+Huntleyauthor=S.+Markisonauthor=S.+A.+Nickollsauthor=A.+C.+Fosterauthor=S.+R.+J.+Hoare&title=Molecular+interactions+of+nonpeptide+agonists+and+antagonists+with+the+melanocortin-4+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1021%2Fbi051316s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi051316s%26sid%3Dliteratum%253Aachs%26aulast%3DFleck%26aufirst%3DB.%2BA.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DHuntley%26aufirst%3DR.%26aulast%3DMarkison%26aufirst%3DS.%26aulast%3DNickolls%26aufirst%3DS.%2BA.%26aulast%3DFoster%26aufirst%3DA.%2BC.%26aulast%3DHoare%26aufirst%3DS.%2BR.%2BJ.%26atitle%3DMolecular%2520interactions%2520of%2520nonpeptide%2520agonists%2520and%2520antagonists%2520with%2520the%2520melanocortin-4%2520receptor%26jtitle%3DBiochemistry%26date%3D2005%26volume%3D44%26spage%3D14494%26epage%3D14508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group">Fleck, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ling, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span> </span><span class="NLM_article-title">Substituted NDP-MSH peptides paired with mutant melanocortin-4 receptors demonstrate the role of transmembrane 6 in receptor activation</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">10473</span><span class="NLM_x">–</span> <span class="NLM_lpage">10483</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi700406k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=10473-10483&author=B.+A.+Fleckauthor=N.+Lingauthor=C.+Chen&title=Substituted+NDP-MSH+peptides+paired+with+mutant+melanocortin-4+receptors+demonstrate+the+role+of+transmembrane+6+in+receptor+activation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1021%2Fbi700406k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi700406k%26sid%3Dliteratum%253Aachs%26aulast%3DFleck%26aufirst%3DB.%2BA.%26aulast%3DLing%26aufirst%3DN.%26aulast%3DChen%26aufirst%3DC.%26atitle%3DSubstituted%2520NDP-MSH%2520peptides%2520paired%2520with%2520mutant%2520melanocortin-4%2520receptors%2520demonstrate%2520the%2520role%2520of%2520transmembrane%25206%2520in%2520receptor%2520activation%26jtitle%3DBiochemistry%26date%3D2007%26volume%3D46%26spage%3D10473%26epage%3D10483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group">Foucaud, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tikhonova, I. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langer, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Escrieut, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dufresne, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seva, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maigret, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fourmy, D.</span><span> </span><span class="NLM_article-title">Partial agonism, neutral antagonism, and inverse agonism at the human wild-type and constitutively active cholecystokinin-2 receptors</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">680</span><span class="NLM_x">–</span> <span class="NLM_lpage">690</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2006&pages=680-690&author=M.+Foucaudauthor=I.+G.+Tikhonovaauthor=I.+Langerauthor=C.+Escrieutauthor=M.+Dufresneauthor=C.+Sevaauthor=B.+Maigretauthor=D.+Fourmy&title=Partial+agonism%2C+neutral+antagonism%2C+and+inverse+agonism+at+the+human+wild-type+and+constitutively+active+cholecystokinin-2+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFoucaud%26aufirst%3DM.%26aulast%3DTikhonova%26aufirst%3DI.%2BG.%26aulast%3DLanger%26aufirst%3DI.%26aulast%3DEscrieut%26aufirst%3DC.%26aulast%3DDufresne%26aufirst%3DM.%26aulast%3DSeva%26aufirst%3DC.%26aulast%3DMaigret%26aufirst%3DB.%26aulast%3DFourmy%26aufirst%3DD.%26atitle%3DPartial%2520agonism%252C%2520neutral%2520antagonism%252C%2520and%2520inverse%2520agonism%2520at%2520the%2520human%2520wild-type%2520and%2520constitutively%2520active%2520cholecystokinin-2%2520receptors%26jtitle%3DMol.%2520Pharmacol.%26date%3D2006%26volume%3D69%26spage%3D680%26epage%3D690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group">Kim, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Rompaey, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Calenbergh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Modeling the adenosine receptors: comparison of the binding domains of A<sub>2A</sub> agonists and antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">4847</span><span class="NLM_x">–</span> <span class="NLM_lpage">4859</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0300431" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=4847-4859&author=S.+K.+Kimauthor=Z.+G.+Gaoauthor=P.+Van+Rompaeyauthor=A.+S.+Grossauthor=A.+Chenauthor=S.+Van+Calenberghauthor=K.+A.+Jacobson&title=Modeling+the+adenosine+receptors%3A+comparison+of+the+binding+domains+of+A2A+agonists+and+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1021%2Fjm0300431&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0300431%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DS.%2BK.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DVan%2BRompaey%26aufirst%3DP.%26aulast%3DGross%26aufirst%3DA.%2BS.%26aulast%3DChen%26aufirst%3DA.%26aulast%3DVan%2BCalenbergh%26aufirst%3DS.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DModeling%2520the%2520adenosine%2520receptors%253A%2520comparison%2520of%2520the%2520binding%2520domains%2520of%2520A2A%2520agonists%2520and%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D4847%26epage%3D4859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group">Ghanouni, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gryczynski, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steenhuis, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrens, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lakowicz, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobilka, B. K.</span><span> </span><span class="NLM_article-title">Functionally different agonists induce distinct conformations in the G protein coupling domain of the β<sub>2</sub> adrenergic receptor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">24433</span><span class="NLM_x">–</span> <span class="NLM_lpage">24436</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=24433-24436&author=P.+Ghanouniauthor=Z.+Gryczynskiauthor=J.+J.+Steenhuisauthor=T.+W.+Leeauthor=D.+L.+Farrensauthor=J.+R.+Lakowiczauthor=B.+K.+Kobilka&title=Functionally+different+agonists+induce+distinct+conformations+in+the+G+protein+coupling+domain+of+the+%CE%B22+adrenergic+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGhanouni%26aufirst%3DP.%26aulast%3DGryczynski%26aufirst%3DZ.%26aulast%3DSteenhuis%26aufirst%3DJ.%2BJ.%26aulast%3DLee%26aufirst%3DT.%2BW.%26aulast%3DFarrens%26aufirst%3DD.%2BL.%26aulast%3DLakowicz%26aufirst%3DJ.%2BR.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26atitle%3DFunctionally%2520different%2520agonists%2520induce%2520distinct%2520conformations%2520in%2520the%2520G%2520protein%2520coupling%2520domain%2520of%2520the%2520%25CE%25B22%2520adrenergic%2520receptor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D24433%26epage%3D24436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group">Palczewski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumasaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hori, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behnke, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Motoshima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Trong, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teller, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stenkamp, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyano, M.</span><span> </span><span class="NLM_article-title">Crystal structure of rhodopsin: a G protein-coupled receptor</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">739</span><span class="NLM_x">–</span> <span class="NLM_lpage">745</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Fjm901084f&amp;key=10.1126%2Fscience.289.5480.739" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Fjm901084f&amp;key=10926528" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlslOqs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2000&pages=739-745&author=K.+Palczewskiauthor=T.+Kumasakaauthor=T.+Horiauthor=C.+A.+Behnkeauthor=H.+Motoshimaauthor=B.+A.+Foxauthor=I.+Le+Trongauthor=D.+C.+Tellerauthor=T.+Okadaauthor=R.+E.+Stenkampauthor=M.+Yamamotoauthor=M.+Miyano&title=Crystal+structure+of+rhodopsin%3A+a+G+protein-coupled+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of rhodopsin: A G protein-coupled receptor</span></div><div class="casAuthors">Palczewski, Krzysztof; Kumasaka, Takashi; Hori, Tetsuya; Behnke, Craig A.; Motoshima, Hiroyuki; Fox, Brian A.; Le Trong, Isolde; Teller, David C.; Okada, Tetsuji; Stenkamp, Ronald E.; Yamamoto, Masaki; Miyano, Masashi</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">5480</span>),
    <span class="NLM_cas:pages">739-745</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Heterotrimeric guanine nucleotide-binding protein (G protein)-coupled receptors (GPCRs) respond to a variety of different external stimuli and activate G proteins.  GPCRs share many structural features, including a bundle of seven transmembrane α-helixes connected by six loops of varying lengths.  We detd. the structure of rhodopsin from diffraction data extending to 2.8 angstroms resoln.  The highly organized structure in the extracellular region, including a conserved disulfide bridge, forms a basis for the arrangement of the seven-helix transmembrane motif.  The ground-state chromophore, 11-cis-retinal, holds the transmembrane region of the protein in the inactive conformation.  Interactions of the chromophore with a cluster of key residues det. the wavelength of the max. absorption.  Changes in these interactions among rhodopsins facilitate color discrimination.  Identification of a set of residues that mediate interactions between the transmembrane helixes and the cytoplasmic surface, where G-protein activation occurs, also suggests a possible structural change upon photoactivation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFTWGKYX8vqLVg90H21EOLACvtfcHk0lgfNgrabdfI5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlslOqs78%253D&md5=b3d229fc696247ec0f4a6efa10490922</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1126%2Fscience.289.5480.739&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.289.5480.739%26sid%3Dliteratum%253Aachs%26aulast%3DPalczewski%26aufirst%3DK.%26aulast%3DKumasaka%26aufirst%3DT.%26aulast%3DHori%26aufirst%3DT.%26aulast%3DBehnke%26aufirst%3DC.%2BA.%26aulast%3DMotoshima%26aufirst%3DH.%26aulast%3DFox%26aufirst%3DB.%2BA.%26aulast%3DLe%2BTrong%26aufirst%3DI.%26aulast%3DTeller%26aufirst%3DD.%2BC.%26aulast%3DOkada%26aufirst%3DT.%26aulast%3DStenkamp%26aufirst%3DR.%2BE.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DMiyano%26aufirst%3DM.%26atitle%3DCrystal%2520structure%2520of%2520rhodopsin%253A%2520a%2520G%2520protein-coupled%2520receptor%26jtitle%3DScience%26date%3D2000%26volume%3D289%26spage%3D739%26epage%3D745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group">Schwartz, T. W.; Frimurer, T. M.; Holst, B.; Rosenkilde, M. M.; Elling, C. E.</span><span> </span><span class="NLM_article-title">Molecular mechanism of 7TM receptor activation—a global toggle switch model</span>.  <span class="citation_source-journal">Annu. Rev. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">481</span>− <span class="NLM_lpage">519</span>, and references cited therein.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2006&pages=481-519&author=T.+W.+Schwartz&author=T.+M.+Frimurer&author=B.+Holst&author=M.+M.+Rosenkilde&author=C.+E.+Elling&title=Molecular+mechanism+of+7TM+receptor+activation%E2%80%94a+global+toggle+switch+model"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchwartz%26aufirst%3DT.%2BW.%26atitle%3DMolecular%2520mechanism%2520of%25207TM%2520receptor%2520activation%25E2%2580%2594a%2520global%2520toggle%2520switch%2520model%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2006%26volume%3D46%26spage%3D481%26epage%3D519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group">Durroux, T.</span><span> </span><span class="NLM_article-title">Principles: a model for the allosteric interactions between ligand binding sites within a dimeric GPCR</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">376</span><span class="NLM_x">–</span> <span class="NLM_lpage">384</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2005&pages=376-384&author=T.+Durroux&title=Principles%3A+a+model+for+the+allosteric+interactions+between+ligand+binding+sites+within+a+dimeric+GPCR"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDurroux%26aufirst%3DT.%26atitle%3DPrinciples%253A%2520a%2520model%2520for%2520the%2520allosteric%2520interactions%2520between%2520ligand%2520binding%2520sites%2520within%2520a%2520dimeric%2520GPCR%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2005%26volume%3D26%26spage%3D376%26epage%3D384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group">Jaakola, V.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffith, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherezov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chien, E. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, J</span><span class="NLM_x">; </span><span class="NLM_contrib-group">IJzerman, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, A. P.</span><span> </span><span class="NLM_article-title">R.C. The 2.6 Angstrom Crystal Structure of a Human A<sub>2A</sub> Adenosine Receptor Bound to an Antagonist</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">322</span><span class="NLM_x">, </span> <span class="NLM_fpage">1211</span><span class="NLM_x">–</span> <span class="NLM_lpage">1217</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=322&publication_year=2008&pages=1211-1217&author=V.-P.+Jaakolaauthor=M.+Griffithauthor=M.+A.+Hansonauthor=V.+Cherezovauthor=E.+Y.+Chienauthor=J+Laneauthor=J.+R.+IJzermanauthor=A.+P.+Stevens&title=R.C.+The+2.6+Angstrom+Crystal+Structure+of+a+Human+A2A+Adenosine+Receptor+Bound+to+an+Antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJaakola%26aufirst%3DV.-P.%26aulast%3DGriffith%26aufirst%3DM.%26aulast%3DHanson%26aufirst%3DM.%2BA.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DChien%26aufirst%3DE.%2BY.%26aulast%3DLane%26aufirst%3DJ%26aulast%3DIJzerman%26aufirst%3DJ.%2BR.%26aulast%3DStevens%26aufirst%3DA.%2BP.%26atitle%3DR.C.%2520The%25202.6%2520Angstrom%2520Crystal%2520Structure%2520of%2520a%2520Human%2520A2A%2520Adenosine%2520Receptor%2520Bound%2520to%2520an%2520Antagonist%26jtitle%3DScience%26date%3D2008%26volume%3D322%26spage%3D1211%26epage%3D1217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group">Gurrath, M.</span><span> </span><span class="NLM_article-title">Peptide-binding, G protein-coupled receptors: new opportunities for drug design</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1605</span><span class="NLM_x">–</span> <span class="NLM_lpage">1648</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Fjm901084f&amp;key=11562281" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADC%252BD3MXosV2gtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2001&pages=1605-1648&author=M.+Gurrath&title=Peptide-binding%2C+G+protein-coupled+receptors%3A+new+opportunities+for+drug+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Peptide-binding G protein-coupled receptors: new opportunities for drug design</span></div><div class="casAuthors">Gurrath, Marion</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1605-1648</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers</span>)
        </div><div class="casAbstract">A review.  Over the last decades distinct members of the G Protein-Coupled Receptor (GPCR) family emerged as prominent drug targets within pharmaceutical research, since approx. 60% of marketed prescription drugs act by selectively addressing representatives of that class of transmembrane signal transduction systems.  It is noteworthy that the majority of GPCR-targeted drugs elicit their biol. activity by selective agonism or antagonism of biogenic monoamine receptors, while the development status of peptide-binding GPCR-addressing compds. is still in its infancy.  Exemplified on selected medicinal chem. projects, this review will focus on the opportunities of therapeutic intervention into a broad spectrum of disease processes through agonizing or antagonizing the functions of peptide-binding GPCRs.  In this context, a brief overview of GPCR-mediated signal transduction pathways will be given to emphasize the biomedical relevance of a controlled modulation of receptor function.  Modern trends on lead finding and optimization strategies for peptide-binding GPCR-targeted low-mol. wt. compds. will be highlighted on the basis of current research programs conducted in the areas of angiotensin II, endothelin, bradykinin, neurokinin, neuropeptide Y, LHRH, C5a antagonists, and somatostatin agonists, resp.  Special emphasis will be laid on the elaboration and utilization of structural rationales on the potential drug candidates, thus facilitating more detailed insights into the underlying mol. recognition event.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxzBTOPJ8sjbVg90H21EOLACvtfcHk0liKuNlhIut8JQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXosV2gtbY%253D&md5=def2f9409abef498add257704da76582</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGurrath%26aufirst%3DM.%26atitle%3DPeptide-binding%252C%2520G%2520protein-coupled%2520receptors%253A%2520new%2520opportunities%2520for%2520drug%2520design%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2001%26volume%3D8%26spage%3D1605%26epage%3D1648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group">Blakeney, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairlie, D. P.</span><span> </span><span class="NLM_article-title">Nonpeptidic ligands for peptide-activated G protein-coupled receptors</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">2960</span><span class="NLM_x">–</span> <span class="NLM_lpage">3041</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr050984g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADC%252BD2sXns1Cru7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2007&pages=2960-3041&author=J.+S.+Blakeneyauthor=R.+C.+Reidauthor=G.+T.+Leauthor=D.+P.+Fairlie&title=Nonpeptidic+ligands+for+peptide-activated+G+protein-coupled+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Nonpeptidic ligands for peptide-activated G protein-coupled receptors</span></div><div class="casAuthors">Blakeney, Jade S.; Reid, Robert C.; Le, Giang T.; Fairlie, David P.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2960-3041</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  There are some 850 human G protein-coupled receptors (GPCRs) currently known (http://bioinfonnatics2.biol.uoa.gr), making this the most abundant family of well-characterized protein receptors on the cell surface.  This perspective review describes a necessarily limited selection of key small mol. nonpeptidic agonists and antagonists that have been identified to date as regulators of peptide-activated GPCRs, and outlines some of their pharmacol. properties.  It provides a cross section of scientific literature up to the end of 2005, in some cases through early 2006. without attempting to describe compd. syntheses or the extensive patent literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqHHwt9f_KarVg90H21EOLACvtfcHk0liKuNlhIut8JQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXns1Cru7o%253D&md5=755daac1f42b387d2fadd0d64ae9c065</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1021%2Fcr050984g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr050984g%26sid%3Dliteratum%253Aachs%26aulast%3DBlakeney%26aufirst%3DJ.%2BS.%26aulast%3DReid%26aufirst%3DR.%2BC.%26aulast%3DLe%26aufirst%3DG.%2BT.%26aulast%3DFairlie%26aufirst%3DD.%2BP.%26atitle%3DNonpeptidic%2520ligands%2520for%2520peptide-activated%2520G%2520protein-coupled%2520receptors%26jtitle%3DChem.%2520Rev.%26date%3D2007%26volume%3D107%26spage%3D2960%26epage%3D3041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group">Ballesteros, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstein, H.</span><span> </span><span class="NLM_article-title">Integrated methods for the construction of three dimensional models and computational probing of structure−function relations in G-protein coupled receptors</span> <span class="citation_source-journal">Methods Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">366</span><span class="NLM_x">–</span> <span class="NLM_lpage">428</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Fjm901084f&amp;key=10.1016%2FS1043-9471%2805%2980049-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADyaK2MXmt1Kmtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1995&pages=366-428&author=J.+A.+Ballesterosauthor=H.+Weinstein&title=Integrated+methods+for+the+construction+of+three+dimensional+models+and+computational+probing+of+structure%E2%88%92function+relations+in+G-protein+coupled+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors</span></div><div class="casAuthors">Ballesteros, Juan A.; Weinstein, Harel</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Neurosciences</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">366-428</span>CODEN:
                <span class="NLM_cas:coden">MENEE5</span>;
        ISSN:<span class="NLM_cas:issn">1043-9471</span>.
    </div><div class="casAbstract">A review, with 135 refs., on approaches that can be used to resolve the apparent ambiguities that burden the pharmacol. testing of G protein-coupled receptor (GPCR) models, based on the integration of structural information about the receptor, about mutants, and about the changes induced by ligand binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfENoRspqa7LVg90H21EOLACvtfcHk0liKuNlhIut8JQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmt1Kmtrk%253D&md5=d3f99e9d07cea245a770f3f099bc8cc7</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1016%2FS1043-9471%2805%2980049-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1043-9471%252805%252980049-7%26sid%3Dliteratum%253Aachs%26aulast%3DBallesteros%26aufirst%3DJ.%2BA.%26aulast%3DWeinstein%26aufirst%3DH.%26atitle%3DIntegrated%2520methods%2520for%2520the%2520construction%2520of%2520three%2520dimensional%2520models%2520and%2520computational%2520probing%2520of%2520structure%25E2%2588%2592function%2520relations%2520in%2520G-protein%2520coupled%2520receptors%26jtitle%3DMethods%2520Neurosci.%26date%3D1995%26volume%3D25%26spage%3D366%26epage%3D428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group">Bissantz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logean, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rognan, D.</span><span> </span><span class="NLM_article-title">High-throughput modeling of human G-protein coupled receptors: amino acid sequence alignment, three-dimensional model building, and receptor library screening</span> <span class="citation_source-journal">J. Chem. Inf. Comput. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">1162</span><span class="NLM_x">–</span> <span class="NLM_lpage">1176</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci034181a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADC%252BD2cXitVOqt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2004&pages=1162-1176&author=C.+Bissantzauthor=A.+Logeanauthor=D.+Rognan&title=High-throughput+modeling+of+human+G-protein+coupled+receptors%3A+amino+acid+sequence+alignment%2C+three-dimensional+model+building%2C+and+receptor+library+screening"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">High-throughput modeling of human g-protein coupled receptors: Amino acid sequence alignment, three-dimensional model building, and receptor library screening</span></div><div class="casAuthors">Bissantz, Caterina; Logean, Antoine; Rognan, Didier</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Computer Sciences</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1162-1176</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">0095-2338</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The current study describes the development of a computer package (GPCRmod) aimed at the high-throughput modeling of the therapeutically important family of human G-protein coupled receptors (GPCRs).  GPCRmod first proposes a reliable alignment of the seven transmembrane domains (7 TMs) of most druggable human GPCRs based on pattern/motif recognition for each of the 7 TMs that are considered independently.  It then converts the alignment into knowledge-based three-dimensional (3-D) models starting from a set of 3-D backbone templates and two sep. rotamer libraries for side chain positioning.  The 7 TMs of 277 human GPCRs have been accurately aligned, unambiguously clustered in three different classes (rhodopsin-like, secretin-like, metabotropic glutamate-like), and converted into high-quality 3-D models at a remarkable throughput (∼3s/model).  A 3-D GPCR target library of 277 receptors has consequently been setup.  Its utility for "in silico" inverse screening purpose has been demonstrated by recovering among top scorers the receptor of a selective GPCR antagonist as well as the receptors of a promiscuous antagonist.  The current GPCR target library thus constitutes a 3-D database of choice to address as soon as possible the "virtual selectivity" profile of any GPCR antagonist or inverse agonist in an early hit optimization process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpC6Zv_92nPmrVg90H21EOLACvtfcHk0lgyk8hXuX2Cdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXitVOqt74%253D&md5=6037a68d2d7ba136a5ab51c822d681f1</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1021%2Fci034181a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci034181a%26sid%3Dliteratum%253Aachs%26aulast%3DBissantz%26aufirst%3DC.%26aulast%3DLogean%26aufirst%3DA.%26aulast%3DRognan%26aufirst%3DD.%26atitle%3DHigh-throughput%2520modeling%2520of%2520human%2520G-protein%2520coupled%2520receptors%253A%2520amino%2520acid%2520sequence%2520alignment%252C%2520three-dimensional%2520model%2520building%252C%2520and%2520receptor%2520library%2520screening%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Comput.%2520Sci.%26date%3D2004%26volume%3D44%26spage%3D1162%26epage%3D1176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group">Thompson, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, T. J.</span><span> </span><span class="NLM_article-title">CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">4673</span><span class="NLM_x">–</span> <span class="NLM_lpage">4680</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Fjm901084f&amp;key=10.1093%2Fnar%2F22.22.4673" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Fjm901084f&amp;key=7984417" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADyaK2MXitlSgu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1994&pages=4673-4680&author=J.+D.+Thompsonauthor=D.+G.+Higginsauthor=T.+J.+Gibson&title=CLUSTAL+W%3A+improving+the+sensitivity+of+progressive+multiple+sequence+alignment+through+sequence+weighting%2C+position-specific+gap+penalties+and+weight+matrix+choice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice</span></div><div class="casAuthors">Thompson, Julie D.; Higgins, Desmond G.; Gibson, Toby J.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">4673-80</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The sensitivity of the commonly used progressive multiple sequence alignment method has been greatly improved for the alignment of divergent protein sequences.  Firstly, individual wts. are assigned to each sequence in a partial alignment in order to down-wt. near-duplicate sequences and up-wt. the most divergent ones.  Secondly, amino acid substitution matrixes are varied at different alignment stages according to the divergence of the sequences to be aligned.  Thirdly, residue-specific gap penalties and locally reduced gap penalties in hydrophilic regions encourage new gaps in potential loop regions rather than regular secondary structure.  Fourthly, positions in early alignments where gaps have been opened receive locally reduced gap penalties to encourage the opening of new gaps at these positions.  These modifications are incorporated into a new program, CLUSTAL W which is freely available.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGox0BWqmybJqbVg90H21EOLACvtfcHk0lgyk8hXuX2Cdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXitlSgu74%253D&md5=b219f8f0a8ea118b20a3e23461b99ccf</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1093%2Fnar%2F22.22.4673&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252F22.22.4673%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DJ.%2BD.%26aulast%3DHiggins%26aufirst%3DD.%2BG.%26aulast%3DGibson%26aufirst%3DT.%2BJ.%26atitle%3DCLUSTAL%2520W%253A%2520improving%2520the%2520sensitivity%2520of%2520progressive%2520multiple%2520sequence%2520alignment%2520through%2520sequence%2520weighting%252C%2520position-specific%2520gap%2520penalties%2520and%2520weight%2520matrix%2520choice%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D1994%26volume%3D22%26spage%3D4673%26epage%3D4680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group">Bissantz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernard, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hibert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rognan, D.</span><span> </span><span class="NLM_article-title">Protein-based virtual screening of chemical databases. II. Are homology models of G-protein coupled receptors suitable targets?</span> <span class="citation_source-journal">Proteins</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2003&pages=5-25&author=C.+Bissantzauthor=P.+Bernardauthor=M.+Hibertauthor=D.+Rognan&title=Protein-based+virtual+screening+of+chemical+databases.+II.+Are+homology+models+of+G-protein+coupled+receptors+suitable+targets%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBissantz%26aufirst%3DC.%26aulast%3DBernard%26aufirst%3DP.%26aulast%3DHibert%26aufirst%3DM.%26aulast%3DRognan%26aufirst%3DD.%26atitle%3DProtein-based%2520virtual%2520screening%2520of%2520chemical%2520databases.%2520II.%2520Are%2520homology%2520models%2520of%2520G-protein%2520coupled%2520receptors%2520suitable%2520targets%253F%26jtitle%3DProteins%26date%3D2003%26volume%3D50%26spage%3D5%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group">Derick, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pena, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durroux, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagnon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serradeil-, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hibert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rognan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillon, G.</span><span> </span><span class="NLM_article-title">Key amino acids located within the transmembrane domains 5 and 7 account for the pharmacological specificity of the human V<sub>1b</sub> vasopressin receptor</span> <span class="citation_source-journal">Mol. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">2777</span><span class="NLM_x">–</span> <span class="NLM_lpage">2789</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Fjm901084f&amp;key=10.1210%2Fme.2004-0124" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Fjm901084f&amp;key=15284336" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Fjm901084f&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpslKksLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2004&pages=2777-2789&author=S.+Derickauthor=A.+Penaauthor=T.+Durrouxauthor=J.+Wagnonauthor=C.+Serradeil-author=M.+Hibertauthor=D.+Rognanauthor=G.+Guillon&title=Key+amino+acids+located+within+the+transmembrane+domains+5+and+7+account+for+the+pharmacological+specificity+of+the+human+V1b+vasopressin+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Key amino acids located within the transmembrane domains 5 and 7 account for the pharmacological specificity of the human V1b vasopressin receptor</span></div><div class="casAuthors">Derick, S.; Pena, A.; Durroux, T.; Wagnon, J.; Serradeil-Le Gal, C.; Hibert, M.; Rognan, D.; Guillon, G.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2777-2789</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">In mammals, the vasopressin V1b receptor (V1b-R) is known to regulate ACTH secretion and, more recently, stress and anxiety.  The characterization of the mol. determinant responsible for its pharmacol. selectivity was made possible by the recent discovery of the first V1b antagonist, SSR149415.  Based upon the structure of the crystd. bovine rhodopsin, we established a three-dimensional mol. model of interaction between the human V1b-R (hV1b-R) and SSR149415.  Four amino acids located in distinct transmembrane helixes (fourth, fifth, and seventh) were found potentially responsible for the hV1b-R selectivity.  To validate these assumptions, we selectively replaced the leucine 181, methionine 220, alanine 334, and serine 338 residues of hV1a-R by their corresponding amino acids present in the hV1b-R (phenylalanine 164, threonine 203, methionine 324, and asparagine 328, resp.).  Four mutants, which all exhibited nanomolar affinities for vasopressin and good coupling to phospholipase C pathway, were generated.  HV1a receptors mutated at position 220 and 334 exhibited striking increase in affinity for SSR149415 both in binding and phospholipase C assays at variance with the hV1a-R modified at position 181 or 338.  In conclusion, this study provides the first structural features concerning the hV1b-R and highlights the role of few specific residues in its pharmacol. selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4qbDQIm4cFbVg90H21EOLACvtfcHk0lgyk8hXuX2Cdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpslKksLg%253D&md5=53f8487765ba5adb5a80de4d7d8924b0</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1210%2Fme.2004-0124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2004-0124%26sid%3Dliteratum%253Aachs%26aulast%3DDerick%26aufirst%3DS.%26aulast%3DPena%26aufirst%3DA.%26aulast%3DDurroux%26aufirst%3DT.%26aulast%3DWagnon%26aufirst%3DJ.%26aulast%3DSerradeil-%26aufirst%3DC.%26aulast%3DHibert%26aufirst%3DM.%26aulast%3DRognan%26aufirst%3DD.%26aulast%3DGuillon%26aufirst%3DG.%26atitle%3DKey%2520amino%2520acids%2520located%2520within%2520the%2520transmembrane%2520domains%25205%2520and%25207%2520account%2520for%2520the%2520pharmacological%2520specificity%2520of%2520the%2520human%2520V1b%2520vasopressin%2520receptor%26jtitle%3DMol.%2520Endocrinol.%26date%3D2004%26volume%3D18%26spage%3D2777%26epage%3D2789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span>SYBYL 7.3; <span class="NLM_publisher-name">Tripos International</span>, <span class="NLM_publisher-loc">1699 South Hanley Road, St. Louis, MO, 63144</span>,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=SYBYL+7.3%3B+Tripos+International%2C+1699+South+Hanley+Road%2C+St.+Louis%2C+MO%2C+63144%2C+2006."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DSYBYL%25207.3%26pub%3DTripos%2520International%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i64"><a href="/doi/suppl/10.1021/jm901084f">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_80130"></div></div></div></div></div><hr /></hr><p class="last">Proposed binding mode of oxytocin to human oxytocin receptor and HPLC tracings for target compounds. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm901084f/suppl_file/jm901084f_si_001.pdf">jm901084f_si_001.pdf (1.64 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm901084f&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2010.53.issue-4%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Fjm901084f" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm901084f" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67992de6dcc722d8","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
